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Resistance to antibiotics is a natural phenomenon in bacteria; an unavoidable 
result of their evolutionary capabilities. This, coupled with their ability to 
transfer resistance genes from resistant to sensitive bacteria, fuels a constant 
arms race between antibiotic use and resistance. Currently, this race is being 
tipped in the bacteria’s favour through human misuse of antibiotics. 
I present a citizen science PhD project, part funded by the Microbiology 
Society, that melds a search for novel antibiotics with an analysis of different 
approaches used to engage members of the public in scientific discourse: 
Antibiotics Unearthed. I adapted and optimised a method for collecting soil 
samples in schools and colleges for use at public events.  
This resulted in the long-term storage of 165 bacterial isolates exhibiting 
antagonistic activity against indicator bacterial strains such as Bacillus subtilis, 
Salmonella enterica serovar Typhimurium, Salmonella enterica serovar 
Typhimurium DT104 and Staphylococcus epidermidis as well as medically 
relevant pathogens including Methicillin-resistant Staphylococcus aureus, 
Vancomycin-resistant Enterococcus faecium, Klebsiella pneumoniae and 
Candida albicans. From these, fifteen isolates with distinct morphological and 
antagonistic profiles were selected to be sent for whole genome sequencing. 
Phylogenetic tree and antiSMASH software allowed the identification of 
underexploited bacterial species and their biosynthetic gene clusters coding 
for antibiotic and secondary metabolite production. 
Facebook metrics suggest that user engagement with this project was not 
affected by the types of content we released. However, the number of people 
who see any given content is driven by external events such as antibiotic 
awareness week.  
Through the application of a coding schedule developed from key literature on 
the public discourse of antibiotics and antibiotic resistance, I identified key 
themes through interview data with participants. These key themes, when 
applied to long-term portfolios have been used to evidence discursive 
transformations of portfolio holders. This study has produced outcomes and 
impacts in the scientific, participant and socio-ecological and economic 
dimension.
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1.1 Antibiotics and Antibiotic Resistance 
1.1.1 The history of the word Antibiotic 
The word ‘antibiotic’ was first used in 1860 to mean - opposed to a belief in the 
presence or possibility of life. Its adaptation to mean injurious to or destructive 
to living matter, especially microorganisms, began in 1890 (Oxford English 
Dictionary, 2018) when there were early attempts to use the ‘antibiotic effects’ 
of some microorganisms therapeutically. Pasteur and Joubert (1877) 
inoculated bacteria into animals with anthrax; Cantani (1885) introduced 
Bacterium termo into the lungs of tuberculous patients and Gasperini reported 
the antagonistic effects of certain actinomycetes against cultures of 
Pseudomonas (1899) (Foster and Raoult, 1974). 
The word ‘antibiosis’ was used to mean the antagonistic effect of Penicillium 
on bacteria following an observation that preceded Fleming’s discovery by at 
least 60 years (Foster and Raoult, 1974). Antibiosis is still used to describe the 
antagonistic effect two microorganisms can have towards each other. 
However, as science began to purify the ‘antibiotic’ compounds away from the 
microorganisms, the word ‘antibiotic’ was used to describe streptomycin and 
several other antibiotics by Selman Waksman in the 1940s. In this case the 
word ‘antibiotic’ was interpreted as:  
“a chemical substance, produced by micro-organisms, which has 
the capacity to inhibit the growth of and even to destroy bacteria 
and other micro-organisms” (Waksman, 1947).  
Research eventually led to the discovery, synthesis and production of synthetic 
compounds that had the same effect as the natural products produced by 
microbes. This led to the argument that the term ‘antibiotic’ should be redefined 
to denote any class of organic molecule that inhibits or kills microbes using 
bacterial targets, without any consideration of the source of the particular 
compound (Davies & Davies, 2010). A current definition of ‘antibiotic’ is  
“Any substance that inhibits the growth and replication of a 
bacterium or kills it outright” (Microbiology Society, 2018). 
This change in definition relates to the effect a compound has on bacteria: 
“Antibiotics are used to treat or prevent some types of bacterial 
infection” (NHS.UK, 2016). 
and: 
“Antibiotics are medicines used to prevent and treat bacterial 
infections” (World Health Organisation, 2017).  
In scientific discourse, antibiotics are understood to relate to bacteria. 
However, outside of scientific discourse there is confusion (Mendelson et al., 
2017). This may be due to the changing definition of the word antibiotic, or the 
presence of words that sound the same but have nuanced meanings. To 
illustrate this, ‘antimicrobial’ is a word that refers to a broad group of medicinal 
products that kill or stop the growth of living microorganisms. These products 
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include antibiotics, antivirals, antifungals and antiparasital drugs (European 
Center for Disease Prevention and Control, 2012). It is noticeable that in each 
instance, the word anti- precedes the type of infectious agent that it is effective 
against, in all cases except for antibiotics (used to treat bacterial infections). 
Instead the word ‘antibacterial’ is used to describe products such as soaps, 
detergents, health and skincare products and household cleaners but not the 
medicines to treat humans or animals with infections. For this project I use the 
term ‘antibiotic’ to mean  
“A substance that inhibits the growth and replication of a 
bacterium or kills it outright (O’Neill, 2016b). 
I now discuss antibiotics as a special category of antimicrobial drugs that 
underpin modern medicine as we know it.  
1.1.2 Antibiotics revolutionised medicine 
Antibiotics, substances that inhibit the growth and replication of or kill a 
bacterium, are arguably the single greatest health care advance in history. 
Medical care as we now know it is founded on the availability of effective 
antibiotics (Rice, 2008b). Antibiotics have transformed surgical operations, 
transplant medicine and childbirth into routine procedures with positive 
outcomes in most cases. Historically this has not been the case; previously 
microbial infections including bacterial infections caused significant mortality 
and morbidity.  
Infectious diseases caused by pathogenic microorganisms such as bacteria, 
viruses, and fungi, were some of the Western world’s largest killers before the 
discovery of antibiotics (World Health Organisation, 2019). The Centre for 
Disease Control (CDC) reported: 
“in 1900, the three leading causes of death were pneumonia, 
tuberculosis (TB), and diarrhoea and enteritis, which (together with 
diphtheria) caused one third of all deaths” (Centers for Disease 
Control and Prevention, 1999a).  
Tuberculosis (TB), diphtheria and many pneumonias are caused by bacterial 
pathogens. Since the discovery of antibiotics, non-infectious (non-
communicable) diseases, often age related, have replaced infectious diseases 
as the biggest killers (Dye, 2014): 
“in 1997, heart disease and cancers accounted for 54.7% of all 
deaths” (Centers for Disease Control and Prevention, 1999a).  
In 1999, heart disease accounted for 268.2 deaths per 100,000 people in the 
United States of America (U.S.A) whilst the two most deadly modern day 
infectious diseases, pneumonia and influenza, accounted for just 34 (Centers 
for Disease Control and Prevention, 2000). Confidence that infections could 
be prevented or treated by antibiotics allowed major leaps forward in research 
into and treatment of non-communicable diseases such as cardiovascular 
diseases, cancer, respiratory diseases and diabetes that replaced infectious 
diseases as the leading cause of morbidity and mortality in the western world. 
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Perhaps the most well-known aspect of the history of the discovery of 
antibiotics occurred in 1928. Dr Alexander Fleming, upon returning from a 
summer vacation, noticed one of his agar plates was contaminated with a 
mould (fungus) that was preventing Staphylococcus aureus, a pathogenic 
bacterium, from growing close by. His investigations identified the fungus as 
Penicillium notatum, which was producing the penicillin that was inhibiting the 
growth of S. aureus (Bowater, 2017). This is credited as the first discovery of 
an antibiotic in the United Kingdom (U.K). However, it took another ten years 
before Howard Florey (1898-1968) and Ernst Chain (1906-1979) along with 
the lesser known Norman Heatley (1911-2004) successfully developed a 
small-scale industrial process for purifying penicillin from a P. notatum culture. 
In 1941, because of economic hardships in the U.K caused by the outbreak of 
the second world war, production moved to the U.S.A where penicillin was 
mass produced1 and became a life-saving drug throughout the second world 
war and beyond (Bowater, 2017).  
Thus began the golden era of antibiotic discovery (Aminov, 2010), a 20-year 
period, between 1950 and 1970 where many antibiotic compounds were 
discovered, natural products were adapted and new compounds were 
synthesised. Antibiotics were commonly referred to as magic bullets2, a term 
coined by Paul Ehrlich (1854-1915) who proposed that there may be clinically 
relevant molecules that could target pathogenic bacteria without harming 
human cells (Bowater, 2017). In 1967, one of modern medicine’s best-known 
quotations was used:  
“It is time to close the book on infectious diseases and declare the 
war against pestilence won”  
This quote was attributed to William H. Stewart, the tenth Surgeon General of 
the U.S.A (1965-1969) (Spellberg & Taylor-Blake, 2013). This quote 
represents the general optimistic outlook of that era; that antibiotic discovery 
had effectively ended our fight with pathogenic bacteria. However, evidence 
from a reanalysis of William H. Stewart’s speech indicated that he never 
actually said this but in fact, advocated for the opposite. He recognised 
infectious diseases had not been conquered (Spellberg & Taylor-Blake, 2013) 
1.1.3 The predictable emergence of resistance 
Predictably, the book on infectious diseases had not been closed. Infectious 
diseases are still a considerable cause of illness and death around the world. 
Two thirds of all deaths are caused by just 20 species of 1400 recognised 
human pathogens and parasites, and the majority of these are mainly bacteria 
and viruses (Dye, 2014). This problem is compounded by the ability of bacteria 
to become resistant to the antibiotics that we have been using to kill them.  
 
1 P. notatum was swapped for Penicillium chrysogenum, due to its ability to produce 
more penicillin in culture. 
2 This term was borrowed from German folklore and was originally magische Kugel. 
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Antibiotics are among the most important tools in medicine, but their efficacy 
is threatened by the evolution of resistance (Baym et al., 2016). Antibiotic 
resistance can be defined as: 
“Bacteria becoming increasingly resistant to the drugs that were 
previously effective against them” (Microbiology Society, 2019b).  
Antibiotic resistant bacteria nullify the standard, previously effective antibiotic 
treatments leading to the development and persistence of illnesses with 
significant morbidity and mortality. Perhaps even more troubling is that these 
hard to treat infections are spreading across the globe. 
In order to understand how humans have contributed to antibiotic resistance, 
it is necessary to understand that antibiotic resistance in bacteria is a natural 
and unavoidable manifestation of their evolutionary capabilities (Peters et al., 
2008). There are two distinct evolutionary processes at play with the spread of 
antibiotic resistance namely genetic mutation and horizontal gene transfer.  
Pray (2008) highlighted the rate at which a bacterial population can mutate. A 
single Staphylococcus aureus bacterium replicates once every 30 minutes and 
has 2.8 x 106 nucleotide base pairs (bp) in its genome. At the expected 
mutation rate of one mutation per 1010 bp, it takes just 30 hours for one, single 
bacterium to grow into a population in which every single bp has mutated 30 
times. Ramaswamy & Musser (1998) identified that Mycobacterium 
tuberculosis, the causative agent of TB, also has spontaneous, predictable 
rates of chromosomally borne mutations that confer resistance to antibiotics.  
Mutations alter cellular mechanisms of bacteria in four ways to confer antibiotic 
resistance (Table 1-1). 







The resistant bacteria retain the same sensitive target as 
antibiotic sensitive strains, but the antibiotic is prevented 
from reaching it because it is modified or broken down. 
The lock out2 Antibiotic resistant bacteria protect the antibiotic target by 
preventing the antibiotic from entering the cell or pumping 
it out faster than it can flow in. 
Change the lock2 Alterations in the antibiotic target may mean that the 
antibiotic penetrates the cell and reaches the target site 
but does not inhibit the target because of structural 
changes in the target molecule. 
Create a decoy1 Bacteria may protect themselves by producing an 
alternative target (usually an enzyme) that is resistant to 
inhibition by the antibiotic while continuing to produce the 
original sensitive target. 
 
 
The ability of a bacterial genome to rapidly mutate inevitably leads to a 
substantial, naturally occurring pool of pre-existing resistance genes (Peters 
et al., 2008). A genomic analysis of 480 bacteria (actinomycetes from the 
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genus Streptomyces) isolated from soil samples originating from diverse 
environments (urban, agricultural and forest) revealed resistance to 21 
different antibiotics, including natural products, their semisynthetic derivatives, 
and completely new synthetic molecules. Concerningly, without exception, 
every strain in the library was found to be multi-drug resistant (MDR) to seven 
or eight antibiotics on average, with two strains being resistant to 15 of 21 
drugs (D’Costa et al., 2006). 
The ability of a single bacterium to develop natural resistance to antibiotics is 
exacerbated by their second evolutionary capability, horizontal gene transfer. 
This is where antibiotic resistance genes can be transferred from a resistant 
bacterium to a susceptible one (Bowater, 2017). There are three main modes 
of genetic transfer between bacterial cells. The most common is conjugation, 
but the process can also occur through transformation and transduction (Table 
1-2). 
 
Table 1-2. The three main modes of genetic transfer between bacterial cells. Taken from Table 6.4 
(Bowater, 2017) 
Acquiring Resistance: Transferring DNA 
Conjugation: Two bacterial cells adhere together, and plasmid3 DNA is passed 
from the donor cell to the recipient cell through specific channels that can include 
resistance genes. 
Transformation: When bacteria die and cells lyse, genetic material is released into 
the environment. Under certain conditions, this DNA is taken up by other bacteria 
in the surrounding area, including resistance genes. 
Transduction: When a bacterium is infected with a phage4, the phage can 
accidentally incorporate bacterial DNA into its own genome. When the phage lyses 
the bacterial cell, phage particles are released into the environment and can infect 
a new bacterium. The phage particles carrying the additional piece of bacterial DNA 
can insert into the new bacterial genome, taking the new DNA with it that can 
include resistance genes. 
 
 
Whilst bacterial resistance to antibiotics is a natural process, the use and 
misuse of antibiotics increases the rate of emergence of these antibiotic 
resistance genes. Fleming himself, in his 1945 Nobel prize lecture, warned of 
the possibility that misuse of antibiotics could lead to a scenario where bacteria 
developed resistance: 
 
3 Separate to the single, dynamic double helical molecule of chromosomal DNA used 
by bacteria to house much of their genetic material, plasmids are small, circular 
(occasionally linear) pieces of DNA that can be copied independently of the 
chromosome. They contain a wide variety of genes that code for different proteins 
and enzymes that give the bacterial cells different properties (including antibiotic 
resistance). 
4 A phage is a virus, specifically a virus that infects bacteria, which contain a DNA or 




“…There is the danger that the ignorant man may easily underdose 
himself and by exposing his microbes to non-lethal quantities of the 
drug make them resistant.”(Fleming, 1945) 
Selection pressure that increases the likelihood of a bacterium developing and 
maintaining an antibiotic resistance gene emerges if suboptimal doses of an 
antibiotic are used. Genetic diversity within populations, combined with rapid 
bacterial generation times, gives bacteria the ability to rapidly adapt to become 
resistant to or tolerant of antibiotics when the bacteria are not destroyed 
through the correct treatment regime (Peters et al., 2008; Meek, Vyas and 
Piddock, 2015; Holmes et al., 2016). Correct dosing of antibiotics limits the 
environmental pressure put on bacteria to develop or maintain resistance 
because the target bacteria are destroyed and cannot mutate or transfer 
resistance genes through horizontal gene transfer. As an example, prior to 
1960, Mycobacterium tuberculosis was treated with an antibiotic regime that 
cured tuberculosis in nearly all patients. This treatment takes a long time to 
work and can cause unpleasant side effects; however treatment was highly 
successful because it was carried out in hospitals where compliance could be 
assured (Wood and Iseman, 1993). In the late 1960s, this antibiotic therapy 
began to take place in an outpatient setting. This shift to outpatient care 
reduced compliance and led to rising rates of treatment failure, relapse, and 
acquired drug resistance among Mycobacterium tuberculosis bacteria (Wood 
and Iseman, 1993).  
Increasing use of antibiotics, particularly inappropriate use, is recognised as 
the main selection pressure leading to the decline in effectiveness of existing 
antibiotic drugs (Bronzwaer et al., 2002; Goossens et al., 2005; O’Neill, 
2016b). An example of antibiotic use correlated with antibiotic resistance can 
also be found in the most common cause of community-acquired pneumonia, 






Figure 1-1. There is a correlation between antibiotic use and resistance. Taken from the Review on 
Antimicrobial Resistance: (O’Neill, 2016b). Outpatient use of penicillin in 2000 (DID - defined daily doses 
per 1000 inhabitants daily) is along the x axis, whilst the % of S. pneumoniae which are penicillin non-
susceptible (2001) are along the y axis. Blue dots represent counties plotted against both axis. The 




Figure 1-1 highlights how the strength of selection pressure, in this instance 
the increased use of penicillin outside of a hospital setting, is intimately and 
positively associated with the rate of evolution of resistance. An increase in the 
occurrence of antibiotic resistant bacteria has the potential to have a 
devastating impact on public health and the provision of healthcare worldwide.  
A serious warning was issued in an April 2014 World Health Organisation 
(WHO) report "Antimicrobial Resistance: Global Report on surveillance". It said 
that the post-antibiotic era, in which common infections and minor injuries can 
kill, is not an apocalyptic fantasy but a real possibility for the 21st century 
(World Health Organisation, 2014). A 2014 press release by the Wellcome 
trust quoted the U.K Chief Medical Officer, Professor Dame Sally Davies:  
“We have reached a critical point and must act now on a global 
scale to slow down antimicrobial resistance” (Wellcome Trust, 
2014).  
In the U.K, antimicrobial resistance (AMR) has been placed on the National 
Risk Register of Civil Emergencies (U.K Cabinet Office, 2015) emphasising 
the significance of this problem. Another review on AMR sponsored by the 
Wellcome Trust and the U.K Department of Health (O’Neill, 2016b) modelled 
the global consequences of AMR to the year 2050. The report issued a stark 
warning that AMR could kill 10 million people per year by 2050, a number 
greater than the present mortality of cancer, as well as amass a global cost of 
$100 trillion U.S Dollars. This sum is equivalent to the profit of the entire globe 
for one full year.  
1.1.4 Incidence of antibiotic resistance infections 
After estimating the risk of antibiotic resistant bacteria in the future, it is worth 
taking stock of the problem as it exists today. Over the last ten years in the 
U.S.A, the CDC has produced two reports highlighting the strains of antibiotic 
resistant bacteria that pose an urgent or serious threat to the general public 
and are responsible for significant levels of hospital acquired infections 
(nosocomial infections). Pathogenic bacteria with the hazard level ‘urgent’ are 
high-consequence antibiotic-resistant threats because they meet significant 
risks across several key criteria. These threats may not be widespread at the 
current time but have the potential to become so and they require urgent and 
aggressive action. Those with the hazard level ‘serious’ are significant 
antibiotic-resistant threats. For varying reasons (e.g. declining domestic 
incidence rate), they are not considered ‘urgent’, but these threats will worsen 
and may become ‘urgent’. Therefore, they also require prompt and sustained 
action (Centers for Disease Control and Prevention, 2013b). Table 1-3 shows 
compiled data taken from the 2019 report identifying the 14 pathogenic 
bacteria (four urgent, ten serious) which pose the greatest threat to the U.S.A 
population but this is also true globally (Centers for Disease Control and 
Prevention, 2019). It also highlights whether each bacterium is Gram-positive 




Table 1-3. Antibiotic-resistant pathogenic bacteria which pose an urgent or serious threat to the general public, as reported by the U.S.A CDC (Centers for 
Disease Control and Prevention, 2019). The pathogenic bacteria are listed with their threat level, details about their role in infection, number of cases, number of deaths 
and medical cost. Also included is whether each bacterium is Gram-positive or Gram-negative. 
Bacteria Threat 
Level 






Urgent Cause pneumonia, 
bloodstream and urinary 
tract infections.  





Urgent Causes life threatening 
diarrhoea and colitis 







Urgent Major concern for patients 
in healthcare facilities. 
Some are resistant to 
nearly all antibiotics. 






Urgent Causes the sexually 
transmitted disease 
gonorrhoea resulting in 
ectopic pregnancy, 
infertility and increased risk 
of HIV infection.  







Serious Causes diarrhoea, fever 
and abdominal cramps and 
can spread from animals to 
humans through 
contaminated food. 






Serious Spread rapidly and cause 
of complicate infections in 
healthy people. 






Serious Cause serious infections in 
healthcare settings 
including bloodstream, 
surgical site and urinary 
tract infections. 






Serious Affects people with 
weakened immune 
systems. Particularly 





dangerous for patients with 




Serious Can spread from animals 
to people through food. 
Causes diarrhoea, fever 
and abdominal cramps. If 
spreads to the blood can 
have life-threatening 
complications. 





Serious Causes typhoid fever 
which can be life-
threatening. 





Serious Spreads in faeces through 
direct contact with 
contaminated surfaces, 
food or water. Causes 
diarrhoea, fever and 
abdominal cramps. 






Serious Causes difficult-to-treat 
staph infections including 
septicaemia. 






Serious Causes pneumococcal 
disease, ranging from ear 
and sinus infections to 
pneumonia and 
bloodstream infections. 






Serious Causes TB, among most 
common infectious 
diseases and a frequent 
cause of death worldwide. 












The CDC proposed actions that must be taken to stop the spread of antibiotic 
resistance. These included changing the narrative of a future post-antibiotic 
era. Instead, they suggest that the narrative should change so that we 
acknowledge that an antibiotic resistance era is already here. The U.S.A 
currently has more than 2.8 million antibiotic-resistant infections each year with 
over 35,000 deaths (Centers for Disease Control and Prevention, 2019). Even 
after the 2013 report was published, the CDC realised the burden of antibiotic-
resistance threats in the U.S.A was greater than they had initially thought. 
Improved infection prevention measures, improvements in antibiotic 
stewardship and prescribing practices, as well as the effective use of vaccines 
that emerged as a result of this report have seen the number of deaths caused 
by antibiotic resistance slowly decreasing (Centers for Disease Control and 
Prevention, 2019).  
Concerns about antibiotic resistance are not restricted to the U.S.A. A 2019 
study looked at 16 antibiotic resistant bacteria monitored by the European 
Resistance Surveillance Network (EARS-Net) throughout 2015. It identified 
671,689 infections and 33,110 deaths attributable to antibiotic-resistant 
bacteria, as well as 874,541 disability adjusted life years, that is the number of 
years lost due to ill-health, disability or early death (Cassini et al., 2019). The 
authors noted that the burden of infections with antibiotic-resistant bacteria in 
Europe (EU) and the European Economic Area (EEA) is substantial when 
compared with other infectious diseases, and it has been increasing since 
2007. 
In the U.K, a Public Health England 2019 report showed 60,788 antibiotic-
resistant infections occurred in England during 2018, a 9% rise from the 55,812 
antibiotic-resistant infections found in 2017 (Public Health England, 2019). 
Further, there was a 32% increase of antibiotic-resistant bloodstream 
infections from 12,972 in 2014 to 17,108 in 2018 (Public Health England, 
2019).  
Of the antibiotic-resistant bacteria causing illness and death, the ESKAPE 
pathogens are extraordinarily important. They cause many of the hospital 
acquired infections and represent paradigms of pathogenesis, transmission, 
and resistance (Rice, 2008). The ESKAPE pathogens, difficult to treat species 
of bacteria, are noted as creating a global burden with the development of 
drug-resistance (O’Neill, 2016a). Each letter of the ESKAPE pathogens 
represents a bacterial genus, detailed in Table 1-4. 
Table 1-4. The bacterial genera, and where available species, that make up the ESKAPE 
pathogens.  
Abbreviation Bacteria 
E Enterococcus faecium 
S Staphylococcus aureus 
K Klebsiella pneumoniae 
A Acinetobacter baumannii 
P Pseudomonas aeruginosa 





Of the 14 pathogenic bacteria listed in Table 1-3, six are ESKAPE pathogens. 
Whilst Klebsiella is not mentioned by name as part of the ESKAPE pathogens, 
it falls under the bracket of Enterobacter spp along with Escherichia coli.  
However, the remaining eight pathogenic bacteria are also a global concern. 
For example, Mycobacterium tuberculosis, the pathogen associated with 
causing TB, is estimated to have infected 67 million children worldwide (Dodd, 
Sismanidis and Seddon, 2016). Almost 15 years ago in 2006, the CDC 
published the results of a disturbing survey of an international network of TB 
laboratories. This survey showed that of all the TB cases detected worldwide, 
20% were MDR (Centers for Disease Control and Prevention, 2006), with half 
of these meeting the criteria for being Extensively drug resistant (XDR), 
showing resistance to first and second-line anti-TB drugs (Shah et al., 2007). 
First-line drugs are those that are chosen to treat an infection in the first 
instance, often cheaper, easier to produce or offer less side-effects. Second-
line drugs are those chosen if first-line drugs fail to treat the infection. In 2004, 
according to a WHO estimate, 424,203 cases of TB were MDR, 261,362 of 
which occurred in China, India or the Russian Federation, 62% of the 
estimated global burden (Zignol et al., 2006). There is a financial, as well as a 
health incentive to tackle this problem, as treatment for MDR-TB patients 
requires use of second-line drugs for ≥24 months. These drugs are more 
costly, toxic, and less effective than first-line drugs used for routine treatment 
of TB (Wood and Iseman, 1993; Rajbhandary, Marks and Bock, 2004). More 
recently, of the 10 million cases of global TB estimated in 2017, around 
458,000 case were MDR-TB (Park, Satta and Kon, 2019).  
Currently, incidences of antibiotic-resistant bacterial infections are on the rise 
globally. Whilst some countries are getting better at preventing death caused 
by these infections, the number of deaths is still far too high. Further, the 
medical cost associated with these infections is placing a significant burden on 
healthcare services. The U.S.A CDC has stressed the need to stop believing 
that antibiotic resistance is a problem ‘over there’ when in fact, it is going on in 
our own backyard (Centers for Disease Control and Prevention, 2019). 
1.1.5 Antibiotic resistance is underfunded and understudied 
When it comes to AMR, the literature indicates that the global response does 
not match the severity of the threat. Antibiotic resistance research is 
underfunded. By 2050, inaction on AMR is estimated to cost the global 
economy $100 trillion USD (O’Neill, 2016b). In a UK report focussed on 
securing new drugs for future generations, commissioned by the UK 
Government, led by the economist Lord Jim O’Neill, a $2 billion USD 
innovation fund was suggested to jump start the discovery of new antibiotics 
and diagnostics. Furthermore, a $16 – $37 billion USD package was proposed 
to overhaul the antibiotics pipeline, providing funds for drug companies after 
new antibiotics are brought to market (O’Neill et al., 2015). In comparison to 
the expected cost of inaction ($100 trillion USD), these funds appear to be 
good value for money. However, even with this incentive, the reality is that 
venture capitalists do not find antibiotic development attractive. Less than 5% 
of venture capital investment in pharmaceutical R&D ($37bn) between 2003 
and 2013 was for antimicrobial development ($1.8bn) (O’Neill, 2016b). An 
30 
 
evaluation of the 2016 review on AMR showed there has been very little 
progress on the central and most expensive recommendations for 
transforming research and development (R&D) incentives (Clift, 2019). This 
may be a disappointment, but recent history should have indicated that this is 
not a total surprise. 
Even government backed funding does not always reach the necessary areas 
to stimulate research. In 1999, the United States Federal Government 
sponsored an interagency task force to create ‘a Public Health Action Plan to 
Combat AMR. The Action Plan includes action items organized into four focus 
areas: Surveillance, Prevention and Control, Research, and Product 
Development (Centers for Disease Control and Prevention, 1999b). Despite 
this effort, funding that was authorised for the activities of the task force was 
never appropriately allocated, and each member of the task force was left to 
its own devices to make good on the action items with which they were charged 
(Rice, 2008). Currently there are large gaps in our knowledge about how to 
combat antibiotic resistance. Examples of areas where antibiotic research is 
trailing behind include, but are not limited to: 
• Definitions for minimal lengths of treatment (Rice, 2008) 
• The benefit of antibiotic therapy over placebo (Peters et al., 2008) 
• The use of a combination of antibiotics without conclusive evidence of 
benefit (Rice, 2008) 
• The utility of basic infection-control measures (Rice, 2008) 
• Best mechanisms for disseminating this knowledge in a way that will 
change clinicians practices (Rice, 2008) 
• Lack of rapid, sensitive and specific diagnostic tests for invasive 
bacterial infections (O’Neill, 2016b) which identify not only the 
pathogen’s current resistance profile but also its future potential for 
evolution of resistance removing barriers for the clinical application of 
selection-inverting treatment strategies (Baym, Stone and Kishony, 
2016) 
• Lack of detailed information regarding the Pharmacokinetics (describes 
the drug concentration-time courses in body fluids resulting from 
administration of a certain drug dose (Meibohm and Derendorf, 1997) 
and Pharmacodynamics (the observed effect resulting from a certain 
drug concentration (Meibohm and Derendorf, 1997) of antibiotics 
(PK/PD) (Sarkar et al., 2007) 
• Lack of effective vaccines against bacterial pathogens (O’Neill, 2016b) 
• Lack of well-designed and executed clinical trials are crucial to the 
rational use of antibiotics. Clinical trials need to address standard-of-
care antibiotic treatment versus shorter durations of therapy or no 
antibiotic therapy at all (Peters et al., 2008; O’Neill, 2016b) 
• Modelling evolution of drug-resistant phenotypes where common 
phenotypic and genotypic changes observed in parallel-evolving 
populations provide promising building blocks (Furusawa et al., 2018) 
Historically, antibiotic research has been underfunded when compared with 
research into chemotherapy options for treating the Human Immunodeficiency 
Virus (HIV) and cancer (Rice, 2008). This lack of funds results in a lack of 
research and as such, the science behind antibiotics and resistance has barely 
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progressed since the golden era of discovery. Instead, there has been a 
reliance on the Pharmaceutical industry to tackle antibiotics through a 
contribution of funds and the conducting of research (O’Neill, 2016b). 
1.1.6 The Failure of Pharma: The Lean Drug Discovery Pipeline 
As life expectancy increases due to medical advancements, so does the 
proportion of the population who are vulnerable to infection. This includes the 
elderly as well as those who are immunosuppressed due to cancer treatments 
or organ transplants (Davies, 2011). The risk of mortality and morbidity caused 
by infections increases as the incidence of antibiotic resistance increases and 
the limited number of new antibiotic agents currently in development remains 
stagnant (Magiorakos et al., 2012). The Infectious Diseases Society of 
America provided a concerning update about the lean pipeline for novel 
therapeutics to treat drug-resistant infections, especially those caused by 
Gram-negative pathogens (Boucher et al., 2009). A U.K report stated that 
global burden will be in a large part due to the lack of current antibiotics coming 
through the discovery pipeline, whilst estimating it could be ten years before 
new antibiotics may become available to treat the worst of the antibiotic 
resistant bacteria (O’Neill, 2016a). 
The leanness of the discovery pipeline is exacerbated by the difficulty of a 
therapeutic agent to reach a stage where it is clinically relevant. The Pew 
Charitable Trusts track products in clinical development globally with the 
potential to treat or prevent serious bacterial infections (The PEW Charitable 
Trusts, 2020). As of December 2019, there were 41 new antibiotics in 
development. Of the 41 antibiotics in development, 15 were in Phase 1 clinical 
trials, 12 in Phase 2, 13 in Phase 3, one has had a new drug application 
submitted, four have been approved. Historically, about 60 percent of drugs 
that enter Phase 3 will be approved. They summarised these findings saying: 
“These drugs would potentially address many, but not all, resistant 
bacteria. However, given the inevitability that some of these 
antibiotics will fail to win approval, and that resistance will 
eventually develop to those that are approved, it is clear that there 
are too few drugs in development to meet current and anticipated 
patient needs” (The PEW Charitable Trusts, 2020). 
To date, there has been an over-reliance on the pharmaceutical industry to 
solve this problem by bolstering the antibiotic discovery pipeline. It is argued 
that it is not in pharmaceutical companies’ best interests to protect the 
effectiveness of antibiotics by minimising antibiotic usage. Their departure 
from R&D is merely an example of their profit-driven approach that is 
understandable from a business perspective (Rice, 2008). In 2018, Lord Jim 
O’Neill, author of the Review on AMR, condemned the pharma industry. 
“I am shocked at the endless words that come from the pharma 
industry about their collective belief in the need to fight AMR, but 
the lack of concrete initiatives and more importantly, money, they 
are prepared to underwrite. In January 2016, a much larger number 
than we ever envisaged signed what is now known as the Davos 
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declaration. There were more than 100 signatories in the end. In 
their important first benchmark on AMR, Access to Medicine could 
only find eight big Pharma companies that were actively working 
on new drugs. I personally think that was very generous… there is 
not really more than three.” (O’Neill, 2018). 
Over 95 percent of the products in development today are based on research 
taking place in small pharmaceutical companies rather than the large 
pharmaceutical firms that once dominated this field (The PEW Charitable 
Trusts, 2020). Davies (2011) stated very clearly in her annual report that she 
feels the leanness of the antibiotic discovery pipeline is in part down to a 
market failure. Antibiotics are used for short durations in small amounts. They 
will always become less efficient over time as resistance inevitably develops 
and some last resort antibiotics will be withheld indefinitely. This limits their 
profitability and decreases the incentive for new antibiotic production. This 
statement was echoed in a 2018 update (O’Neill, 2018). To summarise, the 
issue we face as a society is that the supply of new antibiotic agents has 
slowed whilst levels of antibiotic resistance are increasing, limiting our 
treatment options (Davies, 2011). 
1.2 Tackling Antibiotic Resistance 
1.2.1 The Ten Commandments 
There are two specific issues associated with antibiotic resistance; the 
decreased supply of new antibiotics and the increased incidence of antibiotic 
resistance. These issues can be tackled and should be tackled using a variety 
of different approaches. In 2016, the comprehensive U.K Review on AMR put 
forward ten ‘commandments’ to revolutionise the fight against antibiotic 
resistance (O’Neill, 2016b). These commandments are: 
1.  Launch a massive global public awareness campaign. 
2.  Improve hygiene and prevent the spread of infection. 
3.  Reduce unnecessary use of antimicrobials in agriculture and their 
dissemination into the environment. 
4.  Improve global surveillance of drug resistance in humans and 
animals. 
5.  Promote new, rapid diagnostics to cut unnecessary use of 
antibiotics. 
6.  Promote the development and use of vaccines and alternatives. 
7.  Improve the numbers, pay and recognition of people working in 
infectious disease. 
8.  Establish a Global Innovation Fund for early-stage and non-
commercial research. 
9.  Better incentives to promote investment for new drugs and 
improving existing ones. 
10.  Build a global coalition for real action – via the G20 and the United 
Nations (UN). 
 
In 2018, a subsequent update to the original report was published detailing 
what had been achieved since publication of the review in 2016. This update 
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reported that only two of the ten areas were identified as having experienced 
encouraging progress (O’Neill, 2018). Human capital (Commandment 7) had 
increased as the numbers, pay and recognition of people working in infectious 
disease had increased as exemplified through growth in new university AMR 
centres in the U.K. In addition, the establishment of a Global Innovation Fund 
was partially achieved, however early stage R&D received special mention 
(Commandment 8): 
…If I tally all the announced initiatives from the U.K, German and 
especially U.S.A governments, and the Welcome Trust, and that 
recently of the Danish pharmaceutical company, Novo, the 
amounts announced in the past two years, would equate if 
continued on a five year basis, to the $2 billion in new global 
funding, we specifically suggested was needed (O’Neill, 2018). 
This leaves eight categories where progress had been minimal. The O’Neill 
update (O’Neill, 2018) only indicated partial progress for improved public 
awareness, sanitation and hygiene, unnecessary use in agriculture, global 
surveillance of drug resistance and a global coalition via the G20 and UN. It 
reported no progress for rapid diagnostics, development and use of vaccines 
and alternatives and incentives to promote investment for new or improved 
drugs. If we are to tackle antibiotic resistance as a society, it is important that 
progress is made in all ten of these areas.  
In 2019 an independent evaluation of the 2016 O’ Neill report was published 
(Clift, 2019). This evaluation suggested further progress had been achieved; 
with significant advances in reducing antibiotic use in agriculture in high-
income countries (commandment 3), greater investment in awareness 
campaigns (commandment 1) and investments made in improving surveillance 
of antibiotic use and resistance (commandment 4). It caveated this by noting 
that the central and most expensive recommendations had not progressed 
including investment in the antibiotic discovery pipeline (commandment 8 and 
9). Further, of those areas that had seen progress - noticeably investment in 
awareness - questions still remained about its impact and effectiveness in 
eliciting behaviour change among the public (Clift, 2019).  
This Doctor of Philosophy (PhD) focuses on the issues highlighted in section 
1.1, the decreased rate of novel antibiotic discovery and the increased 
incidence of antibiotic resistance. To tackle the first problem, I go on to discuss 
the reinvigoration of the antibiotic discovery pipeline. To tackle the second 
problem, I discuss the need to re-examine how increased awareness is 
achieved (Commandment 1), noting the issues suffered by public health 
campaigns to date and advocating for the use of public engagement and 
project evaluation.  
1.2.2 Reinvigorating the drug discovery pipeline 
Bacterial resistance driven by human use of antibiotics has been observed 
since the discovery of penicillin in 1928 and the consequential introduction of 
antibiotics in the 1930s and 40s. As resistance to one type or class of antibiotic 
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emerged, new types or classes of antibiotic were developed (Davies, 2011). 
See Table 1-5 for the different classes of antibiotics. 
This was until the drug discovery pipeline began to dry up. O’Neill (2016a) 
stated that despite a growing unmet clinical demand and affluent potential 
markets, the pipeline for new antibiotics has experienced a long-term decline. 
The global pipeline of antibiotics has too few drugs in development to meet 
current and anticipated patient needs (The PEW Charitable Trusts, 2020).  
It could be viewed in a positive light that the antibiotic pipeline is still producing 
a handful of products, but the concern is that these will not be effective against 
the urgent and serious threats highlighted in Table 1-3. For example, history 
has shown that antibiotic resistance in clinical settings has often developed 
before antibiotics are available for clinical use (Bowater, 2017). There is rising 
resistance to carbapenems (Table 1-5), a class of antibiotics that constitute 
doctors’ last good line of defence against a range of potentially life-threatening 
infections, however only three compounds under development have the 
potential to be active against the vast majority of bacteria resistant to 
carbapenems (O’Neill, 2016a).  
One key reason the antibiotic pipeline has slowed dramatically is that until 
resistance against a previous generation of drugs has emerged, there is no 
certainty of profitable development of a new antibiotic. In addition, as we are 
trying to reduce the number of antibiotics we use, a drug may not be used until 
it is near/past the end of its patent, minimising corporate revenue to the point 
where development costs may not be recovered. The Chief Medical Officer 
Professor Dame Sally Davies in her annual report for the U.K Department of 
Health put forward ‘Recommendation 7’ which suggested that AMR is placed 
on the National Security Risk Assessment register. As part of this, 
collaborations to ensure the development of new antimicrobials and vaccines 
such as Private Public Partnerships would be developed (Davies, 2011).  
The urgent need to supply funding in this area has been recognised by 
Governments globally. In the U.K, the Government has been forthcoming in 
setting up the Fleming Fund, contributing $375 million USD to improve disease 
surveillance in low and middle income countries, and has worked with China 
to contribute $72 million USD to a new Global Innovation Fund which aims to 
kick-start early research into new antimicrobials and diagnostics (O’Neill et al., 
2015). In the U.S.A, the Obama administration hoped to accelerate basic and 
applied R&D for new antibiotics. They aimed to have at least two new antibiotic 
drug candidates to prevent human disease and at least three drug 
candidates/probiotic treatments as candidates for promoting 
growth/preventing disease in animals by 2020. Finally, they wanted to promote 
innovation and increase the number of antimicrobials in the pipeline. Funding 
to do this was increased in President Obama’s 2016 Budget, which nearly 
doubled the amount of Federal funding for combating and preventing antibiotic 
resistance to more than $1.2 billion (Obama and The Task Force for 
Combating Antibitic-Resistant Bacteria, 2015).  
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Table 1-5. Depicts the different classes of antibiotics with well-known examples. Classes of antibiotics in capital letters, with well-known examples underneath. Types of antibiotics belonging to 
each class in bold. Taken from Moore (2016). 
Classes of Antibiotics 


























      
 Fourth Generation 
Cefepime 





An independent report as part of the Review on AMR also focused on making 
antibiotics R&D commercially sustainable (O’Neill, 2016b) by jump-starting 
blue sky research. They proposed a system by which a global organisation has 
the authority and resources to commit lump-sum payments to successful drug 
developers. Payments would be set against selective criteria agreed in 
advance, removing the link between drug sales and profitability. Instead the 
financial incentive would come from the savings of treating resistance. For 
example, the cost of treating a patient with TB increases from $12,000 USD 
for a patient with a drug-susceptible strain to $180,000 USD for a patient with 
an MDR strain (Lieberman and Wootan, 1998). Furthermore, according to the 
CDC, AMR adds a 20 billion USD surplus in direct healthcare costs in the 
U.S.A, which is exclusive of about 35 billion dollars in loss of productivity 
annually (Centers for Disease Control and Prevention, 2013a). In comparison, 
the O’Neill report estimates that a comprehensive package of interventions 
could cost as little 16 billion USD and no more than 37 billion USD over the 
course of 10 years and would be sufficient to radically overhaul the antibiotics 
pipeline, which is less than the 40 billion USD per year we pay for antibiotics 
today (O’Neill, 2016b). Since 2016, the report has updated its recommendation 
to suggest that if pharma don’t come forward soon with some action, 
governments should seriously consider implementing a so-called Play or Pay 
model. This charges a surcharge on sales from pharmaceutical companies 
that don’t attempt to research new drugs and uses these funds to finance 
individual Market Entry Rewards (O’Neill, 2018). 
Outside of government action plans, the need for antibiotic discovery has been 
widely understood by the U.K public. In 2014, the public voted that the most 
important challenge to humanity was point-of-care diagnostic tests which 
would aid in antimicrobial stewardship (Nesta, 2017) and in 2017, the British 
public voted antibiotics as Britain’s Greatest Invention5 (BBC TWO, 2017). 
Both victories resulted in funds being set up to encourage antibiotic research.  
These government backed action plans and the U.K public take one key 
stance, that in order to reinvigorate the drug discovery pipeline funds must be 
committed to antibiotic research and drug discovery. 
1.2.3 Preserving the effectiveness of current antibiotics 
The golden era of antibiotic discovery solved the problem of emerging 
resistance by discovering new drugs faster than bacteria could develop 
resistance to them. However, it is clear now that this is not a successful long-
term strategy as new drugs are no longer being found with such success. 
 
5 Antibiotics are not Britain’s invention, moulds and plant extracts were used by some 
of the earliest civilisations. Paul Ehrlich (a German physician) discovered an 
antibacterial chemical in 1909. Selman Waksman (Ukrainian-American inventor) used 
the term ‘antibiotic’ 30 years later and discovered 20 antibiotics in his lifetime 
(Microbiology Society, 2017c). Penicillin was discovered by the British Alexander 
Fleming in 1928, but the process for mass producing the drug was patented in the 
U.S.A (Bowater, 2017). 
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Instead, we must be smarter with our antibiotic usage at the point of 
prescription but also with regards to proper use, consumption and adherence.  
Proper prescribing practices are required to prevent further development of 
antibiotic resistance. When managed poorly, the result of antibiotic use in 
humans can be devastating. In the U.S.A in 1987, antibiotic-resistant 
pneumococci had not been encountered. By 1997, as many as 40 percent of 
Pneumococcus. spp were resistant to penicillin and other commonly used 
antibiotics. A large-scale study of U.S.A hospital records by the Health Care 
Financing Administration showed that 63% of orders for vancomycin, the last 
line of defence against severe hospital-acquired infections, were inconsistent 
with CDC guidelines (Lieberman and Wootan, 1998). In U.K hospitals, 15% of 
antimicrobials did not have the reason for their use recorded in the medical 
notes (Health Protection Agency, 2012). The Chief Medical Officer for England 
published an annual report in 2013 which highlighted the failure of treatment 
of Neisseria gonorrhoea, and our reliance on ‘last line’ antibiotics for which we 
have no replacements (Davies et al., 2013). 
However, case studies have examined the effects of regulating prescription 
practices with mixed results. An example of a successful intervention occurred 
in Finland between 1992 and 1998 when a single clone of Streptococcus 
pyogenes gained macrolide-resistance (erythromycin). Public Health 
authorities noted this increased resistance rate (15%) coincided with a tripling 
in use of macrolide over the previous 15 years. By reducing the prescription 
rates of macrolides for upper respiratory infections, the prevalence of 
erythromycin resistant S. pyogenes dropped from 16.5% to 8.6% between 
1992 and 1996 (Seppälä et al., 1997).  
Interventions are not always this successful. Over the last 80 years Neisseria 
gonorrhoea has gained resistance to penicillin (Martin et al., 1970), 
fluoroquinolones (Fenton et al., 2003; Lewis, 2010), cefixime (Bignell, 2001; 
Ison et al., 2013), ceftriaxone (Bignell, 2004; Ison et al., 2013) and 
azithromycin (Bignell, 2004). This is despite several guidelines being issued 
and implemented by health care providers to try and reduce resistance to each 
antibiotic as resistance arose. 
Interventions can also provide mixed results, as seen in Clostridium difficile 
infections between 1990 and 2000 in the U.K. Infections were seen to greatly 
increase in elderly patients who had recently received antibiotics, specifically 
cephalosporins (Wilcox et al., 2004) and fluoroquinolones (Cooke et al., 2015). 
These infections resulted in diarrhoea (Public Health England, 2014). 
Intervention achieved 60-80% reductions in the use of these two antibiotic 
classes. Furthermore, combining this with an emphasis on hospital hygiene 
saw a reduction in C. difficile associated infection by 77.9% from 2007/08 
(Thelwall et al., 2018). However, in replacing these two classes of antibiotic 
with penicillin-β-lactamase inhibitor combinations, selection pressure was then 
placed on the β-lactamase inhibitor combinations. This is of concern as 
Enterobacteriaceae with carbapenemase resistance (an urgent health threat, 
Table 1-3) are consistently resistant to this class of antibiotics (Livermore et 
al., 2013). This emphasises the point that resistance to one class of antibiotic 
leads to change in prescription practices to a new prescribing regime. This in 
turn leads to increased resistance to the new antibiotic being prescribed. 
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Perhaps one of the more exciting developments is the idea of using 
combination therapy. This is where simultaneous addition of multiple drugs 
results in interactions which may bias evolutionary outcomes of bacteria, 
making it unfavourable to develop resistance (Furusawa, Horinouchi and 
Maeda, 2018). There are two ways in which combination therapy can work. If 
becoming resistant to one drug removes a bacterium’s protection against a 
second drug, resistant mutants would be disadvantaged and as such 
resistance would be unfavourable. If mutations that confer resistance to a drug 
result in the combined effect of the drug and another compound to be greater 
than the summative effect, the mutations would be counteracted. Combination 
therapy relies on trade-offs between resistances to different compounds such 
that resistance to one antibiotic causes collateral sensitivity to another 
antibiotic or to a compound whose toxicity is mediated by the resistance 
mechanism (Baym, Stone and Kishony, 2016).  
There are several trial studies which aim to control resistance evolution by 
adding multiple antibiotics. The author of a review which looked at these trials 
(Baym, Stone and Kishony, 2016) concluded:  
“It is possible to invert the selective advantage of resistant bacteria 
and reverse the evolution of antibiotic resistance” (Baym, Stone 
and Kishony, 2016).  
Altering prescribing practices to correct the mistakes of misuse or overuse of 
antibiotics is a key tool in the fight against antibiotic resistance. However, 
misuse and overuse are not only influenced by the prescriber. The final report 
and recommendations of The Review on Antimicrobial Resistance states that 
the only sustainable, long-term solution to the global problems of antibiotic 
resistance lies in action to address the 'demand’ side, thus reducing the burden 
on our current antibiotics (O’Neill, 2016b).  
This demand for antibiotics is driven by industry and the public. In industry, a 
large quantity of antibiotics are used every year in veterinary practice, whilst 
the fishing and farming industries provide a further vehicle for the development 
of antibiotic resistance (Davies, 2011). For example in the U.S.A, the 
Minnesota State Department of Health showed that only two years after 
fluoroquinolones, a second-line drug, were approved for use in poultry, there 
was an increase in fluoroquinolone resistance in bacteria isolated from 
chickens, turkeys, and humans (Lieberman and Wootan, 1998). A solution, 
recommended by the U.K Chief Medical Officer (Recommendation 8), is to 
manage antibiotics jointly between the Department of Health and the 
Department for Environment, Food and Rural Affairs (Davies, 2011). In the 
U.S.A, as well as calls to stop the use of antibiotics in agriculture, there are 
also calls to ban their use as pesticides. To do this, similar collaboration is 
requested between the U.S.A Food and Drug Administration and the U.S.A 
Environmental Protection Agency (Lieberman and Wootan, 1998).  
The public creates a demand for antibiotics even when antibiotic prescription 
is not the correct treatment. In 2014, 19.5% of a randomly sampled cross 
sectional survey of the Australian population (n=1509) reported that they would 
expect the doctor to prescribe antibiotics, effective only against bacterial 
infections, for viral infections such as cold or flu (Gaarslev et al., 2016). Of 190 
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patient, parents and caregivers, 53% incorrectly believed that antibiotics work 
well for treating viral infections. These patients were more than twice as likely 
to expect a provider to give them an antibiotic for a cough or common cold 
(Davis et al., 2017). This is a particular concern considering patients who 
expect to receive antibiotics at an outpatient visit were prescribed antibiotics 
more frequently than those who were not expecting them (Coenen et al., 2006; 
Cals et al., 2007; Coenen et al., 2013; Cole, 2014; Sirota et al., 2017). This 
links to the discovery that providers report feeling pressured to prescribe 
antibiotics even when they believe them to not be needed (Brookes-Howell et 
al., 2012; Coenen et al., 2013; Little et al., 2004; Macfarlane et al., 1997; 
Watkins et al., 2015).  
It is important to tackle the public demand for antibiotics to help reduce the 
number of prescriptions and improve current prescribing practices. An obvious 
target is reducing prescriptions that happen unnecessarily, for example when 
the infection is not bacterial and is therefore not treatable with antibiotics. 
However, this approach must be done in parallel with increasing awareness 
among members of the general public and patients about the need for smarter, 
evidence-based prescribing in order to protect the usefulness of antibiotics. 
Critically, it also requires the public to play their part by taking the antibiotics 
as prescribed by health-care providers and improving compliance. 
1.3 Public Perception of Antibiotic Resistance 
1.3.1 Key Topics Emerging from the Literature 
In order to raise awareness among members of the public about antibiotic 
resistance (Commandment 1, 1.2.1), it is first important to understand the 
public discourse surrounding this topic. By identifying areas where public 
awareness is lacking, especially if this lack of awareness leads to negative 
behavioural choices with regards to antibiotics, a targeted effort can be made 
to address this. In order to identify key areas or topics that are important with 
regards to behaviour, I undertook a literature review of research. The search 
terms included: public perception, public beliefs, patient expectations, patient 
interpretations, public attitudes towards antibiotics. This search identified 
research papers from which, other relevant literature was established. This 
provided 20 papers spanning a 21-year period that examined public perception 
of antibiotics and antibiotic resistance. As well as examining the key topics 
emerging from this body of literature, I have presented the key features of each 
paper: the number of participants, participant demographic and the data 
collection tools used (Table 1-6). 
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Table 1-6. Summary table of the key features of 20 papers which examine the public’s perception of antibiotics and antibiotic resistance. The key features of each paper, with 




Information about participants and country of 
origin 
Data collection tool 
(Macfarlane et 
al., 1997) 
1014 Previously well adults in Britain presenting to GP with 
illness defined as a Lower Respiratory Tract Infections 
Quantitative intervention study, half received leaflets, half did 




38 GPs and their patients in South Wales who had 
recently consulted for a sore throat or Upper 
Respiratory Tract Infection 
Qualitative study with semi-structured interviews 
(Welschen et 
al., 2004) 
1014 Patients from GP practices in The Netherlands 
presenting with acute respiratory tract symptoms 
Quantitative yes/no questionnaire 
(Van Driel et 
al., 2006) 
298 Patients of family physicians in Belgium making visit 
for acute sore throat 
Quantitative observational post visit questionnaire survey (4-
point Likert scale) 
(McNulty et 
al., 2007) 
7120 Household Survey of randomly selected adults in the 
U.K 




46 Members of the Welsh public Qualitative grounded theory interview study 
(Brooks et al., 
2008) 
23 Primary care patients in low prescribing affluent 
practice vs high prescribing, deprived practice in the 
U.K 




98 Individuals in three family medicine practices (U.S.A)  Quantitative questionnaire. Mix of yes/no, numbered or 5-point 















17 & 5,180 Participants with acute Respiratory Tract Infections at 
English pharmacies & members of the English public 
Qualitative interviews & Quantitative face-to-face questionnaire 
survey 
(Brookes-
Howell et al., 
2012) 
121 Primary care patients with symptoms of Lower 
Respiratory Tract Infections based in 9 EU member 
states 




27680 Members of the public across 28 EU member states Quantitative Eurobarometer Survey 
(Norris et al., 
2013) 
21 &101 Focus group participants & household members from 
the New Zealand public 
Qualitative focus groups & interviews/diaries 
(Gudnadottir 
et al., 2013) 
100 Patients with health care-associated infections placed 
in contact precautions in the U.S.A 
Quantitative questionnaire 
(Hawker et al., 
2014) 
3800000 Active patients across U.K General Practices between 
1995-2011 
Descriptive study on diagnosis and prescription 
(McNulty et 
al., 2016) 
1625 Members of randomly selected households across 
England 




27,969  Members of the public across 28 EU member states Quantitative data from interview data gathered face-to-face at 
home in their  
own language  
(Hawking et 
al., 2017) 
53 & 21 Adolescents (16-18) at educational establishments in 
the South of England 
Qualitative semi-structured focus groups & interviews 
(Dyar et al., 
2018) 
255 Students training to be healthcare professionals at U.K 
Universities 
Quantitative cross-sectional multi-centre web-based survey 
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These 20 studies examine public perceptions regarding either antibiotics 
and/or antibiotic resistance (Table 1-6) from across the U.K, the EU as well as 
New Zealand and the U.S.A. Data was collected using a variety of quantitative 
and qualitative tools and sampled a varied range of individuals. An analysis of 
these 20 studies identified recurring themes. Whilst this list is not exhaustive, 
it provides a useful insight into some of the main perspectives individuals might 
hold towards antibiotics and antibiotic resistance. These six topics are: 
1. Antibiotics and their side effects 
2. The concept of the Resistant Human Body 
3. The Irresponsible Other 
4. Factual knowledge and sensible use of antibiotics 
5. Public Awareness of antibiotics and antibiotic resistance 
6. Understanding why users take antibiotics 
 
Each of these themes are discussed in detail using information from the 
research studies highlighted in Table 1-6.  
1.3.2 Antibiotics and their side effects 
One of the broader themes emerging from the literature is the negative 
consequences of antibiotic use, including the negative side effects. Out of the 
20 papers, eight demonstrated this theme. 
As early as 1998, Butler et al., showed that patients were aware antibiotics are 
not a trouble-free solution to coughs, colds and sore throats and provided 
association between antibiotics and thrush, rashes and oral contraceptive 
failure (Butler et al 1998). This may reflect the fact that these contraindications 
are often highlighted by health care providers when prescribing antibiotics. 
Research undertaken by McNulty et al (2007), on members of the British Public 
supported this finding; less than half of participants agreed that microbial flora 
is good for your health and that antibiotics kill this flora. In general however, 
participants believed that overuse of antibiotics increased the chance of 
resistance (McNulty et al., 2007). This finding was also apparent in a separate 
study (Hawkings et al., 2007). In this study a quarter of participants – members 
of the Welsh Public - described adaptation and mutation of bacteria in 
association with antibiotic use. However, some of these participants, notably 
those with a science background, also highlighted that not finishing the full 
course of antibiotics could account for treatment failure. In 2012, another study 
by Brookes-Howell et al (2012) found that almost all participants, patients 
attending a General Practitioner (GP) for a respiratory tract infection, linked 
unnecessary antibiotic use with resistance. Table 1-7 shows three subsequent 
Eurobarometer surveys on antibiotic resistance conducted by the European 
Commission (European Commission, 2010, 2013, 2016). With regards to side 
effects, these randomly sampled EU wide surveys showed that participants 
understood unnecessary use of antibiotics reduces their efficacy. These data 
show that in 2016, 84% of respondents agreed that taking antibiotics can 
increase antibiotic resistance. This number has not changed since 2010 
(83%). Further, two-thirds of participants agreed that taking antibiotics often 
has side effects such as diarrhoea. The data showed 66% of respondents in 
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2016 agreed that antibiotics can cause significant side effects such as 
diarrhoea, a number which has not changed since 2010 (68%). 
 
Table 1-7. Eurobarometer data mapping the change in % of population’s understanding of 
antibiotics, their uses and the impacts of misuse. Data obtained from three subsequent versions of the 
Eurobarometer Survey spanning six years in 2010, 2013 and 2016 (European Commission, 2010, 2013, 
2016). 
Year 2010 2013 2016 
Agreed Antibiotics 
kill viruses. 
53% 49% 46% 
Agreed Antibiotics 
effective against 
colds and flu. 
47% 41% 36% 
Agreed 








68% 66% 66% 
 
This understanding, that frequent use of antibiotic can be detrimental to health, 
was also seen in the study by Norris et al. This study of the New Zealand public 
showed that the public acknowledged adverse effects of antibiotics as the main 
reason to avoid taking them (Norris et al., 2013). In 2017, students studying a 
health-care provider course identified that overuse of antibiotics results in 
drugs that might not work in the future. Some participants avoided antibiotics 
and painkillers because they were concerned that they would become reliant 
on them or felt that they were harmful (Hawking et al., 2017). A study by Dyar 
et al (2018) focused on university students who discussed the cause of 
antibiotic resistance. They agreed that excessive antibiotic prescriptions 
(100%), excessive use in livestock and food production (98%), too low dosing 
of antibiotic prescriptions (83%) and too long duration of antibiotic therapy 
(75%) were parts of the problem. They generally agreed that overuse of 
antibiotics makes them less effective (96%) and that antibiotics kill commensal 
bacteria as well as pathogenic bacteria (88%) (Dyar et al., 2018). However, 
you would expect that undergraduates studying on a health care degree 
programme would have a thorough understanding of the role of antibiotics and 
the growing problem of antibiotic resistance. 
To summarise, evidence has shown that awareness that antibiotics are not a 
trouble-free solution and that there are consequences when using antibiotics 
is apparent within the general public. There is also a belief that sensible use, 
for example taking the full course, can minimise the effect of these 
consequences. Finally, the negative consequences of antibiotic use are a 
powerful motivator in discouraging the use of antibiotics. This is an important 
outcome for clinical practice. 
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1.3.3 The concept of the Resistant Human Body 
A specific theme emerging from the literature is coined “The Resistant Human 
Body”, where participants understand that the reason antibiotics stop working 
is a result of the human body developing resistance or immunity to them. Five 
studies from the 20 I examined reported this finding. 
In 2007, Hawkings et al found that 13% of participants, members of the general 
public residing in Wales, understood that resistant infections might cause 
treatment failure. Participants generally related this failure to the bodies 
response to repeated antibiotic use rather than changes in resistance 
characteristics of bacterial populations. The body becomes “used to” or 
“immune” to antibiotics (Hawkings et al., 2007). In 2008, the human body 
becoming resistant to antibiotics and not the infectious agent was considered 
a common misconception in a study by Brooks et al who interviewed patients 
with both a high and low income background in GP practices (Brooks et al., 
2008). In 2012, 43 of 121 participants with suspected respiratory tract 
infections from GP practices from nine member states of the EU suggested 
that resistance occurred in individuals’ bodies, whereas 28 of 121 identified 
that resistance is a property of an infectious body. This demonstrates that this 
misunderstanding is not restricted to the U.K. These authors coined the terms 
‘Resistant Body’ and ‘Resistant Bacterium’ to explain these opposing 
perspectives (Brookes-Howell et al., 2012). The following year, it was also 
reported that resistance is used commonly in terms of the body developing 
resistance or becoming accustomed to medication. Further, immunity was 
considered a property of humans, rather than the bacteria in New Zealand 
(Norris et al., 2013). In 2017, pupils that did not self-identify as science 
students suggested that the body or person becomes resistant to antibiotics 
(Hawking et al., 2017), suggesting that this misconception is already 
established by the time a person reaches their teens. 
There is a clear misconception among the public, other than perhaps those 
partaking in scientific study, that resistance is a property of the human body 
rather than an infectious agent. This perception was coined the resistant body 
theory. With regards to clinical practice however, the idea that overuse of 
antibiotics leads to their decreased efficacy, regardless of whether this is a 
result of the body or an infectious agent, likely results in the avoidance of 
antibiotic overuse.  
1.3.4 The Irresponsible Other 
Five papers attempted to understand whether members of the public feel they 
play a role in resolving the issue of antibiotic resistance. Overwhelmingly, the 
perception of an “irresponsible other” emerged from the literature: other 
people’s irresponsible behaviour is exacerbating the problem. 
In a study by Hawkings, Wood and Butler (2007), few participants from the 
Welsh general public mentioned the individual’s potential contribution to 
controlling bacterial resistance. Instead, they focused on antibiotic resistance 
being caused by overprescribing by GPs, poor environmental hygiene in 
hospitals and receiving the incorrect dose for too short a time period. Notably, 
a few of the participants mentioned the role handwashing can play in 
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controlling resistant infections. Interestingly, the authors suggested that the 
attitudes towards infections influenced attitudes towards bacterial resistance. 
This considers germs as being something you caught from someone else or 
something else, not something that an individual can control. This led to the 
perspective that one has little individual responsibility for the control of 
bacterial resistance and instead that the responsibility for managing antibiotic 
resistance lies with the government or National Health Service (NHS) 
managers (Hawkings, Wood and Butler, 2007). I note that participants with a 
science background described the responsibility as belonging to the 
government and society as a whole (Hawkings et al., 2007). In 2008, the term 
“Irresponsible Other” was coined by Brooks et al (2008). Participants generally 
suggested that the individuals role was minimal and the solution to antibiotic 
resistance was out of their personal control, that they did not have the 
knowledge to contribute. Further, it was ‘other’ ‘irresponsible’ patients who 
misuse and overuse antibiotics. Participants did not just blame other patients, 
suggesting that GPs, agriculture and veterinary medicine are misusing 
antibiotics. When considering misuse by patients, participants identified 
needless use, failure to complete the course and sharing antibiotics as issues 
other people have, reflecting the idea that antibiotic use can have negative 
consequences (Brooks et al., 2008). There were members of the public who 
did not apportion blame. In these cases, they said antibiotic resistance is being 
‘dealt with’ (Brooks et al., 2008). In 2017, adolescent participants suggested 
that their peers take a lot of antibiotics and treat them as a quick fix, a ‘cure-
all’ like painkillers (Hawking et al., 2017). Parents were also blamed as they 
have an advisory role; they could influence intentions to take antibiotics, 
despite some feeling that their parents were less knowledgeable about 
antibiotics than themselves. Participants also expressed the view that it is the 
GPs responsibility to prescribe appropriately and monitor antibiotic usage, and 
it is not their concern (Hawking et al., 2017). In 2018, 31% of 255 university 
students training for health-care professions did not believe that the antibiotics 
they would prescribe, administer or dispense would contribute to the problem 
of antibiotic resistance. They did however believe that prescribing, dispensing 
or administering inappropriate or unnecessary antibiotics is professionally 
unethical, perhaps suggesting that they did not believe they would be found 
prescribing unnecessary antibiotics (Dyar et al., 2018). Whilst I am focusing on 
public perception, an interesting piece of research in 1998 showed that GPs 
may also blame ‘irresponsible others’. GPs felt that patients expect antibiotics 
and attempting to educate them is time consuming and unrewarding. 
Furthermore, antibiotic resistance was seen as a community issue rather than 
the GPs issue, which instead was the wellbeing of the patient (Butler et 
al.,1998). 
In general, members of the public, be it those who feel they lack knowledge to 
contribute to the solution of antibiotic resistance, student health-care providers 
or current GPs, have a tendency to blame ‘Irresponsible Others’ rather than 
considering their own contribution to the problem of antibiotic resistance. 
Whilst not conclusive, individuals with a background in science were the only 
reported participants that saw the responsibility of solving antibiotic resistance 
as a societal issue. It is important to raise awareness that individuals can make 
a difference in controlling resistant infections. This has been demonstrated in 
46 
 
the recent Covid-19 pandemic. The U.K government has moved the 
responsibility of containing the spread of the virus to individuals, expecting 
them to adhere to guidance such as ‘Hands, Face, Space’, in order to control 
the rate of infection (Department of Health and Social Care, 2020).  
1.3.5 Factual knowledge and sensible use of antibiotics 
Five studies reported the link between better factual knowledge and desirable 
human behaviour with regards to antibiotic resistance. In this section, I 
examine how individuals take responsibility for their own actions and whether 
better factual knowledge has any affect. 
In 2007, McNulty et al reported that respondents with no formal qualifications 
were twice as likely to respond incorrectly to questions about antibiotics and 
resistance as those with a degree level of education. Further, young women 
or those with lower levels of education were most likely to be prescribed 
antibiotics. However, 87% of people who didn’t finish their course of antibiotics 
knew they should have (McNulty et al., 2007). In 2008, Brooks et al 
demonstrated that participants who believed the solution to antibiotic 
resistance was out of their personal control, and felt they did not have the 
knowledge to contribute, said that the individual’s role was minimal (Brooks et 
al., 2008). In 2013, a survey of 27,680 people living in the EU showed that 36% 
of participants changed their views on antibiotics after receiving information on 
misuse. Those with low levels of education were more likely to be influenced, 
which resulted in 74% of those individuals saying they would consult a doctor 
about needing antibiotics in the future. This research also noted that this 
information was more effective when coming from a doctor (80%), rather than 
the media (69%). Finally, those with better factual knowledge were more likely 
to take antibiotics solely for illnesses that can be treated with antibiotics 
(European Commission, 2010, 2013, 2016). McNulty et al (2016) showed that 
participants from higher social grades and those educated to a higher level 
were more likely to report that they had been given information about 
antibiotics or caring for their infection. People would more readily trust their 
GP’s advice on whether they need antibiotics (88%), compared to a nurse 
(69%) or a pharmacist (66%) (McNulty et al., 2016). In 2017, student 
participants who demonstrated more knowledge of antibiotic resistance, 
mostly science students, felt that it was an important issue and awareness 
should be increased among the general public (Hawking et al., 2017).  
Individuals with lower levels of formal education seem to have less factual 
knowledge about antibiotic resistance. Participants with less factual knowledge 
about antibiotic resistance believe they cannot contribute effectively to the 
solution and are less likely to consider this an important issue. However, when 
information is provided on antibiotics and resistance, those with lower levels of 
education were more likely to be positively influenced to change their 
behaviours, especially if this information came from their GP. This must be a 
target for public health campaigns. Nevertheless, individuals with better 
objective knowledge are more likely to take antibiotics in the correct instance, 
yet even when these individuals know they should complete the full course, 
they often do not.  
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1.3.6 Public Awareness of antibiotics and antibiotic resistance 
Eleven papers reported on the measures of public awareness of antibiotics 
and antibiotic resistance. I go on to specifically discuss public health 
campaigns and their effectiveness in more detail in 1.4. 
In 1997, Macfarlane et al found that participants, patients attending their GP 
with a respiratory tract infection, who were provided with information on 
antibiotic resistance, whether or not they were prescribed antibiotics, were less 
likely to reconsult their GP with the same symptoms within a month because 
that had developed an awareness of antibiotic resistance (Macfarlane et al., 
1997).  
Ten years later in 2007, McNulty et al found that only 20% of English 
respondents, randomly chosen members of the U.K public, had heard of the 
national U.K Andy-Biotic Public Heath campaign focused in GP surgeries 
aimed at discouraging people from unnecessarily taking antibiotics for cold and 
flu. This same study found that 79% of participants had heard about antibiotic 
resistance. Data revealed less awareness about the effectiveness of 
antibiotics to treat viral infections, with only 38% of respondents realising that 
antibiotics cannot be used to treat viral infections. Participants had a lack of 
knowledge about a specific side effect of antibiotics: 43% of respondents were 
unaware that antibiotics can harm our normal microbiota (McNulty et al., 2007).  
Hawkings, Butler and Wood (2008) reported similar findings. They conducted 
interviews with respondents and found that all had used antibiotics and were 
confident in the efficacy and safety of antibiotics but unfamiliar with potential 
disadvantages or side effects. They published another study from the same 
interview carried out with the same respondents that showed participants had 
little awareness of the causes and consequences of antibiotic resistance, and 
participants viewed this with a low sense of perceived importance or personal 
threat (Hawkings et al., 2007). In this study, participants reported that their 
main source of information on this topic was the media: Television, followed to 
a lesser extent by newspapers and radio reports (Hawkings et al., 2007).  
In 2008, three-quarters of participants, patients at a GP surgery, who took part 
in a study by Brooks et al had heard of antibiotic resistance. However, from 
these positive responses, three-quarters had trouble explaining what this term 
meant, what caused antibiotic resistance and its implications. The authors 
showed that no participants reported hearing about antibiotic resistance 
through public information campaigns and only one individual had been 
informed by a health professional (Brooks et al., 2008).  
This finding contrasts sharply with a separate research study conducted the 
same year that found doctors had discussed antibiotic resistance with 68% of 
participants, whilst 88% of participants thought doctors should have done so 
(Filipetto et al., 2008).  
In 2010, a pan EU survey discovered that 37% of participants reported that 
they had seen anti-antibiotics information within the last year (European 
Commission, 2010). The same question asked three years later in 2013, 
indicated that this number had fallen to 33%. Percentages of participants 
differed greatly across European countries and the results were nuanced with 
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higher rates in some countries compared with others. Of these 33%, 11% 
received this information from health professionals and 9% specifically from a 
doctor. As discussed in the previous section (1.3.5), those who did encounter 
antibiotic awareness campaigns generally changed their views on antibiotics 
or enacted more desirable behaviours (European Commission., 2013).  
Another 2013 study that took place in the U.S.A detailed the types of 
information patients received and how patients felt about this information. As 
would be hoped for, most patients with healthcare associated infections that 
took part in the survey had heard of multi-drug resistant organisms (MDROs). 
Most participants reported that this information came from their physician. 
They also indicated that internet-based information was agreed to be the most 
helpful source of information, followed by written and then verbal information. 
Further, 94% of patients thought that getting information about MDROs would 
definitely or probably help them make choices that would improve their care 
(Gudnadottir et al., 2013).  
Another study by McNulty et al, published in 2016, indicated that half of the 
participants lacked knowledge about antibiotic resistance. Half of those who 
consulted for an infection and 67% of those prescribed an antibiotic were given 
advice from a health professional. Only 8% of participants were specifically 
given information on antibiotic resistance after antibiotic prescription (McNulty 
et al., 2016).  
In 2017, most adolescents interviewed by Hawking et al perceived that they 
understood the term antibiotic resistance. Upon further investigation, the 
authors concluded that the participants had a poor understanding of the 
scientifically correct use of this term (Hawking et al., 2017).  
In 2018, 80% of university students training to be health-care professionals felt 
they did not have sufficient knowledge of antibiotic use for their future clinical 
practice. The students indicated that they wanted more information on 
resistance to antibiotics (63%), as well as the links between health of humans, 
animals and the environment (49%), prescription of antibiotics (45%) and how 
to use antibiotics effectively (25%) (Dyar et al., 2018). 
Initial data suggests that information on antibiotics may reduce the numbers of 
re-consultations. Although data indicates that current awareness of antibiotic 
resistance is not pervasive among participants in the different studies, even 
those who self-report having heard of resistance cannot provide an 
explanation that has scientific validity. There is large room for improvement 
with the dissemination of information from GPs. Most people trust GPs to give 
the correct information and want more information on antibiotics and antibiotic 
resistance, but GPs are not providing this. Finally, it seems unlikely that 
antibiotic campaigns are reaching the public. If they are, they are not having 
the desired effect of improving public awareness and engendering behavioural 
change. 
1.3.7 Understanding why users take antibiotics 
Nine papers reported participant perspectives on what they would take 
antibiotics for. Participants were asked specifically about whether antibiotics 
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are useful to treat Cold and Flu in eight studies, with viruses and bacteria also 
being mentioned on several occasions. Cold and Flu is particularly important 
as this is a common target for public health campaigns which is discussed 
further in 1.4.  
The number of participants correctly disagreeing with the statement ‘antibiotics 
kill colds and flu’ has been asked by several researchers in several studies. 
Answers were: 
1. 68% (McNulty et al., 2007),  
2. 55% (Filipetto et al., 2008),  
3. 60% in 2008 and 69% in 2011 (McNulty et al., 2012).  
 
Whilst there are fluctuations, between 2007 and 2011 the number of 
participants disagreeing with this statement remained steady. The EU has also 
sought to establish the knowledge of citizens from member states, concerning 
antibiotics using the following questions:  
1. - Antibiotics kill viruses; 
2. - Antibiotics are effective against colds and flu; 
3. - Unnecessary use of antibiotics makes them become ineffective; 
4. - Taking antibiotics often has side-effects, such as diarrhoea. 
 
Respondents options were a binary choice of either true or false and 
percentage of respondents to each questions can be seen in Table 1-7. Table 
1-7 clearly indicates that over time, members of the EU have increased their 
awareness that antibiotics are not effective treatments for colds and flu 
(European Commission, 2010, 2013, 2016). This contrasts with no real 
increase in understanding about the side effects of antibiotic use (1.3.2).  
In addition, other more qualitative studies indicate that few participants would 
take antibiotics for colds and flu, expressing a feeling that these infections were 
simple and could be treated at home with “natural remedies” (Hawkings et al., 
2007). Participants were quoted as having said: “I would never take antibiotics 
for coughs and colds” (Brooks et al., 2008) and “Antibiotics should be saved 
for dire emergencies, and not coughs and colds” (Norris et al., 2013).  
Studies have also reported on actual treatment for coughs and colds, rather 
than self-reported actions of the public. Hawker et al., examined real 
prescription data retrieved from 2.97 million episodes of cough/cold diagnoses 
from 1995-2011, 46.9% were prescribed antibiotics in 1995, this reduced to 
26.5% in 1999 but increased once more to 50.8% in 2011: similar levels to 
1995 (Hawker et al., 2014).  
Eurobarometer data gathered between 2010-16 (Table 1-8) indicated a small 
decrease in the number of respondents taking antibiotics for cold or flu 
symptoms (European Commission, 2010, 2013, 2016).  
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Table 1-8. Eurobarometer data mapping the change in % of population who had taken antibiotics for 
viral infections. Data obtained from three subsequent versions of the Eurobarometer Survey spanning six 
years in 2010, 2013 and 2016 (European Commission, 2010, 2013, 2016). 
Year 2010 2013 2016 
Treated for 
Flu 
20 18 16 
Treated for 
Common Cold 
14 13 11 
 
Furthermore, several papers reported on specific infections that individuals 
might take antibiotics for. In 1997, 72% of participants said they would take 
antibiotics for a lower/acute respiratory tract infection (Macfarlane, Holmes and 
Macfarlane, 1997). A similar question was asked by Welschen et al in 2004, 
where only 44% of participants said they would take antibiotics for a 
lower/acute respiratory tract infection (Welschen et al., 2004).  
In a 2015 face-to-face computer-assisted survey of 1625 people in the U.K, 
aimed at identifying the public’s reported use of antibiotics, 42% would take 
antibiotics for a runny nose or cold and a cough, 54% for flu symptoms, 60% 
for sinus infections, 62% for throat infections and 67% for ear infections 
(McNulty et al., 2016). This opens a topic which needs further exploration, 
whether respondents realise that the pathogen most likely responsible for each 
for these infections is viral.  
Further, Filipetto et al (2008) demonstrated that as questions include more 
technical language, answers become increasingly incorrect. The authors 
asked whether a discursive object required antibiotic treatment and 
summarised the percentage of participants that agreed they did. In the study, 
45% agreed for colds, 70% agreed for viruses and 86% for yellow nasal 
mucous. I posit that this may be the result of a disconnect between the infection 
itself and the causative agent, be it bacterial or viral. This is something that 
might be considered when comparing different studies. 
Outside of specific types of infection users may take antibiotics for, a 2006 
study discovered that patients who hoped for an antibiotic felt more severely 
ill, had more faith in antibiotics to speed recovery, were less convinced that 
acute sore throat is a self-limiting disease and that frequent use of antibiotics 
is harmful for their own health or a threat to the public (Van Driel et al., 2006). 
Overall, data suggests that public awareness that coughs and colds cannot be 
treated with antibiotics has increased since 2007, as has the understanding 
that antibiotics cannot treat viral infections. This is perhaps one of the bigger 
success stories for public health campaigns. The different responses as 
technical language increased led me to ensure language remained identical 
between interviews, discussed in greater detail in 2.7.1 
1.3.8 Summary 
This section focused on the six key themes emerging from literature spanning 
21 years from 1997 to 2018 which covered public perceptions of antibiotics 
and antibiotic resistance. These emerging themes, whilst not exhaustive, 
provide a foundation on which a coding schedule for my own interviews could 
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be developed (2.7.1). Further, these themes provide direction for clinical 
practice and can guide future public health campaign.  
1.4 Public Understanding and Public Health campaigns 
In 1.3, I examined public awareness of antibiotics and antibiotic resistance 
through the discussion of six key themes emerging from public discourse. In 
doing so, I highlighted key gaps in awareness which likely result in undesirable 
behaviour, such as not taking personal responsibility for the issue. This is 
important because the public are key stakeholders in implementing solutions 
to antibiotic resistance. In the following section I examine the method of public 
understanding to raise awareness about these topics through examination of 
public health campaigns. I discuss the foundation of public understanding, 
before discussing the extent to which campaigns based on this principle have 
been successful.  
1.4.1 The Foundation of Public Understanding 
The public are a diverse array of people and organisations who have a vested 
interest in finding a solution to antibiotic resistance (Phillips et al., 2014). 
Increasing the publics’ scientific literacy is based on the principle that, as the 
public have a stake in shaping what happens in response to scientific 
challenges, they need to strengthen their understanding of how science works 
(Dunn et al., 2016). Lack of scientific knowledge in the public domain isn’t a 
new problem. Indeed, this was picked up in the seminal report by Snow more 
than 60 years ago (1959): 
“I felt I was moving among two groups-comparable in intelligence, 
identical in race, not grossly different in social origin, earning about 
the same incomes, who has ceased to communicate at all. Two 
polar groups: at one pole we have the literary intellectuals, who 
incidentally took to referring to themselves as ‘intellectuals’ as 
though there were no others… – at the other, scientists. Between 
the two, a gulf of mutual incomprehension… but most of all a lack 
of understanding” (Snow, 1959). 
Almost 30 years later, a report by the Royal Society authored by Bodmer 
prompted the beginning of the Public Understanding of Science movement, 
which focused on educating the general public in matters of science: 
“More than ever, people need some understanding of science… 
“Science and technology play a major role in most aspects of our 
daily lives both at home and at work. Our industry and thus our 
national prosperity depend on them. Almost all public policy issues 
have scientific or technological implications. Everybody, therefore, 
needs some understanding of science, its accomplishments and its 
limitations” (Bodmer, 1985). 
Public health campaigns arose from this movement; attempting to foster 
understanding of matters of science in members of the public, bridging the gap 
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between the sciences and the humanities. I now discuss what public health 
campaigns are, provide examples of public health campaigns and to what 
extent the public understanding of science movement has or has not been 
successful.  
1.4.2 Designing a Public Health campaign 
Public Health campaigns attempt to convince a defined public to refrain from 
behaviours that can be considered detrimental (Wakefield et al., 2010). They 
use a mixture of negative and positive messages to convey their point, often 
stressing the importance of the problem at hand, for example; how big an issue 
antibiotic resistance is (Huttner et al., 2010) or how important washing hands, 
covering mouth and nose and keeping two metres distance between 
individuals (Hands, Face, Space) is to prevent the spread of Covid-19 
(Department of Health and Social Care, 2020).  
Public Health campaigns focusing on antibiotic use or antibiotic resistance 
target specific demographics to convey specific messages to help solve a 
specific problem. In section 1.2.3, I discussed how both the prescriber and the 
recipient of antibiotics can contribute to overuse of antibiotics and as such, 
these are two groups that are targeted by campaigns. For example, parents 
are targets for campaigns as prescriptions written for young children 
diagnosed as having colds, upper respiratory tract infections and bronchitis 
represent a substantial proportion of total prescriptions to children (Nyquist et 
al., 1998). Campaigns also focus on the relationship between two groups of 
people. The doctor-patient relationship was targeted by Public Health England 
with the release of the “Keep Antibiotics Working” campaign in October 2017 
(Public Health England., 2017).  
I summarised some of the key behaviours that have been targeted by public 
health campaigns with regards to antibiotics and antibiotic resistance between 
2000 and 2020 in the U.K (Table 1-9).  
Table 1-9. Key themes surrounding antibiotics and antibiotic resistance promoted by public 
health campaigns. Summarised over a 20 year period between 2000 and 2020 in the U.K.  
Key Themes: 
Misuse of antibiotics promotes bacterial resistance 
Most respiratory tract infections are caused by viruses and cannot be treated with 
antibiotics 
Finish the course of antibiotic treatment as prescribed to avoid selection of resistant 
organisms (Take the lot, no matter what). 
Follow the prescription and do not skip doses. 
Hand washing prevents the spread of infectious diseases 
Antibiotics need a prescription 
Do not share antibiotics or keep leftover antibiotics. 
 
 
As Public Health campaigns are disseminated to members of the public, 
research is undertaken to identify the effect they are having. This allows 
themes to be adapted if necessary. For example, the “take the lot, no matter 
what” (Table 1-9) message has been called into question because research 
suggested prolonged treatment might result in higher resistance rates (Rice, 
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2008) and identified that antibiotic use results in 140,000 emergency 
department visits every year in the U.S.A for antibiotic-associated adverse 
events (Shehab et al., 2008). Public Health campaigns must also consider in 
what way they their information or message will be disseminated.  
1.4.3 The Success of Public Health campaigns.  
Public Health campaigns have been successful. A review of 22 campaigns 
done at the national or regional level in high-income countries, aimed at 
reducing antibiotic use, indicated that campaigns are associated with a 
reduction in the use of antibiotics and resistance to antibiotics (Huttner et al., 
2010). This most likely occurred by influencing prescription provision and self-
medication of outpatients, as well as a reduction in the number of 
consultations. 
In the U.S.A, a reduction in antibiotic use was seen after exposure to mass-
media campaigns compared within a controlled community (Gonzales et al., 
2008). The National Ambulatory Medical Care Survey showed that between 
1995 and 2006 office visits decreased by 17%, a number that was 
accompanied by a 36% decrease in prescription of antibiotics for acute 
respiratory tract infections in children younger than 5 years old in the U.S.A 
(Grijalva et al., 2009).  
Public Health campaigns are most effective when they are multifaceted and 
repeated over several years (Huttner et al., 2010), aim to change behaviour 
and target all relevant groups especially parents, children, day-care staff, and 
healthcare professionals (Finch et al., 2004). The use of prime-time Television 
has been noted as elevating the impact Public Health campaigns have (Finch 
et al., 2004; Huttner et al., 2010), highlighting that in order to be successful, a 
campaign must most importantly reach its target audience. 
1.4.4 Issues Identified with Public Health campaigns 
Whilst Public Health campaigns have been successful, for example in the 
reduction in use of antibiotics, reviews of Public Health campaigns are highly 
critical. 
One issue is correlation and causality. It is difficult to distinguish to what degree 
the observed effects of campaigns on the use of antibiotics are because of a 
change in the behaviour of physicians, patients, or both, and how important 
the effect is beyond trends happening in the absence of campaigns (Huttner 
et al., 2010). In many cases, confounding effects like seasonal variation of viral 
respiratory tract infections on antibiotic prescriptions are not accounted for 
(Bauraind et al., 2004). Campaigns often do not have a control population and 
pre-intervention trends are rarely assessed (Huttner et al., 2010).  
A separate issue is that the effect of a campaign might not necessarily be 
desired. A survey in the U.K showed that awareness of the “Andy-biotic” 
campaign was associated with increased knowledge about antibiotics, but 
interestingly this campaign also increased the likelihood of self-medication. 
Also in England a decrease in antibiotic use between 1993 and 2005 was 
linked to an increase in mortality associated with community-acquired 
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pneumonia (Price et al., 2004). This was felt to be a warning that antibiotics 
must be prescribed when appropriate. This was further evidenced in a 
retrospective analysis of data from a large primary care database in the U.K in 
2004, that found patients prescribed an antibiotic on the day of diagnosis of a 
lower respiratory tract infection had a lower likelihood of admission to hospital 
or death (Winchester et al., 2009).  
Other issues include questionable messages not necessarily backed up by 
literature, incomplete evaluation of the effect of the campaign on the target, a 
missed opportunity to base campaigns on behavioural change theory and 
absence of cost effectiveness data.  
1.4.5 Public Health campaigns moving forward. 
Whilst Public Health campaigns do suffer from several issues, it is agreed that 
they are still a highly effective method to influence public behaviour. In knowing 
the issues suffered by Public Health campaigns, analysis of the literature has 
provided suggestions from researchers that might improve the success of 
Public Health Campaign outcomes (Table 1-10).  
These suggestions include targeting the most relevant communities such as 
young women or those with lower levels of education, using patient-based 
interventions, conducting proper evaluation, promotion individual 
responsibility, using natural aversion to antibiotics because of side-effects and 
appealing to trusted authority.  
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Table 1-10. Suggestions to improve public health campaigns through general adaptations or specific messages. Messages pulled from public perception 
papers that mention Public Health campaigns. 
Message Author 
Campaigns need to be better targeted (younger women or those with lower levels of education) and consultation 
behaviour/patients’ expectations for antibiotics needs to be modified, perhaps through delaying antibiotic 
prescriptions or shortening the course prescribed. 
(McNulty et al., 
2007) 
There is an urgent need for patient-based interventions, especially in the U.K. Better information regarding what 
antibiotic resistance is and what it does could go some way to reduce public uncertainty. A particularly focused 
message that any future intervention needs to explain why antibiotic resistance develops and include a 
dimension of causality/responsibility of individuals. 
(Brooks et al., 2008) 
Evaluation is key. Examples of evaluations going forward could include but are not limited to; negative health 
effects and complication rates, unintended consequences of campaigns, confounding factors like seasonal 
variation, success rates of different campaign methods in changing public behaviour and how cost-effective 
each campaign method is when considering the cost of reducing spread of antibiotic resistance 
(Huttner et al., 2010) 
The message that misuse of antibiotics promotes resistance may reinforce the idea that antibiotic resistance is 
an individual, rather than a community, problem. The authors speculate that connecting the individual to the 




Focusing on people’s concerns of and aversion to antibiotics by encouraging for example, natural remedies, 
may aid patient education and health promotion. They finish with the speculation that campaigns that stress 
and build on traditional ways of avoiding infection, building up resistance and treating minor infections may be 
more successful than those that attempt directly to limit antibiotic use. 
(Norris et al., 2013) 
Media campaigns can work but need to be better targeted and then called upon the help of the ‘trusted and 








1.5 Public Engagement and Citizen Science 
In the previous section, 1.4, I discussed how the movement of public 
understanding of science aims to increase the public’s knowledge of science 
through the provision of facts, for example through the use of Public Health 
campaigns. I highlighted how these campaigns are not flawless in their 
approach. A different movement, one that is becoming increasingly popular, is 
that of public engagement with science and technology. Public engagement 
aims, instead of providing facts, to engage people with science through 
discovery led research. In the following section I define a type of public 
engagement, citizen science before discussing the extent to which citizen 
science projects have been successful 
1.5.1 Defining Citizen Science 
The term ‘Citizen Science’ was coined in the 1990s in both the U.S.A (Bonney., 
1991) and the U.K (Irwin., 1995) separately.  
Although the term was coined in the 1990s, citizen science projects and citizen 
scientists have been around for centuries. If you consider a citizen scientist to 
be a non-scientist making a major scientific discovery, you might argue the 
American Colonialists who recorded the weather in the 1600’s were citizen 
scientists. If you consider citizen science projects to be projects when a non-
scientist collaborates with a scientist, then you might suggest the first was The 
North American Bird Phenology Program that started in 1881 (Patuxent 
Wildlife Research Center., 1970). 
Modern definitions of citizen science are constantly evolving, as is this field of 
research. At the start of this PhD project, the most up to date definitions 
considered citizen science to be: 
• a project that includes the involvement of volunteers in science 
(Dickinson, Zuckerberg and Bonter, 2010),  
• the engagement of volunteers and scientists in collaborative research 
to generate new science-based knowledge (Phillips et al., 2014)  
• science where the public participate in the scientific process that allows 
anyone to be involved in discoveries and simultaneously learn how 
science works (Dunn et al., 2016).  
 
As this project progressed, so has the definition of citizen science. It 
progressed beyond being work where amateurs participate in research and 
moved towards projects that have defined methodologies. This was largely in 
response to criticisms that citizen science projects deliver poor science with 
great communication potential (Heigl & Dörler., 2017). The most recent and 
comprehensive attempt to define citizen science considers it to be: 
Public participation and collaboration in scientific research with the 
aim to increase scientific knowledge (Robinson et al., 2018).  
As well as this flexible concept, Robinson et al (2018) also produced ten key 
principles that underpin good practice in citizen science: 
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1. Citizen science projects actively involve citizens in scientific 
endeavour that generates new knowledge or understanding. 
2. Citizen science projects have a genuine science outcome. 
3. Citizen science provides benefits to both science and society. 
4. Citizen scientists may participate in various stages of the scientific 
process. 
5. Citizen scientists receive feedback from the project. 
6. Citizen science, as with all forms of scientific inquiry, has limitations 
and biases that should be considered and controlled for. 
7. Where possible and suitable, project data and meta-data from 
citizen science projects are made publicly available and results are 
published in an open access format. 
8. Citizen scientists are suitably acknowledged for their efforts in the 
projects. 
9. Citizen science programs offer a range of benefits and outcomes 
which should be acknowledged and considered in project 
evaluation. 
10. The leaders of citizen science projects take into consideration legal 
and ethical considerations of the project.  
 
These most recent criteria are perceived as the current standard to which all 
citizen science projects can be evaluated (Heigl et al., 2018). In order to 
understand how citizen science was being used at the conception of this 
project, I present a cross section of citizen science literature, first across all 
science disciplines, and then another specifically in the field of Microbiology.  
1.5.2 Citizen Science and the focus on scientific output 
Kullenberg & Kasperowski (2016) published a meta-analysis looking at which 
scientific fields used citizen science. They also examined to what extent citizen 
scientists were involved. Firstly, the analysis highlighted that citizen science 
has gained a substantial presence in the scientific literature since 2006. In 
quantitative terms, the largest scientific output was found in the fields of 
ornithology, astronomy, meteorology and microbiology. Out of 490 projects, 
only 78 had a scientific output in terms of publications that represent new 
scientific knowledge. I note in the 1.1.1, critics of citizen science perceived it 
as poor science with great communication potential (Heigl & Dörler., 2017). 
Further, of those studies which did produce scientific output, participant 
outcomes were rarely considered. 
In 2016, as part of my initial literature review, I utilised the search string 
presented by Kullenberg & Kasperowski (2016) to identify citizen science 
studies with scientific output that had been published in the year since the 
meta-analysis was conducted. This search string highlighted 19 PubMed 
publications that contained the term “citizen science” in the title or abstract and 
had a scientific output. The aim was to determine the extent to which citizen 
science projects lacked scientific output. 
From the 19 research papers I examined, two showed participant outcomes 
whilst not necessarily increasing scientific knowledge. Caruso et al (2016) 
showed that the introduction of a citizen-science project improved student 
performance of non-science majors at Florida Atlantic University. Kridelbaugh 
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(2016) based a course on projects on the SciStarter website 
(http://scistarter.com/), and the non-science major students attained a 93% 
average on the report. As shown in the Caruso et al (2016) study, the student 
participants benefitted from taking part in a citizen project, however there was 
limited scientific output (Kridelbaugh, 2016). Of the remaining 17 papers, 16 
had strong scientific outputs but seemed to have little in the way of participant 
outcomes.  
Three papers, notably all focused on marine science, provided and/or 
evaluated new tools by which citizen scientists could expand the amount of 
data collected. Raoult et al (2016) suggested the use of GoProsTM, video 
capture devices, as a citizen science mechanism to increase research output 
for motion surveying of desired marine locations. Bardaji et al (2016) 
suggested a $100 Do-It-Yourself machine that has been compared to 
commercial instruments in its ability to assess the environmental status of 
water bodies through the transparency of the water. Parkinson et al (2016) 
offered a simple and inexpensive method for allowing citizens to determine 
coral symbiont quality by observing the colour of the host.  
Thirteen papers used databases or large numbers of participants to collect or 
classify data that would help assist scientific output. Schultz et al (2016) 
verified researcher detected patterns of echinoderm abundance using the Reef 
Environmental Education Foundation (REEF) citizen science database 
(REEF, 2011). Lintott et al (2016) used data from the National Bat Monitoring 
Programme, a long‐running citizen science scheme, to assess how two cryptic 
European bat species respond to the urban landscape. Deguines (2016) 
developed a Photographic Survey of Flower Visitors, now Spipoll, that gave a 
new dataset containing 7167 insects sampled on 1606 plants across France 
over 3 years. Other citizen science projects have used existing data sets but 
mined them or evaluated them to address new research questions to generate 
new scientific knowledge or understanding .Cleary et al (2016) explored bird 
baths and their effect on south-east-Australian bird assemblages. They did this 
by analysing 992 citizen science datasets, collected online at the Atlas of Living 
Australia (ALA) website (ala.org.au). Vallejos et al (2016) used a citizen 
science programme to look for taxonomic homogenisation in terrestrial birds in 
the south Brazilian Atlantic Forest along a human-altered landscape (HAL) 
gradient. Mair & Ruete (2016) examined the effect of urbanisation, using data 
based on voluntary observations made in Sweden between 2000 and 2014 
recorded on Swedish Lifewatch (www.svenskalifewatch.se). Johnson (2016) 
used data from Project BudBurst, a national citizen-science project that tracks 
bloom times and other phenological data for plants across the country, to 
measure the effects of climate change. Gosling et al (2016) used citizen 
scientists to quantify tar spot symptoms on sycamore across England. Roy et 
al (2016) used 13,000 school children (7-11 years old) to sample 26,868 
bumblebees providing evidence that local proximity to flowers, being within five 
metres of a focal plant, had a significant effect on bumblebee abundance as 
part of the Big Bumblebee Discovery. Miyazaki et al (2016) used web data 
mining of Twitter photographs to detail the first apparent illegal introduction of 
Lepomismacrochirus macrochirus in Japan since the Invasive Alien Species 
Act (IASA) was adopted. Daume & Galaz (2016) used data mining on social 
media to capture important environmental information through opportunistic 
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biodiversity observations. Kong et al (2016) developed a smartphone app, 
MyShake, to accurately record magnitude 5 earthquakes, to establish the 
location and magnitude of an earthquake, before sending real time information 
to issue an alert of forthcoming ground shaking. Anderson-Lee et al (2016), in 
the first paper based on dominant writing contribution and co-lead authorship 
by non-expert citizen scientists recruited through a video game, used tens of 
thousands of human participants and three automated algorithms in the Eterna 
massive open library to present several secondary structure elements and 
structural idiosyncrasies that lead to difficult RNA design problems. 
Only in one instance did a citizen science project provide both scientific and 
participant outcomes. Cardamone et al (2016) used students to analyse data 
from the Dawn Mission as part of the project Asteroid Mappers, as well as 
examine interaction between human and natural systems by monitoring the 
health of a local river, as part of Charles River Watershed Association (CRWA). 
Student reflection showed engagement improved and students felt they were 
more capable of finding a job as a result of the course.  
1.5.3 Citizen Science and Microbiology and the focus on scientific 
output 
I examined citizen science in the field of microbiology separately as it was 
specifically relevant to this PhD. I undertook a systematic review based on the 
search terms presented by Kullenberg and Kasperowski (2016). The authors 
search terms were modified to identify only citizen science projects emerging 
from the field of Microbiology in 2016 (Appendix A-1). Five papers were 
identified as relevant.  
Of the five papers that were identified, four used citizen scientists to collect or 
classify data. Fang et al (2016) had undergraduate biology majors plate 
bacteria from facial skin swabs in a Microbiology Laboratory, specifically to 
select for Staphylococcus and test for antibiotic resistance. The students 
checked these results against their own, and 9,000 other students’ 
demographic and lifestyle variables. Agate et al (2016) had college students 
collaborate with secondary school students to investigate bacterial species in 
the local watershed, specifically the prevalence of bacteria that produce 
violacein, a potential treatment for the chytrid fungus that is causing rapid 
amphibian decline. Dunn et al (2016) had middle and high school students 
culture environmental microorganisms to highlight the differing microbial 
diversity of plant root soil compared to adjacent bulk soil to highlight the 
positive role of microorganisms. Schnetzer et al (2016) used willing members 
of the public, citizen scientists, to enrich data collected by international 
scientists with regards to microbial diversity on a single Ocean Sampling Day. 
These four studies suggest that citizen science was used as a method of 
producing scientific output, with little regard for the participant outcomes. This 
aligns with the conclusion of Kullenberg and Kasperowski (2016), that the focal 
point for volunteer contributions consists of participation in observations, 
classification and collection of data, which in turn are used by scientists 
The remaining study also produced strong scientific output, but went further to 
survey the participants to understand how taking part in the project had 
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affected them. Seifert et al (2016) had university students and high school 
students collaborate to promote Lyme disease prevention and to cultivate an 
interest in science through a citizen-science project. Over 2,000 students 
across 9 different educational facilities collected a total of 170 ticks from ~40 
different locations, from which a novel strain of Borrelia burgdorferi has been 
cultured. A survey of the participants after the activity showed increased 
confidence in tick differentiation, and Lyme disease symptom recognition as 
well as a greater interest in pursuing a degree in science.  
Having examined a cross-section of citizen science publications in 2016, both 
in science generally and in the field of microbiology, the criticism that those 
citizen science projects that do produce scientific output use citizen scientists 
for data collection and classification or observations, both in general fields of 
science and microbiology seems founded. However, whilst in the minority, two 
studies did produce novel scientific output and reveal participant outcomes. 
These criticisms were taken on board and provided a basis on which to 
develop a citizen science study which achieved scientific and participant 
outcomes. 
1.5.4 Levels of Engagement within Citizen Science. 
In the previous sections, I have explored citizen science projects through the 
lens of scientific output, that is by examining studies published in scientific 
journals. In the following section, I examine citizen science through the lens of 
participant outcomes. Bonney et al (2009) identified projects as either “top-
down” or “bottom-up”. Most citizen science projects fit the top-down model. 
This is where participants primarily collect and submit data under the guidance 
of a scientific organization. The bottom-up model is where participants notice 
issues they wish to resolve and work together with scientists to do so. Within 
both top-down and bottom-up projects, Bonney et al (2009) identified three 
models of citizen science that focus on the degree to which participants are 
included in various aspects of scientific investigation.  
The top-down projects that focus on collection or classification of data were 
labelled “Contributory”. This is where a participant collects and analyses 
samples. Collaborative projects build on this, having participants develop 
explanations, design data collection methods and analyse data. Finally, Co-
created projects do the same, whilst also having the citizen scientist define a 
question or issue, gather information about said issue before interpreting data 
and concluding, disseminating these conclusions and discussing their results 
or inquiring further. 
To highlight the rarity of co-created citizen science projects, Follett & Strezov 
2015) identified only four of 888 articles in which the projects were initiated and 
driven by the public. I note that the way that scientific research is funded makes 
co-created projects difficult to enact, as often funding has been granted for a 
specific area of research before the data collection method, in which one may 
decide to include citizen scientists, has been considered. In this final level of 
engagement, the citizens are effectively involved in the entire scientific method 
from synthesis of a project to measuring results and coming to an evidence-
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based conclusion. This is the aim of all citizen science projects but is 
understandably difficult to achieve. 
1.5.5 Citizen Science Outcomes 
It is not only the scientist and the participant who benefit from citizen science. 
Shirk et al (2012) suggested that outside of research outcomes (scientific 
findings) and participant outcomes (acquiring new skills or knowledge), there 
are social-ecological system outcomes. Participation in collaborative and 
community-based monitoring has resulted in community-level outcomes, such 
as increased functioning of social groups through interpersonal relationships 
(Adger and Anger, 2003), increased ability for a given community to leverage 
resources to solve collective problems (Donoghue and Sturtevant, 2007), and 
trust between scientists, managers, and the public (Fernandez-Gimenez et al., 
2008). A successful citizen science project can inform ongoing exercises in 
setting goals and objectives for future research projects, policy shift and 
funding decisions (Phillips et al., 2014). Perez et al (2016) suggested that 
involvement in citizen science may contribute to the natural aggregation of 
social norms that influence trends in political positions, opinions, cultural traits 
and scientific progress.  
Many of the citizen science projects that achieve this outcome revolve around 
the monitoring of a specific data point, often as part of a national or global 
monitoring network. For example, Danielsen et al (2007) reported on 
experienced hunters and anglers living near protected areas in the Philippines 
who monitor and react to changes in resource use related to wildlife 
populations. Separately, the Jamaican Water Resource Authority required 
data on water levels from remote sites and so trained volunteers to read river 
gauges at assigned locations, gathering data needed to implement protective 
measures before floods (IFRC, 2000). The Famine Early Warnings Systems 
Network enlisted local monitors to report data such as rainfall and staple food 
prices around the world for use in ensuring food security (Barbara, 2011).The 
sea turtle monitoring network Grupo Tortuguero supports a body of 
hypothesis-driven scientific work. The consequent collaboration between 
biologists, agencies, and communities helped to establish marine protected 
areas and sustainable fisheries practices that are sensitive to the wellbeing of 
both turtle populations and local livelihoods (Delgado and Nichols, 2005).  
Whilst difficult to achieve, a possible and perhaps desirable outcome for a 
citizen science project would be to provide scientific findings, influence an 
individual’s skills and knowledge, as well as to effect change in a broader 
context, within a community or through policy changes. However, in order to 
recognise the outcomes of a project, a project must be carefully evaluated. 
1.5.6 Evaluating Citizen Science Projects.  
In the previous section, I discussed the potential of citizen science to contribute 
to change in science and society. The power of citizen science to achieve 
these outcomes has been recognised and as a result, new funding schemes 
have appeared (Kieslinger et al., 2018). In order to continue convincing funding 
bodies of the power of citizen science, evaluation is important to fill the gaps 
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in understanding of the effectiveness of citizen science. As of 2014, Phillips et 
al (2014) highlighted the less than rigorous evaluations or neglected evaluation 
altogether of the majority of citizen-science projects. The success and 
increased funding for citizen science calls for context-adaptable evaluation 
criteria that assess the impact of citizen science programmes on science, 
society and policy (Kieslinger et al., 2018).  
Shirk et al (2012) suggested that there are three dimensions by which citizen 
science projects can be evaluated. These are project scientific impact 
(research outcomes), learning and empowerment of participants (participant 
outcomes) and impacts for wider society. research outcomes (social-
ecological system outcomes). Evaluation must include outcome-based 
evaluation and process-based evaluation, assessing the overall goals of 
activities or programmes and the benefits to participants and recipients of the 
results as well as the operational strengths and weakness of activities or 
programmes, respectively (Kieslinger et al., 2018).  
An open framework for citizen science evaluation, based on the Ten Principles 
of Citizen Science (1.5.1)(Robinson et al., 2018), was put forward by Kieslinger 
et al (2018) and is shown in Table 1-11. 
Table 1-11. Citizen Science Evaluation Framework. Framework evaluating three core dimensions: 1) 
Scientific dimension, 2) Participant dimension and 3) socio-ecological dimension. For each dimension, 
criteria are proposed at the “process and feasibility” level, and the “outcome and impact” level. Taken 
from (Kieslinger et al., 2018). 
Dimension Process and Feasibility Outcome and Impact 
Scientific • Scientific objectives 
• Data and systems 
• Evaluation and 
adaptation 
• Collaboration and 
synergies 
• Scientific knowledge 
and publications 
• New research fields 
and structures 
• New knowledge 
resources 
 
Participant • Target group 
alignment 
• Degree of 
involvement 
• Facilitation and 
communication 
• Knowledge and 
science literacy 
• Behaviour and 
ownership 




• Target group 
alignment 
• Active involvement 
• Collaboration and 
synergies 
• Societal impact 
• Ecological impact 
• Wider innovation 
potential 
   
 
Kieslinger et al (2018) noted that as the project lifecycle advances, the 
emphasis of evaluation would gradually shift from process and feasibility to 
outcome and impact. As this is the most comprehensive evaluation framework 
for citizen science projects to date, and it emerged towards the end of my 
project, I use this framework to assess the extent to which this PhD project 
was a successful citizen science project (6.1.4).  
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Whilst this framework is the most comprehensive to date, it had not been 
developed at the conception of this project when it was necessary to prepare 
the groundwork for upcoming activities by engaging with concepts, 
methodologies and adaptive planning. Instead, I developed a logic model that 
depicted the relationship between this studies inputs and activities and their 
intended effects (Appendix B-1). I also mapped my expected outcomes for the 
citizen scientist to the framework for evaluating citizen science learning 
outcomes (Phillips et al., 2014). This framework focused only on the participant 
outcomes, breaking these into six categories: 
1. Behaviour & Stewardship 
2. Skills of Science Inquiry 
3. Knowledge of the Nature of Science 




Whilst I do not use these outcomes to evaluate my project in Chapter 6, this 
framework was used for project development and was a useful tool for 
preparing the groundwork for the participant learning outcomes in this citizen 
science project. 
In summary, citizen science can be defined as public participation and 
collaboration in scientific research with the aim to increase scientific 
knowledge. Citizen science often lacks scientific outcomes. Of those projects 
that do achieve scientific outcomes, they often neglect participant outcomes 
scientific power and are used in the most part as a methodology for collecting 
and classifying data produced by members of the public (Kullenberg and 
Kasperowski, 2016). If the focus is changed to improve knowledge and skills 
amongst citizen scientists, often the research outcomes suffer. Despite the 
success of projects in encouraging interested participants to take part, there is 
room for improvement. This improvement focuses on, among others, concerns 
of data quality and ensuring a link between scientific objectives and social 
outcomes (Bonney et al., 2014). In order to tackle the need for better 
evaluation, linking three dimensions of outcomes, an open framework has 
been created to help evaluate the success of citizen science projects 
(Kieslinger et al., 2018). I use both this framework and the ten principles 
underlying good citizen science practice (Robinson et al., 2018) to assess the 
success of this study as a citizen science project in Chapter 6. 
1.6 Antibiotics Unearthed 
Antibiotic discovery revolutionised modern medicine, however each discovery 
of a novel antibiotic was quickly followed by resultant antibiotic resistance in 
bacteria. Failures to develop long term strategies to tackle this has led to a 
global health crisis. Ten commandments were developed to highlight areas in 
which we could be doing better to tackle antibiotic resistance (O’Neill, 2016b). 
Two key methods of tackling antibiotic resistance are reinvigorating the drug 
discovery pipeline and preserving the effectiveness of current antibiotics. A 
key part of both, and the first commandment, is a massive global public 
awareness campaign. There are gaps in the public awareness of antibiotic 
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resistance. This awareness, or lack of, as reported in scientific literature is well 
explained through six key themes (1.3). In understanding these themes, 
recommendations can be made for Public Health campaigns and Citizen 
Science projects which aim to raise awareness. Public health campaigns are 
a useful tool for increasing public awareness, however, suffer issues in terms 
of engaging hard-to-reach individuals, often whom are most in need of being 
reached. Public engagement through citizen science projects is another way 
of attempting to engage members of the public in order to raise awareness. 
Citizen science projects also suffer issues, however strong frameworks for 
evaluation can go some way to reducing these by presenting a case for the 
power of citizen science for scientific research, participant learning and 
societal outcomes. In the next section, I present the Small World Initiative, and 
examine how this PhD project has adapted it to form a comprehensive citizen 
science project focused on reinvigorating the drug discovery pipeline and 
preserving the effectiveness of current antibiotics. 
1.6.1 Small World Initiative, Yale. 
The Small World InitiativeTM was a Yale University project developed by Dr. Jo 
Handelsman to address the global health threat of antibiotic resistance. The 
initiative identified two problems, a growing economic need for more Science, 
Technology, Engineering and Mathematics (STEM) graduates and the issue 
of AMR. The Small World Initiative programme is fundamentally a biology 
course that provides original research opportunities for its University and 
College students with the aim of collecting soil samples, isolating diverse 
bacteria and testing these for antibiotic or antifungal production against 
clinically relevant microorganisms. The Small World Initiative has currently 
trained instructors at more than 330 schools across 45 U.S.A States and 15 
countries. Over 10,000 students have taken or are taking the Small World 
Initiative’s introductory biology course (Small World Initiative., 2019).  
1.6.2 Antibiotics Unearthed and the Microbiology Society. 
In 2015 the Microbiology Society worked with the Small World Initiative to 
implement a spin off programme, Antibiotics Unearthed. The aim was to 
engage schools, undergraduates and the public in the U.K and Ireland in a 
search for novel antibiotics in collaboration with scientists. Like the Small 
World Initiative’s biology course, schools and universities could apply for 
support from the Microbiology Society to run the Antibiotics Unearthed 
programme. Students would then learn how to look for new antimicrobial 
compounds in soil samples through a series of laboratory sessions. The aims 
of the Microbiology Society aligned strongly with those outlined at Yale 
(Microbiology Society, 2019a). To help the school or university partnership, the 
Microbiology Society provided full training for teachers and technicians, 
protocols for the research and all consumables that the institution would need 
for the experiments. Results were presented at the Microbiology Society’s 
Annual Conference. In the case that an interesting and perhaps novel 
antimicrobial was discovered, staff and students would be encouraged to carry 
out more detailed analysis on the compounds. This initiative proved popular 
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(Microbiology Society, 2017a, 2017b) and was part of undergraduate courses 
at five universities and courses at seven schools.  
1.6.3 Contextualising this PhD: Antibiotics Unearthed 
This PhD was a match-funded project between the Microbiology Society and 
the University of East Anglia, using the Antibiotics Unearthed methodology of 
collecting soil samples to identify novel antimicrobial agents. A key feature of 
the project was the design of a citizen science protocol. This protocol included 
pop up stands, interviews, social media interaction and portfolios all with 
members of the public (2.6 and 2.7). These tools were designed to engage the 
public with the issues of antibiotic discovery and antibiotic resistance, whilst 
tracking how this engagement facilitated a participants exploration of these two 
topics, in the hope of ultimately leading to behaviours that help preserve the 
effectiveness of current antibiotics.  
This chapter has presented the history of antibiotics, the emergence of 
resistance to these antibiotics, the problems antibiotic resistance presents and 
the potential solutions to this problem. It has also examined the current 
literature on public perception of antibiotics and antibiotic resistance, as well 
as the history of public understanding and public engagement. It defined 
citizen science and highlighted what it takes to produce a successful citizen 
science project. It finally discussed how this PhD project was conceived. The 
next chapters discuss the methods used to undertake this interdisciplinary 
project and the results that came from both the pursuit of novel antimicrobials 
and the pursuit of public perception data over short, medium and long terms. 
It draws conclusions from these results to determine the extent to which it was 
successful at reinvigorating the drug discovery pipeline and preserving the 
effectiveness of current antibiotics. Finally, it provides suggestions on how 
future citizen science projects could use this project as a toolkit to prepare and 
undertake a successful citizen science project (Table 1-12). 
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Chapter Title Chapter Content 
Chapter 
1 
Introduction Literature Review of antibiotics and 
antibiotic resistance. Public perception of 
antibiotic resistance. Review of public 
health campaigns. The history and state of 
citizen science projects in general, and in 
the field of microbiology. The role of the 
Antibiotics Unearthed Project. 
Chapter 
2 
Materials and Methods Methods used for the microbiology 
research. Methodological underpinnings 
of the social science research and the 
methods used.  
Chapter 
3 
The microbial composition 
and antimicrobial activity of 
citizen science soil 
samples 
Data collection and analysis, followed by 
results of isolating antibiotic producing 
bacteria from soil sample, screening them 
against medically relevant pathogens, 
whole genome sequencing a select few 
colonies and identifying the nearest 
relatives and biosynthetic loci coding for 




Public understandings of 
and attitudes to antibiotics 
and antibiotic resistance: 
Findings from a citizen 
science project 
Design of data collection and analysis 
including pop up stands and interviews. 
Descriptive and thematic analysis of 
interview data using pivotal codes based 
on key themes extracted from public 
perception literature.  
Chapter 
5 
Medium- and long-term 
study of public 
understandings of and 
attitudes to antibiotics and 
antibiotic resistance: 
Findings from a citizen 
science project 
Design of data collection and analysis of 
social media interaction and portfolio 
entries. Descriptive analysis of social 
media data. Thematic analysis of portfolio 




Conclusion Discussed the research questions in the 
light of methodological reflection. 
Reflected on strengths and limitations and 
provided concluding remarks.  
Chapter 
7 
References References to literature discussed 
throughout the PhD. 
Chapter 
8 






































Part One: Natural Sciences Materials and Methods 
2.1 Materials 
Chemicals and reagents used are laboratory standard grade or above, 
purchased from Fisher Scientific (U.K) or Sigma Aldrich (U.K) unless stated 
otherwise. Distilled water (dH2O) was used in all media and solutions. 
2.2 Bacterial strains 
All strains used in this study are listed in Table 2-1. 
2.3 Strain isolation and culture conditions 
2.3.1 Media 
Media compositions are shown in Appendix C-1. When required, media were 
supplemented with appropriate antifungals (Appendix D-1) at the following 
concentrations: cycloheximide (100 µg/mL) and nystatin (20 µg/mL) unless 
otherwise stated. All media were autoclaved at 125°C for 30 minutes at 15 p.s.i 
unless otherwise stated. 
2.3.2 Soil sample collection 
Soil samples were collected from topsoil by members of the public from five 
locations around the U.K: Garwnant Forest, Glasgow Botanical Gardens, 
Kielder Forest, Thetford Forest and the University of East Anglia, Norwich. 
They used faecal sample collection tubes which contained a spoon to collect 
between 2-10 g of soil.
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Table 2-1. Strains used throughout this study. 
Strain Description Reference 
Indicator Strains 
168 Bacillus subtilis (Anagnostopoulos and 
Spizizen, 1961) 
CA6 Candida albicans (Marconi et al., 1976) 
Kp2 Klebsiella pneumoniae (Clarke, Yousafzai and 
Eady, 1999) 
 Methicillin-resistant Staphylococcus 
aureus 
(Y. Qin et al., 2017) 
DT104 Salmonella enterica serovar 
Typhimurium  
(Poppe et al., 1998) 
SL1344 Salmonella enterica serovar 
Typhimurium 4/74, hisG, rpsL 
(Hoiseth and Stocker, 




Staphylococcus epidermidis (Dale et al., 1995) 
B16.06226 Vancomycin-resistant Enterococcus 
faecium  
(Y. Qin et al., 2017) 
   
Environmental isolates 
ELD01 Bacillus subtilis This study 
ELD02 Bacillus altitudinis This study 
ELD03 Bacillus velezensis This study 
ELD04 Bacillus altitudinis This study 
ELD05 Paenibacillus peoriae  This study 
ELD06 Sporosarcina aquamarina This study 
ELD07 Bacillus subtilis This study 
ELD08 Paenibacillus peoriae  This study 
ELD09 Bacillus subtilis This study 
ELD10 Bacillus simplex This study 
ELD11 Bacillus subtilis This study 
ELD12 Pseudomonas vranovensis This study 
ELD13 Bacillus psychrodurans This study 
ELD14 Bacillus altitudinis This study 
ELD15 Pseudomonas vranovensis This study 
 
2.3.3 Overnight culture of environmental strains 
2.3.3.1 In-situ protocol 
One gram of soil was mixed with 10 mL sterilised tap water in situ and shaken 
by hand. Using a Pasteur pipette, five drops (~50 µL) of soil solution were 
transferred on to an LB Agar plate containing antifungals for spread plating. 
The plate was then packaged and transported to the University of East Anglia 
and incubated at 30°C for up to 48 hours and stored at 4°C. Sterilised tap water 
was plated to rule out potential sources of contamination. After incubation, 
digital photographs of the isolates were taken using a Panasonic DCM-FZ18 
LUMIX camera inside a home-made black box. 
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2.3.3.2 Laboratory protocol 
One gram of soil was resuspended in 10 mL dH2O, homogenised on a vortex 
at 13000 rpm for 60 seconds and diluted 1:10; 100 µL soil solution and 900 µL 
dH2O. 100 µL of this 10-1 solution was spread plated on to Brain Heart Infusion 
(BHI) Agar and All Culture (AC) Agar containing antifungals. Plates were 
incubated at 30°C for up to 48 hours and stored at 4°C. Photos were taken as 
stated in 2.3.3.1. 
2.3.4 Isolating potential antibiotic-producing colonies 
Single colonies that appeared to be inhibiting the growth of neighbouring 
colonies were picked from the LB, BHI or AC agar plates and subcultured to 
obtain pure cultures (isolates). Isolates were maintained on the media they 
were originally picked from, but no antifungals were added to the subcultured 
plates. Isolates were incubated at 30°C and stored at 4°C. Photos were taken 
as stated in 2.3.3.1. 
2.3.5 Long-term strain stocks 
Glycerol stocks produced by adding 1 mL of fresh overnight culture grown in 
their respective media to 900 µL of 40% (v/v) glycerol in a 2 mL cryogen tube, 
inverted to mix and stored at -80°C. Microbank™ bead stocks were produced 
by following manufacturer’s instructions (Prolab Diagnostics), stored at -80°C 
2.4 Inhibition of medically relevant laboratory isolates 
2.4.1.1 Overnight cultures  
Indicator strains were aseptically streaked on to LB agar plates from glycerol 
stocks or Microbank™ bead stocks and incubated overnight at 30°C and stored 
at 4°C. 10 mL LB cultures inoculated with a single colony were cultured 
overnight (~15 hrs) at 30°C, 200 rpm. 200 μL cultures of environmental strains, 
inoculated with a single colony, were grown overnight (~15 hrs) in a 96 well 
plate using the media they were isolated from. 96-well plates were left 
stationary overnight at 30°C. All work was completed in a category 2 microbial 
safety hood. 
2.4.2 Drop plate assay 
After overnight growth in a respective broth, indicator strains were spread as 
a lawn using sterile cotton swabs and left to dry on 4% agar plates. Isolates of 
interest were added on top of this dry lawn using an 8-tip multi-pipette with 6 
pipette tips attached. 5 μL samples were taken from the 96-well plates and 
dispensed onto the indicator strains in a 6 x 4 grid. Plates were left to dry and 
incubated at 30⁰C overnight (Figure 2-1). Photos were taken as stated in 




Figure 2-1. Drop plate assay to test inhibition of medically relevant laboratory isolates. Indicator 
strains grown overnight in liquid broth were spread as a lawn using sterile cotton swabs and left to dry on 
4% agar plates. Isolates of interest were added on top of this dry lawn using an 8-tip multi-pipette with 6 
pipette tips attached. 5 μL samples were taken from 96-well plates and dispensed onto the indicator 
strains in a 6 x 4 grid. Plates were left to dry and incubated at 30⁰C overnight. Zones of inhibition left a 
clear circle around the environmental isolate where no indicator strain could grow. 
 
2.5 Genome sequencing of inhibitory isolates 
2.5.1 Samples and DNA extraction 
To rationalise which inhibitory isolates were selected for genome sequencing, 
soil samples or forest locations with multiple inhibitory isolates had to be 
morphologically distinct from each other and have a unique inhibitory profile to 
be selected. From this, 15 distinct isolates were grown overnight in 5 mL broth 
and harvested using centrifugation. Pellets were prepared and snap frozen 
using liquid nitrogen. Genomic DNA (gDNA) was extracted using QIagen ATL 
lysis buffer plus DTT. After isolation, liquid nitrogen was used to flash freeze 
the gDNA which was then transported on dry ice.  
2.5.2 MiSeq Genome Sequencing 
The DNA Libraries for all samples (n = 15) were prepared using the Nextera® 
XT (Illumina, Inc.) sample preparation, and the 600-cycle v3 reagent kit by 
myself and Dr. Hurst. After DNA libraries were prepared, samples were 
sequenced using paired 300 bp reads by the group of Prof. Cooper, School of 
Medicine, University of East Anglia. 
2.5.3 Genome Sequencing data analysis 
The Cooper Lab uploaded all sequence data to BaceSpace™, Illumina’s 
integrated sequencing hub, and produced coverage plots and average quality 
scores. They annotated and assembled genomes with the Prokka annotation 
pipeline V1.12 (Seemann, 2014) and provided FastQ files, in a text-based 
format with quality scores. Reads of inserts had been filtered by quality and 
read length by the Cooper Lab. I conducted 16S rRNA analysis using 
applications within the BaseSpace™ suite, namely MetaPhlAn (Segata et al., 
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2012), 16S Metagenomics (Wang et al., 2007) and Kraken Metagenomics 
(Wood and Salzberg, 2014).  
2.5.4 Phylogenetic analysis 
The 16S rRNA sequences of isolates were retrieved from their genomes and 
compared with sequences of 16S rRNA gene sequences using the National 
Center for Biotechnology Information’s Basic Local Alignment Search Tool 
(BLAST), specifically BLASTN (Altschul et al., 1990). Type strains which had 
a similarity of higher than 97% with each isolate were used for sequence 
analysis. Stenotrophomonas maltophilia (DSM 20030T) was used as the 
Gram-positive outgroup, while Acinetobacter baumannii (DSM 30007T) was 
used as the Gram-negative outgroup. 
The trees of the 16S rRNA gene were constructed. Phylogenetic analysis was 
conducted using the MEGA software package version 7.0 (Kumar, Stecher 
and Tamura, 2016) after alignment of the data via Muscle (Edgar, 2004). 
Phylogenetic trees were constructed by neighbour-joining (NJ) (Saitou and 
Nei, 1987) algorithms and the topology of the NJ tree was evaluated using 
bootstrap analysis on the basis of 500 replications (Felsenstein, 1985).  
2.5.4.1 Detecting secondary metabolite biosynthetic gene clusters 
FASTA files were uploaded to the antiSMASH 3.0 (Weber et al., 2015) web 
server. Gene prediction was performed by Glimmer3 (Delcher et al., 2007). A 
search was conducted using ‘KnownClusterBlast’, ‘SmCOG analysis’, 
‘ActiveSite finder’ and ‘SubClusterBlast’ to identify the secondary metabolite 
biosynthetic gene clusters (BGCs). Probabilistic detection was turned off.
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Part Two: Ontological and epistemological assumptions of 
this study 
Ontological assumptions give rise to epistemological assumptions; these, in 
turn, give rise to methodological considerations; and these, in turn, give rise to 
issues of instrumentation and data collection. These assumptions, both 
implicitly and explicitly, underpin the way one looks at social reality (Cohen, 
Manion and Morrison, 2007). This section explores briefly each of these sets 
of assumptions underpinning social science at large, and this study 
specifically. 
Ontological assumptions concern the very nature or essence of the social 
phenomena being investigated. A key question asked at this stage is whether 
the author sees social reality external to individuals, or as the product of 
individual consciousness. Reality could be of an objective nature or the result 
of individual cognition. The phenomena may be a given in the world, or it may 
be created by an individual’s mind. Ontologically, one is either a realist or a 
nominalist. A realist contends that objects have an independent existence and 
are not dependent for it on the knower, whilst a nominalist suggests that 
objects of thought are merely words and that there is no independently 
accessible thing constituting the meaning of a word (Cohen, Manion and 
Morrison, 2007).  
Epistemological assumptions concern the very bases of knowledge; its nature 
and forms, how it can be acquired and communicated to other human beings. 
One’s epistemological assumptions affect how they go about producing 
knowledge. Epistemologically, one can be a positivist, or non-positivist. A 
positivist holds the view that knowledge is hard, objective and tangible. This 
mindset demands of researchers an observer role, together with an allegiance 
to the methods of natural science. A non-positivist sees knowledge as personal 
and subjective. This imposes on researchers an involvement with their 
subjects and a distancing from the ways of the natural scientist (Cohen, 
Manion and Morrison, 2007).  
A final set of assumptions pertains specifically to the nature of social science 
as the study of humans. These assumptions concern human nature, 
particularly the relationship between human beings and their environment. In 
social science, human beings are both the subject and object of study. A social 
scientist can endorse determinist or voluntarist assumptions. Determinism 
portrays humans as responding mechanically deterministically to their 
environment; as products of the environment, controlled like puppets. 
Voluntarism portrays humans as initiators of their own actions with free will and 
creativity, and co-producers of their own environments (Cohen, Manion and 
Morrison, 2007).  
Methodological decisions are made in the light of ontological and 
epistemological assumptions. An investigator who takes a positivist (or 
objectivist) approach to the social world assumes the world of natural 
phenomena is real and external to the individual, and most often will opt for 
surveys and experiments. An investigator who takes a non-positivist (or 
subjectivist) approach to the social world assumes the world to be personal 
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and humanly created, and most often will opt for personal accounts accessed, 
for example, via interview and participant observation (Cohen, Manion and 
Morrison, 2007).  
The positivist would employ scientific investigation directed at analysing the 
relationships and regularities between selected factors in that world. Their 
investigation will be predominantly quantitative and will be concerned with 
identifying and defining elements and discovering ways in which their 
relationships can be expressed. The non-positivist’s principal concern is with 
an understanding of the way in which the individual creates, modifies and 
interprets the world in which they find themselves. This approach may takes 
on a qualitative as well as quantitative aspect (Cohen, Manion and Morrison, 
2007). 
As the investigator of this PhD, I am coming from a scientific paradigm whereby 
I consider myself a realist and a positivist carrying out research which is 
quantitative in nature. I am transitioning into a citizen science paradigm, which 
navigates across the nominalist and the realist paradigms as well as across 
the non-positivist and positivist paradigms. I note that as human behaviour is 
one focus of the study, my study also navigates between voluntarism and 
determinism. This naturally leads to a mixed methods approach, in which one 
can utilise both quantitative and qualitative methodologies in order to explore 
the natural phenomena that are the focus of the study (for example, the lab-
based analysis of the data collected by the participants) and the social 
phenomena (for example, the evolution of the participants’ discourses on 
science over the course of their engagement with the study). Citizen science 
design itself, where a researcher is engaging human participants with scientific 
research, calls for a mixed methods approach (1.5). Part Three considers the 
issues of instrumentation and data collection associated with the study of 




Part Three: Social Sciences Methods 
2.6 Access to participants 
I focused in depth on a convenience sample of members of the public selected 
at pop-up stands in five locations across the U.K (Table 2-2). The five events 
took place over a 14-month period, beginning 9th September 2016 and ending 
19th October 2017, in Wales, England and Scotland. The forest locations were 
chosen by the Microbiology Society communications team. Convenience 
sampling was used to identify a relevant population for study. Convenience 
sampling is a type of nonprobability sampling in which people are sampled 
simply because they are available and accessible sources of data for 
researchers (Battaglia, 2008). Convenience sampling is cost effective, simple 
and can lead to hypothesis generation in a short duration of time. However, 
like all non-probability sampling, it is prone to volunteer bias and therefore 
could have a high level of sampling error. Due to the nature of convenience 
sampling, whereby we are reliant on volunteers, sample size was limited by 
the factors which influenced the number of volunteers that could be obtained.
Table 2-2. Antibiotic Unearthed Pop-up events. Event locations, visit dates and who the location was 
managed by (noted as approval was given for us to collect samples and hold the intellectual property of any 
discoveries). 
 
Pop-up stands were used and provided a covered area in which Microbiology 
Society and University of East Anglia logos with the project’s name Antibiotics 
Unearthed were made visible to the passing public. I engaged members of the 
public using a factual and narrative account of the potential for volunteers to 
help find novel antibiotics in soil bacteria (storytelling). Storytelling can be used 
to move audiences to action (Woodside, 2010). Explanations about the project 
were enticing, designed to pique interest but were kept deliberately vague so 
as not to provide answers to the questions that were to follow if a participant 
chose to take part in an interview (2.7.1). Once returning from soil collection, 
participants were asked by myself whether they would be comfortable 
Event location Date Managed by 
Brecon Beacons National Park, 
Coed Taf Fawr forest, Garwnant 
visitor centre, Merthyr Tydfil. OS 




Forestry Commission Wales. 
Kielder Forest, Northumberland. 




Forestry Commission England 






Glasgow Botanic Gardens, 




The Friends of Glasgow 
Botanic Gardens. 
Norwich Science Festival, The 
Forum, Norwich. Soil collected 




Event sponsored, funded and 
partnered with multiple 
organisations. Soil and stand 




undertaking an interview. Upon agreeing to be interviewed, the participant was 
given reassurance on confidentiality and their right to withdraw at any time. It 
was clearly stated that this was an investigation into the participants’ 
perception of the issue of antibiotics and antibiotic resistance. After completing 
or declining to complete the interview, participants were shown how to process 
their sample ready to be taken back to the University of East Anglia laboratory 
for further research (2.3.2).They were then advised that they could follow the 
progress of their own numbered soil samples on our Facebook page and they 
were provided with documents providing links to the relevant social media. 
Finally, participants were asked whether they would be willing to take a 
portfolio from us and contribute to long-term data collection. If participants 
agreed to take part in the project, they were given an Antibiotics Unearthed 
starter pack (Figure 2-2). Consent forms were given at each part of this 
process. 
 
Figure 2-2. Packs were given to members of the public upon agreement to collect a soil sample. From 
top left participants were given a booklet explaining Antibiotics Unearthed, a booklet explaining antibiotic 
resistance, a marvellous microbes comic book, soil sample collection pots, a trowel, antibiotics unearthed 
wrist bands, antibiotics Unearthed factsheet, a Microbiology Society advertisement and an Antibiotics 
Unearthed toy. 
 
At the pop-up stands, participants were asked to collect soil samples, 
undertake interviews, follow our social media presence and compose a 
portfolio. Participants were not required to undertake all these tasks. A total of 
455 soil samples were collected, 32 interviews were recorded, 337 email 




Table 2-3. Sampling details for each pop-up event. The number of soil samples obtained, interviews 
conducted, email address collected for future social media engagement and portfolios handed out at each of 














155 13 121 2 
Kielder Forest,  144 10 96 3 
Thetford 
Forest,  








57 1 42 3 
     
 
2.7 Data Collection and Analysis 
Phillips et al (2014) highlighted common data collection methods with 
description, strengths and weaknesses. From this, I selected short-, medium- 
and long-term tools for data collection. Data collection began on the 9th 
September 2016 and was completed in May 2018. 
2.7.1 Interviews – Short Term  
I conducted face-to-face, semi-structured interviews with open- and closed-
ended questions with members of the public (6 - 37 minutes) at pop-up stands 
around the U.K. Participants were informed that the purpose of the interview 
was to understand public perceptions surrounding the topics of antibiotics and 
antibiotic resistance. Questions were based on exploring key themes emerging 
from a literature review (1.3). In total, four distinct topics were explored through 
fifteen questions (Table 2-4). The four topics were soil microbiota’s role in 
medicine, antibiotic resistance, use of antibiotics in a medical setting and 
antibiotic discovery. Each topic was captured by one closed-ended question, 
whilst the remaining questions were open-ended. Questions were developed 
and refined in collaboration with the supervisory team. Questions were 
submitted to the Research in Mathematics Education (RME) group within the 
University of East Anglia School of Education for feedback. Feedback was 
incorporated into the final design of the interview questionnaire. The interview 
questionnaire was trialled at the University of East Anglia on a volunteer by the 
researcher with supervision from the supervisory team. Feedback from this 
process was also incorporated into the design and delivery of the interview. In 
total 32 interviews were conducted on 40 interviewees. In instances where 
there was a couple, rather than isolating an individual, questions were put to 
both. Whilst this deviated from the normal one-to-one nature of an interview, it 




Audiotaped interviews were transcribed using Microsoft Word. These word 
files were uploaded to NVivo 11, read twice, then discussed with an 
experienced qualitative researcher (Prof. Nardi). To ensure the anonymity of 
participants whilst allowing for participant identification, consecutive numbers 
were assigned to interviews (1-32). Participants are referred to by their 
interview number. In some interviews, two participants were present, and were 
so designated A and B. For convention, the first person to have spoken in the 
interview is ‘A’ and the second person to have spoken is ‘B’. The interviewer, 
or researcher, is denoted as ‘R’.  
Coding schedules were agreed and piloted (Table 2-5). These codes 
represented key topics emerging from the public perception literature (1.3), 
conceptions of research and researchers (Brew, 2001) and a commognitive 
framework (Sfard, 2008). Interviews were coded in NVivo 11. One interview 
was selected at random to be double coded (Prof. Nardi); ambiguities were 
resolved in discussion. Coded interviews were distilled into factual accounts 
(Appendix E-1). Codes were reduced to major themes through ongoing 
discussion between researchers and the re-reading of factual summaries and 
transcripts.  
 
Table 2-4. Antibiotic Unearthed Interview Questions. Fifteen questions were based on key topics of 
antibiotics and antibiotic resistance and were refined with the help of the University of East Anglia Research 
in Mathematics Education group. 
Questions asked of respondents 
1. Why are we looking for new antibiotics in the soil? 
2. Antibiotics are made by bacteria, fungi, humans, plants, viruses? 
3. Can you name infections we take antibiotics for? 
4. Antibiotics are taken for bacterial, fungal or viral infections? 
5. When was the last time we discovered new antibiotics? 
6. Have you heard of teixobactin? 
7. How many antibiotics have been discovered since 1962? ^ 
8. What do you know about antibiotic resistance? 
9. Which of the following can become resistance to antibiotics, bacteria, 
fungi, humans, plants, viruses? 
10. What’s causing antibiotic resistance? * 
11. How does antibiotic resistance spread? 
12. Biggest problem for humans if antibiotic resistance spreads? 
13. Can you make a difference to the spread of antibiotic resistance? 
14. How are antibiotics used? 
15. Are antibiotics misused? 
*Question 10 was added to the original questionnaire for the start of the Thetford Forest event on the 
4th May 2017 after looking back at transcripts from the first two events and identifying room for further 
questioning. Interviewee 24 to interviewee 29 were asked this question, and upon analysis of results the 
question was discarded for the remaining two events.  
^Question 7 was removed midway through the Kielder Forest event on the 16th September for 
interviewee 17 to interviewee 21. Answers to this question were guesses, and there was a feel that it 
added confusion to the conversation. It was added back in after it was realised that it could still be used 
to quantitatively identify optimistic or pessimistic nature among interviewees.  
Interviewee 23 was not asked question 6 or question 7 due to the breadth and nature of discussion 
following Q5. This meant these topics were discussed, but question 6 and 7 were not directly asked as 




Table 2-5. Coding schedule. Code abbreviation and description mapped against number of times code was applied in 32 interviews (references) and number of interviews it was applied in (sources). 
Codes were based on key topics emerging from public perception of antibiotics and antibiotic resistance literature and a framework discussing conceptions of research (Brew, 2001). 
Code Code description References Sources 
SKO Evidence of scientific knowledge 310 32 
CON Level of confidence a participant has in their response 212 30 
SWU Evidence of scientific word use 105 26 
TER Evidence of lay word use 79 24 
IRO Irresponsible others are to blame for spread of AMR 70 26 
ABI Understanding of which illnesses can be treated with antibiotics 61 25 
PHN Evidence of public health narrative rhetoric 55 28 
ROD Beliefs about the role of doctors in the problem of AMR 48 23 
ReB The belief that the human body becomes resistant to antibiotics rather than the infectious body 44 19 
UTA What users take antibiotics for 43 20 
ABP Knowledge surrounding antibiotics being used as prophylactics 35 11 
MRB Knowledge of medically relevant bacteria 29 16 
UTO Utopian attitude towards science 29 16 
DRI Confusion using the terms surrounding AMR and antibiotics 22 16 
DYS Dystopian attitude towards science 20 15 
UURE Knowledge that unnecessary use of antibiotics results in a reduced effectiveness 19 15 
BAT Evidence of avoidance of antibiotics due to belief that our body is a temple and antibiotics disrupt that 19 12 
Trading Scientific research as a means of product generation 19 12 
Domino Research as a physical process of daily tasks, events, things, activities, problems, techniques, experiments, 
issues, ideas and questions 
18 14 
CTD Adherence to the narrative of completing the dose of antibiotics 15 11 
Layer Scientific research as bringing to light ideas, explanations and truths 15 8 
SAS Use of stories to explain science, almost like a mythology 14 10 
UVT Narrative of us versus them, can take several forms 12 8 
KID Narrative of elite actors deliberately keeping the public in the dark about emerging technologies 11 8 
PON The potential of nature to provide humans with medicines 10 7 
PB Science as releasing potential and unforeseen evil, likened to pandora’s box 10 6 





WMP A belief that science is gaining wisdom by misusing power 9 5 
MN Ill-considered action will mess with preconceived morals and boundaries set by nature 7 4 
BKM Better objective knowledge about AMR leads to reduced misuse of antibiotics  6 5 
RGR Narrative that emerging technology helps the rich get richer and magnifies injustice and inequality 6 5 
Journey Research as engagement with activities which enable researcher growth or transformation 6 2 
DID Evidence of distinction between the two disciplines involved in this project, science and education 4 3 
NAE Narrative that the participant is not an expert, a qualifier on the potential of being wrong 4 3 
SSP Narrative that science is for smart people 3 3 
PMI Paternal or maternal instincts to protect a child would override the need to protect society 3 3 
FUSE Knowledge that frequent use of antibiotics leads to side effects 3 2 
SAE Narrative that science is evil or presents fake truths 1 1 
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Answers to the closed-ended questions were extracted and tabulated in 
Microsoft Excel. The data from the closed-ended questions were quantitatively 
scored. A yes response was given a score of 1, a no response a score of 2 
and a don’t know response a score of 3. Responses to closed-ended questions 
were analysed using GraphPad Prism 7. Because of the strict responses 
provided to the participants, there was no need to clean the data, or account 
for any missing data points.  
2.7.2 Facebook – Medium Term 
I provided links to the Antibiotics Unearthed Facebook page upon which 
various types of relevant content were published. Participants were informed 
that the purpose of the Facebook page was to follow along the progress of the 
natural science part of the project. Interested participants submitted email 
addresses on which to be alerted once images of their laboratory samples had 
been uploaded. 337 email address were collected, of which 309 were 
successfully sent email updates. The Facebook Page was public and so 
anybody could like the Page. The Page started with 476 likes on the 17th May 
2016 and ended on 1798 likes on the 22nd May 2018 as data collection 
concluded. Content released included web links to relevant news articles, 
event links advertising upcoming pop-up stands, photos from the pop-up stand 
events, videos created by the Microbiology Society, images of relevant tools 
for data analysis and images of laboratory samples (Table 2-6). Details of web 
links to these posts, where available, can be found in Appendix F-1. Posts 
were designed or discussed and edited in collaboration with the Microbiology 
Society’s Communications Team. Participant response guided the release of 
subsequent content. In total, 47 posts were released between the 5th July 2016 
and the 21st February 2018.  
Facebook metrics were downloaded to Microsoft Excel by the Microbiology 
Society’s Communications Team at the end of the data collection period on 
the 22nd May 2018. When users commented, I wrote a response which was 
edited in collaboration with the Microbiology Society. These comments and 
replies were filed in Microsoft Word. These word files were uploaded to NVivo 
11, then discussed with an experienced qualitative researcher (Prof. Nardi).  
Coding schedules were agreed and piloted (Table 2-5). These codes 
represented key topics emerging from the public perception literature (1.3), 
conceptions of research and researchers (Brew, 2001) and a commognitive 
framework (Sfard, 2008). Facebook comments were coded in NVivo 11. A 
series of comments with one user was selected at random to be double coded 
(Prof. Nardi); ambiguities were resolved in discussion. .
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Table 2-6. Chronological account of types of content released to Antibiotics Unearthed Facebook 
Page. Table shows the number of each of the 47 posts released as part of Antibiotics Unearthed social media 
engagement. The date of release of each post is shown, as well as the type of media that the post represented. 
Web links would take users to a page, such as a news article. Event links specifically advertised upcoming 
Antibiotics Unearthed pop-up stand events. Images provided visual aids to discussion. Videos linked to 
relevant media from YouTube. Photo refers to a change of cover photo. Sample Images were images of data 
emerging from the laboratory, labelled so users could identify their own soil samples.  
Post 
Number 
Date Description of Facebook Post 
1 05/07/16 Web Link to the Antibiotics Unearthed Webpages 
2 18/07/16 
Event Link to news event about the pop up stands to take 
place at Garwnant Visitor Centre in the Brecon Beacons, 
and Kielder Castle 
3 25/07/16 
Event Link to the Pop-Up Event taking place at Garwnant 
Forest 
4 10/08/16 
Photograph of a participants attending the Pop-Up Event at 
Garwnant Forest 
5 16/08/16 
Link to a BBC News article that discus finding a Colicin 
Resistant Bacteria found in Scotland 
6 18/08/16 
Video about Phage created by the Microbiology Society 
Attached to a Link to the Microbiology Today society 
magazine 
7/8 23/08/16 
New Image to represent Antibiotics Unearthed project and 
link to website 
9/10 24/08/16 
Photos of agar plates streaked from soil samples brought in 
by participants who attended the Pop-up event at Garwnant 
Forest and Kielder Forest during summer 2016 
 
Graphic of Different Colony Morphology Images 
11 22/09/16 
Link to a news article about UN signing a landmark 
declaration to fight the global challenge of antibiotic 
resistance 
12 23/09/16 
Photos of agar plates, lab-grown by Ethan at the University 
of East Anglia, using the brain-heart infusion media using 
samples found by participants that attended the Pop-up 
event at Garwnant Forest and Kielder Forest during summer 
2016 
13 04/10/16 
Link to News Story about The Microbiology Society staff trip 
to the Ministerial Side-Event on AMR held in New York to 
hear about the global commitment in tackling the issue 
14 03/11/16 
Link to an interactive microscope tool created by the 
Microbiology Society 
15 14/11/16 
Microbiology Society Fact sheet about Antibiotic Resistance 
released as part of Antibiotic Awareness Week 
16 16/11/16 Link to You Tube animation about Antibiotic Resistance 
17 23/11/16 
Photo images of zones of inhibition gathered from bacterial 
species purified from soil samples brought to the Pop-up 





Photos of zones of inhibition gathered from bacterial species 
purified from soil samples brought to the Pop-up event held 
at Garwnant Forest and Kielder Forest during summer 2016 
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Advert for lecture at Nottingham University focused on 
O’Neil Review on AMR 
20 09/01/17 
Two photographs of agar plates from Samples taken the 
2016 pop-up events at Garwnant Forest and Kielder Forest 
21 12/01/17 
News article about spider silk being used to augment 
antibiotic-releasing bandages 
22 23/01/17 
News article about a moth gut bacterium the defends its 
host by making antibiotics 
23 26/01/17 
Link to BBSRC highlighting a research call that address 
AMR in agriculture. 
24 09/02/17 
News article about scientists showing that currently 
available antibiotics can still stop resistant bacteria – by 
exerting enough force 
25 22/02/17 
News article from U.KRI about uncovering the molecular 
mechanisms that make MDR Klebsiella pneumoniae so 
resistant to antibiotics 
26 27/02/17 
NICE article:- Children and young people should be taught 
simple hygiene measures to curb the spread of infections 
27 03/03/17 
Announcement about the BBC Radio 4 drama called 
Resistance a three-part drama series about an outbreak of 
antibiotic resistance 
28 24/03/17 
School Pupil Winners of Antibiotic Unearthed Schools 
programme award 
29 05/04/17 
Agar plate demonstrating the microbial handprint of an 
eight-and-a-half-year-old boy after he’d been playing outside 
30&31 16/05/17 
Photo images of agar plates streaked from soil samples 
brought in by participants who attended the Glasgow 
Botanic Garden Pop up event that took place in May 
32 30/05/17 
Photos of agar plates, lab-grown by Ethan at the University 
of East Anglia, using the brain-heart infusion media using 
samples found by participants that attended the Thetford 
Forest pop up event in May 
33 27/06/17 
Photos of zones of inhibition gathered from bacterial species 
purified from soil samples brought to the Pop-up event at 
Thetford Forest in May 
34 31/07/17 
Lespar comment on the BMJ article that discusses how long 
people should take a course of antibiotics for 
35 10/08/17 
Photos of species identified by Ethan from soil samples 
brought to the pop-up event at Thetford Forest that took 
place in July. Post provided information gathered from 
sequencing to identify the groups of bacteria that were 
found in the various soils collected 
36 19/09/17 
Article about the up and coming launch of the Microbiology 
Society new microbiome-themed colouring book, that 
became available to pre-order 
37 02/10/17 
Photos of agar plates streaked from soil samples brought in 
by participants who attended the Glasgow Botanic Gardens 





Photos of agar plates, lab-grown by Ethan at the University 
of East Anglia, using the brain-heart infusion media using 
samples found by participants that attended the Glasgow 
Botanic Garden pop up event 
Article about the launch of the Microbiology Society new 
microbiome-themed colouring book, that became available 
to pre-order 
40 06/11/17 
Photos of agar plates streaked from soil samples brought in 
by participants for the Norwich Science Festival event that 
took place in October 2017 
41 09/11/17 
Photos of zones of inhibition gathered from bacterial species 
purified from soil samples brought to the Pop-up event at 
Glasgow Botanic Gardens 
42 15/11/17 
Infographic from the WHO that explains the antibiotic 
resistance cycle. Published in Antibiotic Awareness week 
43 20/11/17 
Photos of agar plates, lab-grown by Ethan at the University 
of East Anglia, using the brain-heart infusion media using 
samples brought in by participants to the Norwich Science 
Festival pop-up event in October 2017 
44 05/12/17 
Photos of species identified by Ethan from soil samples 
brought to the pop-up event at Glasgow Botanic Garden that 
took place in September. Post provided information 
gathered from sequencing to identify the groups of bacteria 
that were found in the various soils collected 
45 06/12/17 
Photos of zones of inhibition gathered from bacterial species 
purified from soil samples brought to the Norwich Science 
Festival 
46 15/12/17 
Photos of species identified by Ethan from soil samples 
brought to the Norwich Science Festival. Post provided 
information gathered from sequencing to identify the groups 
of bacteria that were found in the various soils collected 
47 21/02/18 BBC news article: New Family of Antibiotics found in Dirt 
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2.7.3 Portfolios – Long Term 
I handed out portfolios (Figure 2-3) at pop-up stands in England, Scotland and 
Wales. Participants were provided with a portfolio handbook which explained 
what the portfolio was designed for (Appendix G-1), provided detail on how to 
record each entry and then offered suggestions for topics to explore or types 
of entries to make. It concluded with a signed thank you note from myself, with 
University of East Anglia and Microbiology Society branding. The handbook 
was developed and refined in collaboration with the supervisory team. Entries 
were self-guided and could explore any topic the participant wished. 
Participants were given contact information including my email address and 
my social media information. One participant asked to receive a phone call to 
discuss what they should be including. In total, 14 portfolios were given out, 
one person withdrew from the study and eight did not respond to contact on 
request for return of the portfolios. In total, five portfolios were returned with 
varying levels of content.  
Returned portfolios were transcribed using Microsoft Word. These word files 
were uploaded to NVivo 11, read twice, then discussed with an experienced 
qualitative researcher (Prof. Nardi). To ensure the anonymity of participants 
whilst allowing for participant identification, consecutive numbers were 
assigned to portfolios (1-5). A thank you note and a gift of The Microbes Fight 
Back: Antibiotic Resistance (Bowater, 2017) were sent to the participant,. If 
requested the portfolio was also returned. 
Key themes that had emerged from coding of the interviews were agreed and 
piloted (Table 2-7). These themes represented key topics emerging from 
discourse analysis. Two characteristics: consistency and specificity were 
agreed; adapted from analysis to diagnose learning in teaching situations (Biza 
et al., 2018). Two learning levels, object and meta level, were agreed; taken 
from analysis which evidenced discursive transformations in learners (Sfard, 
2008). Portfolios were distilled into factual accounts (Appendix H-1). Excerpts 
representing key themes which evidenced changes in specificity, consistency, 
object or meta level shifts were selected through re-reading of factual 
summaries and transcripts. Excerpts from one portfolio were selected to be 
checked (Prof. Nardi); ambiguities were resolved in discussion. 
 
Table 2-7. Key themes emerging from discourse analysis of participant interviews. A list of the eight 
key themes emerging from coding of verbatim interview transcripts and more general reading of factual 
summaries.  
Key Themes 
1. The correct use of scientific terminology 
2. Using personal experiences in ritualised ways to participant in a new 
discourse 
3. Public Health Narratives 
4. Human Health Narrative 
5. Who is to blame? 
6. What are scientists after? 
7. Do people need a hero? 






Figure 2-3. Front cover of the A4, ring bound Portfolio, displaying the project name and the 
Microbiology Society logo, and a demographics survey for the participant to complete should they 
wish. 
2.8 Ethics 
The University of East Anglia’s Faculty of Education’s Research Ethics 
Committee approved the study (Appendix I-1). As well as an application form, 
a participant information sheet (Appendix J-1) and participant consent forms 
for the interviews and social media (Appendix K-1) and the portfolios 
(Appendix K-2) were submitted. Ethics approval for the project was received 
on the 11th July 2016 from the EDU Chair of the Research Ethics Committee. 
I made myself familiar with the data protection act and the freedom of 
information act. I promised to explain the purpose, procedures of the research 
and potential benefits and costs of participating (including time) to each 
participant before they took part in the project. I promised to treat participant 
data with respect regarding anonymity and confidentiality. I promised to obtain 
written consent from each participant and to not interview any persons under 
the age of 18 without consent from a parent. I promised not to put undue 
pressure on any individual to participate, and to not prejudice those who 
refused. Participants were informed that data generated by the research would 
only be used purely for the purposes of the research project. 
I provided my full identity to potential participants as well as my University of 
East Anglia contact details and those of my supervisor in order that they could 
contact in relation to any aspect of the research. Participants were told of their 
right to withdrawal and that their data would not be held by a third party. 
Research was carried out at times designed to minimise the burden on 
participants. I conducted myself in an appropriate and professional manner, 
including respecting the views of all participants in the research. I took steps 


















Chapter 3 The microbial composition 
and antimicrobial activity of citizen 


















Building on the antibiotic discoveries of the 1920s and 30s by Selman 
Waksman’s laboratory (Bowater, 2017), there was a widespread introduction 
of antibiotics in the 1940s. This began with penicillin (Fleming, 1929) and 
Streptomycin (Schatz, Bugle and Waksman, 1944) and transformed modern 
medicine as we know it; curing the most deadly infectious diseases of the time. 
Novel classes of antibiotics known as the aminoglycosides, tetracyclines, 
macrolides, glycopeptides, amphenicols and carbapenems were discovered in 
the golden-era of antibiotics (Bowater, 2017).  
However in the 1960s, overmining of the limited resource that is cultivable soil 
microorganisms brought the golden-era of natural antibiotic discovery to an 
end (Lewis, 2012). Researchers began increasingly rediscovering compounds 
produced by the overmined actinomycetes (Lewis, 2020). Actinomycetes are 
popular as a source of broad-spectrum antibiotics and their large genomes 
typically harbour a substantial 20 BGCs per isolate (Rutledge and Challis, 
2015). Because of the ease at which these broad-spectrum antibiotics can be 
discovered, Baltz (2007) detailed the low probability of discovering a new 
broad-spectrum antibiotic, suggesting one would need to sieve through a 
library of at least 107 isolates.  
Success of synthetic compounds, at the same time discovery of natural 
products was drying up, meant they took precedence (Lewis, 2020). These 
synthetic compounds however, ran into regulatory, commercial and scientific 
barriers (Payne et al., 2007; Tommasi et al., 2015). In the last 50 years, 
pathogens have continued to accumulate resistance to antibiotics despite a 
faltering anti-infective discovery platform (Lewis, 2020). Currently, antibiotic 
resistance is spreading faster than the introduction of new compounds into 
clinical practice (Ling et al., 2015). History suggests the development of 
resistance limits the lifespan of antibiotics, providing the need for a constant 
introduction of new compounds into the antibiotic pipeline (Bush et al., 2011; 
Spellberg and Shlaes, 2014). I discussed the predictable emergence of 
resistance and the pathogenic bacteria which pose urgent or serious threats 
in chapter 1.1.3 and 1.1.4, respectively.  
Broad-spectrum antibiotics of actinomycetes, effective against Gram-negative 
bacteria, have been overmined, however other bacterial groups have had to 
develop their own compounds to act against their Gram-negative competitors 
(Lewis, 2020). These underexploited bacteria have been shown to devote 
sizeable parts of their genome to BGCs (Crits-Christoph et al., 2018). 
However, these bacteria are challenging to culture. In fact, it has been reported 
that only 1% of cells from natural environments like soil can, and have, been 
cultured (Winterberg, 1898; Lloyd et al., 2018). The difficulty of culturing these 
organisms has been attributed to the requirement of some species for growth 
factors produced by their neighbours (D’Onofrio et al., 2010), but this only 
accounts for around 10% of bacteria that do not readily grow in vitro (Lewis, 
2020).  
Approaches have been developed to grow these underexploited organisms in 
their natural environment, such as the iChip (Nichols et al., 2010), from which 
came a variety of compounds including Teixobactin, a novel class of antibiotic 
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isolated from the soil bacterium Eleftheria tereae in 2015 (Ling et al., 2015). 
Eleftheria tereae is a Gram-negative β-proteobacterium and was previously 
never known to produce antibiotics. In this study, growth media was tested 
which extracted nutrients and growth factors from the soil environment (soil 
extract media) to encourage a more diverse range of culturable organisms.  
Facing the barrier of rediscovery, novel strategies and innovative techniques 
have been developed (Trautman, Eric and Crawford, 2015; Quinn et al., 2017) 
including the integration of genome mining, silent pathway induction and Mass 
Spectrometry-based molecular networking (Trivella and de Felicio, 2018) and 
genetics-based bioinformatic tools such as AntiSMASH on behalf of genome 
mining to detect BGCs (Medema et al., 2011). In 2018, a team of researchers 
developed a culture-independent discovery platform that involved sequencing, 
bioinformatic analysis and heterologous expression of BGCs captured on 
extracted DNA from environmental samples. In doing so, they discovered a 
new class of calcium-dependent antibiotics named Malacidins (Hover et al., 
2018).  
3.2 Aim 
The aim of the Antibiotics Unearthed Laboratory work (and this chapter) was 
to use citizen science to enhance sample collection. Further, a culture-based 
approach combined with WGS was used to identify genomes and predicted 
BGCs of cultured bacteria with antimicrobial potential against a range of 
medically relevant pathogens. To facilitate this an in situ and lab-based 
protocol was first established through manipulation of a variety of parameters 
including diluent, dilution factor, incubation temperature, contamination control 
and growth media. This allowed a balance between large sample processing 
and accuracy.  
3.3 Results 
3.3.1 Isolating Antibiotic Producing Bacteria from the Soil: Pilot Study 
There are 10,000 bacterial species per gram of soil (Torsvik et al, 1990) and 
830,000 species per 1 billion bacterial cells (Gans et al, 2005). Despite this 
considerable abundance and diversity, only 1% of cells can be cultured (Pham 
& Kim, 2012). An absence of information on natural habitat and growth 
requirements have contributed to this dilemma (Stewart, 2012; Chaudhary et 
al, 2019). However, these underexploited bacteria provide a potential reservoir 
for novel antibiotics. A pilot study was conducted to optimise growth conditions 







Figure 3-1. Developing a plan to pilot test citizen scientist’s soil samples. Flow diagram which details 
step by step the processes needed to progress a soil sample through the testing pipeline. Samples were 
plated to determine CFU/sample at each stage to ensure the methods were optimised. 
 
3.3.1.1 Optimising Diluent 
Liquid diluent serves to transfer bacteria from their soil environment to the 
growth media and control their abundance. Two common diluents were tested: 
Phosphate-Buffered Saline (PBS) and dH2O. Bacteria have been shown to 
survive in both for more than 30 weeks, however some bacterial species 
survived better than others (Liao and Shollenberger, 2003). One gram of soil, 
taken from participant soil samples (2.3.2), was added to 10 mL of diluent and 
homogenised. The samples were diluted to 10-2 to allow counting of Colony 
Forming Units (CFU) as CFU/g. 50 µl of soil water was added to each plate. 
Diluents were tested in triplicate across five growth media: Luria-Bertani (LB) 
Agar (BERTANI, 1951), Nutrient Agar (NA) (Wright, 1934), Tryptic Soy Agar 
(TSA) (TSB; Sigma Aldrich), Soy Flour Mannitol (SFM) Agar (Kieser et al. 
2000) and Technical Agar with Calcium Chloride (TA + CaCl2) (TSB; Sigma 
Aldrich). The CFU/g for all media was averaged to give average CFU/g for 
dH2O and PBS (Figure 3-2). Plates were incubated at 30°C which was 
determined to be the optimum temperature for growth (Table 3-1). Data 
showed that CFU/g of soil was similar using both dH2O and PBS. 
 
Figure 3-2. Homogenising diluent did not affect CFU per gram of soil bacteria. Average taken from 15 
samples across 5 different media: Luria-Bertani (LB) Agar (BERTANI, 1951), Nutrient Agar (NA) (Wright, 
1934), Tryptic Soy Agar (TSA) (TSB; Sigma Aldrich), Soy Flour Mannitol (SFM) Agar (Kieser et al. 2000) and 
Technical Agar with Calcium Chloride (TA + CaCl2) (TSB; Sigma Aldrich). CFU/g calculated from samples 



















The total number of colonies showing antagonistic bacteria was also 
determined for each diluent across the five media (Figure 3-3). Results 
indicated that dH2O produced more inhibitory colonies (Figure 3.3a), however 
there is little or no difference between the two diluents with regards to the 




Figure 3-3. Total number of inhibitory colonies and antagonistic activity profiles compared between 
dH2O and PBS. a) Total count of inhibitory colonies taken from triplicate samples across 5 different media: 
Luria-Bertani (LB) Agar (BERTANI, 1951), Nutrient Agar (NA) (Wright, 1934), Tryptic Soy Agar (TSA) (TSB; 
Sigma Aldrich), Soy Flour Mannitol (SFM) Agar (Kieser et al. 2000) and Technical Agar with Calcium Chloride 
(TA + CaCl2) (TSB; Sigma Aldrich) (n=15). Diluted at a concentration of 10-2. B) Percentage of inhibitory 
colonies which inhibit either bacteria of fungi calculated from triplicate samples across 5 different media: 
Luria-Bertani (LB) Agar (BERTANI, 1951), Nutrient Agar (NA) (Wright, 1934), Tryptic Soy Agar (TSA) (TSB; 
Sigma Aldrich), Soy Flour Mannitol (SFM) Agar (Kieser et al. 2000) and Technical Agar with Calcium Chloride 
(TA + CaCl2) (TSB; Sigma Aldrich) (n=15). Diluted at a concentration of 10-2. Media was LB, LB, NA, TSA, SFM 
and TA + CaCl2. 
 
Both datasets suggest a lack of significant difference either in the abundance 
of bacteria or the proportion of colonies showing antagonistic activity between 
the two diluents. dH2O was selected as the trend showed a slightly higher 
CFU/g and inhibitory colony count.  
3.3.1.2 Optimising Dilution Factor and Incubation Temperature for 
Bacterial Growth and Diversity 
Different dilutions of dH2O were tested at different temperatures to assess the 
effect on ability to culture individual colonies whilst maintaining neighbouring 
colony interaction. Serial dilutions of 100, 10-1 and 10-2 were tested in duplicate 
on LB agar media at three different temperatures, 25°C, 30°C and 37°C. 50 µl 
































































Table 3-1. Soil samples diluted to 10-1 and grown at 30°C represent balance between single colonies 
and colony interaction. Colony counts of 100, 10-1 and 10-2 serial dilutions of 1 g of soil (n=2) mixed with 
10 ml dH2O, plated on LB agar and grown at 25°C, 30°C and 37°C.  
Temperature (°C) Sample 1 (CFU) Sample 2 (CFU) 
 100 10-1 10-2 100 10-1 10-2 
25 265 59 6 166 23 3 
30 234 34 2 182 26 1 
37 211 30 2 62 5 1 
       
 
Results informed the decision to use a 10-1 dilution of dH2O as this resulted in 
single colonies large enough to be isolated whilst presenting neighbouring 
colonies on which antagonistic activity could be noted (Figure 3-4). Each 
temperature provided a similar CFU/g count, however less fungal growth was 
observed at 30°C and so was selected.  
 
Figure 3-4. Example of a plate showing single colonies that are interacting allowing zones of 
inhibition to be detected, plated at 10-1. 50 µl soil water diluted 10-1 was added to an LB plate, spread and 
incubated at 30°C. 
 
3.3.1.3 Optimising Removal of Fungal Contaminants 
The rapid spread of fungi on the growth media (Figure 3-4) was a source of 
contamination when picking single colonies. Fungal growth was inhibited with 
the addition of antifungals. Cycloheximide and nystatin were tested. 
Cycloheximide had a working concentration of 50 µg/mL (Lawana, Korrapati 
and Mehendale, 2014), whilst nystatin was shown to have an MIC50 of 8 µg/mL 
on isolates of Aspergillus spp., Candida spp., and C. neoformans. For ease, a 
working concentration of 10 µg/mL was used. At these concentrations fungal 
contamination still occurred. Concentrations were doubled, preventing fungal 
contamination. Final working concentrations were 100 µg/mL cycloheximide 
and 20 µg/mL nystatin.  
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3.3.1.4 Optimising Growth Media 
To create a baseline for abundance and diversity of soil bacteria on common 
lab media, readily available media from The Small World Initiative Research 
Protocols (Hernandez, Tsang and Handelsman, 2015) was selected. Five 
media were tested for abundance (Figure 3-5) and antagonistic profiles (Figure 
3-6). These were LB Agar (BERTANI, 1951), NA (Wright, 1934), TSA (TSB; 
Sigma Aldrich), SFM Agar (Kieser et al. 2000) and TA + CaCl2 (TSB; Sigma 
Aldrich)..
 
Figure 3-5. CFU per gram of soil does not different significantly across five media. Average taken from 
6 samples across 2 dilution liquids (PBS and dH2O). CFU per gram calculated from samples diluted at a 
concentration of 10-2. SD bars show the amount of heterogeneity in the CFU per gram ranges. 
 
Figure 3-5 suggests that whilst SFM and TSA seemed to have slightly higher 
abundance, the difference was not significant. Figure 3-6 suggests that a) the 
nutrient poor media (TA + CaCl2) produced the fewest inhibitory colonies whilst 
TSA seemed to produce the most and b) that most of the TSA antagonism was 
seen against fungal colonies, whilst the nutrient poor TA media showed 
antagonism against bacteria only. LB and NA were similar whilst SFM had 

























Figure 3-6. Total number of inhibitory colonies and antagonistic activity profiles compared between 
5 different common lab growth media. a) Total count of inhibitory colonies on Luria-Bertani (LB) Agar 
(BERTANI, 1951), Nutrient Agar (NA) (Wright, 1934), Tryptic Soy Agar (TSA) (TSB; Sigma Aldrich), Soy Flour 
Mannitol (SFM) Agar (Kieser et al. 2000) and Technical Agar with Calcium Chloride (TA + CaCl2) (TSB; Sigma 
Aldrich) taken from 6 samples across 2 diluents (PBS and dH2O) diluted at a concentration of 10-2. B) 
Percentage of inhibitory colonies on Luria-Bertani (LB) Agar (BERTANI, 1951), Nutrient Agar (NA) (Wright, 
1934), Tryptic Soy Agar (TSA) (TSB; Sigma Aldrich), Soy Flour Mannitol (SFM) Agar (Kieser et al. 2000) and 
Technical Agar with Calcium Chloride (TA + CaCl2) (TSB; Sigma Aldrich)which inhibit either bacteria of fungi 
taken from 6 samples across 2 diluents (PBS and dH2O) diluted at a concentration of 10-2 
In selecting potential lab media, CFU/g did not significantly differ. LB, NA and 
SFM had similar abundance of inhibitory colonies and did not significantly 
produce more colonies which inhibited bacteria of fungi. LB was selected as 
the baseline against which to compare the effects of utilising media which 
utilises nutrients and growth factors from the soil. 
Research has shown that culture media made from a soil-extract increases 
success in isolating previously uncultured or novel soil bacteria (Hamaki et al., 
2005; Liebeke et al., 2009). Media tested included Soil Extract Media (SEM) 
(adapted from Liebeke et al., 2009), dH2O SEM, Autoclaved dH2O SEM, 
Concentrated dH2O SEM and LB (BERTANI, 1951) (Appendix C-1). Media 
was made as broth and mixed with 1.5% w/v agar for pouring with addition of 
antifungals.  
 
Table 3-2. Concentrated SEM results in highest abundance, diversity and number of colonies showing 
antagonistic activity. On five media: Soil Extract Media (SEM) (adapted from Liebeke et al., 2009), three 
modified versions of SEM: dH2O SEM, Autoclaved dH2O SEM and Concentrated dH2O SEM.LB (BERTANI, 
1951), averages were taken from duplicate samples. Total colony count (abundance), count of 
morphologically distinct colonies (diversity) and count of bacteria showing antagonistic activity against 
neighbouring colonies (antagonistic activity) were taken from samples diluted at a concentration of 10-3.  
Sample Abundance Diversity Antagonistic Activity 
SEM 64 4 1.5 
LB 66 4.5 0.5 
dH2O SEM 58 3 0 
Autoclaved dH2O SEM 81.5 3 1.5 








































































Table 3-2 shows Concentrated dH2O SEM resulted in the highest average 
abundance (115.5 colonies), diversity (8 distinct colony types) and antagonistic 
activity (3.5 colonies showing antagonistic activity against neighbouring 
organisms). A physical comparison between LB and Concentrated dH2O SEM 
can be seen in Figure 3-7. SEM and LB produced similar results, contrary to 
what was expected. dH2O SEM produced the fewest total colonies (58) and 
the joint lowest diversity with the autoclaved dH2O SEM (3). Based on these 
results, concentrated SEM was selected as appropriate for use in the testing 
pipeline. 
 
Figure 3-7. Soil extract media produces a more abundant, diverse and more antagonistic soil 
community than LB. Images of one University of East Anglia soil sample diluted to 10-3 on LB (left) and 
diluted to 10-3 on Concentrated Soil Extract Media (right). These plates were investigated for abundance, 
diversity and antagonistic activity. 
 
Both testing and the Small World Initiative Research Protocols (Hernandez, 
Tsang and Handelsman, 2015) provided several options for growth media. 
These were LB, Brain Heart Infusion (BHI) Agar, All Culture (AC) Agar and 
concentrated dH2O SEM. Which media were eventually selected is discussed 
in 3.3.2. 
 
Figure 3-8. Optimised protocol for testing our citizen scientists soil samples. Flow diagram which 
details step by step the processes needed to progress a soil sample through our testing pipeline. The top 
diagram shows the protocol for in-situ testing at each pop-up event whilst the bottom diagram shows the 
protocol for laboratory testing. Square identifies amount of soil and where protocol took place. Soil in both 
protocols was taken from participant soil samples. Arrows show dilution, diluent, growth media, antifungals 
and growth temperature (left to right).  
 
This pilot study provided a protocol through which citizen scientist’s soil 
samples could be analysed. In practice, collection and analysis in the field 
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differed slightly from collection and analysis in the lab (Figure 3-8). In the field 
1 gram of soil was mixed with 10 mL sterilised tap water and shaken by hand. 
Five drops of soil solution were moved using a Pasteur pipette (approx. 50 µL) 
on to growth media. In the lab, 1 gram of soil was resuspended in 10 mL dH2O, 
homogenised and diluted 1:10; 100 µL soil solution and 900 µL dH2O. 100 µL 
of this 10-1 solution was spread plated on to the selected media. All were 
incubated at 30°C, however the field plates had to be transported back to 
University of East Anglia first. To reduce fungal contamination, cycloheximide 
was added at 100 µg/mL and nystatin was added at 20 µg/mL. The method of 
plating bacteria differed between field and laboratory settings due to the need 
for a pragmatic approach which would allow better engagement with the public 
and a large throughput of participants in comparison to reproducible lab 
conditions. 
3.3.1.5 Optimising Antagonistic Assay 
The in vitro antimicrobial activity of environmental isolates was tested using an 
adaptation of the well diffusion method and the cross-streak method 
(Lertcanawanichakul & Sawangnop., 2008). The well-diffusion method takes 
an agar plate with a lawn of indicator strain, cuts wells in the agar and pipettes 
isolates in liquid media into these wells. The secondary metabolites produced 
by the bacterium of interest diffuse into the agar. One can then measure 
whether the secondary metabolites kill or prevent growth of the indicator strain. 
The cross-streak method takes an agar plate on which a line of indicator strain 
is swabbed. Across this line, isolates are swabbed. Once both grow, it is 
possible to see areas of inhibition where secondary metabolites kill the 
indicator strain. Upon testing both methods, I found that the well-diffusion 
method was too time consuming, and the cross-streak method lacked 
accuracy, especially if inhibition zones were large enough that it was difficult 
to tell which isolate was causing toxicity. Instead, I merged the two protocols 
to produce a simple, fast and repeatable antagonistic assay, the drop-plate 
assay (Figure 2-1).  
Using this assay, colonies showing antagonistic activity against neighbouring 
colonies were selected and streaked to pure cultures. Medically relevant 
pathogens covering Fungi, Gram-positive and Gram-negative bacteria were 
selected as indicator strains (Table 2.1). 
3.3.2 Citizen Science Field Studies 
A protocol was devised where participants could safely collect suitable soil 
samples and return them to the pop-up stands to begin their initial experiments 
(2.3.2). Participants followed the in-situ protocol to transfer soil bacteria on to 
growth media and plates were taken back to the University of East Anglia to 
be incubated and imaged (2.3.3.1). Photos were edited on Microsoft 
PowerPoint and uploaded to Facebook with sample numbers, media type and 




Figure 3-9. Example of soil sample grown in the lab and the result of editing on PowerPoint for upload 
to the public on Antibiotics Unearthed Facebook Page. Example of the raw image (left) and the edited 
image (right) of sample number 14, plated in the lab from a soil sample collected by a participant in Thetford 
Forest on an All Culture agar plate. The plate was incubated overnight at 30°C. The edited image was 
uploaded to Facebook as part of the Thetford AC album. 
Once back at the University of East Anglia, soil samples were run through the 
laboratory protocol (2.3.3.2). In Kielder and Brecon, rather than AC and BHI 
as laid out in 2.3.3.2, Concentrated dH2O SEM was used. Topsoil used to 
make the media was taken from the same forests samples were collected in 
so that nutrients and growth factors would most match the organism’s natural 
environment. However, the resultant plates lacked diversity and showed no 
antagonistic activity (Figure 3-10).  
 
Figure 3-10. Soil extract media did not perform in practice. Images of soil samples grown on soil extract 
media taken from Brecon Beacons (left) and Kielder Forest (right). Soil used to make the extract was soil 
taken from the forest in which the samples were collected. 
These results, together with the time-consuming nature of preparing SEM 
justified the decision to stop the use of Soil Extract Media. Instead, All Culture 
and Brain Heart Infusion Media were used for the laboratory protocol for the 
remaining three events. After the in-situ and laboratory images had been 
taken, single colonies that inhibited neighbouring colonies were streaked to 




Figure 3-11. Environmental isolates showing antagonistic activity against neighbouring colonies 
streaked to pure. This colony was taken from a plate made in the lab on All Culture media, from sample 
number 12 collected in Glasgow. This was the 14th colony to show antagonistic activity from Glasgow on AC 
media. The colony had ‘nodules’ forming on its surface which contained a clear liquid. 
A total of 454 soil samples were collected and cultured over the course of five 
events (Table 2-3). 96 well plates were used to allow the simultaneous growth 
of a larger number of isolates. Upon shaking, cross-contamination between 
wells was noted and so shaking was removed. Drop plates were made with 
4% w/v agar rather than 1.5% to limit colony motility. A total of 929 colonies 
were isolated that showed some level of antagonistic activity against 
neighbouring soil organisms. A total of 165 isolates showed antagonistic 
activity against one or more medically relevant pathogens (Table 3-3). Of the 
isolates which showed antagonistic activity against neighbouring soil 
organisms, 17.76% went on to show antagonistic activity against medically 
relevant indicator strains. 
Table 3-3. Story of citizen scientist’s soil samples. Sample location, date of collection, number of samples 
collected, number of colonies screened for inhibitory activity against neighbouring colonies and number of 
isolates inhibiting medically relevant organisms. 
 
To aid with public engagement, photos were taken and uploaded to Facebook 
with media type, forest location and medically relevant pathogen attached to 

















Brecon Beacons  155 142 29 
Kielder Forest,  144 62 11 
Thetford Forest,  47 325 38 
Glasgow Botanic Gardens  51 234 40 




Figure 3-12. Example of Drop Plate assay uploaded to Facebook, where the antagonistic activity of 
soil isolates was tested against medically relevant pathogens. These plates show the raw (left) and 
edited (right) images of Bacillus subtilis indicator strain spread as a lawn using a sterile cotton swab and left 
to dry on a 4% AC agar plate. Isolates of interest were added on top of this dry lawn using an 8-tip multi-
pipette with 6 pipette tips attached. 5 μL samples of the potential antagonistic isolates were taken from 96-
well plates and dispensed onto the MRSA lawn in a grid. Plates were left to dry and incubated at 30⁰C 
overnight. Transparent zones around some of the antagonistic isolate were taken to be zones of inhibition, 
for example in the 4th isolate in the 3rd row. 
The antagonistic assay of the 165 isolates was conducted within a week of 
sample collection at the forest events. Isolates were separated into one of 
seven distinct activity profiles. In total, 45 isolates inhibited Fungi, Gram-
positive and Gram-negative bacteria, 24 isolates inhibited Gram-positive and 
Gram-negative bacteria, eight isolates inhibited Fungi and Gram-positive 
bacteria, 23 isolates inhibited Fungi and Gram-negative bacteria, 31 isolates 
inhibited Gram-positive bacteria, 21 isolates inhibited Gram-negative bacteria 
and 13 isolates inhibited Fungi.  
3.3.3 Identifying bacteria for genome sequencing 
Isolates had to be selected for genome sequencing. To increase the chances 
of selecting underexploited bacteria which were more likely to produce novel 
antibiotics, a filtering process was designed. This was a two-step selection 
process and aimed to select 15 morphologically distinct isolates (Figure 3-13) 
with unique antagonistic profiles (Table 3-4). Antagonistic activity and 
morphology were determined by eye.  
The 165 isolates were grouped into categories based on inhibitory activity 
against Fungi, Gram-positive and Gram-negative bacteria. Antagonistic 
activity was determined using the drop plate assay (Figure 3-12). Due to the 
nature of the interaction, sometimes the isolates grew in a transparent fashion 
and, whilst looking like an inhibition zone, were determined not to be one. This 
can be difficult to determine on a photo. Instead, the decision to consider this 
an inhibition zone or not was discussed with an expert (Dr. Rowley). After 
restreaking, isolates didn’t always continue to show potential antimicrobial 
activity against some or all the medically relevant indicator strains. Considering 
this, in preparation for selection of isolates to be sent for Genomic Sequencing, 
a second assay was conducted. When examining the assay results for the 15 
isolates, the bacteria were less antagonistic in the second assay (Table 3-5). 
After discussion with Dr. Rowley, results of the pre-genome sequence assay 
were used to distinguish the antagonistic activity profiles. Isolates with each 
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type of antagonistic activity profile were separated by colony morphology. This 
was a qualitative process after discussions with Dr. Rowley.  
Of the 15 isolates, six originated from Glasgow Botanical Gardens, five from 
the Norwich Science Festival and four from Thetford Forest. These were grown 
on different growth media, with seven being isolated on All Culture Media, five 
on Brain Heart Infusion media and three on Luria Bertani media (Table 3-4). 
Some isolates inhibited penta-resistant Salmonella (DT104) and not the wild 
type (SL1344). Whilst this was unexpected, it could be a remnant of the drop-
plate assay, where overnight cell density was not calibrated. It is possible that 
the wild-type Salmonella grew faster overnight, which in turn resulted in a 
higher cell density on the spread plate. The antagonistic activity was then not 
strong enough to create an obvious zone of inhibition. It is also possible that 
the zone of inhibition was so weak that it was difficult to determine by eye. 
Whilst the rest of this chapter focuses on analysis of these 15 isolates, the 
remainder were stored as long-term glycerol stocks for future analysis. Details 
such as the participant plate number, colony number, growth media and 
antagonistic assay results have been stored and can be seen in (Appendix L-
1, L-2 and L-3). Some isolates, notably those from Brecon Beacons and 
Kielder Forest, were not frozen because of contamination or poor performance 
in the 2nd round of testing. 
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Table 3-4. Antagonistic profile of 15 isolates selected for whole genome sequencing, as of the first and second wave of testing. ELD represents the names attributed to each isolate. Event 
represents the location from which the soil sample which led to the culture of each isolate was submitted from. G represents Glasgow, NSF the Norwich Science Festival and T represents Thetford. In 
the first wave of antagonistic testing, one Gram-positive Bacillus subtilis, two gram – Salmonella enterica serovar Typhimurium strains were used (WT SL1344 and penta-resistant DT104) and one 
Candida albicans fungi were used. In the second wave of antagonistic testing, three Gram-positive bacteria were used; Bacillus subtilis, Methicillin-resistant Staphylococcus epidermis and Vancomycin-
resistant Enterococcus faecium. Two gram – Salmonella enterica serovar Typhimurium strains were used (WT SL1344 and penta-resistant DT104) and one Candida albicans fungi were used. A ‘Y’ is 
indicative of antagonistic activity against the medically relevant pathogen. 
Collection Info Antagonistic Profile Post-Event Antagonistic Profile Pre-WGS 
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ELD15 T LB Y Y 
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Figure 3-13. Morphologies of ELD01 – 15. From top left, ELD01, collected in Glasgow and grown on AC 
media. ELD02, collected in Glasgow and grown on AC media. ELD03, collected in Glasgow and grown on BHI 
media. ELD04, collected in Glasgow and grown on BHI media. ELD05, collected in Glasgow and grown on BHI 
media. ELD06, collected in Glasgow and grown on LB media. ELD07, collected at NSF and grown on AC media. 
ELD08, collected at NSF and grown on AC media. ELD09, collected at NSF and grown on AC media. ELD10, 
collected at NSF and grown on AC media. ELD11, collected at NSF and grown on BHI media. ELD12, collected 
in Thetford and grown on AC media. ELD13, collected in Thetford and grown on BHI media. ELD14, collected 
in Thetford and grown on LB media. ELD15, collected in Thetford and grown on LB media. Plates were 
incubated at 30°C for two days prior to imaging. 
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Table 3-5. Descriptive results of isolates showing antagonistic activity against medically relevant 
pathogens throughout the course of the project. The category of antagonistic activity is shown in column 
1. Columns 2 and 3 and 4 show the number of isolates inhibiting medically relevant pathogens at different 
stages or at different scopes of the project. Column 2 shows the antagonistic profiles of each of the 15 isolates 
as they were tested in the first assay. Column 3 shows the antagonistic activity profiles of each of the 15 
isolates as they were tested in the second assay. Between the first two events (Brecon and Kielder) and the 
final three events (Thetford, Glasgow and NSF) a different selection of ESKAPE and Medically relevant 












Gram-positive and Fungi 1 4 
Gram-negative and Fungi 2 1 
Gram-positive 0 1 
Gram-negative 1 3 
Fungi 0 1 
 
 
3.3.4 Assessing Quality of Whole Genome Sequencing of Citizen 
Scientists Soil Samples 
Whole Genome Sequencing was carried out in collaboration with the Cooper 
Lab (2.5). Genomic DNA (gDNA) was extracted and DNA libraries were 
prepared using the Nextera® XT (Illumina, Inc.) sample preparation. Indexes, 
number of reads and original concentration of each sample were noted and 
compared to a blank to ensure adequate genomic DNA was collected (Table 
3-6). Samples were sequenced using paired 300 bp reads by the group of Prof. 
Cooper, School of Medicine, University of East Anglia  
Upon completion, sequencing data was assembled by our collaborators in the 
Cooper lab using the Prokka annotation pipeline V1.12 (Seemann, 2014). 
Assembly metrics such as number of contigs and longest read were reported 
to describe the sequence depth. Sequencing produced a high number of 
contigs (169-1538) and short read lengths, suggesting that the gDNA was 
fragmented (Table 3-7). This was considered in future analysis.  
104 
 
Table 3-6. The index, number of reads and original DNA concentration of each of the 15 isolates, as 











ELD01 N701 S513 440,756 14.20 
ELD02 N701 S515 471,386 10.40 
ELD03 N702 S516 347,610 5.49 
ELD04 N702 S517 520,044 10.10 
ELD05 N703 S518 476,096 12.20 
ELD06 N703 S520 599,602 13.00 
ELD07 N704 S521 295,744 15.20 
ELD08 N704 S522 448,418 7.49 
ELD09 N705 S513 439,402 10.80 
ELD10 N705 S515 474,272 8.48 
ELD11 N706 S516 385,776 5.78 
ELD12 N706 S517 456,390 2.09 
ELD13 N707 S518 419,884 11.80 
ELD14 N707 S520 254,366 19.50 
ELD15 N710 S521 211,458 10.70 





Table 3-7. Assembly metrics for ELD01-15 sent for whole genome sequencing. Notably number of 
contigs, genome length, %GC and the longest read. 
Isolate Number no.Contigs Genome Length %GC Longest 
ELD01 411 4143494 43.73 80793 
ELD02 457 3663406 41.57 50409 
ELD03 169 4028619 46.26 128662 
ELD04 232 3732733 41.35 114327 
ELD05 1184 5853633 46.25 54853 
ELD06 303 3430612 42.16 150587 
ELD07 505 4014487 43.90 65232 
ELD08 809 5894691 45.84 65647 
ELD09 442 4141661 43.67 95893 
ELD10 1069 5264469 40.59 56724 
ELD11 305 4150537 43.54 133312 
ELD12 700 5818588 62.62 156697 
ELD13 736 4110725 37.43 56510 
ELD14 400 3620520 41.45 69761 





It was decided that, in collaboration with the Cooper Lab, there was capacity 
to rerun three of the isolates to reduce the number of contigs and improve the 
read depth. ELD05, ELD08 and ELD15 were selected based on data 
presented in sections 3.3.5 and 3.3.6. Assembly metrics for these sequences 
showed better read quality. The number of contigs in ELD05 reduced from 
1184 to 88, ELD08 from 809 to 44 and ELD15 from 1538 to 45. The longest 
read in ELD05 increased from 54853 to 752335, ELD08 from 65647 to 
1385684 and ELD15 from 52042 to 539668 (Table 3-8).  
Table 3-8. Assembly metrics for ELD05, ELD08 and ELD15 sent for whole genome sequencing. 
Notably number of contigs, genome length, %GC and the longest read. 
Isolate Number no.Contigs Genome Length %GC Longest 
ELD05 88 6108531 45.70 752335 
ELD08 44 6020479 45.55 1385684 
ELD15 45 6015083 62.36 539668 
 
3.3.5 Discovering underexploited bacterial species using the nucleotide 
sequence of the 16S rRNA gene 
WGS data from the first run of 15 isolates was provided by the Cooper Lab. 
The data was available on the Basespace (Illumina) Sequence Hub. 16S rRNA 
analysis was conducted using readily available analysis tools on the 
Basespace hub. These tools were MetaPhlAn (Segata et al., 2012), 16S rRNA 
Metagenomics (Wang et al., 2007) and Kraken Metagenomics (Wood and 
Salzberg, 2014). Running the 16S rRNA data through these tools provided a 
preliminary genus and species for each isolate (Table 3-9). 
The 16S rRNA data was also extracted and analysed using the NCBI BLASTn 
database (Altschul et al., 1990). This basic tool looks for regions of local 
similarity between sequences and offers several possible candidates for genus 
and species. Species-level classification for 16S rRNA gene sequences 
remains a serious challenge because existing taxonomic classification tools 
either do not provide species-level classification, or their classification results 
are unreliable (Gao et al., 2017). Instead, only calls for bacterial genera were 
considered (Table 3-10). 
Examining both tables, the 15 isolates represent four genera of bacteria. 
These were Bacillus (10/15), Paenibacillus (2/15), Pseudomonas (2/15) and 
Sporosarcina (1/15). The next step was to attempt to improve the resolution of 




Table 3-9. 'First look' at 16S rRNA profile of 15 whole genome sequence isolates. Data compiled using 
integrated programmes within the Basespace (Illumina) software suite. 
Isolate 
Number 




ELD01 Bacillus subtilis Bacillus sp. Bacillus subtilis 




Bacillus sp. Bacillus 
amyloliquefaciens 








ELD06  Sporosarcina sp.  








ELD09 Bacillus subtilis Bacillus sp. Bacillus subtilis 
ELD10  Bacillus simplex  
ELD11 Bacillus subtilis Bacillus sp. Bacillus subtilis 
ELD12  Pseudomonas sp.  
ELD13  Sporosarcina sp.  
ELD14 Bacillus pumilus Bacillus aerophilus  
ELD15 Pseudomonas sp. Pseudomonas sp.  
Hits that came back as unsure are left out in this table. 
 
 
Table 3-10. 16S rRNA comparison using NCBI BLASTn software for the 15 isolates selected for whole 
genome sequencing. Genera with >97% identity were reported. 
Isolate 
Number 
16S rRNA Call at Genus level using NCBI BLASTn Software 
>97% match 
ELD01 Bacillus   
ELD02 Bacillus   
ELD03 Bacillus   
ELD04 Bacillus   
ELD05 Paenibacillus Paenibacillus 
 
ELD06 Sporosarcina   
ELD07 Bacillus   
ELD08 Paenibacillus   
ELD09 Bacillus   
ELD10 Bacillus Brevibacterium  
ELD11 Bacillus   
ELD12 Pseudomonas   
ELD13 Bacillus Psychrobacillus Renibacterium 
ELD14 Bacillus Geobacillus  





16S rRNA data for each isolate was run through BLASTn software (Altschul et 
al., 1990). Hits with a 97% or higher match were downloaded and imported 
into the MEGA software package version 7.0 (Kumar, Stecher and Tamura, 
2016), along with the 16S rRNA data for each of the 15 isolates. GenBank 
(Benson et al., 2013) was queried to identify the type strain for each species.  
The nucleotide sequences of the 16S rRNA gene from ELD01 to ELD15 and 
the type strain of each of the species identified in the BLASTn search were 
determined and a phylogenetic trees based on these data were constructed 
by the NJ method (Figure 3-14 and Figure 3-15) using the genetic distances. 
Trees were routed on an outgroup, an organism not closely related to the 
isolates of interest which provides perspective for the level of relationship 
between closely matched genus and species. As 16S rRNA analysis had 
identified both Gram-positive and Gram – bacteria, two trees were made. The 
first compared the Gram-negative bacteria (Figure 3-14) and the second 
Gram-positive bacteria (Figure 3-15). 
 
 
Figure 3-14. Gram-negative phylogenetic tree with ELD 12 and 15. Outgroup-rooted maximum-
likelihood (ML) phylogenetic tree of 16rRNA sequences from Pseudomonas spp. and related species from 
environmental isolates (ELD12 and ELD15. Trees were constructed by using the neighbour-joining method 
and genetic distances were computed. Numerical values represent the percentage of bootstrap replications 












Figure 3-15. Gram-positive phylogenetic tree with ELD01-11, 13 and 14. Outgroup-rooted maximum-
likelihood (ML) phylogenetic tree of 16rRNA sequences from Bacillus spp, Sporosarcina spp, Paenibacillus 
spp and Brevibacillus spp., as well as related species from environmental isolates (ELD01-ELD11, ELD13 and 
ELD14). Trees were constructed by using the neighbour-joining method and genetic distances were 
computed. Numerical values represent the percentage of bootstrap replications that support the respective 




















ELD12 and ELD15 had originally been called as part of the Pseudomonas 
genus belonging to the Phylum Proteobacteria using the Basespace hub. 
Figure 3-14 shows that these Gram-negative isolates were most closely 
related to Pseudomonas vranovensis, however they were more closely related 
to each other than they were their nearest relative. For this reason, ELD15 was 
selected for the second genome sequencing run to improve the read depth 
(3.3.4). Pseudomonas vranovensis is a Gram-negative soil bacterium (Tvrzová 
et al., 2006). 
All Gram-positive bacteria had been called as part of the Phylum firmicutes. 
ELD01, 02, 03, 04, 07, 09, 10, 11, 13 and 14 had been called as part of the 
Bacillus genus. Figure 3-15 showed that these Gram-positive isolates 
represented four distinct Bacillus spp. ELD01, 07, 09 and 11 were most closely 
related to Bacillus subtilis. ELD 03 was most closely related to Bacillus 
velezensis. ELD02, 04 and 14 were most closely related to Bacillus altitudinis. 
ELD10 was most closely related to Bacillus simplex. ELD13 was most closely 
related to Bacillus psychrodurans. ELD05 and ELD08 were originally called as 
Paenibacillus spp, now known to be most closely related to Paenibacillus 
peoriae. Finally, ELD06, called as Sporosarcina spp was shown to be most 
closely related to Sporosarcina aquamarina.  
Bacillus subtilis (ELD01, 07, 09, 11) is a Gram-positive bacterium which 
inhabits the upper layers of the soil (Van Dijl & Hecker., 2013). Bacillus simplex 
(ELD10) is a Gram-positive bacterium which is ubiquitous in nature. A 2013 
article showed isolation of one of these bacterium from the rhizosphere of a 
plant (Schwartz et al., 2013). Bacillus velezensis (ELD03) is an aerobic, Gram-
positive bacterium which is an important member of the nutrient-rich zone of 
soil around plant roots, known as the rhizosphere (Rabbee et al., 2019). 
Bacillus altitudinis (ELD02, 04, 14) is a species of bacteria first isolated from 
cryogenic tubes for collecting air samples from high altitudes (Shivaji et al., 
2006). Like the other Bacillus spp, it is ubiquitous. It has been discovered in 
marine soil (Jin et al., 2012) and recently, the rhizosphere of rice (Budiharjo et 
al., 2017). Bacillus psychrodurans (ELD13) is a psychrotolerant Bacillus 
species categorised in 2002 (Abd El-Rahman et al., 2002). Research has 
reported this bacterium in only limited locations.  
Paenibacillus peoriae (ELD05, 08) is a genus of Gram-positive bacteria 
originally included within the genus Bacillus before being reclassified as 
separate in 1993 (Ash et al., 1993). Paenibacillus bacteria have been detected 
in a variety of environments, not least soil (Padda et al., 2017). Sporosarcina 
aquamarina (ELD06) represents a genus of Gram-positive, endospore forming 
bacteria. Species of this genus are known to inhabit soil (Eitinger et al., 2014).  
The 15 isolates selected for this study represent two Phyla, four Genera and 
eight species and represent both Gram-positive and Gram-negative 
organisms. 
3.3.6 Discovering Interesting Antibiotics 
WGS data from the first run of 15 isolates (ELD01 to ELD15) was analysed 
using antiSMASH 3.0 (Weber et al., 2015). This uses the antibiotics and 
Secondary Metabolite Analysis Shell algorithm to predict biosynthetic gene loci 
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for secondary metabolites. Gene prediction was performed by Glimmer3 
(Delcher et al., 2007). A search was conducted using ‘KnownClusterBlast’, 
‘SmCOG analysis’, ‘ActiveSite finder’ and ‘SubClusterBlast’ to identify the 
secondary metabolite BGCs. Probabilistic detection was turned off. A 
representation of the number of BGCs appearing in each isolate can be seen 
in Figure 3-16. The number of distinct types of BGC are represented by the 
different colours. 
 
Figure 3-16. Gene cluster predictions provided by the antiSMASH algorithm. The number refers to the 
isolate (ELD01-15). FASTA files were uploaded to the antiSMASH 3.0 (Weber et al., 2015) web server. Gene 
prediction was performed by Glimmer3 (Delcher et al., 2007). A search was conducted using 
‘KnownClusterBlast’, ‘SmCOG analysis’, ‘ActiveSite finder’ and ‘SubClusterBlast’ to identify the secondary 
metabolite BGCs. Probabilistic detection was turned off. Coloured circles do not represent specific types of 
cluster, but instead identify individual BGCs. Where groups of same coloured clusters are together, these are 
the same type of cluster (e.g. ELD01, green clusters together are all NRPs). Provided as an overview of 
abundance and diversity of BGCs in each isolate.  
 
There were 21 different types of secondary metabolite called across the 15 
isolates (Table 3-11). Within these 21, nonribosomal peptide synthetase 
clusters (NRPS) were the dominant type. They represented five of the 21 types 
of secondary metabolite, yet 110 of the total 210 total BGCs. 96 of these were 
NRPS only, whilst the remaining 14 were NRPS linked with another type of 
secondary metabolite, such as Polyketide Synthase (PKS), shown as transAT-
PKS-NRPS.  
On average, isolates contained 14 gene clusters. This ranged from two gene 
clusters in ELD13, to 39 gene clusters in ELD08. The two Gram-negative 
isolates averaged 10.5 gene clusters, slightly lower than the 14.5 average in 
Gram-positives. On average, isolates were predicted to have six different types 
of antibiotic or secondary metabolite BGCs.  
Isolates belonging to the genus Paenibacillus had the two highest predictions 
for numbers of gene clusters, 30 (ELD05) and 39 (ELD08). ELD08 had the 
most diverse range of antibiotics and secondary metabolite clusters, with 
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eleven predicted. For this reason, ELD05 and ELD08 was selected for the 
second genome sequencing run to improve the read depth (3.3.4). ELD06 and 
ELD13 had the least diverse range, containing only two types of cluster. ELD 
06 and ELD13 were shown to represent different genera and species of 
bacteria but had similar secondary metabolite profiles. Both had only two 
distinct types of cluster, Type III PKS (T3PKS) and Terpene. ELD13 had one 
of each cluster, whilst ELD06 had one T3PKS and two Terpenes. ELD04, like 
ELD13, had one secondary metabolite cluster in each of its called types of 
cluster, however it had six types of cluster in total. These were Bacteriocin (or 
other unspecified ribosomally synthesised and post-translationally modified 
peptide product clusters (RiPP)), NRPS, other (cluster containing a secondary 
metabolite-related protein that does not fit into any other category), T3PKS, 
Terpene and Terpene-Siderophore. Further details of the types of clusters 




Table 3-11. Summary of BGCs in each of the 15 isolates. FASTA files were uploaded to the antiSMASH 3.0 (Weber et al., 2015) web server. Gene prediction was performed by Glimmer3 (Delcher 
et al., 2007). A search was conducted using ‘KnownClusterBlast’, ‘SmCOG analysis’, ‘ActiveSite finder’ and ‘SubClusterBlast’ to identify the secondary metabolite BGCs. Probabilistic detection was 




Isolate Genus and species No. Antismash 
Clusters 
Identified BGCs 
ELD01 Bacillus subtilis 16 Ladderane, NRPS, NRPS-transAT-PKS-otherpks, other, sactipeptide-head to tail, T3PKS, 
terpenes 
ELD02 Bacillus altitudinis 8 NRPS, Other, siderophore, T3PKS, terpenes 
ELD03 Bacillus velezensis 20 Bacteriocin, NRPS, other, otherKS, phosphonate, T3PKS, terpenes, transAT-PKS, transAT-
PKS-NRPS 
ELD04 Bacillus altitudinis 6 Bacteriocin, NRPS, other, T3PKS, terpenes, terpene-siderophore 
ELD05 Paenibacillus peoriae  30 Bacteriocin, lassopeptide, NRPS, NRPS-transAT-PKS-otherKS, other, phosphonate, 
siderophore, transAT-PKS, transAT-PKS-NRPS 
ELD06 Sporosarcina aquamarina 3 T3PKS, terpenes 
ELD07 Bacillus subtilis 17 NRPS, NRPS-transAT-PKS-other’s, other, sactipeptide-head to tail, T3PKS, terpenes, 
transAT-PKS, transAT-PKS-NRPS 
ELD08 Paenibacillus peoriae  39 Bacteriocin, lanthipeptide, lassopeptide, NRPS, NRPS-transAT-PKS-otherKS, other, 
phosphonate, siderophore, T1PKS-NRPS, transAT-PKS, transAT-PKS-NRPS 
ELD09 Bacillus subtilis 15 Lanthipeptide, NRPS, other, sactipeptide, T3PKS, terpenes, transAT-PKS-otherKS-NRPS 
ELD10 Bacillus simplex 9 Bacteriocin, NRPS, other, siderophore, T3PKS, terpene 
ELD11 Bacillus subtilis 15 Lanthipeptide, NRPS, other, sactipeptide-head to tail, T3PKS, terpene, transAT-PKS-
otherKS-NRPS 
ELD12 Pseudomonas vranovensis 8 Arylpolyene, NRPS, other, 
ELD13 Bacillus psychrodurans 2 T3PKS, terpenes 
ELD14 Bacillus altitudinis 10 Bacteriocin, NRPS, other, siderophore, T3PKS, terpene 
ELD15 Pseudomonas vranovensis 13 Arylpolyene, NRPS, other, ppysks, 
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3.4 Discussion and future work 
3.4.1 Development of field and lab methods to isolate antibiotic 
producing bacteria from soil 
The Small World initiative has instructed over 10,000 students on how to 
collect bacteria from soil samples across 45 U.S Sates and 15 countries (Small 
World Initiative., 2019). This protocol (Hernandez, Tsang and Handelsman, 
2015) has been extensively field-tested. However, Antibiotics Unearthed 
aimed to move student learning out in to the public and as such, the protocol 
needed to be optimised and modified to reflect that. Modifications considered 
the nature of asking citizen scientists to experiment in-situ. This meant the 
strict and aseptic techniques had to be flexible, whilst repeatable. Further, the 
aim was to discover potentially novel bacteria producing potentially novel 
antimicrobials and as such, the protocol was optimised towards identifying 
underexploited organisms and improving abundance and diversity of 
antagonistic isolates producing antibiotics or secondary metabolites. Results 
of these modifications and optimisations are presented in Figure 3-8.  
Antimicrobial drug discovery is particularly difficult (Payne et al., 2007). Some 
of the barriers to antimicrobial drug discovery are beyond the scope of this 
project, such as the need for antibiotics to pursue molecular targets not prone 
to rapid resistance development and the need for chemical diversity which can 
overcome barriers to bacterial entry and efflux mechanisms especially in the 
Gram-negative organisms (Silver., 2011). One barrier that this project aimed 
to target was that of the uncultured organisms. Approximately 99% of all 
species in external environments do not grow under laboratory conditions 
(Lewis, 2013). This is a promising source of novel antibiotics (Lewis et al., 
2010), as was highlighted by the discovery of Teixobactin (Ling et al., 2015). 
Whilst diluents, dilutions, growth temperature and fungal contamination were 
all optimised, growth media received the greatest focus. SEM has a long 
history of giving higher plate counts and encouraging growth of otherwise 
unculturable bacterial isolates compared to liquid media without soil-extract 
(Taylor, 1951; Nguyen et al., 2018).Therefore, part of the method development 
of the Antibiotics Unearthed project attempted to incorporate the use of SEM 
into the protocol. However, whilst original results were encouraging, soils taken 
from event locations did not act as a successful growth media and this protocol 
was removed. Instead, AC and BHI media were selected from the Small World 
Initiative’s list of media for successful growth of a range of soil organisms 
(Hernandez, Tsang and Handelsman, 2015).  
The most significant problem posed by the antagonistic drop-plate assay was 
bacterial motility. Whilst a lawn was made of the medically relevant indicator 
strain, the droplets of antagonistic isolate were required to grow only in the 
location they were placed. Bacteria can swarm over the agar surface (Kearns, 
2010). In lab strains, swarming motility has been selected against, however 
natural isolates are often motile. Whilst some bacteria can swarm over nearly 
any agar surface, most swarming bacteria require soft agar in a narrow range 
of agar concentrations (Kearns, 2010). Agar concentrations between 0.5% and 
2% have been shown as ideal for bacterial swarming over the agar surface 
116 
 
(Harshey, 1994). To prevent this, 4% agar was selected for the antagonistic 
assays which successfully prevented this bacterial swarming motility. To 
improve the drop-plate assay further, overnight cell density of the clinically 
relevant indicator strains could be controlled to ensure that antagonistic 
activity, no matter how weak, could be identified clearly. Future work may 
consider the length of growth time before maximum antimicrobial activity is 
observed (Von Der Weid et al., 2003).  
Over five events, 454 soil samples were collected. Table 3-3 shows the story 
of these 454 soil samples. Of these 454 samples, 299 were collected at the 
first two events. Despite this large number of samples, less colonies which 
showed antagonistic activity against neighbouring soil colonies (204) and 
medically relevant pathogens (40) were isolated than in the remaining three 
events. The number of soil samples collected was reduced after the first two 
events to increase accuracy in the lab, allowing more time to be spent on each 
sample. This, along with further optimised protocol (using AC and BHI rather 
than SEM) resulted in more antagonistic colonies per plate. The modified and 
optimised protocol resulted in the analysis of a total of 929 bacterial isolates 
that showed antagonistic activity against neighbouring soil organisms and the 
selection of a total of 165 isolates which showed antagonistic activity against 
one or more medically relevant pathogens (Table 3-3). 15 isolates were 
selected for further analysis.  
3.4.2 Whole Genome Sequencing 
High throughput WGS has transformed the study of microbial genomics, not 
least through bacterial identification notably in infection control (Hasman et al., 
2014; Walker et al., 2013), antibiotic resistance (Pallen et al., 2010) and 
antibiotic discovery (Ziemert et al., 2016). In collaboration with the Cooper Lab, 
WGS was used to characterise 15 antagonistic isolates, ELD01-15.  
Double-barrelled shotgun sequencing utilises pairs of reads obtained from 
both ends of inserts of various sizes (Sundquist et al., 2007) which assists with 
assembling complex genomes. Illumina’s MiSeq provided paired 300 bp read 
lengths. One of the limitations of reading comparatively short lengths of DNA 
is that more reads must be done to cover the same sequence. Further, 
stitching the results together into longer genomic sequences is a lot more 
complicated (Rogers and Venter, 2005). Producing high-quality assemblies 
with short reads is a challenge for bacterial genomes (Chaisson et al., 2004). 
This limitation was noticeable in the first round of sequencing which produced 
highly variable densities of reads across the length of the 15 genomes (Table 
3-7). This must be considered when examining the results of analysis in the 
remaining sections.  
A successful attempt was made to reanalyse the DNA from initial DNA 
extraction of three of the isolates. These three isolates were chosen based on 
phylogenetic analysis (3.3.5) and identification of BGCs (3.3.6). The Cooper 
Lab calculated recommended coverage and reran the samples, successfully 
reducing the number of contigs and increasing the depth of coverage (Table 
3-8). Analysis of this data is part of future work for publication.  
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3.4.3 Discovery of interesting bacteria producing interesting 
antimicrobials 
Actinomycetes have been overmined due to their substantial number of BGCs 
(Rutledge and Challis, 2015) and the ease at which broad spectrum antibiotics, 
particularly effective on troublesome Gram-negative pathogens, can be 
discovered (Baltz., 2007). However other underexploited bacteria have had to 
develop their own compounds to act against their competitors (Lewis, 2020). 
In this study, ELD01-15 were identified as eight species of bacteria (Figure 
3-14, Figure 3-15): Bacillus subtilis (ELD01, 07, 09 and 11), Bacillus altitudinis 
ELD02, 04 and 14), Bacillus velezensis (ELD03), Bacillus simplex (ELD10), 
Bacillus psychrodurans (ELD13), Paenibacillus peoriae (ELD05 and 08), 
Sporosarcina aquimarina (ELD06) and Pseudomonas vranovensis (ELD12 
and 15). Each of these bacteria are known soil organisms. Importantly, these 
organisms are not part of the overmined actinomycetes.  
Underexploited bacteria have been shown to devote sizeable parts of their 
genome to BGCs (Crits-Christoph et al., 2018). In this study, the use of 
genome mining software allowed the identification of a substantial number of 
BGCs in ELD01-ELD15.  
3.4.3.1 Bacillus spp. 
Of the eight species of bacteria, five are of the genus Bacillus. The genus 
Bacillus comprises 403 species (last update in November 2020) of Gram-
positive, rod-shaped bacteria (Gordon et al.,1973). Like streptomycetes and 
fungi, members of the genus Bacillus are characterized by the presence of 
many genes coding for biosynthesis of secondary metabolites. The type 
species is Bacillus subtilis (Ehrenberg CG, 1835).  
Whilst not a member of the actinomycetes, Bacillus spp., are common lab 
strains and as such, their antibiotic production has been well documented. As 
predicted, the Bacillus isolates produced a wide range of antimicrobial 
compounds (AMCs). For any given strain of the Bacillus group, it is now 
estimated that at least 4–5% of its genome is devoted to AMCs production 
(Stein, 2005). The main clades of AMCs within the Bacillus group are the 
ribosomal peptides (RPs) (bacteriocins and enzymes), the PKS, the NRPs and 
the volatiles (Caulier et al., 2019). This aligns with the laboratory results which 
indicated a broad spectrum of activity against Fungi, Gram-positive and Gram-
negative bacteria.  
To focus this discussion, I concentrate in more detail on the lesser explored 
species isolated in this project, namely Paenibacillus spp (3.4.3.2), 
Sporosarcina spp (3.4.3.3)., and Pseudomonas spp (3.4.3.4).  
3.4.3.2 Paenibacillus spp. 
The genus Paenibacillus comprises 262 species (last update in November 
2020) of Gram-positive, rod-shaped, facultatively anaerobic bacteria (Ash, 
Priest and Collins, 1993). ELD05 and 08, identified as Paenibacillus peoriae, 
inhibited different indicator strains. ELD 05 inhibited Candia albicans, 
Salmonella WT, Salmonella DT104 and VRE. ELD08 however only inhibited 
MRSA. I note in the first round of testing, ELD08 also inhibited Salmonella WT 
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and Salmonella DT104. ELD05 was collected from Glasgow, where ELD08 
was collected from the NSF.  
Paenibacillus peoriae was first isolated from soil (Montefusco et al., 1993). The 
antibiotic and secondary metabolite production of this species is not well 
published, however P. peoriae generally shows a broad inhibition spectrum 
with activity against several taxonomic groups of bacteria and fungi (Von Der 
Weid et al., 2003). For a more comprehensive understanding of the known 
secondary metabolite and antibiotic production of Paenibacillus, I look to the 
type species Paenibacillus polymyxa (Ash, Priest and Collins, 1993). 
Several members of the genus Paenibacillus have been reported for the 
production of diverse antimicrobial peptides (Baindara et al., 2020). Genome 
sequencing of P. polymyxa strains revealed numerous antibiotic biosynthetic 
genes in the genome encoding NRPS, PKS and bacteriocins (Jeong et al., 
2019).  
Of the NRPS, P. polymyxa strains produce polymyxins (bactericidal activity 
against Gram-negative bacteria), Fusaricidins (Gram-positive and fungi) and 
Tridecaptins (Gram-negative). The NRPS-Trans-AT-PKS Paenilipoheptin is 
an antibiotic whose activity spectrum is yet to be elucidated . The lantibiotic 
Paenilan is effective against Gram-positive bacteria (Jeong et al., 2019), and 
has also been called antimicrobial (Daud et al., 2019). 
Genome analysis revealed the presence of additional, yet uncharacterized, 
antibiotic BGCs including Trans-AT-PKS-OtherKS-NRPS and lassopeptide 
gene clusters (Jeong et al., 2019).  
Paenibacillus polymyxa produces antimicrobial volatile organic compounds 
(Benzothiazole, benzaldehyde, undecanal, dodecanal, hexadecanal, 2-
tridecanone and phenol), bactericidal Lipopeptides (Polymyxin E1 & E2) and 
antimicrobial Lipopeptides (Polymyxin B). It also produces iron chelating 
Siderophore (Hydroxamate) (Daud et al., 2019).  
Several works have shown that strains of P. polymyxa can produce different 
antimicrobial substances effective against fungi and bacteria (Dijksterhuis et 
al., 1999; Piuri et al., 1998; Rosado & Seldin, 1993), including human 
pathogenic bacteria and fungi (Seldin et al., 1999). Recently, P. polymyxa has 
shown antimicrobial activity against Staphylococcus aureus, Escherichia coli, 
and Klebsiella pneumoniae (El-Rahman et al., 2020).  
ELD05 was predicted to contain BGCs for Trans-AT-PKS-NRPS, NRPS-
Trans-AT-PKS-otherKS, Lassopeptide, NRPs, Siderophore, Trans-AT-PKS, 
Phosphonate and Bacteriocin. Phosphonate, not mentioned above, is a gene 
cluster responsible for bacterial degradation of phosphonates which releases 
biologically available phosphate. This is important as phosphate is a major 
limiting nutrient in soils and a large proportion of phosphate in soils is 
sequestered in mineral compounds. This has been shown as present in P. 
polymyxa (Eastman et al., 2014).  
ELD08 was also predicted to contain BGCs for NRPs, Trans-AT-PKS, Trans-
AT-PKS-NRPS, Siderophore, NRPS-Trans-AT-PKS-otherKS, Phosphonate, 
Bacteriocin and Lassopeptide. Additionally, it was predicted to contain a BGS 
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for a T1PKS-NRPs and a Lantipeptide. These have all been shown to occur in 
Paenibacillus spp.  
3.4.3.3 Sporosarcina spp. 
The genus Sporosarcina comprises 18 species (last update in November 
2020) of Gram-positive, non-pathogenic, spore-forming, facultatively aerobic 
bacteria (Kluyver and van Niel., 1936; Yoon et al., 2001). ELD06, identified as 
Sporosarcina aquimarina, inhibited VRE and Candida albicans. Research on 
the specific antibiotics or secondary metabolites produced by Sporosarcina 
spp is limited and would make a good target for future work. Sporosarcina 
aquimarina has been shown to produce the enzyme urease (Jiang et al., 
2016). Sporosarcina spp have also been preliminarily proposed for use in 
probiotics for poultry (Priyodip and Balaji, 2019). A key component of validating 
an organism’s probiotic potential is its ability to show antagonistic activity 
against enteric pathogens. The activity against Gram-variable enteric 
pathogens was hypothesised as the production of broad-spectrum 
bacteriocins, as seen in closely related Bacillus spp (Priyodip and Balaji, 
2019). ELD06 was predicted to contain BGCs for Terpene and T3PKS. To my 
knowledge, these are clusters which have not yet been shown to be produced 
by Sporosarcina spp.  
3.4.3.4 Pseudomonas spp. 
The genus Pseudomonas comprises 302 species (last update in November 
2020) of rod shaped, Gram-negative bacteria (Migula, 1894; Krieg, 1984). 
Members of this genus inhabit a wide variety of environments due to their 
metabolic capacity and broad potential for adaptation to different conditions 
(Moradali et al., 2017). ELD12 and 15, identified as Gram-negative 
Pseudomonas vranovensis, inhibited Candida albicans. ELD12 also inhibited 
MRSA. ELD12 was grown on AC, whilst ELD15 on LB. Both ELD12 and ELD15 
were samples from Thetford. Pseudomonas vranovensis was proposed as a 
novel species by Tvrzová et al (2006) and described as Gram-negative, non-
spore-forming rods. This species of Pseudomonas, along with its antibiotic and 
secondary metabolite production is not well published. Instead, I discuss the 
known secondary metabolite and antibiotic production of Pseudomonas spp.  
Pseudomonas spp produce a spectrum of structurally diverse peptides. Many 
of these are synthesized by large, multifunctional proteins called non-
ribosomal peptide synthases (NRPS). These include iron-chelating 
siderophores such as Pyochelin, Pseudomonine and Pyoverdines. It also 
includes lipopeptides (antifungal, antibacterial and antiviral), Safracin (anti-
tumour) and Pyrrolnitrin (antifungal) (Gross and Loper, 2009).  
Polyketides are a large class of structurally diverse natural products that 
include compounds with antibiotic, chemotherapeutic, and phytotoxic 
activities. Collectively, polyketide biosynthesis in Pseudomonas spp involves 
each of the three types of PKS. These are type I, type II and type III (Gross 
and Loper, 2009). Pseudomonas species are also known to produce hybrid 
NRPS-PKS compounds (Gross and Loper, 2009).  
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Other known compounds include Phenazines (antibiotic, antitumor, and 
antiparasitic activity), Quinolones (antibacterial) and Hydrogen Cyanide 
(extremely poisonous to most organisms) (Gross and Loper, 2009). 
Genome-guided strategies have increased the appreciation for the metabolic 
potential of the Pseudomonads, especially once the prevalence of secondary 
metabolite gene clusters in their genomes was discovered. Notable 
compounds discovered in this way include the Orfamides (antifungal) and the 
Rhizoxins (phytotoxic, antifungal and antitumoral) (Gross and Loper, 2009). 
ELD12 was predicted to contain gene clusters for production of NRPS and Aryl 
polyene. NRPS are common in Pseudomonads. Aryl polyenes, structurally 
similar to the well-known carotenoids and providing a protective function 
against reactive oxygen species (Schöner et al., 2016), are highly abundant in 
bacteria and have been discovered in Pseudomonas spp (Trantas et al., 2015; 
Schöner et al., 2016). ELD15 was predicted to contain gene clusters for 
production of NRPS and Aryl polyene, but also for PpyS-KS. PpyS-KS, a PPY-
like pyrone cluster has been found in other Pseudomonas spp using 
antimicrobial cluster mining (Steiner et al., 2020). Known biological functions 
of PpyS-KS include intermediates and end products in primary metabolism and 
signalling molecules and molecules which are applied for defence against 
competitors and predators. The biological activities these compounds exhibit 
includes antimicrobial, antitumor and cytotoxic activities (Schäberle, 2016). 
3.4.4 Future Work 
With regards to taking a bioinformatic approach to analysis, there are several 
avenues for future work. In order to improve the read depth of genome 
sequences, all 15 isolates could be sent for further WGS. Calculating the gDNA 
required to obtain deeper read coverage proved successful on the three select 
isolates. Further, a method of sequencing which obtains longer reads than the 
300 bp used by the Illumina MiSeq would assist in stitching together longer 
genome sequences (Rogers and Venter, 2005). Moss, Maghini and Bhatt 
(2020) used nanopore sequencing with read lengths on average 20 times 
longer than our Illumina reads to assemble seven genomes into single contigs. 
Often a mix of short and long read sequences can provide the optimum mix of 
nucleotide accuracy and read lengths.  
Complete genomes would increase confidence in antiSMASH and 
phylogenetic data. Phylogenetic data could be further improved through 
comparison of other highly conserved genes. Research often compared gyrB, 
rpoB and rpoD genes as well as 16S rRNA. Yamamotot and Harayama (2017) 
used 16S rRNA, gyrB and rpoD genes to examine the phylogenetic 
relationships of Pseudomonas putida strains. It is also common to concatenate 
16S rRNA, gyrB, rpoD and rpoB genes as shown by Wang et al (2020) to 
identify a novel species of Pseudomonas, Pseudomonas laoshanensis.  
To compare the similarity of whole genomes, rather than specific conserved 
genes, one could also use Average Nucleotide Identify (ANI) to get a measure 
for genome sequence similarity (Lee et al., 2016) or Genome-Genome 
Distance (GGD), an in-silico procedure to calculate the closeness between 
genomes (Srivastava et al., 2020). Synteny, that is where in the genome is 
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conserved or divergent, can be measured with software such as BLAST Ring 
Image Generator (BRIG) (Alikhan et al., 2011) and CGView Comparison Tool 
(CCT) (Grant et al., 2012). 
Further culture-dependent approaches could also be explored with these 
isolates. A simple exploration would be to expand the bioassays against a 
broader spectrum of sensitive and drug resistant isolates of important clinical 
pathogens. One might start by testing against the bacteria labelled as of 
serious or urgent concern by the CDC (Table 1-3). For example, Ling et al 
(2015) tested the potency of their novel antibiotic Teixobactin against 
Mycobacterium tuberculosis.  
Beyond bioassays, purification and identification of the secondary metabolites 
with antimicrobial activity needs to occur. Liquid Chromatography Mass 
Spectrometry (LC-MS) on culture’s supernatants could be conducted to 
determine antibiotics produced by an isolate. Do et al (2020) used this 
approach to identify eight antibiotics in aquaculture and river water samples in 
Vietnam. Vikeli et al (2020) used LC-MS to detect production of Kyamicin from 
sample extracts and downstream chemistry can purify active fractions and 
eventually active compounds. Further, in the discovery of a new Streptomyces 
species, Streptomyces formicae, Z. Qin et al (2017) used high-resolution LC-
MS and metabolomics to identify the presence of novel metabolites in fractions 
exhibiting antibacterial and antifungal activities. They used high resolution 
Electrospray-tandem-mass spectrometry (ESI-MS) and Nuclear Magnetic 
Resonance (NMR) data to identify the structure of the novel metabolite (Z. Qin 
et al., 2017). Once potentially novel metabolites have been identified, one 
could test for spontaneous resistance, for example against MRSA as it was in 
Z. Qin et al (2017).  
If the isolate was genetically tractable, inducing a knock-out mutation in the 
BGC expected to code for antibiotic production would allow us to determine if 
the cluster in question was solely responsible for the antimicrobial potential of 
the isolate or whether multiple active compounds were being produced. If the 
isolate was not genetically tractable, you could instead clone the BGC believed 
responsible for the antibiotic production and see if you can bestow the killing 
potential in a recipient strain that produces no antimicrobials. 
Whilst much of this work can begin on the three isolates sequenced with a 
greater read depth, there are many strains which could be brought forward to 
the level of these three. 
3.4.5 Summary 
Through a citizen science field study which successfully collected and 
analysed 454 soil samples, 15 partially sequenced genomes of eight species 
of bacteria have been determined (Figure 3-14, Figure 3-15): Bacillus subtilis 
(ELD01, 07, 09 and 11), Bacillus altitudinis ELD02, 04 and 14), Bacillus 
velezensis (ELD03), Bacillus simplex (ELD10), Bacillus psychrodurans 
(ELD13), Paenibacillus peoriae (ELD05 and 08), Sporosarcina aquimarina 
(ELD06) and Pseudomonas vranovensis (ELD12 and 15). Despite their 
geographical isolation and varied environments of collection, most of the 
predicted antibiotic and secondary metabolite clusters were highly conserved 
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between species. However, some of the predicted BGCs have not been 
reported previously. All isolates which showed inhibitory activity against one or 
more medically relevant pathogens are available for future study.  
Furthermore, the antibiotic discovery pipeline optimised as part of this project 
provided a continuous source of media with which to engage interested citizen 
scientists. The contribution of this to the citizen science project is the focus of 


















Chapter 4 Public understandings of and 
attitudes to antibiotics and antibiotic 



















The increase in incidence of AMR has the potential to reverse arguably the 
single greatest health care advance in history (1.1). Individuals prescribed an 
antibiotic are more likely to develop bacterial resistance to that antibiotic for up 
to 12 months after treatment (Costelloe et al., 2010). Furthermore, patient 
expectations for antibiotics are linked to higher prescribing (1.2.3). Therefore, 
in the comprehensive U.K Review on AMR by O’Neill (2016), one of the ten 
commandments was to launch a massive global public awareness campaign. 
Yet, despite continued Public Health campaigns aimed at improving public 
understanding of antibiotic resistance, global antibiotic use has grown 66% 
since 2000 (Klein et al., 2018). In order to guide future Public Health 
campaigns, it is important to identify what the current public awareness of 
antibiotics and resistance looks like. In chapter 1.3, a review of key research 
examining the public discourse of antibiotics and antibiotic resistance was 
undertaken. From this, six key themes emerged.  
When discussing antibiotics and their side effects, there was an awareness 
that antibiotics are not a trouble-free solution and can cause side effects. 
Sensible use and taking the full course were believed to minimise the effects. 
Researchers concluded that negative consequences of antibiotic use can be 
a powerful motivator in discouraging antibiotic use (1.3.2). 
The public often mistook antibiotic resistance as a property of the human body, 
rather than of an infectious agent. This concept was coined the resistant 
human body theory. In either case, the logical conclusion to be drawn is that 
overuse of antibiotics can limit their efficacy. This is a misunderstanding that 
likely does not affect the outcome of sensible use (1.3.3). 
The public blame the irresponsible other rather than consider their own 
contribution to the problem of antibiotic resistance. Researchers concluded 
that campaigns should be aimed at convincing individuals to take personal 
responsibility for the spread of resistance (1.3.4).  
Factual knowledge and awareness of Public Health narratives has been 
positively and negative associated with sensible use of antibiotics. Individuals 
with lower levels of education were less likely to understand antibiotic 
resistance but were more likely to be positively influenced to change their 
behaviour when provided information. Researchers concluded that this should 
be a target for future public health campaigns (1.3.5).  
Public awareness of antibiotics and antibiotic resistance is limited, and where 
awareness is present, it is often superficial and does not reflect a deep 
understanding of terms like antibiotic resistance. Public Health campaigns 
focused on antibiotics seemed not to be reaching the public, improving 
awareness or engendering behavioural change (1.3.6).  
Finally, in understanding why users take antibiotics, evidence suggests that 
there has been an increase in awareness surrounding the ineffectiveness of 
antibiotics on viral infections. This knowledge seemed to be limited to viruses, 
rather than specific examples of viral infections (1.3.7). 
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I aimed to investigate these key themes, other less frequent themes and the 
public’s conceptions of research using Brew's (2001) framework (Table 2-5). I 
also aimed to apply an adaptation of research by Biza et al (2018), which uses 
changes in consistency and specificity as a measure for learning. Finally, 
codes which emerged from the analyses themselves were incorporated into 
the analysis.  
In Chapter 2, Part two, I laid out the theoretical perspectives which underpin 
my position as a researcher in the field of citizen science. These theoretical 
perspectives guided the selection of methods for collection and analysis of 
data on public discourse surrounding antibiotics and antibiotic resistance.  
To facilitate the data collection a pop-up stand was used (2.6). For data 
analysis, a semi-structured interview was designed (2.7.1). The semi-
structured interview included closed-ended yes/no questions to allow 
quantitative analysis built upon the positivistic approach to measuring 
phenomenon (Cohen, Manion and Morrison, 2007). The semi-structured 
interview also included open-ended questions to allow qualitative discourse 
analysis. 
In 1998, Sfard (1998) discussed two metaphors for learning; the participation 
metaphor which frames learning a subject as a process of becoming a member 
of a community, and the acquisition metaphor which frames learning as a 
knowledge transfer from teacher to student. The acquisition metaphor sits well 
within the positivist epistemological framework, that there is an objective truth 
and therefore student misunderstandings are errors which can and should be 
corrected. The participation metaphor sits well within the non-positivist 
epistemological framework, as it views participant misunderstandings as a 
normal part of participating in a community of subjective views. Of crucial 
importance to the ontological and epistemological underpinning of this project 
was Sfard’s recommendation that one metaphor is not enough.  
“Acquisitionists and participationists might admit that the 
difference between them is not a matter of differing opinions but 
rather of participating in different, mutually complementing 
discourses” (Sfard, 1998, p. 11). 
These metaphors assume that the learner engages with an unfamiliar 
discourse. To successfully engage in an unfamiliar discourse a participant 
must agree to an unwritten learning-teaching agreement (Sfard, 2015). This 
simply states that the learner will be exposed to communicational conflict. To 
turn this conflict into a lever for learning rather than an obstacle, the learner 
must be in one mind regarding:  
1. Whose discourse is to be eventually shared;  
2. Who needs to act as the teacher and who as a learner; and 
3. What is the expected form, mechanism and pace of the learning 
process? 
 
To measure the extent to which a participant engaged with an unfamiliar 
discourse and undertook learning, Sfard (2008) put forward the phrase 
‘thinking as communicating’. Sfard (2008) suggested that interpersonal 
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communication and individual thinking are two facets of the same 
phenomenon, coining this commognition, that is a combination of 
communication and cognition. That is to say that by analysing an individual’s 
interpersonal communication (discourse), be it speaking, writing or some other 
medium, one can attempt to understand what a person thinks about an issue 
(cognition). Sfard defines discourse as communication consisting of four key 
characteristics; word use, visual mediators, routines and endorsed narratives 
(Sfard, 2007).  
In the following chapter, I descriptively analyse closed ended, yes/no 
questions. I then apply a coding schedule to transcripts of 32 participant 
interviews. In doing so, participant discourse is taken to reflect their internal 
thought processes surrounding antibiotics and antibiotic resistance. In the 
analysis that follows, participant is used as the person who takes part in the 
project, interviewee as the person who is interviewed, citizen scientist as a 
member of the public who collects and analyses data as part of this project 
and volunteer as a person who freely offers to take part in helping run our 
project. 
4.2 Results: a descriptive analysis 
4.2.1 Public understanding of soil microbiota’s role in medicine 







and could respond to each of five categories with either a yes, no or unsure 
response (Figure 4-1). Participants correctly identified that bacteria (88%) and 
fungi (72%) can produce antibiotics. 53% of participants identified humans as 
being able to make antibiotics. In 3/17 cases where participants answered yes, 
they clarified it was the bacteria on or in us that produced the antibiotic. In a 
further 5/17 cases the participant directly stated that they are only answering 
yes if they can clarify that they mean in a laboratory setting. There was a 
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Figure 4-1. Participants see plants in a medicinal light. Participant responses (N=32) to the closed-ended 
question “Do you think most antibiotics are made by…?” Responses of either yes, no or unsure were noted 
for each of five categories: Bacteria, Fungi, Humans, Plants and Viruses. Responses are shown as percentages 
of total responses for each category.  
 
4.2.2 Public understanding of antibiotic resistance 
Participants were asked “Can you tell me which of the following can become 







and could respond to each of five categories with either a yes, no or unsure 
response (Figure 4-2). 96.875% of participants responded yes to bacteria 
being able to become resistant to antibiotics. 87.5% of participants responded 
yes to humans. Fungi received less yes responses, 78.125%. Plants received 
a yes response in 62.5% of cases, whilst viruses received the lowest number 
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Figure 4-2. Members of the public align with the resistant body theory. Participant responses (N=32) 
to the closed-ended question “Which of the following can become resistant to antibiotics?” Responses of 
either yes, no or unsure were noted for each of five categories: Bacteria, Fungi, Humans, Plants and Viruses. 
Responses are shown as percentages of total responses for each category.  
 
4.2.3 Public understanding of use of antibiotics in a medical setting 
Participants were asked “We often refer to infections as bacterial, fungal or 





and could respond to each of five categories with either a yes, no or unsure 
response (Figure 4-3). Participants responded that antibiotics could be used 
to treat bacterial infections in 97% of cases, more than any other category. 
75% of interviews produced a yes response to the treatment of fungal 
infections with antibiotics. Viral infections received the fewest yes responses, 
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Figure 4-3. Members of the public are aware that viral infections are treated differently than 
bacterial or fungal infections. Participant responses (N=32) to the closed-ended question “Which of the 
following infections do you think are treatable with antibiotics?” Responses of either yes, no or unsure were 
noted for each of three categories: Bacterial, Fungal and Viral. Responses are shown as percentages of total 
responses for each category.  
 
4.2.4 Public understanding of antibiotic discovery 
Participants were asked “Have you ever heard of teixobactin?”. They could 
respond with either a yes, no or unsure response (Figure 4-4). Of the 32 





















Figure 4-4. Members of the public had not heard of Teixobactin, a novel antibiotic discovered in 
January 2015. Participant responses (N=32) to the question “Have you heard of Teixobactin?” Responses 
of either yes, no or unsure were noted. Responses are shown as percentages of total responses. 
4.3 Results: a thematic analysis 
In 4.2, a descriptive account of the responses to closed-ended questions 
asked in the face-to-face interviews has been given. I now use a coded 
analysis of participant interview transcripts and factual summaries to identify 
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what the participants think about antibiotics and antibiotic resistance in a 
discourse analysis approach (Sfard, 2008). Participant consistency and 
specificity is also examined (Biza et al., 2018). As described in chapter (2.7.1), 
codes were reduced to major themes through ongoing discussion between 
researchers and re-reading of factual summaries and transcripts. Here, I 
present the eight key themes which emerged from coding of the interviews: 
1. The correct use of scientific terminology 
2. Using personal experiences in ritualised ways to participant in a new 
discourse  
3. Public Health Narratives 
4. Human Health Narrative 
5. Who is to blame? 
6. What are scientists after? 
7. Do people need a hero? 
8. Do people make bad decisions in the face of better knowledge? 
4.3.1 The correct use of scientific terminology 
One part of organising new experiences in terms of those with which an 
individual is already familiar requires using familiar words following pre-existing 
rules that seem in agreement with the new context (Sfard., 2008). However, 
when a new word is metaphorically introduced in this way, there is no 
guarantee that the word’s meaning will be correct in its new context. This 
ambiguity can threaten the effectiveness of communication. In order to 
investigate this phenomenon, I developed the code “Scientific Word Use 
[SWU]” (105 references from 26 sources) to capture each time an interviewee 
used a scientific word or phrase, either correctly or incorrectly.  
A reoccurring example was the familiar word “virus” or “viral” (ten references 
from eight sources). This word was used in a way not consistent with the 
scientific use of the word in the literate discourse. I note, for example, the 
following exchange between myself and interviewee 01. When asked what 
they knew about antibiotic resistance, they responded: 
01: I know that err they’re becoming, there are strains of viruses 
erm that are becoming immune to what we have developed.  
In the above, the metaphorical use of strains of viruses does not match the 
operationalised, scientific version. Of the ten references, interviewee 01 was 
responsible for three, and in each case used the word incorrectly in the 
scientific context. This misuse of the word virus did not preclude interviewee 
01 from understanding that bacteria are the focus of antibiotic resistance 
discussion. Later in the interview whilst discussing the last time new antibiotics 
were discovered; interviewee 01 said: 
01: …everything seems to sort of be able to sort of um beat us now 
if that makes sense, like MRSA and all that and what’s the other 
one, C. diffa something or other.  
Interviewee 01 correctly identified two species of human pathogenic bacteria 
relevant to the topic of antibiotic resistance. This highlights that this individual 




Further to how an individual might explicitly use the keywords of a discourse, 
I also examined how an individual might react to keywords when used by 
myself. In section 4.2, participants gave less yes responses to viruses (Figure 
4-1, Figure 4-2 and Figure 4-3). Looking at the level of confidence of these 
answers, participants tended to answer more confidently when viruses were 
mentioned. The following example shows interviewee 01 responding when 
asked if viruses produce antibiotics: 
01: Definitely yes. 
Interviewee 01 used a qualifier. Qualifications made by participants were 
captured using the code “Confidence [CON]” (212 references from 30 
sources). Interviewee 01 did respond yes to each of the five options presented 
to them during this question, however upon hearing viruses they inserted the 
positive qualifier ‘definitely’.  
The following example is interviewee 23 responding when asked what the 
biggest issue would be if antibiotic resistance were to spread: 
23: And also it means that err, that kind of, mild things are still 
gonna be as mild as ever when there is particularly bad, well I was 
about to say viruses but that’s entirely wrong, but particularly bad 
erm bacterial infection, which might be pandemic, which might be 
epidemics etc, none of the normal things work.  
Interviewee 23 had a close relationship with a practicing Microbiologist and as 
such had prior access to the literate discourse on such topics. In this excerpt 
there is a moment of conflict when interviewee 23 used the familiar word 
viruses in the incorrect context. They noticed their mistake and corrected 
themselves to say bacteria. This participant had a solid understanding of the 
topic, however had to actively correct themselves mid-sentence as their 
discourse slipped back into the colloquial.  
This thematic analysis supports the notion that individuals bring familiar words 
to a new discourse as they begin to engage with it. The incorrect use of these 
words, which have specific operationalised meanings in the literate discourse, 
can cause ambiguity. This does not mean that the individual does not 
understand the key concepts of the discourse.  
4.3.2 Using personal experiences in ritualised ways to participate in a 
new discourse 
Sfard (2008) considers routines as repetition-generated patterns of our 
actions. When a participant engages with a new discourse, routines are initially 
implemented as rituals (process-oriented routines). Rituals simply mimic or 
replicate, sometimes not very critically, what has been bequeathed by previous 
users, for example out of respect for authority. This theme examines more 
broadly the concept of engaging with new experiences in terms of those with 
which an individual is already familiar. It examines how participants use habits, 
often based upon personal experiences, to engage with a new discourse and 
how this shapes the words they use, narratives they endorse and routines they 
 
132 
follow. The following except was captured by the code “What Users Take 
Antibiotics For [UTA]” (43 references from 20 sources). The following response 
was from interviewee 3a and 3b, when asked what kinds of infection they might 
take antibiotics for:  
03a: I took antibiotics after my op against MRSA. 
… 
03a: Yeah I have used antibiotics loads!  
Interviewee 03a used the experience of having had an operation to introduce 
the term “MRSA”, an infectious agent that can be treated with antibiotics. In 
the same interview, the code “Role of Doctors [ROD]” (48 references from 23 
sources) captured another example of interviewee 03a repeating their own 
experience to engage with the discourse, this time when asked the ways in 
which they thought antibiotics were used: 
03a: Cos our doctor won’t give anything for viral things will he…  
R: No.  
03a: If you’ve got a viral sore throat then ‘no you’re not having it’ 
but if you got septic pus-y throat then you have the antibiotics.  
Interviewee 03a correctly distinguished between viral and bacterial infections 
because of conversations they had with their own doctor. They went as far as 
to directly quote their doctor in the last sentence.  
Whilst participant 03a recalled personal experience, the ability to imitate 
extends to experiences which one is indirectly aware of. An example of this 
was captured by the code “UTA”. Interviewee 04 recalls their Mum’s 
experience with antibiotics when asked which kind of infections are treatable 
with antibiotics. I first draw attention to my wording of the question: 
R: Okay, we take antibiotics to combat infections, which kind of 
infections do you think, or if you know anyone who has had an 
infection that was treatable with antibiotics, or?  
By interview 04, I had seemingly noticed that participants often drew on 
personal experiences to answer this question and as such expanded the 
question to include “if you know anyone…” to prompt participant engagement 
with the discourse. Interviewee 04 responded: 
04: Err my mum takes antibiotics all the time at the moment 
because she is not very well, but I have no idea what sort of thing, I 
should probably know more about it, but ye erm  
Interviewee 04 recalled their mother’s experience with antibiotics to engage 
with the question. In this case the participant could not remember the specific 
details of the experience. Just like interviewee 03a, interviewee 04 used the 




04: *Whispers viral*. So when you have a virus does the doctor say 
you can have it or you shouldn’t have it? Hahaha, I can’t 
remember!  
Interestingly when comparing the two interviewees, it is noticeable that 03a, 
who more accurately recalled their own experiences, engaged more with the 
literate discourse than 04, that is used scientific terms correctly and expressed 
the expected narratives regarding viruses. Finally, the code UTA, captured the 
following statement from interviewee 05 when asked which types of infection 
to take antibiotics for: 
05: I am just more familiar with viral infections, I am from having 
the kids. Everything they have seems to be viral.  
Interviewee 05 stated explicitly that they were using their familiarity with viral 
infections due to personal experience to answer the question.  
This thematic analysis highlights how individuals used rituals or recall their own 
or other’s experiences to engage with a new discourse. Whilst these 
experiences were not always relevant or specific, they did facilitate 
engagement. In some instances, these experiences assisted individuals with 
utilising operationalised terms, as discussed in 4.3.1. 
4.3.3 Public Health Narratives 
In 4.3.2, I showed how in the process of engaging with a new discourse, a 
participant might use rituals or experiences. Public Health narratives are rituals 
bequeathed by authorities familiar with the literate discourse. These rituals are 
meant to be imitated and encourage behaviour considered sensible by a given 
community. Not imitating these rituals makes one an outsider. With regards to 
antibiotics and antibiotic resistance in the U.K, the authority is Public Health 
England. In order to identify moments where a participant implemented these 
ritualised public health narratives, the code “Public Health Narrative [PHN]” (54 
references from 27 sources) was applied. The 54 references were divided into 
six key public health narratives. Four of these were mentioned frequently.  
The first narrative is that antibiotics are taken for everything (overuse), and that 
they should not be (misuse). Misuse in these instances was linked to taking 
antibiotics for the common cold, coughs, viral infections, giving antibiotics to 
dogs and using antibacterial hand gel. One example came from interviewee 
20, when answering whether they can personally make a difference to the 
spread of AMR: 
20: Err ye, so only taking antibiotics when I absolutely need them. 
Erm, obviously antibiotics can be used for all manners of things but 
sometimes yano illnesses can just take their natural courses. I mean 
humans are very efficient at dealing with bacterial infection and 
even viral infection. So there’s no, there’s not always requirement 
to take antibiotics. 
The participant drew on the narrative that antibiotics should only be taken when 
necessary. This included the narrative that some illness, both viral and 
bacterial, should be allowed to run their course.  
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The public health narrative surrounding overuse states that people should not 
be taking antibiotics as often, and that if they do, they no longer work. 
Participants thoughts on overuse were often captured by the code “The 
Resistant Body Theory [ReB]” (44 references from 19 sources). Individuals 
made the leap that the reason antibiotics no longer work when you take too 
many is that our own bodies develop immunity to antibiotics, rather than the 
infectious agent:  
03: I know that if you have antibiotics for the same things, your 
immune system yano you handle them better so they aren’t as 
effective.  
Interviewee 22 gave an insight in to the reason the Resistant Body Theory 
occurs so frequently, when asked whether humans, and then plants, can 
become resistant to antibiotics:  
22: Well you kind of say humans, but there’s things in us which are 
resistant but yet, ye”. 
and 
22: Well they get bacteria still and bacterial infections, ye, they’re 
living,  
Interviewee 22 highlighted how an individual may say that humans can 
become resistant to antibiotics, without qualifying that this is because of the 
bacteria living inside of them.  
The second narrative is that an individual should take their full course of 
antibiotics once prescribed. Within this theme I included the need for shorter 
courses mentioned by one interviewee, and the returning of unused antibiotics 
to the doctor. Interviewee 28 provided a clear example, correctly mimicking the 
ritual that one must take their full course: 
28: Erm, and to erm carry on taking your entire course of 
antibiotics, don’t stop halfway through. 
The third narrative is that antibiotics do not work on viruses. In the closed-
ended questions, interviewees seemed to understand that viral infections are 
to be treated differently from bacterial or fungal infections (Figure 4-3). This 
was expanded upon in the open-ended questions, where interviewee 08 said: 
08: Well not viral, because you can’t use antibiotics for a viral 
infection, it’s gotta go its course. 
This linked elements of the first narrative, that infections should run their 
natural course, with the third, that antibiotics do not work on viral infections.  
The fourth narrative is the need for better personal hygiene: Within this theme, 
participants touched on washing hands, covering mouths and enforcing a self-
quarantine. On one occasion an interviewee recommended only the use of 
your own towel. Interviewee 14b, when asked how you could personally make 
a difference to the spread of AMR, said: 
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14b: And by the way in which you behaved, you know, you can 
spread it and people who sneeze all over the place and get their 
hands filthy dirty and don’t wash them, it’s easy, it’s by better 
hygiene and being careful.  
I note that question 11 in particular, “How does antibiotic resistance spread?” 
targeted this public hygiene narrative by specifically asking participants about 
the environmental and genetic spread of bacteria. The code “PHN” was used 
during question 11 (4 references from 4 sources). Excerpts that were coded 
for usually referred to individual hygiene. Participants were much more likely 
to understand the concept of environmental spread of resistance than genetic 
(“SKO” 14/40 references):  
22: Well, erm it’s spread, well it’s mainly close proximity contacts 
and airborne, plus, oh no bacteria, ye no it’s close and bodily fluids 
isn’t it bacteria, rather than viruses are airborne.  
The common knowledge of two major routes of transmission; close contact 
and contact with bodily fluids (airborne), fed in well to the subsequent idea that 
you must take care not to spread infection via these routes, through the 
application of sensible personal hygiene measures:  
31a: Erm its spread when you sneeze on the bus and when you 
shake hands and you haven’t washed your hands properly.  
The fifth narrative is the need for individuals to stay healthy, including the 
concept of remaining active as you grow older. Interviewee 16 touched on this 
when asked how they can help to limit the spread of AMR: 
16: But we keep active and stuff like that. I certainly my jaw’s very 
active yano.  
The final narrative, mentioned by only one participant, is antibiotic stewardship. 
Interviewee 30, who was beginning a PhD project looking at discovering new 
antibiotics, answered in response to what they can do to make a difference to 
the spread of AMR:  
30: Well antibiotic stewardship.  
Most participants (27/32) ritualised at least one public health narrative as they 
engaged with the literate discourse. Some participants (5/32) did not draw on 
a public health narrative. Of these five, one participant offered an opposing 
view to the narrative that antibiotics are being misused. When asked whether 
antibiotics were being misused, interviewee 10 said: 
10: Cos they are helping us so why, why would you be misusing 
them?  
I note that interview 10 lasted below the average time for an interview in 
Breccon Beacons (8 minutes, average was 10 minutes 16 seconds from 13 
interviews). Commenting generally on the mood of the interview, I also note 
that there was little engagement with the questions asked.  
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This thematic analysis has identified six key public health narratives which are, 
on the most part, being ritualised by members of the public as they engage 
with a new discourse. It has also touched on the frequency with which each of 
these narratives is drawn upon. Finally, it has highlighted that not all individuals 
are willing to mimic these rituals or engage fully with the discourse. 
4.3.4 Human Health Narrative 
In 4.3.3, I discussed how individuals use public health narratives to engage 
with a new discourse. In this section I examine how individuals engaged with 
the common rituals surrounding human health, and whether this was 
influenced by their perspective of science. In question 12, I asked interviewees 
what the biggest problem for humans would be if antibiotic resistance were to 
spread. Most responses (31/32 responses) focused on human health to some 
extent. 17 responses provided a more detailed response and so I could 
determine that the extent to which human health would be affected was linked 
to two narratives, coded “Utopian [UTO]” (10 references from 10 sources) and 
“Dystopian [DYS]” (7 references from 7 sources). Utopian and Dystopian 
narratives might be considered as part of a more general outlook, that is 
whether a participant is an optimistic or pessimistic person. Interviewee 05 
provided a utopian narrative:  
05: Not having anything up to date to help fight, when we become 
immune to things, to the antibiotics, and we are still getting ill, 
what are we going to do then?  
… 
05: So we need people like you then. 
They presented the risk to human health, that antibiotics will no longer be able 
to fight infections, and then revealed their opinion of scientists. This was one 
of optimism, that scientists like me can help solve this problem. Interviewee 18 
provided a utopian narrative of science: 
18: Things like basic operations yano, just wouldn’t be able to do 
them would ya. Infections you would be dying of like minor 
ailments wouldn’t ya,  
… 
18: Or what they call minor ailments now.  
They mentioned how in the future, basic operations would become difficult and 
spoke of what we now call minor ailments. I interpret this as the participant 
being aware that science and medicine have successfully minimised the risk 
of death by infectious disease. Interviewee 22 provided a dystopian narrative:  
22: The biggest problem, well there’s too many of us living in this 
planet in close proximity and we’re just gonna spread it. And, erm 




22: But yano, these things happen don’t they haha, this always 
happens. 
Interviewee 22 stated that overpopulation will be to blame for the spread of 
AMR and that the result will be reduction in the population. They then stated 
that these things always happen, which suggests science and scientists are 
powerless to overcome this. Interviewee 01, when asked how many antibiotics 
have been discovered since 1962 said: 
01: …something is going to kill us all, or kill 90% of the planet. 
This dystopian narrative, that between 90-100% of the planet will die from an 
infectious disease, is again an example in which science and scientists are 
powerless to stop it. This followed discussion about the common cold or flu, 
which I note is difficult to vaccinate against due to its ability to evolve, however 
not deadly enough to cause this level of death. The link between amount of 
faith placed in science and scientists and a utopian or dystopian narrative, that 
is an optimistic or pessimistic outlook, seemed particularly clear in interviewee 
05’s answer when asked how many antibiotics have been produced since 
1962:  
05: Mmm, I don’t know, I would say you’d think it’d be more 
because obviously everything is more advanced now, but would it 
be less because we haven’t had the need to create, cos like you said 
we thought we were safe so why would they have continued to 
waste money and time on testing. So I’d say, can I say less?  
They acknowledged the success of science in advancing technology, which 
has increased the number of antibiotics taken to clinical trial (optimistic), before 
suggesting science and scientists may have become complacent with their 
successes and cautious with their funds, resulting in fewer numbers of 
antibiotics taken to clinical trials (pessimistic).  
This thematic analysis highlights the different narratives an individual might 
bring to a new discourse and how this affects the way they engage with it. 
Specifically, it seems that faith in science and scientists is linked to a utopian 
narrative and optimistic outlook, whilst lack of faith in science and scientists is 
linked to a dystopian narrative and pessimistic outlook.  
4.3.5 Who is to blame? 
In 4.3.4, I highlighted how trust or faith in science or scientists seems linked to 
an individual’s narrative of dystopian or utopian. In this section, I investigate 
participants narratives of blame. It is important to know who the public blame 
for the current antibiotic crisis, described in 1.3.4, to repair the faith and trust 
that is necessary to work together to resolve this issue.  
The dedicated code “Role of Doctors [ROD]” (48 references from 23 sources) 
aimed to capture the level of blame attributed to doctors. A narrative which 




16b: Well the doctors don’t want to prescribe it as much as they, I 
mean they used to just write out a prescription but nowadays they 
are saying unless you really think you need it, don’t use it if you go 
for an antibiotic. 
There are few explanations from the interviewees as to why this might be the 
case. One interviewee mentioned updated guidelines from the British Medical 
Association; another touched on increased awareness of the problem of 
resistance. One interviewee provided the opposite opinion, that in fact doctors 
back then were more likely to offer bed rest as an antidote: 
18: I think it’s very easy for a doctor to just prescribe antibiotics as 
opposed to prescribe bed rest and water and good food, Ye, ye 
which is what it would’ve been wouldn’t it years ago. So ye I do, I 
think, but I think what we do here is just the tip of the iceberg. 
However, despite most participants thinking doctors now prescribe fewer 
antibiotics than doctors in the past, doctors are still taking a large portion of the 
blame for antibiotic misuse: 
04: Haha, erm only having antibiotics when you, when well I was 
going to say when the doctor prescribes it but actually sometimes 
they prescribe it all the time when you don’t even need it. 
This lack of trust in GPs to know when it is best to hand out antibiotics could 
affect current public health messages which encourage you to trust your GP 
rather than demand a certain prescription. This is not to say that participants 
are not sympathetic with the predicament doctors are facing. One example 
from interview 14, interviewee 14b was:  
14b: Oh yes, I think it’s, I think an awful lot of doctors have people 
come to see them who expect a prescription. And a lot of doctors 
are so overworked they haven’t got time, and so they write a 
prescription. You know they are trying to stop people doing that 
aren’t they. 
Interviewees 14a and 14b perceived doctors as being overworked and on top 
of that, having a patient demand for prescriptions. This inevitably leads to 
prescriptions being written unnecessarily. Interviewee 13 hinted at a potential 
avenue through which to repair trust and encourage faith in doctors moving 
forward:  
13: They do tell you that now when you get it, they say you must 
finish it, it’s really important. But they never say why do they!  
Faith in GPs encourages individuals to want to work together with them to 
contribute to resolving the issue of AMR, as explained by interviewee 31b:  
31b: I think they’ve got to explain like all of the side effects, and all 
the things that are gonna happen to you if you take antibiotics. It’s 
gonna destroy the bad bacteria but it’s also gonna destroy your 
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good bacteria, so you might not recover, you might have a lower 
immune system or whatever.  
… 
31b: Ye exactly, ye, cos I mean there’s no point in erm, in taking 
something that has side effects and the side effect is going to lead 
you back to your original state. Yano, what’s the point. 
The code “Kept in the Dark [KID]” (11 references from 8 sources) captured the 
level of blame attributed to figures of authority who hold power. Interviewees 
identified a similar feeling of not being listened to or cared for: 
22: Unfortunately, it’s the people at the top, don’t listen, and the 
people with the money isn’t it, that’s what you are fighting against 
a lot of it.  
Finally, the code “Irresponsible Other [IRO]” (70 references from 26 sources) 
captured the level of blame attributed to other members of the public, often 
therefore not attributed to oneself. When interviewee 05 was asked whether 
they had an opinion on whether antibiotics are being misused, they answered: 
05: I think they do be misused by certain people like erm I suffer for 
example with tonsillitis, I can’t have them taken out, because I 
don’t have it the 6 times within the 12 months. But I don’t go and 
get antibiotics for it because there’s no point me taking it all the 
time. They won’t do anything because I have it so often. But I think 
a lot of people are quick to be like, no let’s just go and get it, get rid 
of it, don’t leave our body fight it on its own. So I think maybe, they 
can be misused. 
Interviewee 05 suggested that other people are quick to take antibiotics, unlike 
themselves. Often this theme manifests in the use of the word people, when 
discussing the issue. When asked whether antimicrobials are being misused, 
interviewee 08 says:  
08: Well they probably are, because people will drop in to the 
doctors when they have a cold, and erm the doctors will prescribe 
them antibiotics. 
In this instance, it is the fault of other people for going to the doctors, and the 
doctors for being willing to prescribe in this case. When a person talks about 
themselves, using words like I or we, the story changes and often details how 
many ways a person might be doing their bit to solve the problem. When asked 
if they can make a difference to the spread of antibiotic resistance, 
interviewees 09a and 09b responded by saying: 
09a: From a limited knowledge, only in as much as we know that, 
so ye we don’t, we try to avoid using antibiotics or trying to, we 
don’t go to the doctor and get them unless we need to (we think), 
and if we do have  
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09b: keep reasonably healthy so you don’t need to  
09a: Ye and if we do happen to have them we’ll finish the course or 
return them to the doctors 
This is of course not to say that our interviewees do not all practice sensible 
behaviour when it comes to the prescription of antibiotics. Interestingly the 
same interviewees later went on to admit that they could be part of the 
problem. Not because of any bad practices however, but because of their 
contribution to the total population of humans in general: 
09a: Erm I think we’d like to say, particularly based on the 
discussion we’ve had, that they are clearly being misused but then 
we appreciate we are part of the problem of that as well. So, 
because we are just more people so erm err.  
This thematic analysis shows that blame is mostly directed at doctors, whilst 
also being directed at people in power and other irresponsible individuals. The 
general feeling is that doctors and people in power do not listen to individuals 
and this could be an important part of repairing faith and trust in experts. This 
faith may be key when asking the public to work together with experts to solve 
the problem of AMR. Further, analysis of participants word use suggests that 
people are irresponsible, yet I, we or you are responsible. This is a cause for 
concern if individuals do not perceive a reason to modify their own antibiotic 
use.  
4.3.6 What are scientists after? 
In 4.3.5, I examined the attribution of blame to certain groups and discussed 
how this may provide a barrier to working together to develop a solution to the 
crisis that is AMR. Building on public perspectives of science and scientists in 
4.3.4, I now apply Brew's (2001) framework which presents four qualitatively 
different ways in which research is understood. Fundamentally, Trading and 
Domino are product focused perspectives, whilst Journey and Layer are 
process focused. Furthermore, Trading and Journey are perspectives which 
include the researcher in their awareness, whilst Domino and Layer do not 
(Table 4-1). 
Table 4-1. Relationships between conceptions of research (Brew., 2001) 
 Researcher present to, or 
the focus of awareness 
Researcher absent from, or 








These four conceptions of research became codes for my framework, namely: 
“Domino [DOM]”, “Trading [TRA]”, “Layer [LAY]” and “Journey [JOU]”. The 
definitions of each of these themes provided by Brew were not easily adapted 
to help designate codes to the interview transcripts. Instead, I relied heavily on 
utilising the more simplistic Table 4-1, asking first whether the excerpt was 
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product or process focused and then whether the researcher was present or 
absent in the awareness.  
Interviewee 23, during the after-interview discussion where the participants 
could talk to me about anything they wanted to, said: 
23: Err nah, I think it’s all intriguing stuff, working out, and also cos. 
So once you’ve, I was having a look at some of the plates in there, 
and you’ve got the areas of exclusion where the bacteria is clearly 
winning in some form. How would you go about finding out kind of 
why it’s winning? 
Their question focused on the internal processes of research “go about finding 
out” whilst including me, as the researcher, in their awareness “how would 
you”. This is coded for as Journey. Brew’s definition of Journey is that that 
research informs, and is informed by, life issues (Brew & Lucas., 2009) where 
the researcher grows or is transformed by a personal journey of discovery 
(Brew et al., 2016).  
Unlike Journey, trading is external-product orientated where the intention is to 
produce an outcome, whilst still having the researcher present in the 
awareness. Interviewee 03 provided an example during our after-interview 
discussion: 
03: And then obviously if you do find any antibiotics, we’ll have a 
cut! 
Trading is defined as researchers undertaking research in order to trade for 
other things such as promotion and recognition (Brew & Lucas., 2009). 
Layer is focused on internal processes, however, does not include the 
researcher in the awareness. Interviewee 07, when asked whether antibiotics 
are being overused, said:  
07: Overused, yes, it has improved, definitely because obviously 
there’s been so much highlighted, we are trying to get that down 
but they are still being overprescribed. 
Interviewee 07 talked about how information has been highlighted and how 
that has helped to reduce overuse of antibiotics. This matched well with the 
definition of Layer which says research is bringing to light the ideas, 
explanations and truths lying in the background by illuminating or uncovering 
the underlying layer of knowledge (Brew, 2001). 
Finally, domino is product focused when the researcher is absent from 
awareness. Interviewee 32a provided an example during our after-interview 
discussion: 
32a: Yes, I do agree, I mean the other thing of course is that part of 
the way science works is to dispute the consensus and to challenge 
it and to, and to err, I can’t think of what the term is but really try 
and disprove,  
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They talked about research with the researcher absent from awareness. They 
talked about how the outcome of science is to dispute the consensus and 
disprove, later mentioning this is based on evidence. Domino is defined as 
research viewed as a series of separate tasks, events, things, activities, 
problems, techniques, experiments, issues, ideas or questions, each of which 
is presented as distinct (Brew, 2001).  
This thematic analysis has provided examples of each of Brew's (2001) 
concepts of research, qualitatively distinct from each other. Participants view 
research through the lens of these four concepts. The perspective they take 
influences their opinions of research and researchers. This ties in well with 
section 4.3.4 and 4.3.5, as understanding how researchers are perceived 
could provide useful in regaining the public’s trust.  
4.3.7 Do people need a hero? 
Whilst analysing the interviews, I noticed occasions where a participant 
recalled names of famous scientists or responded positively when I recalled 
famous discoveries. Whilst this has some overlap with rituals (4.3.2), I thought 
this distinct enough to warrant developing a new code to capture this 
phenomenon. This code was “Science as a Story [SAS]” (14 references from 
10 sources). Interviewee 08, when asked the last time we discovered new 
antibiotics said: 
08: Erm… Fleming?  
R: Okay. So that’s  
08: Hahaha, Marie Curie?  
R: A long time ago.  
08: Yes, a long time ago. Not Marie Curie, she was cancer!  
By using names of famous scientists as a direct answer to the question, there 
was an assumption that the name could be paired with a discovery and a 
timeline which answers the question. Interviewee 23 used the name of a 
famous scientist, Fleming, to attempt to engage with a landmark in scientific 
history: 
23: So do we have, so if that was 50 years ago and the first one was 
Fleming what 200 years ago now?  
I note that Flemings discovery of Penicillin, often considered one of the first 
major antibiotic discoveries, was in 1928, less than 100 years ago. Other 
interviewees who could not remember Fleming by name instead remembered 
the name of the antibiotic that he discovered. When asked the last time we 
discovered a new antibiotic, interviewee 18 said: 
18: No, but I do know the story about penicillin, that was quite an 
interesting story.  
Interviewee 18 could have responded no, but instead chose to engage with 
the new discourse by recalling the story of penicillin. Whilst this was not 
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explained further, it was an attempt at a show of knowledge relevant to the 
discussion. When interviewee 29 was asked when a new antibiotic was last 
discovered, they were stuck until Penicillin was mentioned. Penicillin instantly 
conjured up a date that they had associated with its discovery:  
29: Oo, I don’t know, quite a while ago I would say.  
R: So penicillin is an antibiotic, things like that.  
29: Oh well that was 1800’s or something isn’t it?  
This was the second interviewee who thought that Fleming’s discovery of 
penicillin took place somewhere in the 1800’s, almost 100 years before the 
actual discovery was made in 1928. Even when participants have no idea 
about the answer to the question, they might try to bring in a name of someone 
who they think is related to the topic at hand. When asked the last time we 
discovered a new antibiotic, interviewee 27 said: 
27: Couldn’t tell you no. There’s only the one piece of history that 
sort of most people know about. Err was it Florence nightingale, I 
think that’s what I’m gonna go with.  
This thematic analysis shows that individuals view the evolution of science as 
the succession of work of some very clever people. Names of famous 
scientists or scientific discoveries help paint a picture of scientific history, even 
if not quite accurate. This in turn helps participants engage with the new 
discourse, providing some familiarity.  
4.3.8 Do people make bad decisions in the face of better knowledge? 
In the literature review (1.5), I discussed how citizen science represents the 
move away from public understanding and towards public engagement. Public 
engagement follows the principle that provision of objective facts to improve 
public understanding is not the way to effect change in the general public. 
Instead the public should be engaged. I also presented literature which 
showed that better factual knowledge did not always lead to individuals making 
better decisions with regards to antibiotics and antibiotic resistance. To capture 
the relationship between a participant’s factual knowledge and an individual’s 
actions with regards to antibiotics and antibiotic resistance, I developed the 
code “Better objective knowledge [BKM]” (6 references from 5 sources). 
Interviewee 29 said:  
29: I think perhaps people rely on them, it’s like a wonder drug. I 
mean, it’s not nice getting a sore throat is it, but what you’re saying 
to us all is you should try and fight it, or let your body fight it in 
other ways rather than relying on antibiotics. Having said that if I 
had a sore throat I’d probably be down there the doctors asking for 
some penicillin. So then perhaps it’s the doctors sort of, they are 
trying to say no, they are trying not to prescribe it, they are. 
They represented the general theme emerging from this code; that whilst 
participants were aware that they should not ask for antibiotics and that they 
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needed to use less, if they or their immediate family were sick, they would 
ignore that advice.  
The code “Paternal and Maternal instincts [PMI]” (3 references from 3 sources) 
was developed upon analysing interview data for the relationship between 
objective knowledge and resulting decisions. Interviewees 09a and 09b, when 
asked which infections are treated with antibiotics against, said: 
09b: When you have a child yano you do loads of, she’s had, not 
loads, but she’s had at least four courses already.  
09a: The only time in our lives so far really  
The interviewees stated that their child had been provided with four courses of 
antibiotics prior to which they had not personally taken antibiotics at any point 
in their lives. These interviewees then go on to state: 
09a: She’s a primary teacher, she should know something, but 
anyway.  
… 
09b: Ye, I teach a lot of antibiotics. 
It is clear then that this was an individual who self-reported their own education 
on antibiotics. This phenomenon was also seen from interviewee 17 when 
asked whether people are misusing antibiotics: 
17: Erm, mmm I don’t know really, because I know with the kids 
obviously my immediate reaction is well, must be something, 
*child’s name* has got a really bad cough at the moment, so my 
immediate reaction was there must be some kind of antibiotic, but 
then at the other side of my brain is going well yano, maybe she 
shouldn’t get them so often, yano so I dunno, I am on the fence 
really.  
… 
17: Ye, it’s like oh it’s my kid I want it but everybody else no. 
Interviewee 17 was aware that their child should not have antibiotics often but 
stated than when it is your child, you want to do what you can to help. This 
contradicted the irresponsible other theme that emerged in 4.3.5, that other 
people are to blame for overuse of antibiotics. Interviewee 32a, who was with 
their son during the interview, said during our after-interview discussion: 
32a: And even people that know about the subject, if it was my, if it 
was *son’s name* here, and he had a really bad skin infection and 
the doctors said well antibiotics could help but there’s a problem 
cos err, I’d say ‘give him the antibiotics, he looks terrible’… So, and I 
would say I was a fairly sort of conscious person around the issue, 
until it really bites I suppose.  
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This again saw interviewee 32a self-reporting their knowledge around the topic 
of antibiotic prescription and resistance (made clear over the course of the 
interview). They then said that if it came to seeking treatment for their son when 
they were sick, they would ask for antibiotics.  
The code “Body as a temple [BAT]” (19 references, 12 sources) also highlights 
the relationship between factual knowledge and the resulting decisions 
individuals make. This code was developed in response to literature which 
reported that individuals prefer to let their body take care of the illness, a 
general aversion to antibiotics (more generally, medicine) partly based on the 
knowledge that antibiotics kill both good and bad bacteria (Norris et al., 2013). 
The narrative that the body can look after itself, at its extreme, can lead to a 
distrust of modern medicine such as antibiotics. Interviewee’s 19a and 19b 
discussed this when asked if they could personally make a difference to the 
spread of resistance:  
19a: Err yes, yes. By my attitude towards antibiotics. I hate them, I 
will not take them. 
19b: Build up your own immune system really.  
19a: Yep, I just wanna fight my all through my life mostly my 
immune system has fought any infections I’ve had. Erm and I took 
them after an operation and quite honestly I stopped taking them 
cos I hated them, I just don’t like antibiotics.  
Interviewees 19a and 19b’s expressed their belief that the immune system 
could be built up and could fight any infections, whilst 19a expressed their 
hatred of antibiotics. In a separate interview, interviewee 06 expressed their 
preference of using herbal medicine rather than antibiotics: 
06: Err, for anything really. They pass them out too often. I mean 
there’s other ways and means of using… erm other things like tea 
tree and eucalyptus, without using pills.  
This preference to rely on homeopathy was also represented in interview 31, 
as interviewee 31a and 31b discussed the biggest problem for humans if 
antibiotic resistance were to spread. I note that the two interviewees clearly 
began with a different stance on this matter: 
31a: Erm the struggle of finding a new antibiotic, which was, which 
could combat this one, and then again the struggle of that 
becoming resistant to that, and then eventually we could all end up 
with something as serious as MRSA and it could be fatal. 
31b: We could refer to other treatments, I don’t think it’s the end of 
the world if antibiotic resistance becomes, like if all bacteria are 
antibiotic resistant. I think they’ll erm… 




31b: Other treatments, like there are loads of treatments that like…  
31a: Really?  
… 
31b: There’s homeopathy for a lot of things, my mum did 
homeopathy so I erm, there are things that can  
31a: Is that like ginseng?  
31b: Ye like health things I dunno, like if you’ve got I dunno, if 
you’ve got erm something like erm tuberculosis or something you’d 
go and do stuff like inhaling stuff, inhale mints. 
31a: Oh right?  
31b: Like there’s always something else. 
31a: I believe in it to be honest.  
31b: Ye. I mean it’s not only medicine, you’ve only got to take 
medication or else we’ll die. 
Interviewee 31a began with the narrative that resistant bacteria pose a serious 
threat to human health if they become resistant to antibiotics. 31b expressed 
their belief that antibiotics are not the only medicine that can be used for 
illnesses and over the course of the discussion, 31a changed their stance. This 
shows that despite understanding the risk posed by antibiotic resistance, one 
can be convinced to forego antibiotic treatment in exchange for homeopathic 
remedies. This distrust or move away from modern medicine, medicine which 
has been the foundation for improved life expectancy and quality of life (1.3.5) 
is a decision not recommended in the literate discourse. 
This thematic analysis shows that participants would generally make bad 
decisions in the face of their own objective knowledge. This was through the 
need to feel like they were actively taking something to get better, the need to 
help their children get better or the distrust of modern medicine through either 
trust in your own immune system or a preference for homeopathic remedies.  
4.4 Discussion and Future Work 
4.4.1 Pop-up stands and interviews are part of a potent design for a 
citizen science project 
Pop-up stands were used at five different events in different parts of the U.K 
to collect 454 soil samples and 32 interviews (Table 2-3). Four of the events 
were held in forests, with one at a science festival. These utilised neutral ‘third 
places’ that allow parties to meet on equal terms, rather than a hierarchical 
environment such as work or home (Dowell., 2017). Pop-up stands facilitated 
transparent, fully consensual and enriched active participation of citizens; 
however such practices and methodologies are far from being a well-
established standard tool for citizen science research (Sagarra et al., 2016). 
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The success of the interviews was the result of a carefully constructed set of 
interview questions adapted from existing instruments (Creswell, 2012). These 
instruments were prior public discourse research, utilising themes emerging 
from the literature to guide the interview (Table 2-5). The complete list of 32 
codes taken from public discourse literature and added to during analysis of 
the interview data represents a methodological contribution to the field. The 
development of eight key themes emerging from the interview data is a 
contribution to the public discourse literature surrounding antibiotics and 
antibiotic resistance.  
4.4.2 Descriptive analysis reveals that our participants’ scientific 
understanding resonates with participants in other research 
Quantitative analysis suggests that participants are aware that bacteria and 
fungi produce antibiotics. Many antibiotics which have proven highly valuable 
in clinical practice are natural products (Wright, 2014, Table 1) and some of 
the most famous examples of these have been isolated from soil microbes, 
namely bacteria and fungi (Bowater, 2017). Participants incorrectly identified 
plants as producing antibiotics, however plants do have a key role in the 
production of pharmaceuticals other than antibiotics (Cowan, 1999). Fewer 
participants believed humans and viruses to produce antibiotics. Whilst 
research has suggested that most members of the public do not understand 
the distinction between bacteria and viruses (European Commission., 2013; 
McNulty et al., 2007; Norris et al., 2013) my findings challenge this.  
Participants were aware that bacteria become resistant to antibiotics. 
Concurrent with literature and coined the ‘resistant body’, participants believed 
humans could also become resistant to antibiotics (Brookes-Howell et al., 
2012; Brooks et al., 2008; Hawking et al., 2017; Hawkings et al., 2007). This 
literature separates the perspective of resistant body from resistant bacterium; 
however, my findings suggest participants think both bacteria and humans can 
develop resistance to antibiotics. Further, most participants believed fungi and 
plants could develop resistance. Participants were less likely to suggest 
viruses can become resistant, echoing the earlier finding that members of the 
public can distinguish between bacteria and viruses.  
Participants were aware that bacterial infections are to be treated with 
antibiotics whilst viral infections are not. This echoes the increase in 
percentage of members of the public that understand antibiotics cannot kill 
viruses (Dyar et al., 2018; European Commission, 2013; Filipetto et al., 2008; 
McNulty et al., 2007, 2016) and could well be a result of exposure to media 
campaigns (Gonzales et al., 2008). Most participants believed fungal infections 
could be treated with antibiotics. This may suggest some confusion between 
the term antibiotic and antifungal or antimicrobial (Mendelson et al., 2017). 
Participants were unaware of Teixobactin; a high-profile novel class of 
antibiotics discovered in 2015 (Ling et al., 2015) which received substantial 
coverage by U.K main stream media (Sample, 2015). My findings are in line 
with survey data, which demonstrate members of the public receive limited 




To develop the rigour of these analyses, statistical tests would be carried out 
to understand whether the differences in responses were significant. However, 
the quantity of responses would need to be increased and questions would 
need to be more specific. The current quantitative interview data does not allow 
for rigorous statistical analysis.  
4.4.3 Thematic analysis reveals key themes in public understanding of, 
and attitudes towards, antibiotics 
Qualitative analysis suggests that participants use both familiar words and 
familiar rituals as they attempt to engage with a new discourse. This finding is 
in line with research that suggests we organise new experiences in terms of 
those with which we are already familiar (Sfard., 2008).  
My findings suggest that participants engage with the literate discourse 
through the ritualising of public health narratives. Six public health narratives 
were mimicked by participants: overuse/misuse, taking the full course, 
antibiotics do not work on viruses, need for personal hygiene, need to stay 
healthy and antibiotic stewardship. Literature suggests that rather than public 
health campaigns which don’t reach the public (McNulty et al., 2007b; Brooks 
et al., 2008; European Commission, 2010, 2013, 2016) it is likely that this 
information is bequeathed by doctors (European Commission., 2013; Filipetto 
et al., 2008; Gudnadottir et al., 2013; McNulty et al., 2016), Television 
(Hawkings et al., 2007) or the internet (Gudnadottir et al., 2013). My findings 
show that the resistant body theory (Brookes-Howell et al., 2012; Norris et al., 
2013; Hawking et al., 2017) is a common misconception that emerges when 
participants mimic the ritual of overuse of antibiotics. The tendency for 
members of the public to imitate public health narratives is an important 
phenomenon for public health officials, particularly relevant in the face of the 
coronavirus pandemic where the mimicking of public health narratives like 
“hands, face, space” is saving lives (Department of Health and Social Care, 
2020).  
My findings suggest that participants who place faith in science and scientists 
harbour an optimistic outlook on antibiotic resistance. Scientific optimism, a 
favourable expectancy of the future of science, has increased and decreased 
over human history and is shaped by global events such as world wars 
(Onghena, 2011), whilst trust in science is affected by individual factors such 
as age, gender, political ideology, religiosity, education, income and science 
knowledge (Huber et al., 2019). Evidence suggests that people who are 
inherently optimistic, in that they hold positive expectations for the future, 
respond to difficulty and adversity in more adaptive ways than people who hold 
negative expectations (Carver et al., 2010). A positive attitude about science 
helps to increase support toward scientific research and industry, enabling 
political actors to legitimize relevant decisions and encourage public 
participation in scientific research projects (Huber et al., 2019). Huber et al 
(2019) posited that people who do not believe in anthropogenic climate change 
will see no need to take political action to slow its progress. I would posit the 
same about antibiotic resistance. One who does not believe in the threat of 
antibiotic resistance sees no need to follow sensible behaviours to mitigate the 
risk. This has been seen in the coronavirus pandemic with news reports 
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discussing individuals who refuse to wear masks (Morgan, 2020), despite 
scientific consensus agreeing that masks reduce the rate of transmission 
(Centers for Disease Control and Prevention, 2020). It is important that 
scientists interact with members of the public, engage them in their research 
and develop a level of trust so that the public actively engage with the 
narratives that help mitigate the effects of antibiotic resistance. 
Many of my findings concerning participants’ views of responsibility and blame 
for antibiotic resistance can largely be predicted by attribution theory (Brooks 
et al., 2008). Attribution theory is concerned with people’s explanation of 
events or behaviour by attributing causes. People offer one of two types of 
explanations about why things have happened: external attribution (causality 
attributed to an outside factor), or internal attribution (causality attributed to 
factors ‘within the person’). In my findings, participants tended to make 
external attributions. They did not find themselves personally responsible but 
instead blamed outside factors like overprescribing by GPs, lack of care from 
people in power and irresponsible use of antibiotic by others. This concurs with 
other literature on the attribution of blame (Brooks et al., 2008; Butler et al., 
1998; Dyar et al., 2018; Hawking et al., 2017; Hawkings et al., 2007). It is also 
reflected in the current political climate where, for example, the President of 
the U.S.A recently accused a pharmaceutical company of delaying 
announcement of a coronavirus vaccine until after an election for political gain 
(Ensor, 2020). Further, in line with my own findings, Brooks et al (2008) 
identified that participants wanted to present themselves and their own 
behaviour in a positive light. Applying these findings to clinical practice, one 
might encourage patients to consider why antibiotic resistance develops 
before assigning causality to the self rather than to others. My findings also 
show that participants believed doctors do not take time to explain why they 
refuse to prescribe antibiotics. Catering to the emotional side of an illness may 
alleviate the need to physically prescribe something (Butler et al., 1998; 
Macfarlane et al., 1997). Given that educated individuals in higher social 
grades are more likely to report being given information about antibiotics or 
caring for their infection (McNulty et al., 2016) it is even more important to not 
neglect those that are most vulnerable. 
My findings suggest that participants consider research to be worthwhile 
despite deriving worth from different aspects of scientific process or outcome. 
In line with research by Brew (2001), I saw evidence of the domino, layer, 
trading and journey conceptions when participants discussed science. The 
trading concept, that there is money, fame or status to be had from scientific 
research, is a common thought pattern. Whilst it is true that productive 
academics are research-active (outcome focused); driven to grow social 
networks, gain reputation through going to conferences and collaborating with 
other researchers (Brew et al., 2016), this does not mean that they are ‘in the 
pocket of big pharma’. Recent political attacks on researchers describe them 
as being motivated by financial and political outcomes (Alexander, 2020). This 
is a concept which undermines public trust in scientists and, as discussed 
above, can lead to individuals disengaging emotionally from major scientific 
crises. Applying these findings, it is important to engage participants in 
research. There they can explore the process focused mind of a scientist in 
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their own work. The extent to which a citizen science project can facilitate this 
is discussed in Chapter 5.  
My findings suggest that participants relate historical figures to discoveries and 
timelines; the figures are the ‘heroes’ of scientific history. Humans are ‘story-
telling animals’ and perceive facts, numbers and urgent appeals that surround 
global crises inherently as stories (Arnold, 2018). Climate change research has 
suggested that in order to make the fight against climate change a priority, 
climate advocates need to tell stories, to mobilise people and guide their 
actions (Shenhav, 2015). Within all stories are heroes, villains, victims, an 
object of struggle, a beginning, middle, end and morale of the narrative (Arnold, 
2018). Scientific crises, such as antibiotic resistance, need to be explained as 
problems that are characterised by uncertainty over consequences, diverse 
and multiple engaged interests, conflicting knowledge and high stakes 
(Lazarus, 2009). In practice, utilising storytelling, within which you need 
scientific heroes, to frame antibiotic resistance in a way that encourages 
people to act is of importance to a joint, global solution.  
My findings suggest that participants would make ‘bad’ decisions in the face of 
their factual knowledge, often when acting on an ‘urgent’ problem in the 
present is considered lower risk than the consequential resistance that might 
develop in the future. This links to the above, that facts alone do not encourage 
action and instead a narrative approach would be better used (Shenhav, 
2015). Research on the effect of better factual knowledge is inconclusive. 
Better factual knowledge has been linked with bad decision making (McNulty 
et al., 2007) and good decision making (European Commission., 2013). Within 
science, there has been a move away from the provision of objective facts 
(public understanding) and towards joint negotiation for future science by 
scientists, laypeople and policy makers (public engagement) (Gregory and 
Lock, 2008; Schäfer, 2009). In chapter 5, I discuss how engaging members of 
the public in a citizen science project affects their decision making considering 
improved scientific literacy.  
My findings also show that some members of the public consult unorthodox 
medicine, homeopathy. Whilst one might expect that unorthodox medicine 
would have diminished as a result of advances in medicine during the second 
half of the twentieth century, that does not seem to have been the case 
(Loudon, 2006). Whilst members of the public are being encouraged to only 
take antibiotics when necessary, it is important to note that the complete 
rejection of modern medicine in favour of homeopathy can be dangerous. In 
2018, a total of 1.5 million people died from tuberculosis and TB is one of the 
top 10 causes of death and the leading cause from a single infectious agent. 
Furthermore, MDR-TB remains a public health crisis and a health security 
threat, whilst modern medicine is estimated to have saved 58 million lives 
through TB diagnosis and treatment between 2000 and 2018 (World Health 
Organisation, 2020).  
4.5 Summary 
One of the aims of my study was to explore if codes and frameworks identified 
in the literature review which describe various topics of discourse of antibiotics 
and antibiotic resistance (Table 2-5), or research conducted on conceptions of 
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research (Brew, 2001), are fit for purpose when investigating the public’s 
experiences and understandings of antibiotics, antibiotic resistance and 
scientific research. My analyses of participant interviews indicate that there 
was no one code or framework that enabled the mapping of all themes 
emerging from the study. Instead, a combined use of codes and frameworks 
was necessary. My analyses show that from both quantitative and qualitative 
analysis of the interview data, eight key themes emerge.  
My study set out to explore how participants perceive the issue of antibiotic 
discovery and antibiotic resistance, as well as how they perceive scientific 
research. Participants use familiar words and familiar rituals as they attempt to 
engage with a new discourse. Of these rituals, participants frequently mimic 
public health narratives to facilitate their engagement with the discourse. 
Mimicking existing narratives without an understanding of why those narratives 
exist is an essential part of engaging with a new discourse, but leads to 
misunderstandings, such as the belief that the human body becomes resistant 
to antibiotics, rather than the infectious agent. These misunderstandings don’t 
always produce a negative behavioural outcome as shown by this 
misunderstanding, which still leads to the avoidance of antibiotic overuse. 
Campaigns should first target those misunderstandings that do produce 
negative behavioural outcomes. 
Individuals who place faith in science and scientists and show scientific 
optimism are more likely to actively help mitigate their own behaviours which 
contribute to antibiotic resistance. Scientists should consider this when 
deciding on whether to engage the public with their research. Participants 
generally consider research to be worthwhile, however derive this worth from 
different aspects of the scientific process or outcomes. As well as scientists, 
those who receive the most blame from the public: doctors and people in 
power, should strive to rebuild trust with the public. This trust provides the 
belief that working together to achieve the same goal is possible and is crucial 
in the effort to tackle this global problem. Further, individuals should be 
encouraged to consider why antibiotic resistance develops before assigning 
causality to the self rather than to others. Each of these groups could benefit 
from the use of storytelling to engage the public, including the use of heroes 
and villains. This use of storytelling might dissuade individuals from acting 
against their factual knowledge in the present to resolve an urgent problem, 
neglecting the increased risk of an apocalyptic outcome in the future.  
In Chapter 5, I aim to use medium- and long-term data collection methods to 
understand the effect engaging with a citizen science project has on 
participants discourse surrounding these key themes. I trace discursive 
transformations (Sfard, 2015) by examining the expanding set of endorsed 
narratives familiar to participants (object level learning) and the way these new 
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Raising public awareness of antibiotic resistance is a critical step in tackling 
the global crisis (1.2.1) In 1.4, I discussed public health campaigns and their 
role in provoking behavioural change to combat significant public health issues 
such as antibiotic resistance. Analysis of participant interviews highlighted 
current public awareness with regards to key topics surrounding the issues of 
antibiotic and resistance. Specifically, interviews indicated that there are still 
misconceptions about the definitions, causes, implications and solutions to this 
global concern. Extrapolating from this finding, the results in Chapter 4 suggest 
that public health campaigns aimed at raising public awareness about this 
issue are having limited effect. 
In Chapter 1 and Chapter 4, I described how my analysis of the literature 
provided a list of key topics emerging from research on the public discourse of 
antibiotics and antibiotic resistance and the subsequence coded analysis 
resulted in the emergence of eight key themes. These themes are outlined in 
4.3. Participants were found to use familiar words (4.3.1) and familiar rituals 
(4.3.2) as they engaged with a new discourse, concurrent with research by 
Sfard (2008). Common rituals included, for example, public health narratives, 
bequeathed by Public Health England through a variety of public health 
campaigns (4.3.3). Participants who placed faith in science and scientists 
harboured an optimistic outlook on antibiotic resistance (4.3.4), which has 
been shown to increase support for scientific research and industry (Huber et 
al., 2019). Participants largely externally attributed blame for the antibiotic 
resistance crisis to GPs, people in power and irresponsible others (4.3.5). This 
concurred with previous research on attribution of blame (Brooks et al., 2008; 
Butler et al., 1998; Dyar et al., 2018; Hawking et al., 2017; Hawkings et al., 
2007). Participants considered scientific research to be mostly worthwhile, 
however concepts of research were diverse; research was both product and 
outcome focused and with researchers both absent and present in awareness 
(4.3.6). This mapped to the concepts of research as held by researchers, 
presented by Brew (2001). Participants also used historical scientific ‘heroes’ 
and major scientific discoveries to navigate the landscape and timeline of 
antibiotic discovery (4.3.7). Finally, participants reported that they would act 
against better knowledge if they deemed the short-term gain to be greater than 
the longer-term risk (4.3.8). Research on the effect of better knowledge on 
improving the uptake of ‘sensible practice’ is not conclusive (McNulty et al., 
2007a; European Commission, 2013).  
In Chapter 1.5, criticisms of citizen science were discussed; notably the lack 
of evaluation which determines scientific or participant outcomes. Separately, 
public discourse research summarised in Table 1-6 used mostly short-term 
data collection tools such as surveys and semi-structured interviews. My 
analysis showed that of the 20 articles examined, only one used portfolios 
(Norris et al., 2013). These portfolios were used to detail medicine taking or 
contact with medication through avenues such as advertisement, however the 
length of time participants made entries for was not reported. The need to 
measure several dimensions of project outcomes (1.5.6) and the potential of 
medium- and long-term tools for data collection were gaps in the literary 
landscape which this chapter aims to close.  
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In this project, medium-term data collection was based upon data obtained 
from participant engagement on social media, notably Facebook (2.7.2). To 
analyse this medium-term data, web analytics and discourse analysis were 
used. Web analytics looks at the use of a website or parts of a website to find 
which sections are visited most often (Phillips et al., 2014). This was useful for 
understanding and optimising web usage and trends in those that visited the 
Antibiotics Unearthed Facebook page. Participants from across the globe 
could engage with the project and this was a low-cost method (Phillips et al., 
2014). However, web analytics only have limited utility for summative 
evaluations and information on users’ choices cannot be obtained (Phillips et 
al., 2014). To mitigate these limitations, in 5.2 only trends are reported. 
Discourse analysis looks at recording forms of discourse for later analysis. 
Social media is ideal as comments are already transcribed and timestamped, 
however as with all discourse analysis, issues may be oversimplified when 
taken out of context (Phillips et al., 2014). In 5.3, I explore the extent to which 
social media facilitated enough discourse to be analysed.  
In this project, I recognised the potential that portfolios may have for revealing 
the perspectives of the writer over a period of extended time. Longer-term data 
collection was based upon data obtained from participant portfolios (2.7.3). 
Portfolios can provide a personal recording of ideas, thoughts, or activities over 
a time span, revealing the perspective of the writer (Phillips et al., 2014). They 
provide feedback on a specific topic on a particular day and can provide an 
understanding of thought evolution over time (Phillips et al., 2014). However, 
they can be narrowly restricted to a specific question, require consistency and 
determination from the participant and are labour intensive to review (Phillips 
et al., 2014). To manage these limitations, as part of this project I designed 
and developed a document with a wide range of different topics that provided 
food for thought on antibiotic resistance. This document was not designed to 
be prescriptive but to act as a prompt if required by the participant. This 
document can be found in Appendix G-1. 
Using medium-and long-term data, I aimed to understand user trends when 
visiting the Antibiotics Unearthed Facebook page (5.2) and conduct discourse 
analysis on Facebook comments (5.3) and portfolios (5.4 and 5.5). The 
discourse analysis aimed to build on the work undertaken in Chapter 4, to track 
longer-term evolution of public understandings and attitudes to antibiotics and 
antibiotic resistance through discursive transformations (Sfard, 2015). 
Discursive development is studied by identifying transformations in given 
discursive characteristics at different levels of learning: object and meta. 
Object-level development expands what is already known about an existing 
universe of objects. On an individual level, object-level development occurs 
when a learner increases the set of endorsed narratives with which they are 
familiar (Sfard, 2015). An example of this would be an individual who learns 
that viruses, with which they were already familiar, cannot be treated by 
antibiotics, with which they were unfamiliar. 
Meta-level developments are those that change the rules of a discursive game, 
when objects contradict previously endorsed narratives. At the level of an 
individual, meta-level development cannot be attained by pure logic, instead 
the learner must try to participate, to engage in reflective imitation of an expert 
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(Sfard, 2015). An example of this would be a member of the public’s realisation 
that there is relative truth and uncertainty in science. This would result in a 
more nuanced perspective of what science is and what scientists do. This 
process involves changes in more than just narratives, but in vocabulary (word 
use), visual mediators and discursive routines as well; the entire discourse.  
5.2 Results: A descriptive analysis of key metrics for the 
Antibiotics Unearthed Facebook Page 
Nowadays, the public increasingly gets science news online, particularly via 
social media such as Twitter, Facebook, or YouTube (Brossard, 2013). Social 
media has the potential to promote user engagement with science, especially 
when content is posted by trusted social contacts (Huber et al., 2019). In order 
to achieve this however, users must want to interact with science content. In 
the following section, I examined web analytics from the Antibiotics Unearthed 
Facebook page, the chosen social media platform for engaging participants in 
this project (2.7.2). What follows is a descriptive analysis of analytics which 
examines how successfully this study attracted users to a science-focused 
Facebook page, before discussing which content best reached or engaged the 
user. 
5.2.1 How to attract participants to a Facebook Page 
I examined the total number of people who liked the Facebook page over time 
(Lifetime Total Likes, Figure 5-1). Data collection began on the 17th May 2016 
with lifetime ‘total likes’ at 476. The Antibiotics Unearthed Facebook page was 
created by the Microbiology Society’s Communication Team and had been 
used prior to the 17th May 2016 to advertise other parts of the Microbiology 
Society’s Antibiotics Unearthed Mission (1.6.2). From the 17th May 2016, it was 
used solely for the purpose of the PhD study. By the 5th July 2016 [Post 1], 
lifetime ‘total likes’ had reached 581. This number increased steadily and at 
the time of the final post on 21st February 2018 stood at 1,795. Web analytics 
were downloaded on the 22nd May 2018, at the conclusion of the social media 
data collection. On this date, the number of lifetime ‘total likes’ had plateaued 
and stood at 1,798. A linear trend-line shows that lifetime ‘total likes’ increased 
in a linear fashion until Jan/Feb 2018, where the lifetime ‘total likes’ plateaued 
(Figure 5-1). My findings suggest that lifetime ‘total likes’ increase in a steady, 
linear fashion for as long as content is being published. Detailed descriptions 
of the Facebook posts can be found in Table 2-6, whilst links to the news 
articles can be found in Appendix F-1. Following the completion of data 
collection for the Antibiotics Unearthed Facebook Page, the Microbiology 
Society Facebook Page was taken down by the Microbiology Society and is 
no longer available to members of the public. Therefore links to the Facebook 






Figure 5-1. Lifetime total likes of Antibiotics Unearthed Facebook Page. The Y axis displays the total number of people who have liked the Facebook Page (unique users). 
The X axis displays dates from 2016-2018. The solid black line shows the number of lifetime total likes from 2016-2018. The dotted red line is a linear trendline used to show 




































































































































































































































5.2.2 Understanding how to best reach, impress upon and engage 
participants 
Whilst number of lifetime ‘total likes’ increased steadily with the release of any 
new Facebook content, I hypothesised that certain types of content would lead 
to greater engagement from users, specifically media in which the participants 
had a stake, for example images of bacteria they had collected personally. 
Over the course of the study, 47 different posts were released. For these 
analyses I consider all sample images released on the same day as one post. 
Of these 47 posts, starting on the 5th July 2016 [Post 1] and ending on the 21st 
February 2018 [Post 47], 21 web links, two event links, four images, two 
videos, one photo and 17 images of samples provided by members of the 
public were posted (Table 2-6). 
Three key metrics were used to identify the level of engagement of posts. 
These were the number of people for whom any of our Facebook content 
entered their screens (Reach of Posts), the number of times content entered 
peoples screens (Total Impressions) and the number of people who engaged 
with the Antibiotics Unearthed Page, either through clicking or creating a story, 
which included commenting on posts or liking posts (Total Page Engaged 
Users). These metrics were visible daily, weekly or 28-daily. Table 5-1 shows 
the daily figures. Daily figures were chosen as some posts were released 
within a week of each other, and so a weekly or 28-daily average did not give 
the resolution necessary to distinguish between separate media types.  
Of the 21 web-links posted to Facebook, the lowest number of engaged users, 
reach and impressions was three, 36 and 58 respectively. Each of these was 
on the 18th July 2016. The smallest number of engaged users over the course 
of the study was one, on the 25th July 2016 in response to an event link for the 
pop-up stand at Brecon Beacons. The same event link was responsible for the 
smallest reach, at 31. The smallest impression was in response to the release 
of a web link detailing upcoming pop-up stands at the Brecon Beacons and 
Kielder Castle on the 18th July 2016, at 58 (Table 5-1). The highest number 
was 197, 2,580 and 3,537 respectively on the 21st February 2018 (Table 5-1).  
Of the 17 images of samples provided by participants posted to Facebook, the 
lowest number of engaged users, reach and impressions was 15, 146 and 388 
respectively. The lowest engaged users and reach occurred on the 5th 
December 2017 one month after the Norwich Science Festival and just before 
Christmas, whilst the lowest impressions occurred on the 16th May 2017, eight 
months after the pop event in Glasgow Botanic Gardens. The highest number 
was 43, 15,106 and 80,552. The highest engaged users occurred on the 27th 
July 2016, after the first pop up event at Brecon Beacons, whilst the highest 
reach and impressions occurred on the 9th November 2017 straight after the 
pop up event at the Norwich Science Festival (Table 5-1). 
The largest number of engaged users over the course of the study was 197, 
on the 21st February 2018 in response to a web link to a BBC news article 
about a new family of antibiotics found in dirt. The largest reach was 15,106, 
in response to sample images on the 9th November 2017. The largest 




As would be expected, the data show posts released earlier on in the study 
had a lesser reach, lesser total impressions and lesser page engaged users. 
Inversely, posts released later in the study had a greater reach, greater total 
impressions and greater page engaged users. The three posts which reached 
and impressed upon the greatest number of users were sample images, 
however these fell between the 6th November and 20th November 2017. This 
is significant because Antibiotic Awareness Week spanned from the 13th to 
19th November and as such, may have driven the sharp increase in these 
numbers. In addition, these occurred immediately after the pop-up event that 
took place at the Norwich Science Festival. The greatest number of page 
engaged users occurred not during this week, but instead in response to the 
last post released, a web link. This suggests that reach and impressions do 
not drive engagement. Perhaps instead, engagement is driven by total number 
of likes of the Facebook Page. 
 
Table 5-1. Level of engagement of types of relevant Facebook content. Table shows the release date and 
media type of each of the 47 Antibiotics Unearthed Facebook posts. For each release, the daily page engaged 
users (number of people who engaged with your Page, that is any click or story created), the daily reach 
(number of people for whom any content from your Page entered their screen) and the daily total 
impressions (number of times that any content from your Page entered a person's screen) are shown.  
Date Media Type 








Web Link 7 38 83 
18/07/2
016 
Web Link 3 36 58 
25/07/2
016 
Event Link 1 31 78 
10/08/2
016 
Image 19 559 1039 
16/08/2
016 
Web Link 82 1049 1768 
18/08/2
016 
Video 23 254 407 
23/08/2
016 
Web Link/Photo 37 409 794 
24/08/2
016 
Image and Sample 
Images 
60 743 4297 
22/09/2
016 
Web Link 17 92 157 
23/09/2
016 
Sample Images 39 420 2768 
04/10/2
016 
Web Link 6 86 155 
03/11/2
016 
Web Link 14 144 262 
14/11/2
016 
Web Link 22 148 244 
16/11/2
016 
Video 13 63 117 
23/11/2
016 





34 531 1358 
09/01/2
017 







Web Link 8 151 263 
23/01/2
017 
Web Link 37 788 1153 
26/01/2
017 
Web Link 18 220 337 
09/02/2
017 
Web Link 18 280 460 
22/02/2
017 
Web Link 65 786 1248 
27/02/2
017 
Web Link 13 170 334 
03/03/2
017 
Web Link 18 158 243 
24/03/2
017 
Web Link 16 220 306 
05/04/2
017 





19 176 388 
30/05/2
017 
Sample Images 38 612 2735 
27/06/2
017 
Sample Images 43 682 4075 
31/07/2
017 
Web Link 5 77 107 
10/08/2
017 
Sample Images 34 1396 3697 
19/09/2
017 
Web Link 11 110 138 
02/10/2
017 





62 1335 3125 
06/11/2
017 
Sample Images 20 13634 32020 
09/11/2
017 
Sample Images 22 15106 80552 
15/11/2
017 
Image 49 915 1400 
20/11/2
017 
Sample Images 20 8129 37122 
05/12/2
017 
Sample Images 15 146 401 
06/12/2
017 
Sample Images 23 186 954 
15/12/2
017 
Sample Images 33 177 536 
21/02/2
018 




5.3 Results: A coded analysis of Facebook Comments 
Facebook comments were hypothesised to be a tool through which discourse 
analysis could be conducted to identify discursive transformations in 
participants across the eight key themes highlighted in Chapter 4. I 
hypothesised that participants would use resources made available on the 
Facebook page in order to conduct data analysis of their own samples. I also 
hypothesised that in doing so, participants would become researchers and 
adopt process focused perspectives of research. 
However, upon examining the data set at the end of data collection 21st May 
2018, it became clear that the medium-term engagement did not provide a rich 
enough pool of data from which to draw these conclusions. Instead, the coding 
schedule used for interview analysis (Table 2-5) was applied to each of the 
user comments. In doing so, user comments, as part of participant discourse, 
were taken to reflect their internal thought processes surrounding antibiotics 
and antibiotic resistance.  
Twenty-six users commented on Facebook content over the course of the 
study, amounting to a total of 39 comments. Four participants posted twice, 
either on separate samples or tagging somebody else before asking a 
question. Five participants engaged in conversation with me. Three of the five 
participants asked a question, and then proceeded to reply to my response. 
This took the form of enthusiastic remarks about the information provided, 
good lucks or compliments regarding the images and took place over a range 
of two to five days. One participant engaged in comments and responses over 
the course of a month. One participant sent five comments in response to two 
images over the course of 11 days. In total, excerpts were captured by 11 
codes over 52 references. In the next sections, I examine the key themes 
emerging from these data. 
5.3.1 Participants did not feel confident utilising resources provided to 
analyse data 
Facebook comments, unlike the face-to-face interviews, offered participants a 
chance to engage with the project by leading the questions. In doing so, it 
highlighted participants thought processes upon examining images for the first 
time:  
FB01: This is my sample. What does it mean? 
Captured by the code “Confidence [CON]” (14 references from 14 sources), 
participants viewed their images and asked for my help in analysing the data 
in front of them. In order to assist with this process, a diagram was uploaded 
[Post 9, 24th Aug 2016] which could be used to describe colony morphology 
(Figure 5-2). This diagram was also pinned on the Facebook page, so that it 
would be the first thing users saw as they entered the page. Despite this, 






Figure 5-2. Terms used to describe bacterial colony morphology. Whole colony, often described as 
colony shape, describes the shape of the colony. Edge, often described as margin, describes the edge of the 
colony. Surface describes the way the surface looks. Elevation describes the 3D shape of the colony growing 
away from the 2D nutrient source. Taken from Wikipedia, free of license, adapted and redrawn from Seeley 
& Vandemark (1962). This was posted on the Facebook page on the 24/8/16. 
 
For user FB10, confidence increased as they engaged in conversation about 
how to analyse their sample data:  
FB10: I don't think my sample is showing much. 
… 
FB10: Wow, is that really all it takes? I think I see another slightly 
up and to the left of the bottom red circle and on the right hand 
side opposite the left circle. I took this sample from the stream. 
… 
FB10: You are spot on with the two I saw Ethan. I'm glad I wasn't 
just imagining things. So fascinating to learn more about this so 
thanks for replying to my comments. 
They began cautiously, suggesting their plate of bacteria was not showing 
much. In response, I pointed out examples of inhibition. Once they had seen 
this done, they began analysing their own plate, spotting different examples of 
inhibition. I highlighted these examples for them to finalise the analysis, for 
which they thanked me for engaging them.  
Not all participants felt confident enough to try this, as shown by FB11:  
FB11: So what does that mean have we found something ha I'll 





FB11: That's sounds great! Very interesting...good luck 
In response to their request for help analysing their sample data, I provided 
examples of inhibition. Unlike FB10, they chose to thank me for the information 
but then took their leave.  
This analysis suggests that when participants were given an opportunity to 
conduct self-driven data analysis, confidence was a limiting factor. By working 
in partnership with a researcher, this confidence can be fostered, however only 
when the participant is willing.  
5.3.2 The correct use of scientific terminology  
Like with the interview data, I used the code “Scientific Word Use [SWU]” (14 
references from 14 sources) to capture each time an interviewee used a 
scientific word or phrase, either correctly or incorrectly. Within this code, I 
developed the code “Drug Resistant Infection [DRI]” (2 references from 2 
sources). This code was developed in response to research which highlighted 
the failure of experts to use simple, clear and consistent language in the face 
of antibiotic resistance, and that this risked undermining the global response 
(Mendelson et al., 2017). This research recommended that the term drug-
resistant infection be used to describe infections caused by organisms that are 
resistant to treatment, including those caused by bacteria that do not respond 
to antibiotics. User FB12 and user FB19 had excerpts captured by these 
codes: 
FB19: …Do you think mine shows any signs of antibiotic resistance? 
and 
FB12: …We think there is some resistance activity over on the left 
hand side but not certain… 
Both used the term resistance incorrectly, where the appropriate term would 
have been antibiotic activity.  
This analysis suggests that individuals use familiar words following pre-
existing rules when engaging with a new discourse (Sfard 2008). This is in line 
with my own findings in 4.3.1.  
5.3.3 A comment on Medium-Term Facebook data for identifying 
discursive transformation in participants 
During development of methods for this study, Facebook was identified as a 
relatively low-cost way of engaging participants after the initial interaction at 
pop-up stands. The low number of comments received, combined with the lack 
of users who came back to post on several occasions prevented analysis of 
discursive transformations. Coded analysis has shown that, just like in 4.3.1, 
participants use familiar terminology, sometimes incorrectly, when engaging 
with a new discourse. My results suggest that when participants are given an 




However, a limitation of discourse analysis is that issues may be oversimplified 
when taken out of context (Phillips et al., 2014). Due to the lack of context 
provided by the small number of Facebook comments, these themes are not 
added to the following thematic analysis in 5.4. Instead, Facebook comments 
are used, along with the interview transcripts, to add to the long-term data 
providing further detail when assessing the evolution of participant learning 
over the course of project engagement.  
5.4 Results: Detailed thematic analysis of Portfolio 
Participant 01 (PP1) 
So far, I have provided a descriptive and thematic account of Facebook 
interaction and engagement. Now, I present the detailed thematic analysis of 
one participant portfolio. Portfolios are defined generally as a purposeful 
collection of work that illustrates efforts, progress, and achievement in one or 
more areas over time (Stiggins, 1994). Portfolios in education are seen as a 
means of student assessment that capture the learning process (Barrett, 
2005). Herman & Winters (1994) wrote that well-designed educational 
portfolios represent important, contextualized learning that requires complex 
thinking and expressive skills and went on to suggest that portfolios encourage 
focus on important student outcomes, student achievement, and inform policy 
and practice at every level of the educational system. In understanding the 
potential that portfolios might have to evaluate the effectiveness of citizen 
science projects, they were selected as a method of tracing participants’ 
discursive development as they engaged with the topic of antibiotics and 
antibiotic resistance, as well as initialising the practices and the processes of 
research.  
Participant PP1 took part in an interview on the 4th May 2017, as interviewee 
24b [Day 1]. Therefore in Chapter 4, Participant PP1 would have been referred 
to as 24b. This participant was the first participant to agree to complete a 
portfolio (PP1) and was the 24th participant to be interviewed across the five 
pop-up events (24). They were annotated 24b as they interviewed with their 
partner, who spoke first, and was thus annotated 24a. They made their first 
portfolio entry on the same day as they attended the pop-up event at Thetford 
Forest. They submitted their first and only social media comment as FB16 on 
26th May 2017 [Day 23], by which point they had made 13 portfolio entries. In 
total, they submitted 39 portfolio entries until their last entry on the 19th 
November 2017 [Day 200]. The portfolio contained 9,052 words over 40 pages 
and was the lengthiest and most substantial portfolio submitted.  
With a focus on continuity and coherency, I examine evidence of discursive 
shifts at the object (what has the participant learnt about science) and meta 
(what the participant now sees scientists as doing and how they work) level 
over the course of 200 days. I do so by applying the eight key themes 
presented in Chapter 4 to PP1’s discourse throughout the portfolio and the 
course of the study. In doing so I present the story of a participant who was 
willing to engage long-term with the project. I note that in the portfolio, the act 
of selecting something to write about is already evidence that the participant 




moments when they see or hear something and decide to add it to the portfolio. 
In the following sections, I analyse the portfolio whilst referring to relevant 
interview and social media data provided by this participant.  
5.4.1 The correct use of scientific terminology 
As one engages with a new discourse, one uses familiar words following pre-
existing rules that seem in agreement with a new context, regardless of 
whether others are using this word in the same way (Theme 1) (Sfard, 2008).  
In the interview [Day 1], in response to a question about what might be causing 
antibiotic resistance, PP1 said: 
24b: Everything’s evolving, improving themselves ain’t they to fight. 
[Interview, Q10] 
They drew on a familiar word ‘evolving’. It is true that bacteria evolve antibiotic 
resistance, however I would expect to specifically see the use of the term 
bacteria. Whilst ‘everything’ may be evolving, that is not strictly an accurate 
response to the question at hand. This is pertinent because of the five 
questions asked to the participant prior to this response to a question about 
what we take antibiotics for, PP1 says: 
24b: Flu?  
R: Okay. 
24b: You get flu and colds. [Interview, Q3] 
In this instance colds and flu were used incorrectly as these are two diseases 
not treatable with antibiotics.  
On the 5th May [Entry 3, Day 2], PP1 included a reflection of what they had 
remembered or learned from their interview. I note that during the interviews, 
I avoided providing facts that might affect participant’s proceeding answers, 
however after the interviews I would answer any questions the participants had 
and provide detail on topics of questioning. This included information on where 
antibiotics came from, the drying up of the antibiotic discovery pipeline, the 
spread of resistant bacteria through genetic and environmental means and 
which types of infection are treated with antibiotics, among others. PP1 wrote: 
PP1: The shortage of new antibiotics: no new antibiotics for roughly 
30 years & who would have thought about antibiotics being found 
in the soil – I definitely didn’t know that. I didn’t know that there’s 
lots of bad germs in soil, if you cut yourself & get soil or dirt in the 
wound you need to have a tetanus jab. I’ve never really thought 
about antibiotics only that they can given to patients in tablet form  
Whilst PP1 reflected on multiple topics and self-reported learning, a key 
feature was the use of the term ‘bad germs’. Early excerpts from interviews 
and portfolio entries give a baseline that this participant was not familiar with 
scientific terminology and instead chose to use colloquial terms to facilitate 




already expanding their knowledge of one discursive object, bacteria, and 
provided an example of object level change. Bacteria became of interest not 
just because of their threat to humans, but also that they can be found in the 
soil.  
As the time spent engaging with the project increased, word use transitioned 
from colloquial to literate discourse. On the 15th May [Entry 9, Day 12], PP1 
discusses what type of infection cold and flu are: 
PP1: Cold & flu are viral infections & antibiotics are not effective 
against them. [Entry 9] 
PP1 showed object level change in relation to a new discursive object, viral 
infections. They now appreciated that viral infections cannot be treated with 
antibiotics.  
On the 19th May [Entry 12, Day 16] PP1 analysed their soil sample which had 
been uploaded to social media: 
PP1: When I first saw my soil sample I thought it was just a thick 
mass & I wouldn’t be able to see anything from it, but once I got 
looking at it more closely I could see zones of inhibitions; circular; 
irregular & filamentous colonies & the edges were entire; undulate; 
filamentous & curled. Fascinating really to see all the different 
shapes. I only know these terms because I saw the definitions also 
on the microbiology facebook page. [Entry 12] 
Not only did the participant display the correct use of scientific terminology like 
filamentous and undulate, the participant gave an insight as to how they 
acquired the use of these words. They reported that they noticed the terms on 
the Facebook page (Figure 5-2) and then used them to describe their own 
experiences. The change in ways in which this participant chose to learn about 
science is a meta level change, which includes their experimenting with new 
sources of information. I note their correct use of scientific terminology such 
as zones of inhibition and fili.  
On the 31st May [Entry 14, Day 28], the participant examined the difference 
between a bacterial, fungal and viral infection. In the interview [Day 1, Q3], the 
participant suggested that all three types of infection could be treated with 
antibiotics. In the portfolio Entry 28 days later, they stated: 
PP1: Antibiotics which are used to treat bacterial infections will not 
work against fungal infections & vice versa. [Entry 14] 
I observe here a realisation by PP1 that not all infections can be treated with 
antibiotics as well as correct use of the terms bacterial and fungal infections. 
This evidences an increasing familiarity with the discursive object antibiotics 
showing object level change.  
During the interview [Day 1, Q8], participants were asked what they knew 
about antibiotic resistance. PP1 responded: 





24b: Well it’s gotta be how your body reacts to fight the antibiotics 
what you’re trying to give us. [Interview] 
This would have been captured by the code “The Resistant Body [REB” in 
Chapter 4.3.3 as part of the Public Health Narrative theme, which I go on to 
discuss in 5.4.3. On the 6th June [Entry 16, Day 34], the participant made a 
portfolio entry which set out to answer the question: What is antibiotic 
resistance?  
PP1: Antibiotic resistance is the ability of microbes to resist the 
effects of drugs. [Entry 16] 
PP1 confused ‘antimicrobial resistance’ and ‘antibiotic resistance’ when using 
the term ‘microbes’ rather than the correct ‘bacteria’, however they showed a 
new awareness that resistance is a product of an infectious agent, not the 
human body. This is an example of object level change. At the end of the entry, 
the participant added a diagram which explained the process of antibiotic 
resistance, which specifically mentioned antibiotics and bacteria (Figure 5-3). 
This evidences object level change as the participant had cemented their 
knowledge that antibiotics can only kill bacteria.
 
Figure 5-3. What is antibiotic resistance?’ an image created by PP1. The entry breaks resistance down 
in to four steps. Firstly, there are a mix of sensitive and drug resistant germs. We then face a scenario where 
antibiotics are added, killing the sensitive bacteria, before explaining that this leaves the drug-resistant 
bacteria to grow and take over. Finally, we have a scenario where drug-resistance is shared between 
bacteria.On the 26th June [Entry 22, Day 54] the participant asked the question: 
 
 
PP1: “Is all bacteria bad for us?”. [Entry 22] 
Posing this question itself highlighted the move from general terminology like 
germs and microbes to the more specific terminology bacteria. I also see the 





PP1: This is why we must use antibiotics only when really necessary 
because if they can harm the dangerous bacteria, they can also 
harm the friendly good bacteria as well. [Entry 22] 
This highlighted a new familiarity with this discursive object, that the word 
‘bacteria’ is not an all-encompassing word but is instead nuanced, another 
example of object level change. I note that it is at this point of the portfolio that 
PP1 begins to ask specific questions and use scientific terminology with a 
greater consistency.  
The next few entries from the 4th July [Entry 25, Day 62] to the 25th July [Entry 
29, Day 83] are focused on the specifics of antibiotics:  
PP1: When a person is admitted into hospital with something 
wrong with then & the doctor needs to prescribe antibiotics, a 
broad spectrum of antibiotics is used. [Entry 25] 
and 
PP1: Since the discovery of penicillin over 100 new antibiotics have 
been created; each capable of fighting different bacterial 
infections. Mostly antibiotics are produced naturally in living 
organisms such as fungi & bacteria. Some of the modern antibiotics 
are produced artificially. [Entry 26] 
and  
PP1: Each antibiotic is only effective against certain types of 
infections., Your GP assess your needs & match them with the 
drugs available. Mostly a GP will choose an antibiotic based on the 
most likely cause of the infection. The number of doses & common 
side effects are also taken into consideration & patterns of infection 
in your community when choosing an antibiotic. [Entry 27] 
and 
PP1: Aminoglycosides – tend to be used in hospitals to treat very 
serious illnesses e.g. Septicaemia. As they can cause serious side 
effects; including kidney damage & hearing loss, they’re usually 
given by injection. May be given as drops for some ear & eye 
infections. [Entry 29] 
 
These four excerpts taken from the portfolio entries over this 22-day period 
highlighted a developing use of scientific terminology. The participant talked of 
broad-spectrum antibiotics, bacterial infections, doses & common side effects. 
They also delved into specific antibiotic classes such as aminoglycosides. As 
well as a notable lack of colloquial terminology, this showed an increasing level 
of specificity in knowledge they were gaining. It is as this point that I see the 
participant realised that each discursive object, like antibiotics and bacteria has 




exploring the nuance of these words. These excerpts evidence object level 
change with regards to the object antibiotics.  
On the 4th August [Entry 32, Day 93] the participant adapted data they saw in 
a newspaper article identifying average prescription rates per child in the first 
year of life by country (Slezak, 2017) and provided a personal view of data 
presented. This is an example of their journey into becoming a scientist and is 
an example of meta level change. They then commented:  
PP1: Surely the best way to try to keep babies healthy is by making 
sure they are vaccinated; this will cut down on some of the life 
threatening infections. Having too many antibiotics must change 
the good bacteria which is present in our stomach & skin. [Entry 32] 
This comment showed an increased level of confidence and specificity. The 
phrase ‘surely the best way’ is a confident qualifier. PP1, in increasing their 
understanding of antibiotics, began to realise that they were not always the 
correct solution and suggested vaccines to reduce overuse. This a further 
example of object level change.  
Towards the end of the portfolio entries on the 12th September [Entry 36, Day 
132], PP1 reflected on a piece in the New Scientist. They noted: 
PP1: It said that antibiotics can save your life, but they can also 
mess up your microbiome. But now they’ve formulated some 
charcoal which could protect your body from the side effects of 
antibiotics & perhaps even help fight against antibiotic resistance. 
By killing too many of the good bacteria in our guts, it’s making 
way for the harmful, drug resistant bacteria like C. difficile, which is 
responsible for about 30,000 deaths in the U.S.A. [Entry 36] 
I note that when comparing the word use in this entry to those during the 
interview, I see more specific, scientific terminology used in a more confident 
manner. These words included but were not limited to ‘microbiome’, ‘antibiotic 
resistance’ and ‘drug resistant bacteria’ and evidenced an object level shift with 
regards to each of these discursive objects. That this information was taken 
from The New Scientist highlights that not only was the participant seeking out 
new information, but they were finding new sources of information from which 
to do so. The participant often relied on newspapers at the beginning of their 
journey, however towards the end they began exploring more technical 
sources. This is an example of meta level change, as the participant changed 
the ways in which they were learning about science.  
This thematic analysis shows that as part of engaging with this study, PP1 
experienced discursive transformations. They became more familiar with 
discursive objects such as bacteria, antibiotics and antibiotic resistance in 
examples of object level change. They changed the ways in which they 
conducted scientific data analysis and gathered new information about science 
in examples of meta level change. These shifts were combined with an 
increasing consistency and specificity. These shifts were most dramatic in the 




5.4.2 Using personal experiences in ritualised ways to participant in a 
new discourse 
Sfard (2008) says that in initial encounters with a new discourse, learners 
participate in routinised ways, using rituals. Some rituals are more exploratory 
and have more agency, for example if an individual were to form a hypothesis 
and this led to experiments being set up to test this. Some rituals simply mimic 
or replicate, sometimes not very critically, what has been provided by previous 
users, for example out of respect for authority (Theme 2). Examples of this 
might include following rituals prescribed by Public Health England, such as 
handwashing and social distancing. As a society, we are expected to adhere 
to these rituals and often we do so without knowing the scientific reasons 
behind them. There is an assumption that when you belong to a community of 
practice, some of your actions may be rituals or ritualised engagements with 
what the community would do. If you don’t follow these rituals, you will be an 
outlier. These rituals are process-oriented routines, where routines are 
repetition-generated patterns of our actions. Whilst an individual may not know 
why they must take the whole course of antibiotics, beginning to understand 
the underlying principles is what helps individuals transition into part of the 
discursive community. As rituals underpin many of our participants actions, I 
discern these across the remaining sections.  
5.4.3 Public Health Narratives 
Public Health Narratives are rituals bequeathed by Public Health England. As 
a member of the U.K public, you are expected to mimic these (Theme 3). In 
Chapter 4.3.3, I highlighted six public health narratives that had become part 
of people’s everyday practice when engaging with the discourse on antibiotics 
and antibiotic resistance: 
1. Antibiotics are taken for everything (overuse) but shouldn’t be 
(misuse) 
2. You should run the full course with prescriptions 
3. Antibiotics do not work on viruses 
4. Practice better hygiene 
5. Stay healthy, including staying active 
6. Practice antibiotic stewardship 
 
During their interview [Day 1], when asked about how to make a difference to 
the spread of antibiotic resistance, PP1 said: 
24b: Make sure you wash your hands. [Interview, Q13] 
and  
24b: Hygiene. [Interview, Q13] 
Coded using Public Health Narrative [PHN], this was a direct reference to the 
ritual of practicing better personal hygiene (4). This was the only public health 
narrative that PP1 referred to throughout the 13 questions asked in their 
interview. In their portfolio, PP1 ritualised or discussed four of the six public 
health narratives across their 39 entries. In the following, I cover the two 




engagement: overuse/misuse of antibiotics (1) and not taking antibiotics for 
viral infections (3).  
The narrative that PP1 most frequently referred to was that of overuse and 
misuse. In their seventh entry [Day 8], PP1 tackled a question I had posed in 
my portfolio factsheet; what causes antibiotic resistance? They focused on 
overuse as the main, but not only, cause of antibiotic resistance: 
PP1: Antibiotic resistance results from the overuse of antibiotics, so 
when you do become ill the antibiotic may not work to over-power 
the germ bacteria & may led to you being sick for a longer time. 
[Entry 7] 
In this entry, the participant explained the narrative in the simplest terms, that 
misuse of antibiotics prevents them working. The next portfolio entry [Entry 8, 
Day 10] provided a bullet point list of how we use (surgeries and fighting 
infection) and misuse (over prescription by doctors, self-prescribing, farming) 
antibiotics.  
Their 13th portfolio entry [Day 23] touched on how antibiotic awareness 
campaigns reduce antibiotic use: 
PP1: Read today that the number of antibiotics prescribed in 
England has fallen from 37.3 million in 2014-2015 to 34.3 million in 
2015-2016. Antibiotic awareness campaigns help to reduce 
antibiotic use. [Entry 13] 
In this entry, the participant began to expand on their knowledge of the 
narrative, specifically quantifying the scale of the problem whilst noting the 
reduction of prescriptions year on year in the light of antibiotic awareness 
campaigns. This is an object level change.  
The 16th entry [Day 34] tackled what antibiotic resistance is, how it happens, 
where infections happen and how to fight resistance. When detailing core 
actions to fight resistance, they wrote: 
PP1: Only use antibiotics when necessary & use them properly as 
instructed by the doctor. [Entry 16] 
and 
PP1: Improving antibiotic use. In order to slow down the 
development & spread of antibiotic resistant infections, must 
change the way in which they are used. Antibiotics are given 
unnecessarily to people & animals – (up to half). They should only 
be used when needed to treat a disease & the correct antibiotic 
used & in the proper way. [Entry 16] 
PP1 expanded the narrative, primarily aimed at humans, to include animals. 
They also detailed how ‘the correct antibiotic’ should be used ‘in the proper 
way’ to treat disease. This shows an increased understanding of antibiotics 




of antibiotics and different ways in which to use them, they have expanded 
their understanding of what specifically constitutes overuse/misuse. This is an 
example of object level change.  
In their 20th entry [Day 48], they discussed an internet article about the misuse 
of antibiotics causing harm in and of itself: 
PP1: Over a 6-year period this lady received 400 injections, took 20 
pills a day & had a lung removed. The drugs were so toxic that they 
changed the colour of her skin, damaged her hearing & vision, 
caused excruciating joint pain, triggered bouts of psychosis, left her 
constantly nauseous & unable to eat. [Entry 20] 
This entry coupled with Entry 22 [Day 54] asking if all bacteria are bad for us, 
discussed in 5.4.1, showed an expanded understanding of antibiotics as the 
discursive object in relation to the narrative of misuse/overuse. Instead of 
seeing misuse as bad only for reducing efficacy of medication when sick, they 
discovered that misuse can be bad due to the severe side effects of antibiotics 
themselves. This is an example of object level change.  
Over the last few entries, PP1 diverged from the common health narrative, that 
overuse/misuse of antibiotics can lead to antibiotic resistance and explored 
other risks present with the abuse of antibiotics in examples of object level 
change. This learning was facilitated by the participant’s active reading on this 
topic; the collection of new information which expanded their understanding of 
the discursive object. The active seeking of knowledge is an example of a meta 
level change. I note that much like in 5.4.1, the participant experienced this 
significant shift at around the two-month mark. 
Their 23rd entry [Day 57] focused on alternatives to antibiotics. The participant 
began to explore antibiotics as an interesting standalone topic, rather than 
focusing only on their role in the narrative of overuse/misuse. The participant 
noted ways in which we can reduce misuse with novel medical techniques, an 
example of object level change. These techniques included the use of maggots 
to remove infection & dead tissue and orthopaedic implants which resist 
infection.  
In their 30th portfolio entry [Day 85], they wrote:  
PP1: Growing resistance to antibiotics is an increasing problem 
around the world. They are becoming less effective because we 
take so many of them & this means that deadly infections spread 
more easily. [Entry 30] 
The participant, after expanding their knowledge of antibiotics over the last few 
entries, circles back to update their definition of the narrative of 
misuse/overuse. Their level of specificity had improved since their earlier 
definition [Entry 7] as had their consistent use of scientific terminology.  
In Entry 34 [Day 97], PP1 took a more critical view of the narrative, based on 
newspaper articles surrounding a debate between scientists about completing 




It is true that by reducing the use of antibiotics should help with the 
spread of superbugs, but you do have to be careful because a 
person could be feeling better, but still got the infection in their 
bodies, so causing either a relapse or treatment failure. By coming 
up with new ideas, it does leave patients wondering what advice to 
believe. Prescribing antibiotics in such a readily way & in such large 
volumes does need to change, because we will run out of 
antibiotics if we don’t reduce the usage, also the resistance 
problem will worsen. [Entry 34] 
This is the first entry where PP1 actively discussed both sides of the underlying 
aspect of the narrative surrounding overuse and misuse. This is not to say they 
hadn’t considered this, but this was the first time they felt it important enough 
to make a note of it, an example of object level learning. It is also an example 
of increased specificity when compared to earlier entries [Entry 7] which 
suggested that misuse is bad as antibiotics will stop working.  
In their 36th entry [Day 132], they discussed another solution to overuse of 
antibiotics. They begin by stating another critical argument behind taking 
antibiotics; that antibiotics can both save your life and ruin your microbiome. 
The use of the term ‘microbiome’ is an example of object level learning. They 
then discussed activated charcoal which had been used in drug overdoses to 
soak up the excess drug: 
PP1: The biotech company in Paris have evidence that a modified 
version could do the same for antibiotics. Apparently there are 
plans to start testing the charcoal in people taking antibiotics to 
treat infections next year. [Entry 36] 
In Entry 38 [Day 163], PP1 read a newspaper headline (Donnelly, 2017) which 
reported the U.K Chief Medical Officer talking about a potential antibiotic 
apocalypse. They rounded off the topic of overuse/misuse by saying:  
PP1: Antibiotics should be used more sparingly, apparently patients 
think that GP’s were being “mean” when the refuse to give them 
antibiotics, but this is to cut out the needless use & to conserve the 
antibiotics for use when they are really needed. [Entry 38] 
They considered criticism levelled at GPs for being mean in context of all the 
information they had gathered over the previous 163 days. They concluded 
that rather than being mean, it was action taken in consideration of the 
narrative of overuse/misuse. PP1 has transformed from an individual who 
mimicked the ritual of overuse/misuse bequeathed by Public Health England, 
to an individual who critically assessed behaviour of experts considering this 
narrative.  
The second most frequent narrative referred to is that one should not take 




PP1: The more antibiotics are used in excess to treat colds; flu & 
other viral infections, the more they become ineffective against 
bacterial viruses. [Entry 7] 
At this early stage, it is clear PP1 was still getting to grips with the scientific 
terminology. Instead of using the term ‘bacteria’ they used the term ‘bacterial 
viruses’. This mistake is one that is not repeated in further portfolio entries as 
they continued to engage with the project, an example of object level learning. 
However, object level learning has taken place with regards to overuse of 
antibiotics and the resultant reduction in efficacy. They did accurately highlight 
the narrative that antibiotics should not be used for viral infections.  
Their ninth entry [Day 12] answers what type of infection are cold and flu. They 
first noted that these are viruses and so antibiotics are of no effect. They then 
described a viral infection their husband had at the time, which culminated in 
the participant believing the pharmacist had prescribed antibiotics. On this, 
they wrote: 
PP1: Why were these prescribed though as apparently antibiotics 
are no longer routinely used for sore throats? Surely this is an 
example of the misuse of antibiotics! [Entry 9] 
This shows PP1 imitating the ritual that we should not take antibiotics for viral 
infections. Perhaps more notably, it also shows PP1 questioning the advice 
given by an authority figure, in this instance a pharmacist, through conducting 
their own research. This is an example of meta level change as it shows the 
way in which the participant views authority changing.  
Their 14th entry [Day 28] covered the difference between a bacterial, fungal 
and viral infection. One excerpt from this was:  
PP1: Viruses are smaller than bacteria. They require living hosts to 
multiple; if not they do not survive. They reproduce by infecting a 
host & using the DNA from the host they can make copies of 
themselves. [Entry 14] 
Interestingly, the focus on the discursive objects (bacteria, viruses and fungi) 
switched from being in the lens of antibiotics and antibiotic resistance, and 
more towards the distinct physical differences between the three organisms. 
This development of interest in the organisms themselves, rather than just the 
focus that I imparted on the participant, feels particularly noteworthy and is an 
example of object level change. 
Skipping forward to Entry 33 [Day 94], the participant continued to express 
interest in the discursive objects themselves as they stuck in several Scanning 
Electron Microscope (SEM) images of bacteria, viruses and fungi: 
PP1: I am quite fascinated with the different shapes of bacteria. So 
today I thought I’d find some photos which have been taken with a 
“Scanning Electron Microscope”. The detail on the photos is 
unbelievable, you wouldn’t think that bacterial infections could look 




make them more impressive & to stand out, well it certainly did this 
to me! I feel quite silly really & a bit disappointed, but this is 
something else that I have learnt since doing this project. [Entry 33] 
In exploring this newly developed interest in the discursive object, the 
participant self-identified as having learnt something new, object level change. 
This is an important reflection for public engagement and speaks to the power 
of encouraging self-driven research based on personal interests, rather than 
the presentation of facts as is popular in public understanding. The fact that 
the participant was curious enough to seek out of new information is an 
example of meta level change.  
Entry 27 [Day 70], 28 [Day 76] and 29 [Day 83] covered different types of 
antibiotics and the specific infections these can treat. PP1 increased their 
specificity of knowledge around antibiotics during these 14 days, delving 
beyond the narrative that antibiotics are for bacterial infections and instead 
asked which specific types of antibiotics treat which specific types of bacterial 
infections. In Entry 27, they noted: 
PP1: Antibiotics are not needed for viral infections e.g. cough & 
colds, flu, sore throats or acute sinus. Usually your own immune 
system will kick in & fight the virus off. [Entry 27] 
This goes beyond viral infections as a general term and provides specific 
examples of viral infections you would not take antibiotics for, an example of 
object level change. Further, in Entry 29 they note:  
PP1: Cephalosporins – used to treat a wide range of infections; also 
effective for treating more serious infections e.g. septicaemia & 
meningitis. [Entry 29] 
PP1 focused with far greater specificity than they had done previously on the 
use of individual antibiotic classes in the treatment of bacterial infections. This 
is an example of an object level shift, whereby the participant was looking 
deeper into the object itself, rather than using it as part of a predisposed 
narrative. It is also of note that they were using the term bacteria and virus 
correctly in a consistent and specific fashion at this stage of their engagement.  
During their engagement with this study, PP1 used scientific terminology more 
consistently and specifically. They experienced object level learning as they 
examined in closer detail ‘bacteria’, ‘viruses’, and ‘fungi’ but also as they 
improved their understanding of ‘antibiotics’ outside of the role they play in 
overuse/misuse. In examples of meta level learning, they challenged authority 
and sought new information on topics that were of interest to them. The 
combination of these shifts resulted in discursive transformation, whereby the 
participant developed a more evidence based, critical approach to the rituals 
adopted by the literate discourse. 
5.4.4 Human Health Narrative 
In chapter 4.3.4 I showed that participants who placed faith in science and 




science optimism was linked to a likelihood to act to help mitigate effects of 
global crises. In this section, I examine the extent of PP1s science optimism 
and whether this changes over the course of the study.  
Whilst PP1 presented a more dystopian perspective of antibiotic discovery and 
the threat of antibiotic resistance in their interview [Day 1], they expressed 
science optimism from the outset in their portfolio. In PP1’s second portfolio 
entry [Day 1], they wrote: 
PP1: Today I took a soil sample from Thetford Forest. Who knows, 
perhaps a new antibiotic will be discovered in my sample! [Entry 2] 
It was made clear to PP1 that finding new antibiotics was a very difficult task 
Yet still, PP1 showed faith in my ability as a scientist, as well as a utopian 
perspective that a cure is out there to be found, that underpinned this 
utterance.  
Rather than provide quotes for each time the participant expressed positive or 
negative emotions, utopian or dystopian perspectives or optimistic and 
pessimistic outlooks, I describe my general feeling from the data analysis. 
Reading through the 39 entries over a 200-day period, there is a continued 
sense of science optimism.  
The most noticeable transformation of PP1 captured by this theme was their 
development of the understanding of what a scientist is, facilitated by their role 
playing as a scientist or researcher. In their earlier entries, such as Entry 5 
[Day 5] PP1 said:  
PP1: It appears to represent a new class of antibiotics & seems 
hopeful that the new isolation techniques could lead to further 
antibiotic discoveries. Which would be would great news as 30 
years is a long, long time to wait since the last antibiotic was 
discovered. [Entry 5] 
The final sentence suggests a sense of relief that scientists may have 
discovered a new class of antibiotics, there is emotion attached to the factual 
account of this novel drug. As the entries continue, the participant began to 
divorce themselves from emotion and instead presented factual summaries of 
the discursive objects they were researching. Entry eight [Day 10] is an 
example: 
PP1: There are many used for antibiotics – heart surgery; organ 
transplants, joint replacements, severe burns, chemotherapy, blood 
transfusions, chest infections – to name but a few. By using 
antibiotics they have helped to increase our life expectancy. If 
antibiotics lose their effectiveness then key medical procedures as 
mentioned above could become too dangerous to perform. [Entry 
8] 
Here there is no emotion attached to their writing. Whereas before they 
expressed happiness, they now presented key facts on behaviours which may 




must objectively analyse the facts and attempt to remove emotion from the 
discussion. This suggests a meta level change, that the participant was 
developing their understanding of what a scientist is as they themselves 
engaged with their role of becoming a citizen scientist and a researcher.  
This thematic analysis suggests that PP1’s level of science optimism did not 
change over the course of their engagement. They showed science optimism 
from the first portfolio entry. Instead a meta level shift occurred with regards to 
the emotion they used in their writing. They developed from including their 
emotions in their writing to writing objectively about the facts they were 
researching.  
5.4.5 Who is to blame? 
In Chapter 4, I found that individuals would often blame external factors, that 
is other people, as responsible for the worsening antibiotic resistance crisis 
(Theme 5). Specifically, participants blamed doctors, people at the top and 
irresponsible others. Very rarely would an individual acknowledge their own 
contribution to antibiotic resistance. In this section, I examine the apportion of 
blame by PP1 and whether their perspective changed as they engaged with 
the project.  
In their interview [Day 1], when asked whether antibiotics were misused, PP1 
suggested that they were, placing the blame mainly on doctors:  
24b: Ye probably ye, I’m gonna say perhaps, perhaps they’re 
prescribing them, or giving them to you a bit too much. [Interview, 
Q15] 
In Entry 3 [Day 2], the participant wrote: 
PP1: I was rather surprised that so many people said “No”! [Entry 
3] 
I note that the question to which the participant believed people answered no 
was whether they wanted to take part in our project. Most people asked during 
the pop-up stand were enthusiastic. Whilst done in the passive voice, the 
participant revealed an elevation of their own level of responsibility compared 
to others; whilst others said no, they took the time to learn about antibiotics, 
something that they didn’t know before. In the same entry, PP1 wrote: 
PP1: I’m hardly ever ill, apart from coughs & colds, just minor 
illnesses. [Entry 3] 
This again divorced their own actions regarding misuse of antibiotics from that 
of the general public: if they are not ill, then they are not the person asking for 
medicine. Whilst this may be accurate, the fact they felt it important enough to 
write suggests that they are proud of their own behaviour. In Entry 4 [Day 4], 




PP1: I don’t believe I’ve got much in the medicine cabinet, but it 
was surprising what I found once I started to take things out & 
make a note of them! [Entry 4] 
Participation in the study provided an opportunity for reflection that otherwise 
the participant may not have had. I note that none of the medicines the 
participant had contained antibiotics. In Entry 7 [Day 8], the participant talked 
about a bug which is resistant to all antibiotics and killed a woman (Gallagher, 
2017). They said: 
PP1: The lack of new drugs & over prescribing antibiotics have all 
led to bacteria becoming more & more resistant to modern 
medicines. [Entry 7] 
This entry infers the pharmaceutical industry may be to blame for not producing 
new drugs and the doctors that are prescribing too many of the current drugs. 
In Entry 8 [Day 10], the participant discussed how we use and misuse 
antibiotics. Naturally this entire section attributes blame. During this entry, PP1 
attributed blame to doctors, people who self-medicate and farmers whilst 
suggesting that antibiotics used for surgery are used properly, increasing our 
life-expectancy: 
PP1: As well as doctors overprescribing antibiotics, you can buy 
them without prescription on the internet. This is encouraging self-
medication & a low quality care, as you’re probably taking the 
incorrect antibiotics. [Entry 8] 
Whilst this is still an example of external attribution, there was a move from 
‘they’ as large groups of individuals to ‘they’ as individuals. However, this 
almost pardons the individual by suggesting they are encouraged to self-
medicate, perhaps placing blame at those who are selling the antibiotics 
online.  
In Entry 9 [Day 12], discussing what type of infection is cold and flu, the 
participant noted an infection that their husband had been suffering. The final 
part of this entry was discussed in 5.4.3 as a meta level change in their 
perspective of authority. The first part of the entry described the experience of 
going to a chemist belonging to a well-known pharmacy chain to receive over 
the counter medication to manage the symptoms, they noted: 
PP1: She said to help with his throat “Tyrozets6” would be what she 
recommended; along with paracetamols. These tablets are dual 
action, containing “Benzocaine” & “Tyrothricin”. Apparently an 
anaesthetic to quickly numb throat pain & an antibiotic to help 
fight throat infection. [Entry 9] 
The use of objective facts to make real life decisions is an example of a meta 






they engaged with the study. With regards to apportioning blame, whilst the 
participant suggested the prescription of an antibiotic for a likely viral infection 
is misuse by the pharmacist, they personally assumed the responsibility to 
ensure this medication was suitable. This is another example of a meta level 
change, where they are moving from the external attribution of blame to the 
internal attribution of blame.  
Entry 20 [Day 48] covered a newspaper article about misuse of antibiotics 
leading to dangerous resistance (Picard, 2017). The article discussed a 
woman who had MDR TB and her resultant treatment plan which left her very 
sick: 
PP1: The problem was that she never had diagnostic tests to 
identify the drugs to which her TB was resistant. The drugs were 
prescribed on a hit-or-miss basis & actually made her more ill. 
[Entry 20] 
Whilst the participant used the passive voice in saying ‘were prescribed’ rather 
than ’the doctor prescribed’, I assume with some confidence that the 
participant was alluding to practitioners of the medical profession.  
Entry 21 [Day 48] about TB in Britain included the following: 
PP1: Experts want all immigrants & long-stay visitors from 
countries rife with TB in Asia, Africa & South America to be 
screened on entry to Britain7. [Entry 21] 
PP1: TB is making a comeback because of complacency & lack of 
medical staff to trace victims & offer prompt treatment. [Entry 21] 
PP1: Multi drug-resistant strains of TB are becoming more common 
because patients fail to take their treatment correctly & so this 
allows the bacteria to fight back. [Entry 21] 
PP1: In the 1970’s we were close to wiping out TB, but once again 
development of new drugs did not come about & the disease has 
re-established itself in Britain. [Entry 21] 
These four consecutive sentences have been split to highlight the four key 
places in which blame was attributed. Whilst the participant appealed to 
experts, they were not taking a critical stance on what they had read and so 
we can assume that they agreed. Thus, there was blame for immigrants and 
long-stay visitors from countries rife with TB, tracing staff and those 
responsible for employing medical staff, individuals who fail to take their 
treatments and finally the pharmaceutical companies who are not developing 
new drugs. Based on the specifics of these entries and their factual accuracy, 






a topic of interest sparked by a previous entry. This is an example of meta level 
change.  
Entry 22 [Day 54], previously discussed in 5.4.1, explored whether all bacteria 
are bad for us: 
PP1: …That’s why it’s important to do exactly what the label says 
regarding hours between taking the pills. Always make sure that 
the full course of antibiotics prescribed are taken. [Entry 22] 
PP1 adopted personal responsibility, which notably coincided with the more 
prominent use of public health narratives in the participants writing. This meta 
level change, the imitation of experts narrative that we must all be personally 
responsible, is facilitated by object level change, the objects being ‘bacteria’ 
and ‘antibiotics’, discussed in detail in 5.4.3.  
In Entry 25 [Day 62], PP1 discussed the use of broad-spectrum antibiotics by 
doctors for recently admitted patients: 
PP1: When an antibiotic is used in this way to cover against 
everything; it is known as “carpet bombing” but actually what is 
needed is more precision targeting. So this is why DNA sequencing 
could be used as it would be more accurate & diagnosis would be 
quicker. [Entry 25] 
This entry is markedly different from those attributing blame earlier on. Firstly, 
the participant was more specific with their language and used researched 
facts to explain a practice used by doctors that they did not agree with. They 
then went on to suggest the solution to this problem. This fact-based criticism 
followed by the provision of a solution is something the participant continues 
to do across the following entries and is an example of meta level change. 
Entry 30 [Day 85], discussed in 5.4.3, documented a news report on the debate 
between the British Medical Portfolio and longstanding Public Health 
Narratives; that one should complete their full course. In this entry, the 
participant used the phrase ‘we take so many of them’. In doing so, the 
participant had stopped divorcing themselves from actions taken by individuals 
of others. This is increasingly noteworthy given that scientists and doctors are 
questioning each other in this debate, and so it would have been very easy to 
pick a side and blame one or the other. This continued transition from external 
to internal attribution over the course of the study is further example of meta 
level learning.  
Entry 32 [Day 93] focused on a news article (Slezak, 2017) which discussed 
antibiotic prescription rates per child in the first year of life in different countries. 
This was discussed earlier in 5.4.1. PP1, instead of attributing blame to doctors 
as would have been understandable, presented a potential solution to 
overprescribing (vaccinations) and presented information to back up reducing 
the use of antibiotics at an individual level.  
In Entry 38 [Day 163], discussed in 5.4.3, PP1 read a newspaper headline 
which reported the U.K Chief Medical Officer talking about a potential antibiotic 




for the first time, actively defended doctors. PP1 suggested doctors had a 
reason to be acting with prudence when considering antibiotic prescriptions. In 
the same entry, PP1 wrote about a GP from Manchester who went on to a 
Television breakfast news show to talk about misuse of antibiotics:  
PP1: She was only on for about 4 minutes if that, surely to get 
people’s understanding of antibiotics more time should be taken to 
explain things, instead of trying to cram more & more subjects – 
which don’t amount to anything into the breakfast news. [Entry 38] 
The participant again defended a doctor seen as trying to educate the public 
and criticised the news programme for not allowing the doctor enough time to 
do so. As the participant had increased their knowledge of the discursive object 
‘antibiotic resistance’, they began to understand the roles doctors play. This 
facilitated a change in attitude towards doctors, in which the participant started 
to see public education as a noble cause that should be defended. This is 
another example of meta level change.  
This thematic analysis shows that over the course of engagement with the 
project, the participant experienced meta level learning. They moved from only 
external to a mix of external and internal attribution of blame for antibiotic 
resistance. They began to seek out new information from a wide variety of new 
sources. They began to think like an objective scientist, using facts to back up 
their opinions or base their decisions and they developed a growing 
appreciation for the role experts play in communicating with the public.  
5.4.6 What are scientists after? 
Brew (2001) presented four qualitatively different ways in which research is 
understood (Theme 6). These were labelled Domino, Trading, Layer and 
Journey (Table 4-1). In Chapter 4, I provided examples of participants who 
perceived research through each of these four different lenses. This section 
focuses on PP1’s perception of research and how engaging with this project 
changes this perception of science and scientists.  
During PP1’s interview [Day 1], when coding for Domino, Truth, Journey or 
Layer, there were no examples registered. This is likely a reflection of the lack 
of targeted questions based around the concept of research. In the portfolio 
Entry 1 [Day 1], the participant wrote:  
PP1: Today I was asked if I’d like to be part of a scientific 
experiment. I was very excited!! Me & *Husband’s name* only 
went for a walk around, or so we thought! Never expected to be 
asked to take a soil sample. We were happy to do so. Something 
you don’t get asked to do every day! [Entry 1] 
The participant expressed their excitement at the prospect of being part of a 
scientific experiment, that was exploring their role as a citizen scientist. I have 
touched slightly on PP1’s growing understanding of what is it to be a scientist 
in the previous sections. The participant was excited to be part of the 




In Entry 2 [Day 1], discussed earlier in section 5.4.4, the participant wondered 
whether a new antibiotic might be discovered in their sample and expressed 
their wonder at what the sample would look like once grown in the lab. This is 
a product focused perspective with the researcher absent from awareness, an 
example of Domino. 
In Entry 3 [Day 2] the participant said: 
PP1: I was very happy to be involved with the soil samples, & I’m 
interested in learning about things that I don’t know about... [Entry 
3] 
The participant adopted the internal process focused nature of a scientist, that 
is to learn about things they didn’t know about. As a scientist, I suggest that 
much of the excitement surrounding experimentation is driven by the possibility 
of discovering things that weren’t previously known. The products generated 
along the way are a pleasant consequence but are not the underlying 
motivation. This mindset is a continuation of Journey, seen in Entry 1. In the 
same entry, they wrote: 
PP1: By you having information on stands & getting out in the 
community & talking about things, this must make people aware of 
what’s happening about antibiotics, even if it’s only a few people at 
a time! [Entry 3] 
This excerpt was written with the researcher absent from awareness. The 
focus was on how the information itself must increase awareness; a process 
focused perspective and as such is coded by Layer.  
In Entry 5 [Day 5] the participant detailed their day to day workings, how they 
were going about conducting research: 
PP1: I decided today to try to find out the answer to the above 
question. I put the computer on & went onto the Wikipedia site & 
there I found out that… [Entry 5] 
This entry is coded by Journey. The participant discussed their role as a 
researcher, that is the internal processes of searching for new information to 
help answer a question of interest. This is also an example of meta level 
learning.  
In Entry 6 [Day 6], the participant again discussed the process they undertook 
to discover new information, providing a source, a date and their overall feeling 
about the information: 
PP1: Today I read an article on line from the mail (08/03/17) which 
I found very interesting & fascinating. [Entry 6] 
I will not highlight every example, but I note that the participant did this often. 
In each case, this would be coded by Journey. The participant was fulfilling 
their role as a citizen scientist and was going through the process of research 
to discover information that they were previously unaware of. When writing 




As entries progressed, they added a date. In later entries, they provided the 
title of the article, the date they read it and the information they deemed 
important. This was an increasingly structured and mature method of data 
entry and is an example of meta level learning. 
In Entry 12 [Day 16], the participant noticed their soil samples had been 
uploaded to Facebook. They wrote: 
PP1: Today I’ve noticed that our soil samples are on the Facebook 
page, wonder what they’ll look like, only hope my sample hasn’t 
failed! I’ll be really disappointed if there’s no results. [Entry 12] 
The participant was no longer worrying specifically about whether they 
discovered a new antibiotic [Entry 2] but was generally hopeful that there would 
be results. It is a common feeling as a scientist to be invested in your 
experiment, hoping that the time spent will produce an outcome. Often 
outcomes are then used to justify undertaking new processes of research. As 
researchers are absent from the awareness, this is coded as Domino. The 
participant went on to describe the results of their sample, as discussed in 
5.4.1. The participant discussed their data, together with the hidden meanings. 
That is, they had their sample, and using a tool provided by the Antibiotics 
Unearthed Facebook Page, they uncovered the truth of the results of their 
sample. They then detailed their fascination with this process. This is coded 
for by Layer.  
In Entry 16 [Day 34], in response to the question “Where do infections 
happen?” the participant talked about tracking: 
PP1: CDC (Centers for Disease Control and Prevention) gather data 
on antibiotic resistant infections, the causes of infection & whether 
there’s a particular reason why some people are more susceptible 
to getting a resistant infection. With this information, experts can 
develop strategies to prevent these infections & prevent the 
resistant bacteria from spreading. [Entry 16] 
The participant discussed data collected by the researchers at the CDC, 
focusing on the separate issues which come together to produce meaningful 
strategies to fight antibiotic resistance (Domino).  
In Entry 17 [Day 36] the participant had a realisation: 
PP1: It wasn’t until I was reading a bit of information on the 
computer about the history of antibiotics, that I realised penicillin 
(the first commercialized antibiotic) was discovered in 1928 by 
Alexander Fleming (which I have mentioned previously in this 
diary). But it wasn’t until 1945 when it became used for the general 
public, so that had taken 17 years before it was processed into a 
proper commercial drug. [Entry 17] 
Like Entry 12, the participant uncovered the hidden truth behind the data they 
were examining (Layer). In this instance the data was information about the 




a novel drug into a commercial product takes a substantial amount of time. 
This is an example of object level learning as the participants knowledge about 
antibiotics had increased. It also examples meta level learning, as the 
participant expressed a change in understanding that science takes time, 
something highlighted a few more times throughout the portfolio. 
In Entry 18 [Day 37] PP1’s development as a data analyst was highlighted. An 
email alerted the participant to further sample data having been uploaded to 
Facebook. Like the first analyses [Entry 12, day 16], they used the tools 
provided to describe the morphology of their sample. However, they went 
further:  
PP1: This time I actually compared my husbands soil sample with 
mine (our samples were from the same hole but his were deeper). 
The same grown in the all culture media looked totally different to 
my soil sample, looked to be different shades of yellowy/orangey – 
a lot lighter shade from mine. He still had filamentous shapes, but 
his circular shapes looked larger & not all of them were circular but 
irregular. Could also see zones of inhibitions. The sample grown in 
the brain-heart infusion media looked to be the same colour as my 
sample. He did have bigger circular growths & a few more irregular 
ones along with filamentous. Looked at the other soil samples 
which other people took, surprising how different they looked, very 
diverse. [Entry 18] 
Over the course of six entries, 21 days apart, the participant had gone from a 
descriptive to a comparative account of their data. Descriptive account 
describes the process by which a scientist would describe their data as what 
they could see, for example when the participant said ‘I could see zones of 
inhibitions; circular; irregular & filamentous colonies & the edges were entire; 
undulate; filamentous & curled’ [Entry 12]. Comparative account describes the 
process by which a scientist would take the description of their data and 
compare it to other data. This would often be other data in the literature, but 
PP1 made use of the other samples collected at the pop-up event ‘This time I 
actually compared my husband’s soil sample with mine’ and ‘Looked at the 
other soil samples which other people took, surprising how different they 
looked, very diverse’. Examining this entry technically, there were several 
typographic errors and spelling mistakes. This entry is an example of Domino, 
where separate elements are synthesised so that questions are opened.  
In Entry 19 [Day 44] the participant watched a BBC2 programme called 
Britain’s Greatest Invention (BBC TWO, 2017). Whilst the public voted, the 
participant documented the history and then future of antibiotic discovery: 
PP1: This study opens new avenues of research & possibly a new 
antibiotic. Very fascinating, something else knew I have learnt since 
I began doing this project. [Entry 19] 
The participant discussed a study about antibiotics found on the skeleton of 
ants, before writing that how hidden beneath this study were new avenues of 




In Entry 21 [Day 48] at the end of a discussion about cases of TB in Britain, 
the participant said:  
PP1: Researchers in Oxford & Birmingham have managed to isolate 
different strains of the disease, using a process called “genome 
sequencing”. This means patients who may have waited months to 
get the right drugs for the treatment of TB can now be diagnosed in 
just a few days, so they have a greater chance of recovery. [Entry 
21] 
This entry is coded by Domino. The participant described the synthesis of 
research which used genome sequencing which ended up solving the problem 
of rapid diagnosis of TB.  
Entry 23 [Day 27] is an example which highlighted how the media depiction of 
science and scientists influences public perspectives of science. The media is 
overwhelmingly outcome focused: 
PP1: A method to treat the surface of titanium orthopaedic 
implants, hip & knee joints, plates & screws; so that they resist 
bacterial infection, which often developed following surgery, 
without the use of antibiotics. [Entry 23] 
When discussing news report throughout the portfolio, PP1 mimicked this 
perception of science and took an outcome focused perspective. Media often 
creates a discovery focused image of science and scientists, whereby the trials 
and tribulations are not reported unless they are juicy, for example Penicillin 
being discovered by accident because Fleming’s bench was not tidied away 
before a holiday. Discussion of products with the scientist in the perspective is 
coded for by Trading.  
In Entry 24 [Day 60], whilst watching a BBC 2 programme about milk 
production, PP1 wrote: 
PP1: The man who works at “Aria” said that they didn’t want 
antibiotics being present in the milk because it would make people 
become immune to the antibiotics. I would have said the same 
before I started learning more about antibiotics, but actually that 
statement is wrong! It’s not people but the bacteria inside of us 
that actually becomes resistant to the antibiotics. This really does 
show that getting science communication out to the general public 
& making people aware of things is very important!! [Entry 24] 
The participant, through their own exploration, self-reported their personal 
journey of discovery. This is coded for by Journey. The participant corrected 
the suggestion that the human body becomes resistant to antibiotics, a 
perception that PP1 shared at the beginning of their portfolio and was 
discussed in 5.4.1. This is evidence of object level learning. They correctly 
identified why this was the incorrect view and went on to suggest the 
importance of science communication in making people aware of key ‘things’. 




the need for science communication. Their own learning was highlighted when 
forced to reflect on how much knowledge they had gained since taking part in 
the study. This facilitated the realisation that their own exploration of discursive 
objects had empowered them.  
Entry 25 [Day 62] talked about scientists moving from a broad stroke when 
prescribing antibiotics to a more targeted approach where the correct antibiotic 
is prescribed for the bacterial agent: 
PP1: DNA sequencing is being done but as in all scientific research it 
takes time to get it right & the “100,000 Genomes Project” has 
been extended from 2017 until the end of 2018. [Entry 25]. 
The participant was further exploring the notion that scientific research takes 
time, first exampled in Entry 17. In this instance, rather than discussion about 
the historical development of penicillin, the participant discussed the difficulty 
of active research and the need to take time to ‘get it right’. Scientific rigour is 
a key foundation of all research projects. This evidences meta level learning 
and is coded by Journey.  
In Entry 29 [Day 85], the participant wrote about a scientific study by the British 
Medical Portfolio:  
PP1: Doctors have always said that you should always finish a 
course of antibiotics, even if you do feel better. This is being 
challenged now by a group of leading medical experts writing in a 
British medical journal. It is being argued that taking antibiotics for 
longer than necessary can raise the risk of developing a resistance 
to the drugs. However Englands Chief Medical Officer says that 
people shouldn’t change their behaviour because of one study. He 
has said that the evidence will be reviewed, but for now the 
message remains that you should stick to prescriptions & always 
follow the doctors advice. [Entry 29] 
This focused on the outcome of a culmination of scientific research, without 
the researcher present in the awareness (Domino). This excerpt is of further 
interest as it was the first time that the participant encountered a scenario 
where scientific findings disagreed, an important part of scientific study. 
Conflicting studies can bring in to question how true the findings from any 
scientific studies are. Scientists are aware that it is the overwhelming 
consensus of multiple studies which support hypotheses and lead to the 
generation of theories. In imitating the Chief Medical officer’s narrative, that 
behaviour should not change based on one study, PP1 experienced meta level 
learning. 
In Entry 32 [Day 94] the participant glued in images taken of Bacteria, Fungi 
and Viruses under a Scanning Electron Microscope. They provided descriptive 
analysis of each, as well as a summary paragraph. This was discussed in 
5.4.3. This is an example of Journey, object and meta level change. The 
participant, in their role as a citizen scientist, conducted the internal process of 




their knowledge of the discursive objects ‘bacteria’, ‘viruses’ and ‘fungi’, as well 
as ‘Scanning Electron Microscopes’. In being a researcher, their perspective 
of what data was changed. They self-reported disappointment and 
embarrassment when they realised the data was not what they expected; that 
the colours added to these photos are superimposed. They reported this to be 
learning. Further, this excerpt is an example of increased specificity, both in 
their chosen topic of exploration and the resultant technical language they 
used when describing their findings.  
In Entry 33 [Day 97], the participant wrote about the BMJ debate discussed 
earlier in Entry 29: 
PP1: By coming up with new ideas, it does leave patients wondering 
what advice to believe. [Entry 33] 
This example is coded by Journey. As scientific theory is constantly evolving, 
the narratives released to the scientific community and the public might only 
be true at the time. This can cause confusion. The participant was beginning 
to understand the difficulty of engaging with the public, that the narratives 
provided by experts are subject to change. This is an example of meta level 
learning, understanding some of the complexities of being a scientist and 
sharing results with the general public. Giving credit to the power of this citizen 
science project, the object and meta level learnings experienced up until this 
point gave the participant the ability and confidence to decide where they stood 
in the debate between the BMJ and the narrative that one should complete the 
full course.  
Entry 35 [Day 100] covered an antibiotic working against Gonorrhoea:  
PP1: A new class of antibiotic has been found to work in the lab 
against the STD gonorrhoea, which can cause infertility & damage 
to babies & it is fast becoming resistant to all existing drugs. 
Successful lab tests of “closthioamide” show potential as an 
effective new treatment, it’s early days as yet as the antibiotic has 
yet to be tested in animals or humans. [Entry 35] 
This entry is captured by Domino, considering product generation with the 
researcher absent from awareness. This was an important milestone in the 
participants shifting perspectives towards science and scientists when 
reflecting upon media releases. They presented the outcome focused 
discovery of a new antibiotic before qualifying this with the fact it was early 
days and further experiments would need to be undertaken. This is an example 
of meta level learning. 
In Entry 38 [Day 163] the participant talked about a GP from Manchester on 
Breakfast Television. This entry was discussed earlier in section 5.4.5. This is 
captured by Journey. Like in Entry 33, the participant identified the 
complexities involved in being a scientist who shared results with the general 
public. Further to Entry 33 however, Entry 38 was a reflection on the way 
scientists were communicating with members of the public and how it wasn’t 
working. This was a substantial comment on science communication at 




would likely have been aimed at. It is also of interest in the light of the 
movement away from public understanding towards public engagement; a 
negative review for this example of a provision of facts from a participant who 
had been engaging with the literate discourse and had self-reported learning 
on several occasions.  
This thematic analysis shows object level learning. The participant provides 
evidence of learning about ‘antibiotics’ and the process through which scientific 
findings are reached. It also shows meta level learning. PP1 sought out 
information to explore new topics of interest and matured in their reporting of 
the sources from which they gained their information. They developed an 
understanding that science takes time. They learnt that scientific narratives are 
built upon many studies, rather than just one, and that these narratives are 
subject to change as the literature expands. Finally, they discussed the 
importance of communicating with the public based on their own learning 
experiences engaging with this study, and critically assessed one form of 
science communication as not achieving its aims. Over the course of the study, 
the participant showed examples of perceiving science through each of the 
four lenses described by Brew (2001). Toward the end of the study, the 
participant was often captured by Journey. In the middle of the study, Domino 
and Layer were more common. Trading occurred when the participant 
presented information from news articles.  
5.4.7 Do people need a hero? 
In 4.3.7, I presented evidence that suggests individuals use elements of 
storytelling, notably heroes, to engage with a new discourse (Theme 7). Whilst 
the discoveries and historical timelines attributed to these heroes (famous 
scientists or scientific discoveries) were not always accurate, they helped the 
learner picture a historical timeline in which a succession of discoveries were 
made by particularly clever individuals. In this section, I examine PP1’s use of 
heroes when discussing their thoughts about antibiotics and antibiotic 
resistance and whether this use changes over the course of engagement.  
There were no examples of PP1 using heroes during their interview. In Entry 
Five [Day 5], the participant discussed what Teixobactin is. In Entry 11 [Day 
15], PP1 provided an update on Teixobactin: 
PP1: Scientists are still waiting on the development of teixobactin 
as a drug. It’s been 2 years since it was discovered, but still it’s only 
at the stage of development in a laboratory. This just shows how 
long a process the development of a new antibiotic takes. All the 
time; dedicated effort by the scientists & of cause the cost of it!! 
[Entry 11] 
Teixobactin is discussed as an important discovery and the scientists working 
on it modern heroes. Just like with the historical penicillin, Teixobactin is an 
important antibiotic discovery. Unlike the discussion of penicillin by 
interviewees in 4.3.7, and PP1’s own discussion of teixobactin in Entry 5 
(5.4.4), PP1 now provided nuance when talking about Teixobactin. Whereby 




Fleming, Teixobactin was considered in the light of scientists. This is an 
example of meta level learning in which the participant begins to appreciate 
the way in which teams of scientists work together to collaborate on scientific 
discoveries, as well as the time requirement and the significant level of 
financial investment required to get the scientist’s research into the clinic.  
In Entry 15 [Day 33] the participant mentioned Alexander Fleming: 
PP1: Predicted figures are that by 2050 10 million people a year will 
die! That’s not many years away only 33. (considering when 
Alexander Fleming won the Nobel Prize for penicillin, at his 
acceptance speech he did warn of bacteria becoming resistant to 
it!) [Entry 15] 
Alexander Fleming is a hero in the story of antibiotic discovery. The participant 
used Fleming as an authority to emphasise their point, that we likely should 
have been aware antibiotic resistance was going to happen. They also hinted 
at the length of time that has passed since Fleming’s Nobel Prize to infer that 
33 years is not very far in the future. The participant’s increased awareness of 
the facts surrounding the threat of antibiotic resistance to human health is an 
example of object level learning. There is also a growing realisation about the 
scale of the issue with the addition of the number of possible deaths from 
antibiotic resistant infections. 
In Entry 17 [Day 36], the participant wrote about the history of Penicillin, from 
its initial discovery to its use in World War 2 to treat Gonorrhoea. They used 
Penicillin, Fleming, World War 2 and Churchill as anchor points for this story 
as familiar historical figures who were influential in creating the antibiotic 
landscape. This entry was discussed in section 5.4.6. The participant, in 
exploring the heroic discovery of Penicillin by Fleming, began to uncover the 
successive sequence of events that resulted in the testing of Penicillin in World 
War 2. It was at this time that they realised how long it takes to develop 
antibiotics into commercial products usable by the general public, a meta level 
change, through improved object level understanding, specifically 17 years. 
These are examples of learning about the antibiotic discovery pipeline 
facilitated by the exploration of a famous historical discovery. 
In Entry 19 [Day 44], the participant wrote a descriptive history of antibiotics as 
reported by the BBC TWO programme “Britain’s Greatest Invention”. This was 
a long entry (645 words), that began with antibiotics saving human lives and 
ended with new studies which are continuing to probe novel antibiotic 
discovery. In this entry, PP1s repertoire of historical heroes expanded: 
PP1: It wasn’t until 10 years later in a laboratory in Oxford, that 
Howard Florey & a team of brilliant minds, turned Flemings 
unexpected discovery into a miracle cure. [Entry 19] 
and 
PP1: Dr Ian Bedford (Head of Entomology at John Innes Centre) 
along with other scientists are working on inventing a brand new 




In order to construct this story about the history of antibiotics, the BBC TWO 
programme and then the participant used famous scientists as heroes. The 
result of this storytelling was antibiotics being voted Britain’s Greatest 
Invention by the British public. The participant ended this entry, as discussed 
in 5.4.6, self-reporting their fascination and learning. This is further evidence 
that the use of storytelling can encourage engagement and object level 
learning. The use of historical discoveries also builds a base upon which the 
importance of modern science is elevated.  
In Entry 23 [Day 57], the participant again mentioned penicillin, this time 
considering the use of alternative medicines to fight infection: 
PP1: This sounds really horrible but actually throughout 1930’s & 
1940’s maggot therapy blossomed until the discovery of penicillin. 
Maggots are really good at removing infection & dead tissue in 
wounds. [Entry 23] 
The discovery of Penicillin is used as a historical anchor on which other 
scientific discoveries were explored. This included historical maggot therapy 
discussed above and a modern technique used by Indian researchers which 
removed the need for antibiotics in Orthopaedic implants, discussed in 5.4.6. 
These are examples of object level learning. 
In Entry 29 [Day 83], PP1 talked about types of antibiotics and what they treat:  
PP1: Penicillins – Widley used to treat a variety of infections e.g. 
chest; skin & urinary tract infections. [Entry 29] 
Penicillins, as well as Cephalosporins, Aminoglycosides, Tetracyclines, 
Macrolides and Fluoroquinolones/quinolones were mentioned and what they 
are used for was detailed. In this entry, the participant had moved away from 
the use of the discovery of Penicillin to track the history of science or discuss 
novel discoveries of antibiotics. Instead they began increasing their specificity 
and knowledge of ‘antibiotics’. Penicillin was used as a jumping-off point, the 
first of six bullet points exploring the specifics of antibiotic classes and their 
uses. This improved understanding of ‘antibiotics’ as a discursive object 
highlights further object level learning. 
In Entry 35 [Day 100], discussed in 5.4.6, the participant discussed a new class 
of antibiotics found to work against Gonorrhoea. They last discussed 
Gonorrhoea in the light of Penicillin in Entry 17 [Day 36]. Sixty-four days later 
they came back to this infection. When comparing the two entries, it becomes 
clear that the participant had increased their level of specificity. In the original, 
they called it “the clap” and focused on its treatment with Penicillin in WW2. In 
this entry, they went into detail about number of infections, its associated 
priority level and its incidence in the U.K. Penicillin was not mentioned in this 
entry. This shows object level learning with regards to new antibiotic 
discoveries and relevant resistant infections. They also actively explored topics 
of interest. The participant explored Gonorrhoea as its own interesting object, 
rather than through its relationship to Penicillin. The participant used the WHO 




which they were gaining object level knowledge. This is an example of meta 
level learning. 
This thematic analysis shows that famous scientists and scientific discoveries 
provide familiar ground from which PP1 felt safe to explore novel objects. 
Object level learning included ‘Penicillin’, ‘Fleming’, ‘Gonorrhoea’, classes of 
antibiotics and their treatment options, the difficulties of the drug discovery 
pipeline and the threat of antibiotic resistance to human health. Throughout 
their engagement, the length of entries and the level of specificity increased. 
In exploring these discursive objects, the participant also showed meta level 
learning as well as an intellectual curiosity. They began to appreciate that 
scientific discoveries are made by teams of people, rather than the hero 
figures. They explored a diverse range of sources to allow the seeking of 
information on new topics of interest. Finally, they self-reported fascination and 
learning.  
5.4.8 Do people make bad decisions in the face of better knowledge? 
In 4.3.8 I found that participants would make incorrect decisions in the face of 
better factual knowledge, especially if they felt acting in the present was more 
critical than the risk of antibiotic resistance in the future (Theme 8). This was 
especially the case when acting on behalf of someone else, like a child. In this 
section, I highlight examples of PP1s decisions in the light of information 
gained or shared as the study progressed.  
PP1’s interview [Day 1] had no examples of this theme, however, does provide 
a picture of the factual knowledge the participant had to begin with. PP1 was 
aware that bacteria and fungi produce antibiotics, however, was not aware that 
that plants, humans and viruses do not. They were not aware that colds and 
flu cannot be treated with antibiotics and were not aware that resistance is a 
result of an infectious agent, rather than the human body. They were aware 
that personal hygiene is a powerful tool in the battle against the spread of 
antibiotic resistance. They believed doctors to be key individuals when 
attributing blame for antibiotic resistance.  
In Entry 3 [Day 2], discussed in 5.4.6, the participant self-reported their 
willingness to take new factual knowledge on board. In the last seven sections, 
I have highlighted evidence of increased knowledge of many discursive 
objects. Throughout the study, the participant’s factual knowledge increased.  
One of the key early entries was Entry 9 [Day 12]. Parts of this entry have been 
discussed in 5.4.1, 5.4.3 and 5.4.5. The participant, based on the factual 
knowledge that colds and flu are viral infections not treatable with antibiotics, 
researched medication provided by a leading chain pharmacist. They decided 
that this medication was irresponsibly prescribed based on its containing an 
antibiotic. This is a notable example of an instance where better factual 
knowledge results in making better decisions, that is to be aware of and upset 
about being prescribed an antibiotic for a viral infection.  
In Entry 34 [Day 97], discussed in 5.4.3, PP1 discussed a BMJ article that was 
circulating in mainstream news reports, the conclusions of which suggested 




began by reinforcing the factual knowledge they had gained over the course 
of the 97 days. The participant talked about the confusion new factual 
knowledge can cause. This highlights that better factual knowledge does not 
necessarily mean a clearer picture of the best course of action. Instead, in this 
instance, better factual knowledge has led to two viewpoints which conflict with 
each other and, perhaps more importantly, the current public health narrative 
which advises individuals to take their full course. This could ultimately lead to 
decisions which go against the literate discourse.  
This thematic analysis shows that better factual knowledge can lead to better 
decisions with regards to what the literate discourse considers sensible 
behaviour. However, it also highlights the risk of confusion that better factual 
knowledge can cause, especially when the discourse is not congruent.  
5.5 Results: Selective thematic analysis of four Portfolios 
In section 5.4, I presented the lengthiest and the most substantial of the five 
portfolios that were submitted. I thoroughly and extensively analysed this 
portfolio considering the eight themes that emerged from the coded analysis 
in the interviews. In the following section, my narrative accounts aim to 
highlight the discursive shifts at object and meta level of the participants in a 
summary. I make highly selective summaries of the contents of each of the 
other four portfolios and examine them using the eight themes. I present this 
information as a narrative account of the contents of each portfolio, providing 
examples and the themes that these elements relate to.  
5.5.1 Analysis of Portfolio Glasgow 001 (PP2), Interview 030 
Participant PP2 took part in an interview on the 7th September 2017, as 
interviewee 30 [Day 1]. I note that in Chapter 4, Participant PP2 would have 
been referred to as 30. This participant was so named as the 30th participant 
to be interviewed across the five pop-up events. They made their first portfolio 
entry the next day [Day 2]. In total, they submitted 14 portfolio entries until their 
last entry on the 13th February 2018 [Day 158]. The portfolio contained 1,902 
words over 19 pages. 
During the interview, I learnt that PP2 was about to embark on a PhD project 
looking at antibiotics and soil bacteria, having worked as a pharmacist 
previously. They were familiar with the literate discourse and answered my 
interview questions with specificity and detail. They were consistent in their 
use of accurate scientific language. They were the only participant to focus on 
antibiotic stewardship as a way we can individually make a difference to 
antibiotic resistance in their interview responses. They did suggest doctors 
should not hand out antibiotics willy-nilly and antibiotics should never be used 
prophylactically in animals. They suggested GPs and patient education had a 
role to play in reducing misuse of antibiotics and thought farmers should be 
sanctioned regarding misuse in animals.  
In general, PP2 used technical language with a higher specificity and 
consistency than any other participant during the study. They also glued in 




by others which were more often the media, radio or educated friends (GPs). 
However, in this highly selective analysis I focus on their ability to compare 
and reflect on parts of their own life. This reflection provided new insights into 
several themes. In 5.4.6, I discussed PP1’s move from descriptive to 
comparative accounts of data. PP2 utilised this comparative skill from the 
beginning of the portfolio and on several occasions following. For example, in 
Entry 4 [Day 12], the participant described the similarities and differences 
between their experience with antibiotics as both a patient, both in Nigeria and 
the U.K, and then in Entry 5 [Day 21], as a professional pharmacist.  
In Entry 4 [Day 12], the PP2 wrote: 
PP2: I’ve only had two courses of antibiotics in the last 14 years or 
so. Both courses were for seven days, which I completed on both 
occasions. I was issued more antibiotics than I needed on the 
second occasion, I returned extra tablets and capsules to my local 
pharmacy for destruction. My first course (about eight years ago) 
was monotherapy; while my second course (earlier this year) 
consisted of two types of antibiotics. [Entry 4] 
Not only does this highlight the participant’s familiarity with the discursive 
objects in this field, using words like ‘monotherapy’ correctly (Theme 1), it also 
shows action guided by the current Public Health Narratives (Theme 3). 
Further, as I know the level of education and experience of this participant, I 
suggest that PP2 makes sensible decisions in the face of better factual 
knowledge (Theme 8). The participant went on to write: 
PP2: Would I have completed the seven day course of treatment if I 
wasn’t aware of the implications of not doing so, bearing in mind 
the pills tasted awful and made me feel sick, and I had no 
counselling whatsoever? [Entry 4] 
The participant expressed an inferred belief that individuals may not be 
following the narrative to complete the course, whilst highlighting side effects 
of antibiotics like nausea (Theme 3 and Theme 5). Based on their own 
experience, they express empathy and understanding in the reasons behind 
this noncompliance. Strengthening the evidence for Theme 8, the participant 
described a level of emotional commitment to the public health narratives; 
holding the importance of completing the course above their own physical and 
emotional comfort.  
Entry 4 provided support for the use of public health narratives in the U.K: 
PP2: Prior to the last 14 yrs, I lived in Nigeria. From what I can 
remember, I would have had at least a course of antibiotics every 
year. This is in sharp contrast to my more recent experience. [Entry 
4] 
They went on to detail reasons why this might be, including government-led 
initiatives and existent antibiotic stewardship in the U.K, as well as the lack of 




an example of the participant following a Public Health Narrative, it is a 
participant statement which evidences their perceived importance of public 
health narratives and the vital role they play in reducing antibiotic prescription 
(Theme 3). It also provides awareness of the global approach that is required 
to tackle this issue, moving outside of the U.K. Further, antibiotic stewardship 
examples internal attribution of blame. Even if one were to be taking all 
measures to ensure they are following public health narratives, the 
responsibility is then to advise others of the need to do so (Theme 5).  
In Entry 5 [Day 21] the participant wrote about their experience with antibiotics 
as a pharmacist: 
PP2: Where dental prescriptions for antibiotics represent about 
50% of all dental prescriptions issues during the week, at the 
weekend the proportion jumps to almost 90%. It would be 
interesting to investigate whether dental patients are more likely to 
present with acute infections at the weekend; or dentists are more 
inclined to prescribe antibiotics “just in case” during out of hours 
consultations. [Entry 5] 
The participant detailed a personal experience, formed a hypothesis and 
discussed the idea of testing it. This is an example of the Layer perception, the 
process-focused task of discovery without the researcher present in the 
awareness (Theme 6). The participant, as a scientist, has observed a 
phenomenon and wishes to understand the underlying factors which bring this 
about. This is the cornerstone of the natural sciences. Knowing PP2 was 
embarking on a PhD, this finding provides a window into the motives of a 
prospective scientist.  
In the same entry, the participant wrote:  
PP2: While I haven’t seen a noticeable change in the volume of 
scripts issues for antibiotics as a whole, I think more patients are 
presenting at the pharmacy counter for advice on treating viral 
infections (especially colds and coughs) because the doctor “won’t 
give them anything”. [Entry 5] 
Their professional opinion is that doctors are changing their prescribing habits 
in line with public health narratives to not take antibiotics for viral infections 
(Theme 3 and Theme 5). The result of this is members of the public asking for 
advice on how to go about treating viral infections without the need for 
antibiotics. This means that individuals still receive treatment, but precious 
antibiotics are spared.  
Finally, the participant again touched on the cultural differences of antibiotic 
use and antibiotic prescription: 
PP2: I have had a few requests by people visiting the U.K to buy 
antibiotics over the counter. They are usually very surprised that 




During the interviews and now with PP2, there is a consensus that different 
countries are dealing with the threat of antibiotic resistance in different ways. 
PP2 suggests that the U.K is taking measures to tackle the problem where 
other countries may not be, or to a lesser extent. This reinforces Theme 3 in 
suggesting that the public health narratives are making a real, measurable 
difference to U.K prescription rates and to U.K perspectives of antibiotics.  
This thematic analysis shows the specificity and consistency with which 
technical language is used by someone familiar with the discourse. It also 
highlights the use of routines to both objectively analyse and reflect, as well as 
to observe, hypothesise and experiment.  
5.5.2 Analysis of Portfolio Norwich Science Festival 001 (PP3) 
Participant PP3 visited the pop-up stand on the 19th October 2017. They made 
their first portfolio entry on the 8th November 2017 [Day 21]. In total, they 
submitted 16 portfolio entries until their last entry on the 1st March 2018 [Day 
134]. The portfolio contained 1,087 words over nine pages.  
In Entry 1 [Day 21], the participant provided a list of things they thought they 
knew and what they didn’t know. They knew antibiotics don’t work on viruses, 
the less often you take them the better, the more you take the more likely is 
antibiotic resistance, antibiotics destroy harmful as well as good bacteria, it 
takes a long time for good bacteria to return to pre-antibiotic levels and you 
should eat organic foods to avoid antibiotics in the food chain. They didn’t know 
how antibiotics work. They went on to say: 
PP3: Do I care? Not really: I don’t want to understand how my car 
works. I just want to drive it. [Entry 1] 
This statement sets PP3 apart from the other participants in that there is an 
active admission that they don’t care to fill in the gaps in knowledge they may 
have. This highlights an output-oriented focus rather than process oriented 
(Theme 6). They don’t wish to explore how the process works, but instead are 
just happy that the outputs do work, and that they can benefit from this. This is 
an example of viewing research through the concept of Trading. This sets up 
the rest of the portfolio entries where most entries explore discursive objects 
that they already admitted to knowing, albeit whilst discussing these objects in 
greater detail or with a greater breadth.  
Jumping to the very last entry, Entry 16 [Day 134], the participant wrote: 
PP3: Thanks for allowing me to keep this diary and reading it. I’ve 
really enjoyed heightening my awareness for AB items in the media 
and I’ve learnt a lot. [Entry 16] 
Self-reported learning is important as part of our evaluation, but even more 
interesting considering the participant’s own admission that they weren’t 
necessarily interested in exploring new topics of information. The result seems 
to contrast with their statement in Entry 1. This highlights the potential 
importance of public engagement versus public understanding. By allowing the 




set of topics that I deemed important, the participant continued to engage with 
the portfolio for 134 days and experienced object level learning as a result. 
This point is further highlighted by the participant in Entry 12 [Day 101]: 
PP3: Incentivisation: I find this really very patronising. It also points 
to an ethos I don’t really like. [Entry 12[ 
This excerpt is taken from writings the participant made about a Television 
Programme they watched called ‘The truth about Hawaii’. In this play, only one 
antibiotic is left to which there is no resistance. Following the play was a talk 
provided by an academic from Bristol University. The participant felt patronised 
that the population might have to be incentivised. This is likely because the 
participant believed they were doing all the correct things and they did not need 
incentivisation to do so. This also expresses a narrative of discontent with the 
perceived elitism of the scientific community. This would be captured by the 
code ‘Us vs Them [UVT]’. In the same entry, they asked:  
PP3: Did she mean me or those poorer and less educated? [Entry 
12] 
This statement highlights the external attribution of blame, an us vs them 
mentality (Theme 5). In this case, PP3 saw the academic providing the talk as 
‘them’ but also sees the ‘them’ as being poorer and less educated members of 
society.  
Still focusing on Entry 12, the participant wrote: 
PP3: This was a difficult program and I gave up trying to 
understand it. [Entry 12] 
This excerpt was taken from writings made about a Radio 4 Programme ‘The 
Infinite Monkey Cage’ in which Brian Cox and Robin Ince looked at the history 
and future of antibiotics. The participant noted that this was too difficult to 
understand and spoke to the difference between public understanding and 
public engagement. It is important to note that the participant had been actively 
seeking out programmes that relate to the topic of antibiotics and antibiotic 
resistance. Exploring a diverse range of sources is an example of meta level 
learning. However, some of these programmes failed to meet the mark and 
were disengaging the participant. This is perhaps a criticism of public 
understanding, whereby you are talking to someone rather than discussing 
with someone.  
Comparing this disengagement of public understanding to the public 
engagement approach used in this study, it is clear that the participant was 
engaged enough to spend the large majority (13/16 entries) of their 134-day 
engagement with this project exploring a topic which was of clear interest to 
them; the relationship between food, the microbiome, antibiotics and antibiotic 
resistance. Of the three entries in which they did not cover food or the 
microbiome in some fashion, one was Entry 12 where they felt patronised and 
struggled to understand, one where they were excited that a new antibiotic 
family had been discovered in dirt [Entry 13, Day 118] and their final entry 




134]. Notably, as the entries progressed, the participant began to write more 
positively about science, showing an increased level of science optimism 
(Theme 4). 
This thematic analysis shows that self-guided learning using the portfolio can 
engage individuals who may otherwise feel like science communication is not 
aimed at them. PP3 gave up listening to or felt patronised by media aimed at 
increasing public understanding of the issues of antibiotic resistance. Despite 
this, they spent 13 entries over 134 days increasing their knowledge of the 
discursive objects surrounding the human microbiome and self-reported 
learning by the end of the study. This participant experienced lots of object 
level learning, however a little less meta level. This could have been linked to 
their outcome focused, rather than process focused, perspective. 
5.5.3 Analysis of Portfolio Norwich Science Festival 002 (PP4), Interview 
032 
Participant PP4 took part in an interview on the 19th October 2017, as 
interviewee 032b [Day 1]. I note that in Chapter 4, Participant PP4 would have 
been referred to as 32b. They were so named as the 32nd participant to be 
interviewed across the five forest events. They have been annotated 32b 
because they interviewed with their father, who spoke first, and was thus 
annotated 32a. Their first portfolio entry was not dated; however, the second 
portfolio entry was submitted on the 28th October [Day 10]. In total, they 
submitted four portfolio entries until their last entry on the 24th January 2018 
[Day 98]. The portfolio contained 332 words over four pages.  
During their interview, PP4 understood that there were bacteria in the soil 
which can become antibiotics and knew antibiotics were made by bacteria and 
fungi. They pointed out that humans can use bacteria and fungi to make 
antibiotics, but incorrectly suggested plants can too. They did say no to viruses. 
They knew bacterial infections were treatable by antibiotics and only bacterial. 
They thought that discovery of novel antibiotics was recent and had an 
optimistic guess about how many antibiotics scientists had taken to market. 
They knew that resistance is a property of an antibiotic losing effectiveness 
treating bacteria and attributed this to overuse.  
In Entry 1 [No Date] they went through the questions provided in the 
supplemental pack (Appendix G-1) and answered each of them with short 
responses. Their responses, whilst short, were accurate in nearly all cases. 
They also mirrored their views presented in the interview, as described above. 
The remaining three entries detailed instances where PP4 heard or watched 
something which mentioned antibiotics or antibiotic resistance.  
Entry 2 [Day 10] described the Radio 4 programme they had listened to: 
PP4: Heard a radio programme on Radio 4 about the dangers of 
antibiotic resistance spreading, and what the situation might be 
like if antibiotics were no longer to work [Entry 2] 
Entry 3 [Day 97] described a Television drama about a future world where 




PP4: It explains how A.R. occurs and follows the story of a girl who 
has a scratch in her knee which becomes infected. She cannot be 
treated and her leg is at risk of being amputated. [Entry 3] 
Finally, Entry 4 [Day 98] described an episode of Countryfile about surfers 
ingesting antibiotic resistant superbugs which made their way into rivers after 
being excreted by animals. Unlike the previous entries, PP4 took time to write 
the takeaway messages of this programme:  
PP4: Antibacterial cleaning products should only be used if 
necessary, not routinely. Plus AR bacteria enters rivers through 
treated waste water from water treatment works. The message 
was to take personal responsibility for antibiotic use. They also 
advocated use of UV in water treatment works. [Entry 4] 
These excerpts were largely representative of Public Health Narratives 
(Theme 3). They detail misuse/overuse, a theme which this participant 
frequented through the course of their engagement with this project. In their 
final excerpt, they also discussed who is to blame (Theme 5), suggesting that 
the message of a Television programme they watched was that people should 
internally attribute blame and responsibility for the antibiotic resistance crisis. 
Further, in exploring the topic of antibiotics and antibiotic resistance, the 
participant sought out diverse sources of information in an example of meta 
level learning.  
This thematic analysis shows that even in a small number of entries, a 
participant can begin to provide greater depth of description and some analysis 
in explaining key messages provided by varying sources of information. Their 
exploration of new sources of knowledge is an example of meta level learning. 
This portfolio also highlights the pervasiveness of public health narratives. 
Within an 88-day period the participant found three different sources of 
information on antibiotics or antibiotic resistance, one radio, one a Television 
drama and one a Television nature programme.  
5.5.4 Analysis of Portfolio Norwich Science Festival 003 (PP5) 
Participant PP5 visited the pop-up stand on the 19th October 2017. Their first 
portfolio entry was not dated; however, their second and final portfolio entry 
was submitted on the 2nd April 2018 [Day 166]. In total, they submitted two 
portfolio entries. The portfolio contained 246 words over three pages. As a 
child, PP5’s experience with antibiotics and antibiotic resistance was kept to 
their inner circle, that is describing experiences of family members (Dad, 
Sister, Mum, Sister’s Boyfriend, Aunt). On only one occasion did they mention 
a source outside of family, a newspaper. In general, their focus was on 
describing times where people they knew had to take antibiotics or had an 
association with antibiotics. 





PP5: When I was little I had tonsillitis and I took Antibiotics. Every 
time I had them, I was sick so, I hate to have banana flavour 
instead. [Entry 1] 
This participant provided a child’s perspective of the issues of antibiotics and 
antibiotic resistance and hinted at the fact antibiotics can produce side effects 
such as nausea. PP5 had taken antibiotics enough to know the flavour they 
preferred. This links to the theme surrounding better factual knowledge 
(Theme 8), in which parents often suggest the only time they have antibiotics 
is for their child.  
In Entry 1 [No Date], the participant wrote: 
PP5: I think my sister is growing bacteria (possible Antibiotics) in 
her old tea cups that she leaves in her room. My Mum had a sore 
tooth and she has to take Antibiotics (called Amoxicillin 500 mg 
Capsules) for a week, (one per day)*. My sisters boyfriend took 
antibiotics for a chest infection. [Entry 1] 
This shows that the participant was aware of bacteria and that they can 
produce antibiotics. They describe the antibiotic by its technical name and the 
dose. They are descriptive in their writing, with little elaboration. The participant 
reports that their sister’s boyfriend took antibiotics for a chest infection, 
perhaps contrary to the public health narrative of not taking antibiotics for viral 
infections, as chest infections are often viral. 
In Entry 2 [Day 166], the participant wrote: 
PP5: My Aunt took Antibiotics because she had a sinus infection. 
[Entry 2] 
This continues the theme of descriptive writing; however, this was the only text 
in Entry 2 and shows no signs of discursive shifts at the object or the meta 
level. It is another example of antibiotics being taken for infections which are 
likely to be viral.  
In their first entry, PP5 identified viral infections as not treatable with antibiotics:  
PP5: My Dad told me that Antibiotics don’t work on viruses, they 
only work on bacterial infections. [Entry 1] 
As they did not actively state that they thought their family should not have 
taken antibiotics for viral infections, I assume that they were unaware. This 
highlights the issue with the application of public health narratives. Whilst the 
public may now be aware that antibiotics are not to be taken for viral infections, 
they might not know which infections are viral. This increases the need for 
doctors to advise as such.  
This thematic analysis shows that even in the portfolio with the fewest words 
and fewest entries, some form of learning can take place. In this case, it was 
object level learning gained from asking family members about their 




5.6 Discussion and Future Work 
5.6.1 Descriptive analysis of social media data reveals how to best 
attract and engage participants with relevant content 
Quantitative analysis of social media data suggests that in order to increase 
total users on a Facebook page, relevant content must be released regularly. 
The type of content seemed to have little effect. The more users who have 
liked the Facebook page, the more users are engaged by content released. 
Content released during Antibiotic awareness week was seen by the most 
people, however the level of engagement did not increase. In clinical practice, 
I recommend that significant dates in calendars such as antibiotic awareness 
week are exploited to increase reach and are a good time to disseminate key 
information, such as public health posters, rather than to drive engagement.  
5.6.2 Coded analysis of social media data reveals key themes aligning 
with interview research 
Social media did not drive the level of medium- to long-term engagement that 
I expected. Thematic analysis of comments that were posted suggest that 
participants often lack confidence to analyse their own data, even when the 
tools to do so are made readily available. Participants, like in the interviews, 
use familiar words following pre-existing rules when engaging with a new 
discourse. In the clinical setting, I suggest that researchers must go as far as 
possible to help foster confidence in participants. I discuss the portfolios ability 
to foster confidence in the next section. I also suggest, in concurrence with 
Mendelson et al (2017), that in order to help participants engage with literate 
word use, the community of experts might choose less ambiguous terminology 
and apply it consistently in both academic writing and in media releases. 
5.6.3 Selective thematic analysis of four Portfolio Participants 
highlights emerging themes. 
Selectively applying thematic analysis to the most unique aspects of four 
portfolios provided interesting topics for more detailed analysis. In the case of 
PP2, thematic analysis highlighted the specificity and consistency used by an 
individual who is familiar with the literate discourse. It highlighted the use of 
scientific routines which allowed the critical observation of external and internal 
phenomenon. It also highlighted that discursive transformation is less evident 
when the participant is already familiar with the literate discourse.  
In the case of PP3, selective thematic analysis highlighted the importance of 
the portfolio in facilitating self-guided learning. The participant made clear that 
they felt that messages delivered in pursuit of public understanding were not 
aimed at them and felt patronised when subjected to this information. Instead, 
they explored themes related to antibiotics and antibiotic resistance that were 
of interest to themselves. Doing so, they experienced object level learning 
surrounding the human microbiome and self-reported learning at the end of 




Both PP4 and PP5 highlight how without the continued contribution of 
participants, portfolios do not hold the power to evidence discursive 
transformation. Despite this, the eight themes captured key excerpts of fewer 
and less lengthy entries, showing their use for discourse analysis. For PP4, 
the themes highlighted their increase in descriptive detail and level of analysis 
of information they chose to write about. For PP5, the themes highlighted that 
for a child, their main source of information is experiences of family members 
and the narratives bequeathed by their inner circle.  
5.6.4 Thematic analysis of Portfolio Participant reveals portfolio 
facilitated discursive transformation 
In Chapter 4, participants used familiar words as they engaged with a new 
discourse (Sfard 2008). In this chapter, my findings suggest that the portfolio 
facilitated object level and meta level changes with regards to the participant’s 
use of scientific terminology. At the object level, the participant became more 
familiar with discursive objects such as bacteria, viruses, antibiotics, and 
antibiotic resistance, among others. This increasing familiarity was evidenced 
through a more specific and consistent usage of the relevant terminology. This 
concurs with research conducted by Biza et al (2018). At the meta level, the 
participant changed the ways in which they viewed certain objects. The 
participant changed the sources from which they gained object level 
knowledge utilising increasingly varied and technical sources of information. 
Furthermore, they developed the confidence to take the data from these 
sources and adapt it, presenting it in a way which suited their portfolio entry.  
In Chapter 4, participants organised new experiences in terms of those with 
which they were already familiar. In this chapter, my findings are consistent 
with this. However, more specific thematic analyses are required in order to 
pick apart this phenomenon and provide insights into the nuances of this 
concept: scaffolding new experiences on to familiar knowledge and 
experiences.  
In Chapter 4, participants engaged with the literate discourse through the 
ritualising of six key public health narratives. Participants mimicked narratives 
bequeathed to them by Public Health England. In this chapter, my findings 
suggest that the portfolio facilitated object and meta level change with regards 
to the participant’s ritualised use of public health narratives. At the object level, 
the participant expanded their knowledge of what was already known about 
bacteria, viruses, and fungi, as well as their understanding of antibiotics 
outside of the role they play in overuse/misuse. This object level learning 
resulted in increased specificity and consistency when using terms familiar to 
public health narratives. At the meta level, the participant, rather than 
mimicking narratives passed down from authority, began to challenge authority 
when the evidence they had researched contradicted the narratives they were 
provided. They also developed an interest in topics they were not initially 
familiar with as a result of research into public health narratives and went about 
exploring these topics in greater detail.  
In Chapter 4, participants who placed faith in science and scientists harboured 




individuals who are inherently optimistic are more likely to take action to avoid 
crises like antibiotic resistance (Huber et al., 2019). In this chapter, my findings 
suggest that the portfolio did not facilitate change in the level of optimism held 
by the participant. Instead, the participant experienced a meta level change in 
the way they wrote about the information they were researching. At the 
beginning of the portfolio they would include their emotional reaction to topics 
they wrote about. At the end of the study, they discussed information 
objectively examining only the relevant facts.  
In Chapter 4, participants made external attributions of blame, not finding 
themselves personally responsible. This was congruent with previous literature 
which showed the same (Brooks et al., 2008; Butler et al., 1998; Dyar et al., 
2018; Hawking et al., 2017; Hawkings et al., 2007). In this chapter, my findings 
suggest that the portfolio facilitated both object and meta level changes with 
regards to who is to blame for antibiotic resistance. The participant 
experienced object level learning with regards to antibiotics and antibiotic 
resistance, as well as on specific topics such as antibiotic prescription. This 
object level learning was further evidenced by an increase in specificity and 
consistency over the course of the study. Increased knowledge of these 
discursive objects preceded meta level learning. Understanding the role of 
doctors, the participant contradicted their earlier blaming of doctors and began 
to defend doctors by the end of the study. The participant began to use the 
word ‘we’ when describing actions that needed to be taken, placing 
responsibility on themselves to help mitigate the effects of antibiotics. Like in 
the other themes, the participant sought information to explore this theme from 
new sources. They also developed their ability to think like an objective 
researcher as they began to base decisions and opinions on the growing basis 
of facts they accumulated. Finally, they showed an appreciation for the role 
experts, like doctors, play in communication with the public. 
In Chapter 4, participants considered research through multiple perspectives 
outlined by Brew (2001). These perspectives could be outcome or process 
focused and would consider or not the researcher. In this chapter, my findings 
suggest that the portfolio facilitated opportunities for the participant to see 
research through each of the four perspectives and understand more about 
what it is to be a scientist. This occurred through both object and meta level 
learning. At the object level, the participant increased their knowledge about 
antibiotics and the process of science. Their specificity and consistency 
increased as the study progressed. Specific to this theme, the participant 
experienced meta level learning with regards to the time it takes to undertake 
scientific research. They realised that rather than being a succession of 
discoveries, it was instead a process of experimentation which eventually 
produced outcomes. They also learnt that narratives are built on multiple 
studies and as such are subject to change as new studies are released. Finally, 
as they reflected on their own learning experiences, they appreciated the 
importance of engaging the public whilst critically commenting on the 
ineffectiveness of one form of public understanding.  
In Chapter 4, participants related historical scientific heroes to discoveries and 
timelines. Research has suggested that in order to mobilise people to act, 




2015; Arnold, 2018). In this chapter, my findings suggest that science heroes 
and famous discoveries are used as familiar ground on which a participant can 
safely explore unfamiliar topics. Object level learning was seen through 
increased knowledge about Penicillin, Fleming, Gonorrhoea, classes of 
antibiotics and their treatment options, the difficulties of the drug discovery 
pipeline and the threat of antibiotic resistance to human health. This learning 
was matched with an increased specificity and consistency as the study 
progressed. With regards to meta level learning, the participant began to 
appreciate that rather than the heroes of science, discoveries are made by 
teams of scientists. In further support of the power of stories, the participant 
self-reported fascination and learning after writing about a Television 
programme which used storytelling to explain the history of antibiotic 
discovery.  
In Chapter 4, participants admitted that they would make bad decisions in the 
face of better knowledge in situations where they felt the immediate gain of 
antibiotic use outweighed the future risk of antibiotic resistance. There is no 
literary consensus regarding the links between decision making and factual 
knowledge; better factual knowledge has been linked with both bad decision 
making (McNulty et al., 2007) and good decision making (European 
Commission., 2013). In this chapter, the gaining of factual knowledge does 
seem to facilitate better decision making by the participant. As the participant 
gains agency, as they gather the fundamental knowledge on which they can 
make their own evidence-based decisions, they advised their husband to not 
take medication prescribed by a pharmacist for a throat infection as it 
contained an antibiotic. This medication is being discontinued as of 2022 and 
as such, the participant made a positive decision (National Institute for Health 
and Care Excellence (NICE), 2018). However, they go on to report that as 
science is an ever-changing field and results can contradict each other, 
improved knowledge can be a source of confusion. 
5.7 Summary 
One of the aims of my study was to understand the roles social media and 
portfolios play in medium- to long-term study of participants discursive 
transformations. Whilst quantitative analysis of social media metrics provided 
suggestions on how to best utilise social media, the qualitative analyses of 
social media comments lacked the richness to highlight discursive 
transformations. Instead, the short-term interviews and medium-term social 
media comments were added to the pool of data provided by the longer-term 
portfolios to present a picture of the evolution of the citizen scientist’s learning. 
Building on the work in Chapter 4 which highlighted eight key themes occurring 
in participant discourse about antibiotics and antibiotic resistance, I used 
portfolios to evidence discursive transformations. My analyses indicate that no 
one theme enabled the mapping of all discursive transformations but instead 
a combined use of themes was necessary.  
My study set out to explore how participants’ discourse of antibiotic discovery 
and antibiotic resistance changed as they participated in self-guided learning. 




antibiotic resistance. In doing so, the portfolio has encouraged participants to 
actively seek out new sources of information. In engaging with this information, 
participants increased their understanding of key discursive objects and 
utilised learned terminology with increasing specificity and consistency. 
Finally, the expanding knowledge of discursive objects provided conflict as 
new objects changed the participant’s perception of previously endorsed 
narratives. In total, participants showed discursive transformation as they 







































6.1 Research Questions and Methodological Reflection 
In this final chapter, I highlight the major outcomes of this study, their 
significance in the wider context of research in this area and their potential 
societal and educational impact.  
6.1.1 Context 
In 2019, the US Centers for Disease Control issued a list of antibiotic-resistant 
pathogenic bacteria which pose an urgent or serious threat to the general 
public (Centers for Disease Control and Prevention, 2019). The list contains 
14 bacteria (Table 1-3) and is not finite. 
Bacterial resistance to antibiotics threatens their efficacy (Baym et al., 2016) 
which in turn threatens modern medicine as we know it. The rate in which 
bacteria are developing resistance to antibiotics is increasing through human 
misuse (Bronzwaer et al., 2002; Goossens et al., 2005; O’Neill, 2016b). To 
combat the development of antibiotic resistance, new antibiotics need to be 
developed whilst current antibiotics need to be preserved. 
Development can be based on (i) designing a new antibiotic derivative of a 
known antibiotic family with improved properties, (ii) discovering new chemical 
structures that act on known or a novel bacterial target or (iii) employing 
alternative therapeutics such as phages or antibodies (Banin et al., 2017). Soil 
bacteria provide a large reservoir for antibiotic discovery and the 
actinomycetes in particular have provided one of the richest source of 
antibiotics to date (Van der Meij et al., 2017). Whilst these bacteria have been 
well mined (Lewis, 2012), underexploited bacteria and technological 
advancements have opened a new reservoir for antibiotic discovery (Ling et 
al., 2015; Hover et al., 2018; Lewis, 2020)  
Preservation relies on smarter antibiotic usage, specifically at the point of 
prescription but also proper use, consumption and adherence to treatment 
regimes. Reducing antibiotic demand is crucial and is driven by industry and 
the public. A key component of this is reducing public expectation of receiving 
a prescription for antibiotics, which has been shown to increase the likelihood 
of prescriptions being handed out (Cals et al., 2007; Coenen et al., 2013; 
Coenen et al., 2006; Cole, 2014; Sirota et al., 2017). Science communication 
in the form of public health campaigns, aims to provide scientific facts to the 
public in the hope of encouraging desirable behaviour that promote health, 
following the movement of public understanding of science. These campaigns 
have suffered from issues such as lack of evaluation to determine success 
(Bauraind et al., 2004; Huttner et al., 2010), undesirable effects (Price et al., 
2004) and absence of cost effectiveness data. The more recent movement of 
public engagement in science and technology looks beyond providing facts to 
individuals, but rather engages them in science and research. One form of 
public engagement, citizen science, is defined as public participation and 
collaboration in scientific research with the aim to increase awareness of 
scientific facts as well as of how scientific knowledge is produced (Robinson 





To pursue both the development of new antibiotics and the preservation of 
current antibiotics, this PhD used a citizen science approach. Using pop-up 
stands, interviews, social media interaction and portfolios, I aimed to engage 
members of the public with the story of antibiotic discovery and the issue of 
antibiotic resistance. In doing so, I aimed to discover novel antibiotic 
candidates from soil bacteria. I also aimed to increase understanding of public 
perceptions on topics surrounding antibiotics (discovery and resistance), as 
well as perceptions of science and scientists. I aimed to understand how these 
perceptions changed as participants engaged with the project in a long-term 
study. I aimed to understand the role social media and portfolios played in 
evaluating project outcomes for its citizen scientists.  
6.1.3 Judging success of this project according to Robinson’s ten 
principles of citizen science 
Citizen science projects must include public participation and collaboration in 
scientific research with the aim to increase awareness of scientific facts as well 
as how scientific knowledge is produced (Robinson et al., 2018). Whilst citizen 
science has been an emerging field since 2006, research is criticised as failing 
to produce new scientific knowledge (Kullenberg and Kasperowski, 2016); 
instead it is poor science with great communication potential (Heigl & Dörler., 
2017). My own literature review suggested that as scientific outputs have 
increased, research has failed to identify participant outcomes or to conduct 
proper evaluation (1.5.1). To guide citizen science practice, Robinson et al 
(2018) produced ten key principles which underlie good practice in citizen 
science (Table 6-1). In this section, I provide a narrative account of the 
outcomes of this study in relation to these ten principles. 
The first principle is that projects actively involve citizens in scientific 
endeavour that generates new knowledge or understanding. This study has 
actively involved citizens in scientific endeavour, collecting soil samples, 
analysing laboratory data and conducting self-guided research. In doing so, it 
has generated new knowledge and understanding as evidenced in 5.4 and 5.5. 
The second principle is that projects have a genuine science outcome. This 
project has resulted in genuine scientific outcomes. In Chapter 3, I presented 
a discovery pipeline which collected 454 soil samples, assayed the 
antagonistic activity of 929 bacterial isolates, leading to the long-term storage 
of 165 antagonistic isolates ready for future analysis. Further, whole genome 
sequencing provided 15 genomes, three of which were sequenced a second 
time to improve read depth and quality. For each of the 15 isolates, 
phylogenetic trees based on 16S rRNA were constructed. These 15 isolates 
represented eight species of soil bacteria, none of which were part of the well 
mined actinomycetes. BGCs were identified in each of the 15 isolates and 
compared with those present in their nearest characterised relatives. Focusing 
on five isolates representing underexploited species, BGCs were identified that 
were not found in my literature search of their nearest relatives. These are 
Terpene and type III Polyketide Synthases in Sporosarcina aquimarina. 




secondary metabolite clusters which were highly conserved between species, 
even considering their geographical isolation.  
In Chapter 4 I presented the application of a coding schedule compiled from 
key literature on public discourse of antibiotics and antibiotic resistance. In 
applying these codes, current themes in the public discourse emerged which 
contributes to the literature. These themes can be used to direct clinical 
practice and public health campaigns. In chapter 5, I presented the application 
of object and meta level learning, as well as the use of consistency and 
specificity, to identify discursive transformations in participants as they 
engaged with the study over a 98-200 day period. In doing so, participants 
were shown to have expanded what they already knew about an existing 
universe of objects relating to antibiotics and antibiotic resistance, as well as 
to have explored new objects which contradicted their previously endorsed 
narratives. They were shown to discuss these discursive objects more 
consistently, and with greater specificity. The application of these tools is 
presented as a methodological contribution to the field which can assist with 
evaluation of other project outcomes, something that was noted as missing 
from many citizen science projects (1.5).  
Combined, these data can benefit science and society, providing a new pool 
of underexploited soil isolates which show antagonistic activity against 
medically relevant pathogenic organisms. It also makes a methodological 
contribution to the field of citizen science in the use of codes, frames and 
themes to evidence participant learning in future evaluative studies. It offers 
current public perception data contributing to the knowledge base of what the 
public understands about antibiotics and offers insight into the power of tracing 
participant learning as citizens engage with a citizen science project over 
different time frames including interviews and pop-up stand participation, 
medium term engagement via Facebook pages, and over several months 
using portfolios. 
The third principle is that a study provides benefits to both science and society. 
This is one of the more difficult principles to achieve and I present the 
aspirations of this project to achieve these benefits. This small PhD project, 
over 5 years, has made a modest contribution to the longstanding issue, 
debate and effort to make an ecological impact. It has influenced a small 
number of people; however, it offers the tools to show that, in engaging with 
scientific research, improvement of scientific literacy can take place in 
members of the public. Furthermore, this study hopefully provides the 
foundations to encourage a move in the field of citizen science towards a more 
evidenced based, qualitative justification of participant outcomes; relying 
minimally on self-reporting and optimally on change in participant discourse.  
The fourth principle is that citizen scientists may participate in various stages 
of the scientific process. As discussed in the first principle, citizens engaged 
with data collection, data analysis and exploration of the discursive objects of 
science.  
The fifth principle is that citizen scientists receive feedback from the project. 
The consistent publication of laboratory data on social media allowed for timely 




phone call were used to offer feedback on portfolio entries when participants 
were unsure of how they could contribute.  
The sixth principle is that the limitations and biases of citizen science should 
be considered and controlled for. In the literature review, both the limitations 
and potentials of citizen science were discussed. This understanding guided 
method selections and participant interactions throughout the study. I discuss 
the limitations of the project and how these were or could be controlled for in 
future studies in greater detail in section 6.2. 
The seventh principle is that, where suitable, project data and meta-data from 
citizen science projects are made publicly available and results are published 
in an open access format. Whilst this is an aspirational achievement of this 
study, project data and meta-data from the PhD will be open source and a link 
will be sent to the participants. Further, plans for future publications include 
open access articles.  
The eighth principle is that citizen scientists are suitably acknowledged by 
projects. Citizen scientists, as a cohort, have featured in the 
acknowledgements of this PhD and will be acknowledged in any additional 
publications. Further, a product of this study is a toolkit with which future citizen 
science projects can better evaluate participant outcomes.  
The ninth principle is that citizen science programs offer a range of benefits 
and outcomes which should be acknowledged and considered in project 
evaluation. This study has considered and offered a range of benefits in 
science, participant and socio-ecological and economic dimensions. The three 
dimensions of citizen science outcomes (Kieslinger et al., 2018) are discussed 
further in 6.1.4.  
The tenth principle is that leaders of citizen science projects take into 
consideration legal and ethical considerations of the project. Upon choosing a 
citizen science methodology, the ethics of the study were considered, and 
ethical approval was sought from and granted by the University of East Anglia 
ethics committee (Appendix I-1).  
When examining the practices of this study in light of the ten principles of good 
citizen science practice (Robinson et al., 2018), it is clear that this study has 
achieved many of the ten principles. Whilst Robinson et al (2018), did not 
provide a quantitative approach to understanding how many categories must 
be achieved to conclude that a project was successful, they did note that whilst 
some principles are implemented within every citizen science project, others 
are more challenging to incorporate and require a greater investment of time 





Table 6-1. Table showing the ten principles which underlie good citizen science practice (Robinson et 
al., 2018). 
Number Good Citizen Science Practice 
1 Citizen science projects actively involve citizens in scientific endeavour 
that generates new knowledge or understanding. 
2 Citizen science projects have a genuine science outcome. 
3 Citizen science provides benefits to both science and society. 
4 Citizen scientists may participate in various stages of the scientific 
process. 
5 Citizen scientists receive feedback from the project. 
6 Citizen science, as with all forms of scientific inquiry, has limitations and 
biases that should be considered and controlled for. 
7 Where possible and suitable, project data and meta-data from citizen 
science projects are made publicly available and results are published 
in an open access format. 
8 Citizen scientists are suitably acknowledged by projects. 
9 Citizen science programs offer a range of benefits and outcomes which 
should be acknowledged and considered in project evaluation. 
10 The leaders of citizen science projects take into consideration legal and 
ethical considerations of the project. 
  
6.1.4 Judging success of this project according to Kieslinger’s open 
framework for citizen science evaluation 
At the outset of this PhD, there were no commonly established indicators of 
evaluating citizen science (Kieslinger et al., 2018). Different experts focused 
on different aspects of evaluation, notably participant learning (Phillips et al., 
2014; Masters et al., 2016) or scientific gains and socio-ecological relevance 
(Jordan, Ballard and Phillips, 2012; Bonney et al., 2014). In 2018, Kieslinger 
et al presented a comprehensive evaluation framework (Kieslinger et al., 
2018). This framework is split into three core dimensions: scientific, participant 
and socio-ecological and economic. For each, criteria were proposed at two 
levels: process and feasibility as well as outcome and impact. In the following 
section, I will be focusing on if and to what extent this study has achieved 
outcomes and impacts in each of the three dimensions. 
6.1.4.1 Scientific Dimension 
In the scientific dimension, indicators of outcomes and impacts include 
scientific knowledge and publications, new fields of research and research 
structures as well as new knowledge resources. These indicators and some of 
the ways in which the project can evidence its success are presented in Table 
6-2. To help identify where these indicators have been met, Kieslinger et al 
(2018) presented supporting questions, which I answer.  
To examine scientific knowledge and publications, the framework asks 
whether the study demonstrates an appropriate publication strategy in 
scientific and other media outlets. I have, during the PhD, presented 
preliminary findings through poster presentations at three consecutive 
Microbiology Society Annual Conferences in Liverpool, Edinburgh and 




presented and received an honorary award for a poster of preliminary findings 
at the American Society of Microbiology conference in New Orleans titled 
‘Antibiotic Discovery and Citizen Science’. I have also been an invited speaker 
at the Open University and South Devon College. There are plans for 
publication, the writing of which has already began, however this is an area in 
which progress must be made to ensure this can be considered a successful 
study. It then asks if citizen scientists are recognised in publications and if so, 
whether they can participate in dissemination of results. This PhD will be open-
source and will be sent to participants who took part in the long-term portfolios. 
Further, the findings from this PhD will be disseminated in collaboration with 
the Microbiology Society on their website and social media platforms.  
To examine new fields of research and research structures, the framework 
asks whether the project generated new research questions, projects or 
proposals. This study highlighted the shortage of citizen science studies which 
conduct evaluation of participant learning outcomes and utilised portfolios to 
trace outcomes as participants engaged with the study. The thematic analysis 
used to trace these discursive transformations and learning experiences is a 
contribution to the field. Further, this PhD is designed to serve as a new 
resource in the field of citizen science and act as a lessons-learned guide for 
future citizen science projects. The isolates generated using the optimised 
laboratory protocol present a platform for future research projects and already 
led to collaboration (Cooper Lab – WGS). The framework then asks whether 
the project contributed to any institutional or structural change. Whilst 
aspirational, it is hoped that the success of this multidisciplinary PhD 
encourages other researchers to embark on similarly interdisciplinary studies. 
This is increasingly important as the role of a researcher begins to incorporate 
the engagement of citizens in research.  
To examine new knowledge resources, the framework asks whether the 
project eases access to traditional and local knowledge resources. This project 
did not set out to achieve this goal. The framework then asks whether the study 
contributed to a better understanding of science in society. It is clear, from 
analysis in Chapter 5, that participants who engaged with this project have 





Table 6-2. Examples of evidence from this project which supports the outcome and impact level of 
the scientific dimension of the citizen science evaluation framework. 
Scientific Dimension 
Scientific Knowledge & 
Publications 




PhD published open 
source and sent to 
participants 




literacy of long-term 
participants 
Article in preparation for 
open source publication 
with the Microbiology 




Lessons learned guide 
for future multidisciplinary 
and citizen science 
projects 
 
Presented award winning 
posters in New Orleans 




 Collaboration with 




6.1.4.2 Participant Dimension 
In the participant dimension, indicators of outcomes and impacts include 
improving knowledge, skills and competencies, improving scientific literacy, 
encouraging behaviour and ownership and fostering motivation and 
engagement. These indicators and some of the ways in which the project can 
evidence its success are presented in Table 6-3.  
To examine knowledge, skills and competencies, the framework asks what the 
learning outcomes are with regards to new knowledge, skills and 
competencies for the participant. In combination with the portfolios, the tools 
provided for data analysis on social media facilitated PP1’s improvement as a 
researcher, as they began to compare their own samples to those collected by 
other people. Participants also showed an increasing diversity of sources they 
used to obtain their information on science. 
To examine science literacy, the framework asks whether the project 
contributed to a better understanding of science and a better understanding of 
the scientific topic. In Chapter 5, the expansion of what was already known 
about scientific objects such as bacteria, viruses, antibiotic discovery and 
antibiotic resistance highlight increased understanding of this scientific topic 
especially using medium-term and long-term approaches. The improved 
specificity and consistency with which these objects were used highlights 
increased scientific literacy. The use of Brew’s conceptions of research (Brew, 
2001) highlighted that participants changed their understandings of science, 
which was captured often by meta-level learning.  
To examine behaviour and ownership, the framework asks whether the study 
fosters ownership amongst participants. The theme which examined ‘who is to 
blame’ evidenced ownership, PP1 began to internally attribute responsibility 




questions posed in the portfolio handbook and instead took their own course, 
exploring the relationship between antibiotic resistance and the gut 
microbiome. The framework next asks if the project contributes to facilitating 
personal change in behaviour or political citizenship. In Chapter 5, as scientific 
knowledge increased, PP1’s behaviour also changed. The standout example 
of this was the research they undertook focusing on medication provided by a 
pharmacist for a sore throat. They concluded that this medication should not 
be taken due to its containing an antibiotic. 
To examine motivation and engagement, the framework asks whether the 
project raises motivation, self-esteem and empowerment amongst 
participants. The participant self-reported motivation to learn new things at the 
start of the study and evidenced continued motivation and engagement 
through consistent portfolio entries over a 200-day period. Further, all five long-
term participants engaged for an extended period; a minimum time of 98-days. 
Of the 14 participants who received a long-term portfolio, five returned the 
portfolio. The framework then asks if the project motivated participants to 
continue the project or involve in similar activities. The actions of the 
participants following engagement has not been tracked, however would be an 
avenue for a follow up study. 
Table 6-3. Examples of evidence from this project which supports the outcome and impact level of 











use of sources 
of scientific 
information 
Object level learning 












Meta level learning 
that science takes 
teamwork, long efforts 
and isn’t all knowing 
Participant taking 











having taken part 
in the portfolios 
 Improved consistency 
and specificity of use 
of scientific 
terminology 









6.1.4.3 Socio-ecological and economic dimension 
In the socio-ecological and economic dimension, indicators of outcomes and 
impacts include societal impact, ecological impact and a wider innovation 
potential. These indicators and some of the ways in which the project can 
evidence its success are presented in Table 6-4. When it is too early to 
comment on the impact of this PhD, I cover the aspirations of things that might 
follow from this study. 
Societal impact is split into collective capacity and political participation. Within 
collective capacity, the framework asks whether the study contributed to the 
participants collective capacity to achieve common goals. By working directly 
with the public, the project has shown the potential to improve collective 
capacity for citizens to work towards the preservation of current antibiotics. For 
political participation, the framework asks whether the project stimulates 
political participation and whether the projects impacts on policy processes 
and decision making. This was not an aim of this project; however, one avenue 
of future research could examine whether participants have involved 
themselves with political policies based on their improved understanding of the 
research topic. 
Ecological impact focuses on targeted interventions which can be evidenced if 
the project includes objectives that protect and enhance natural resources 
and/or foster environmental protection. By engaging the public in the issue of 
antibiotic resistance and seeing resultant behaviour change, this study has 
made a modest contribution to highlighting the potential for public engagement 
to reduce the personal use of antibiotics, which are contributing to sub-
therapeutic levels of antibiotics in nature. The framework then asks whether 
the project contributed to higher awareness, knowledge and responsibility for 
the natural environment. This topic was not explored in this study, however 
modification to future studies might include a stronger link between the effect 
of antibiotic misuse and the natural environment. 
Wider innovation potential is split into three categories: New technologies, 
sustainability and social innovation practice as well as economic potential and 
market opportunities. To examine new technologies, the framework asks 
whether the project fosters the use or development of new technologies. As 
developing new technology was not an objective of this project, this outcome 
has not been met. With regards to sustainability and social innovation practice, 
this study did not consider sustainability as part of the project plan. However, 
the framework also asks whether the project results are transferrable to other 
contexts or organisations. This study adapted frameworks conceived initially 
for application in other areas of social science research, mainly mathematics 
education (Sfard, 2008; Biza et al., 2018) and science education (Brew, 2001), 
to conduct discourse analysis on data collected from the participating citizen 
scientists. It offers the methodological framework for thematic analysis using 
eight themes as a flexible tool which can itself be adapted. This study aims to 
move the field of citizen science towards a more evidenced based, qualitative 
justification of progress of participants; relying minimally on self-reporting and 
optimally on their discourse. The framework then asks whether the project 
contributed to social, technical or political innovation. Whilst aspirational, it is 




behaviours in citizens contributes a method by which science can strengthen 
civil society to resist not just antibiotic resistance, but other global crises like 
climate change. To examine economic potential and market opportunities, the 
framework asks whether the project generated any economic impact or 
competitive advantages. This study did not achieve this outcome. The 
framework then asks whether the project fosters co-operation for exploitation. 
Collaboration with the Cooper Lab highlighted this studies potential to foster 
co-operation. The 165 antagonistic isolates are to be made use of and the 
aspiration is that future studies will examine these in greater detail.  
Table 6-4. Examples of aspirations of this project which support the outcome and impact level of the 
socio-ecological and economic dimension of the citizen science evaluation framework. 
Socio-ecological and Economic Dimension 




potential of citizen 
science to improve 
collective capacity 







which has the 
potential to reduce 
personal use of 
antibiotics which are 
contributing to sub-
therapeutic levels of 
antibiotics in nature 
Adaptation of frameworks for 
application in other fields of 
research to conduct discourse 
analysis on citizen scientists 
  Methodological framework for 
thematic analysis as a flexible tool 
  Moves away from tick box 
evaluation exercise 
  Fostered opportunities for 
collaboration 
6.1.4.4 Summary 
Using Kieslinger et al's (2018) open framework for citizen science evaluation, 
it is clear that this study has demonstrated outcomes and impacts in each of 
the three dimensions: scientific, participant and socio-ecological and 
economic. Whilst not every aspect of each dimension was achieved equally, 
this was to be expected and concurs with Kieslinger et al's (2018) own 
thoughts, that criteria need to be prioritised and may receive different weighting 
depending on project goals. Aspirational goals were discussed where relevant, 
and further highlight Kieslinger et al's (2018) suggestion that long-term 
monitoring is necessary to capture a project’s far-reaching impact. Ultimately, 
in conducting this evaluation this study has evidenced its impact on science, 
participants and the wider field of citizen science.  
6.1.5 What citizen scientists have gained from participating in this study 
At the outset of this study, citizens were asked whether they would like to take 
part in a project that is trying to find a new antibiotic. Whilst this overambitious 
outcome was not achieved in five years, participants have contributed to 
genuine scientific knowledge with regards to antibiotic discovery in the form of 





Citizens were asked to contribute to our understanding of the public’s 
perception of antibiotics and antibiotic resistance. Participants have 
contributed to our understanding of public discourse surrounding these topics. 
Participants use familiar words and familiar rituals as they attempt to engage 
with a new discourse. Public health narratives are mimicked to facilitate 
engagement with the discourse, however, often lead to misunderstandings 
such as the belief that the human body becomes resistant to antibiotics. 
Individuals place varying levels of faith in science and scientists. Participants 
generally consider research to be worthwhile. They derive this worth from 
different aspects of the scientific process or outcomes. Those who receive the 
most blame for antibiotic resistance are doctors and people in power.  
Participants were asked to follow their soil sample over a longer-time period 
through social media engagement. In doing so, participants have contributed 
to understanding of how to best reach users and how to best engage users. 
Finally, participants were asked to conduct self-guided research into topics 
surrounding antibiotics and antibiotic resistance. In doing so, participants 
experienced discursive transformation. Evidence that this occurred can be 
seen in Chapter 5, where object level learning surrounding discursive objects 
like antibiotics, bacteria, viruses and Penicillin was demonstrated. Evidence of 
meta level learning can also be seen in Chapter 5 where previous narratives 
were contradicted by knowledge of new objects and as a result, new narratives 
emerged. This included the increased diversity of sources used to obtain 
information on science, the evidence-based questioning of authority, an 
interest in previously unknown topics, development of an objective writing 
style, defending the motives of doctors, internally attributing responsibility for 
antibiotic resistance, an appreciation for the need to communicate science to 
the public, the time it takes to undertake scientific research, the process of 
experimentation, the importance of scientific consensus in developing 
narratives and the teams of scientists that contribute to famous discoveries. 
6.2 Reflection on strengths and limitations  
The strengths of the project have been outlined in the previous sections, and 
can be summarised as: 1) The engagement of citizens through hands on 
experimental research which produced genuine scientific outcomes, 2) The 
contribution of citizens to the current literature surrounding public perception 
of antibiotics and related topics, 3) The engagement of citizens through self-
guided research which resulted in discursive transformations and learning 
experiences and 4) Evaluation, not often conducted in citizen science projects, 
suggesting this study as a good, successful citizen science project. Following 
the strengths of the project, I now discuss the limitations of the project. These 
provide reflections on opportunities for future studies, which are discussed in 
this section.  
Laboratory study was limited by available resources. Whilst this created 
opportunity for collaboration, for example WGS with the Cooper Lab, it also 
meant that experiments of interest such as LC-MS to elucidate which 
secondary metabolites or antibiotics were being produced by the isolates could 




aim of reinvigorating the antibiotic pipeline is a task that was realistically 
beyond the scope of one PhD. This is made clear in the O’Neill report which 
suggests that to overhaul the antibiotics pipeline would cost between 16 and 
37 million USD over the course of 10 years (O’Neill, 2016b).  
Whilst genuine scientific knowledge emerged from the lab work, the balance 
between scientific data for publication and scientific data to be used as material 
to be posted specifically to engender social media engagement was difficult to 
balance. The time demands of the laboratory work took time away from 
analysing participant engagement. It was only once the social media 
engagement ended and the laboratory work could be brought to its end 
(considering the length of time for any further experimentation) that the 
analysis of participant outcomes could forge ahead. This made it difficult to 
adapt interviews, social media engagement and portfolios during the study 
period. This balancing act was further limited by the natural demands placed 
on this interdisciplinary study by four supervisors. There was an expectation of 
lab data for the Facebook page which created difficult to meet deadlines. In 
hindsight, knowing that type of content didn’t affect engagement, I would be 
inclined to release fewer labour intensive media and instead publish media 
such as easy to digest monthly reviews of scientific literature surrounding 
antibiotics and resistance, news articles, photos and descriptions of lab 
methods, rather than lab results. This is not to say that lab results should be 
neglected entirely. Robinson et al's (2018) fourth principle is that citizen 
scientists may participate in various stages of the scientific process and this 
includes analysis of laboratory data. 
Analysing the interviews, I feel confident that the questions asked covered a 
broad range of topics which contribute to the current field of public discourse 
of antibiotics and antibiotic resistance. However, given more time to analyse 
interview responses after each pop-up event, I may have tweaked questions 
to better identify novel areas of interest, such as participant’s understanding of 
the link between antibiotic misuse and the environment, providing evidence for 
Kieslinger et al's (2018) ecological impact. Further, I may have decided to add 
explorative questions if I felt underlying reasons behind perceptions or 
misunderstandings could be uncovered. An example of this would have been 
understanding why citizens tend to believe the human body becomes resistant 
to antibiotics rather than infectious agents. When asking if humans could 
become resistant to bacteria, I might have asked why to see if citizens would 
refer to the bacteria inside us, which was offered up as an explanation naturally 
in some instances. In future, studies should consider setting aside time to 
iterate interview questions after each collection event if themes emerge. 
Finally, I acknowledge the small sample size for the interviews and as such, 
the inability to conduct any correlational statistical analysis; for example, to find 
associations between codes which co-emerge or participants who answer 
yes/no to all yes/no questions. This lack of statistical power could be resolved 
through increasing number of participants or length of interviews or number of 
questions asked in future studies.  
The idea of engaging with participants on social media was the driving force 
behind most of my time spent pursuing certain areas of the PhD. Social media 




snapshot interview data and the long-term portfolio data. In hindsight, social-
media comments lacked richness and offered opportunity for only descriptive 
analysis. It was only when the social media data was considered as part of the 
long-term portfolio analysis, that is as a single part of a participant’s long-term 
journey, that these comments offered a more substantial contribution. Studies 
may want to consider this if their only form of mid- or long-term data collection 
is through social media comments.  
Furthermore, the social media page was managed by the Microbiology 
Society. They were the gatekeepers for the information that was posted on 
their Facebook page set up through their site for this project. This meant that 
the procedure of publishing data and responses was cumbersome and subject 
to time restraints. The immediate responses that are inherent in social media 
interactions were constrained using the procedure for posting that we had in 
place. One example was a comment from social media participant 24, who 
posted a question on the 15th December 2017. This was answered on the 20th 
December 2017. However, whilst this response engaged a further comment 
on the 23rd December 2017, I was unable to respond until the 15th January 
2018; until the team at the Microbiology Society had returned after the 
Christmas period. In retrospect, I realise that this two-step process limited 
opportunities to experiment with posting different types of social media content 
and responses to participant engagements via the Facebook page. This may 
have impacted on the insights I gained about how to best engage participants. 
In future, I would have either developed a faster method with which to verify 
posts with the Microbiology Society Communications Team or created our own 
Facebook page on which to publish instant responses.  
I realise that the limited time I spent considering the social media dimension of 
this project, because of the constraints of undertaking laboratory analysis of 
samples, meant that the social media data was not analysed throughout the 
project. Instead this took place after the laboratory work had been completed. 
Knowing, for example, that antibiotic awareness week increased reach, I may 
have arranged an ‘Ask Me Anything’ type of forum for that week which in turn 
could have encouraged users to follow the page and provided opportunities for 
more engagement interactions. The processes I set in place with the 
Microbiology Society to manage the Facebook page as well as the time 
constraints I detail above also meant that live forums did not occur. A mix of 
synchronous (live chats and dedicated times) and asynchronous (people post 
questions or comments) engagement would have improved the creative 
aspect of discussion over social media. 
The decision to leave portfolios with participants until the end of the study 
period resulted in the need to analyse, in detail, multiple portfolios at once. 
This provided little opportunity to act on emerging themes and adapt future 
portfolios to explore topics of interest more thoroughly. It also meant that it was 
possible that no portfolios were returned, and this would have had a significant 
impact on this PhD project. In retrospect, I might have given participants a 
specific time frame in which to complete the portfolio after the pop-up stand 
was completed and I would have arranged to have portfolios collected in a 
timelier and considered manner. Analysing these portfolios during the project 




they asked, information they wanted to get clarification on or provide feedback 
on portfolio entries. An example of this would be PP1’s mention of the 
confusion caused by the article in the British Medical Portfolio discussing 
whether to take the full course.  
Further, whilst I had contact details for participants, my expectation was that 
they would contact me if they had any issues. I realise now that it might have 
been more sensible to arrange monthly ‘check ins’ with all portfolio participants 
to see if any questions had arisen that I could answer, establishing a 
conversation and demonstrating two-way public engagement. For example, I 
did arrange a phone call with one participant who was struggling with what to 
write (PP3) which resulted in them pursuing their own interests in this area, 
rather than the questions I had highlighted and provided to the participants in 
the portfolio handbook (Appendix G-1). I would also have liked to hand out 
more portfolios to participants. Participants were not always keen in 
contributing a significant portion of their time to engaging with the project, but 
due to the power of this tool to highlight impact and engender participant 
learning, it should be a focus of future studies. I note that in this study, 
transcribing and analysing portfolios took significant amounts of time, making 
iterative analysis during the study period more difficult. However, modern 
technology is making these techniques faster. Autograph software is beginning 
to make this method scalable in that much of the transcription is done 
automatically. Further, if a research team undertook a similar study, analysis 
of portfolios could be split amongst team members to increase throughput.  
6.3 My concluding remarks 
The work presented in this thesis has generated 165 antagonistic isolates 
which kill or inhibit a variety of medically relevant pathogens, 15 of which were 
analysed with WGS (Chapter 3). It has contributed to the current 
understanding of the public’s perception of antibiotics and related topics 
(Chapter 4), has examined social media as a tool for public engagement 
(Chapter 5) and has shown that long-term engagement with a citizen science 
study engenders participant learning (Chapter 5).  
The scientific isolates require analysis by future researchers to assess their 
value as candidates for the antibiotic pipeline. This research will include a 
bioinformatic approach to improve WGS read lengths and as such confidence 
in phylogenetic analysis and identification of BGCs. It will also include a 
culture-dependent approach to conduct further bioassays, purification of 
secondary metabolites (LC-MS) and knock-out mutation experiments.  
The interview data gathered in this project was analysed using a coding 
schedule (Table 2-5) based on key topics emerging from public perception 
literature, as well as frameworks for understanding individuals concepts of 
research (1.3). The interview questions and coding schedule provide tools with 
which to build a detailed understanding of how the public perceive antibiotics 
and antibiotic resistance. This also provides a time point prior to the arrival of 
the Covid19 pandemic, from which the change in science optimism of the 




The social media data collected through Facebook metrics suggests that user 
engagement is not affected by the types of content released. However, the 
number of people who see any given content is driven by external events such 
as antibiotic awareness week.  
The use of portfolios to track participant outcomes is my contribution to the 
field of citizen science. Further, the portfolio data shows that engaging citizens 
in a citizen science study results in a multitude of participant outcomes whilst 
simultaneously contributing general science outcomes. This should encourage 
future studies to deploy the citizen science design and data analysis methods 
presented in this thesis.  
In total, this study has achieved most of the principles which underlie good 
citizen science practice (6.1.3) and has evidenced outcomes and impacts 
across the scientific, participant and social-ecological and economic 
dimensions (6.1.4). 
Whilst this study has focused upon the learning experienced by the participant, 
it has also facilitated learning for its researcher. I have learnt that a 
multidisciplinary PhD offers many unique opportunities. These include the 
opportunity to consult with a variety of experts, to learn how to balance multiple 
avenues of research and to develop expertise on several fronts in order to put 
the results into context in several fields. It also offers a unique set of 
challenges: managing the demands of two or more fields of research, 
supervisors and interested parties. Whilst not easy, it is rewarding to be able 
to evidence that participants have gained as much from this study as I have. 
Many citizen science projects use participants as tools for data collection. 
Being able to say that as well as the science outcomes, the participants have 
experienced outcomes too is a wonderful feeling. Most of all, this project has 
taught me that perfection is aspirational, elusive, and pursuing it can be an 
enemy of productivity. In working in several fields, I constantly find experts who 
are more familiar with the discourses of science and social science than myself 
and who have a deeper grasp of the fundamentals than myself. However, I feel 
that the amount of data I collected, how I analysed it and the impact I had on 
participants has been productive. Whilst it may take finer tuning of analysis to 
tease the most out of each element of this study, I feel optimistic that I have 
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Figure A-1. Search String for PubMed to identify Citizen Science publications in the field of 
Microbiology which produce scientific output. Based on search string presented by Kullenberg & 







TableB-1. Logic model. Maps inputs (what is put into project), activities (things somebody will do), outputs (what comes out of the project) and outcomes (measurable outcome/impact) over the 
course of the project. These were considered for citizen scientists and the research team. I mapped my expected outcomes for the citizen science project to the framework for evaluating citizen science 
learning outcomes (Phillips et al., 2014). 
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• Data visualisation tools 
• Number of individuals 
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• Number of individual 
hours engaged. 
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• Funding sources 
• Expertise 
• Lab Resources 
• Designing protocol, 
• Research topic, 
• Questions we will ask 
• Protocol 
• Evaluation form for 
participants 
• Equipment to collect 
sample 
• Website with data 
uploaded 
• Twitter/forum for 
discussion 


































• Interactive website 
• Data quality/data 
assurance filters 
• Reference data set for 
scientific community 
• Number of training and 
workshops offered 
• Number of sites or 
acreage monitored 
• Data tools for managing 
data rewards 
• Increased exposure of 
project to wider audience 
























































Table C-1. Media composition. 
Media Description 
Luria-Bertani (LB) 
Broth (g L-1) 
 
10 Sodium chloride 
10 Tryptone 




Dissolve in ~800 mL dH2O. Make up to 1 L with dH2O and 
sterilise by autoclaving. 
Luria-Bertani (LB) 
Agar (g L-1) 
 
10 Sodium chloride 
10 Tryptone 
5 Yeast extract 
1.5% (w/v) Agar 
(BERTANI, 1951) 
 
Prepare LB broth as described. Take 200 mL of LB and add 
3 g of agar. Sterilise by autoclaving. 
 
NB. For indicator strain plates, increase agar to 4%, 12 g 
per 200 mL. 
 




5 Sodium chloride 
2 Yeast extract 
1 Beef extract 




Dissolve in ~800 mL dH2O. Make up to 1 L with dH2O and 
sterilise by autoclaving. 
Tryptic Soy Agar 
(TSA) (g L-1) 
 
15 Casein peptone 
(pancreatic) 
5 Sodium chloride 
5 Soya peptone 
(papainic) 
1.5% (w/v) agar 
 
(TSB; Sigma Aldrich) 
 
Dissolve in ~800 mL dH2O. Make up to 1 L with dH2O and 
sterilise by autoclaving. 
Soy Flour Mannitol 
(SFM) Agar (g L-1) 
 
20 Soya flour 
20 Mannitol 
2% (w/v) agar 
  
(Kieser et al., 2000) 
Dissolve mannitol in ~800 mL dH2O, add Soya flour and 
Agar. Make up to 1 L with dH2O and sterilise by 
autoclaving. 
Technical agar with 
Calcium chloride 
(TA + CaCl2) (g L-1) 
 




(TSB; Sigma Aldrich) 
 
Dissolve in ~800 mL dH2O. Make up to 1 L with dH2O and 
sterilise by autoclaving. 
 
To add the Calcium chloride, add 1.47 g of CaCl2 dihydrate 
to 10 mL dH2O, sterile filter through a 0.22 nm filter disc. 
Add 60 µL of this to 1 L.  
 
All Culture (AC) 
Broth (g L-1) 








3 Beef extract 
3 Yeast extract 
3 Malt extract 
5 Dextrose 
0.2 Ascorbic acid 
 
Dissolve in ~800 mL dH2O. Make up to 1 L with dH2O and 
sterilise by autoclaving. 
All Culture (AC) 




3 Beef extract 
3 Yeast extract 
3 Malt extract 
5 Dextrose 
0.2 Ascorbic acid 
1.5% (w/v) Agar 
 
(TSB; Sigma Aldrich) 
 
Prepare AC broth as described. Take 200 mL of AC and 
add 3 g of agar. Sterilise by autoclaving. 
 
NB. For indicator strain plates, increase agar to 4%, 12 g 
per 200 mL. 
 
Brain Heart Infusion 
(BHI) Broth (g L-1) 
 
12.5 Calf brain 
10 Peptone 
5 Beef heart 






(TSB; Sigma Aldrich) 
 
Dissolve in ~800 mL dH2O. Make up to 1 L with dH2O and 





Brain Heart Infusion 
(BHI) Broth (g L-1) 
 
12.5 Calf brain 
10 Peptone 
5 Beef heart 





1.5% (w/v) Agar 
 
(TSB; Sigma Aldrich) 
 
Prepare BHI broth as described. Take 200 mL of BHI and 
add 3 g of agar. Sterilise by autoclaving. 
 
NB. For indicator strain plates, increase agar to 4%, 12 g 
per 200 mL. 
 
Soil Extract Media 
 
100g topsoil 
300 mL MOPS 
buffer 
1.5% (w/v) Agar 
 
(Adapted from Liebeke et al., 2009) 
 
100 g of air-dried topsoil suspended in 300 mL of sterile 
MOPS buffer (10 mM, pH 7.0) at 37 °C with shaking at 200 
rpm for 1 h. Extract filtered sequentially through filter paper 
(Whatman) and filters with a pore size of 5 and 0.45 µM in 
order to remove particulate matter. Directly after 
preparation, the extract was filtered to sterility using a 0.22-











300 mL dH2O 
1.5% (w/v) Agar 
 






300 mL dH2O 
1.5% (w/v) Agar 
 
(Adapted from Liebeke et al., 2009) 
 
300 mL MOPS replaced with 300 mL dH2O. Once particles 






100 mL dH2O  
1.5% (w/v) Agar 
 
(Adapted from Liebeke et al., 2009) 
 
MOPS replaced with dH2O. 1:3 soil to water ratio changed 
to 1:1 before filtration. Once filtered, add 200 mL dH2O to 





Table D-1. Antifungals. All antifungals were aliquoted in 1 mL fractions and stored at -20°C. Nystatin was 






































Figure E-1. Factual Summary for Interview 32, interviewees 32a and 32b. After reading the transcript 
of the interview twice, I compiled a factual summary of the parts of the interview which I considered key. 







Table F-1. Chronological account of types of content released to Antibiotics Unearthed Facebook 
Page. Table shows the number of each of the 47 posts released as part of Antibiotics Unearthed social media 
engagement. The date of release of each post is shown, as well as the type of media that the post represented. 
Web links would take users to a page, such as a news article. Event links specifically advertised upcoming 
Antibiotics Unearthed pop-up stand events. Images provided visual aids to discussion. Videos linked to 
relevant media from YouTube. Photo refers to a change of cover photo. Sample Images were images of data 
















































Web Link to the Antibiotics Unearthed Webpages A 
2 18/07
/2016 
Web Link to news event about the pop up stands to take place at Garwnant 




Event Link to the Pop Up Event taking place at Garwnant Forest B 
4 10/08
/2016 





Link to a BBC News article that discus finding a Colicin Resistant Bacteria 








Video about Phage created by the Microbiology Society 




Web Link and Photo 




Image and Sample Images 
Photo images of agar plates streaked from soil samples brought in by 
participants who attended the Pop up event at Garwnant Forest and Kielder 
Forest during summer 2016 
 





Link to a News Article about United Nations signing a landmark declaration 





Photo images of agar plates, lab-grown by Ethan at the University of East 
Anglia, using the brain-heart infusion media using samples found by 
participants that attended the Pop up event at Garwnant Forest and Kielder 





Link to News Story about The Microbiology Society trip to the Ministerial 
Side-Event on AMR held in New York to hear about the global commitment 


















Microbiology Society Fact sheet about Antibiotic Resistance released as 

















Photo images of zones of inhibition gathered from bacterial species purified 
from soil samples brought to the Pop up event at Garwnant Forest and 







Sample Images and Web Link 
 
Advert for a talk at Nottingham University about the recently launched O’Neil 






Two photographs of agar plates from Samples taken the 2016 pop-up 

























Link to BBSRC highlighting a research call that address AMR in agriculture  





News article about scientists showing that currently available antibiotics can 









News article from UKRI about uncovering the molecular mechanisms that 
make multidrug-resistant Klebsiella pneumoniae so resistant to antibiotics 





NICE article:- Children and young people should be taught simple hygiene 









Announcement of The BBC Radio 4 drama called Resistance a three-part 
















Agar plate demonstrating the microbial handprint of an eight and a half year 




Sample Images and Event Link 
Photo images of agar plates streaked from soil samples brought in by 
participants who attended the Glasgow Botanic Garden Pop up event that 





Photo images of agar plates, lab-grown by Ethan at the University of East 
Anglia, using the brain-heart infusion media using samples found by 





Photo images of zones of inhibition gathered from bacterial species purified 








Lespar comment on the BMJ article that discusses how long people should 








Photo images of species identified by Ethan from soil samples brought to the 
pop up event at Thetford Forest that took place in July. Post provided 
information gathered from sequencing to identify the groups of bacteria that 





Article about the up and coming launch of the Microbiology Society new 





Photo images of agar plates streaked from soil samples brought in by 
participants who attended the Glasgow Botanic Garden Pop up event that 




Web Link and Sample Images 
Photo images of agar plates, lab-grown by Ethan at the University of East 
Anglia, using the brain-heart infusion media using samples found by 
participants that attended the Glasgow Botanic Garden pop up event. 
 
Article about the launch of the Microbiology Society new microbiome-





Photo images of agar plates streaked from soil samples brought in by 






Photo images of zones of inhibition gathered from bacterial species purified 





Infographic from the WHO that explains the antibiotic resistance cycle. 





Photo images of agar plates, lab-grown by Ethan at the University of East 
Anglia, using the brain-heart infusion media using samples brought in by 





Photo images of species identified by Ethan from soil samples brought to 
the pop up event at Glasgow Botanic Garden that took place in September. 
Post provided information gathered from sequencing to identify the groups 





Photo images of zones of inhibition gathered from bacterial species purified 





Photo images of species identified by Ethan from soil samples brought to 
the Norwich Science Festival. Post provided information gathered from 















Figure G-1. Participant portfolio handbook. Handbook was created in collaboration with the supervisor 
team to explain the purpose of the study and provide examples of ways participants could contributed. This 
also laid out the suggested template for making entries, including adding dates which assisted with later 























Figure H-1. Factual Summary for Portfolio Participant 3 (NSF01). After reading the transcript of the 
portfolio twice, I compiled a factual summary of the parts of the portfolio which I considered key. This was 







Figure I-1. Ethics Approval Form. Ethics application form from East Anglia’s Faculty of Education’s 
Research Ethics Committee approving the collection of participant interview, social media and portfolio data 







Figure J-1. Participant Information Statement. A participant information statement was provided to each 
participant prior to interview data collection at the pop-up stands. It explained details of the study, how long 











Figure K-1. Participant Interview, Soil Sample and Social Media Consent Form. Developed with the 
Microbiology Society, the consent form notes Sample Number and Name, as well as Email Address as a 
signature. The participant could agree to any or all parts.  
 
Figure K-2. Participant Portfolio Consent Form. Developed with the Microbiology Society, the consent 







Table L-1. Norwich Science Festival antagonistic isolates stored at -80°C. Colonies are divided into which growth media they were grown on (AC, BHI or LB). They are 
presented as the plate number they were picked from and their sequential colony number. The results of the pre-event (1st) and post-WGS (2nd) antagonistic assays are 
shown.  
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Table L-2. Glasgow Botanical Gardens antagonistic isolates stored at -80°C. Colonies are divided into which growth media they were grown on (AC, BHI or LB). They 
are presented as the plate number they were picked from and their sequential colony number. The results of the pre-event (1st) and post-WGS (2nd) antagonistic assays are 
shown. 
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Table L-3. Thetford Forest antagonistic isolates stored at -80°C. Colonies are divided into which growth media they were grown on (AC, BHI or LB). They are presented 
as the plate number they were picked from and their sequential colony number. The results of the pre-event (1st) and post-WGS (2nd) antagonistic assays are shown. 
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